type_of_nucleic_acid,aptamer_sequence,sequence_length,gc_content,affinity,kd_(nm),pool_type,pool_random_region,binding_buffer/conditions,divalent_salt,type_of_the_buffer,ph,post-selex_modifications_to_the_aptamer,additional_information,smiles,new_sequence_of_the_target_protein
ssRNA,GGGAGAAUUCCCGCGGCAGAAGCCCACCUGGCUUUGAACUCUAUGUUAUUGGGUGGGGGAAACUUAAGAAAACUACCACCCUUCAACAUUACCGCCCUUCAGCCUGCCAGCGCCCUGCAGCCCGGGAAGCUU,132.0,0.5606060606060606,Kd~600µM,600000.0,5'-GGGAGAATTCCCGCGG-N98-CTGCAGCCCGGGAAGCTT-3',98.0,"0.6 ml, 0.5 M LiCl, 20 mM Tris-HCl, pH 7.6, 1 mM MgCl2",MgCl,Tris Buffers,7.6,Not applicable,"The aptamer was reported in DNA (include thymine nucleotide, instead of Uridine). The T was changed to U to match the discription of paper content.
DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3NC4=CC(=C(C=C4)NC5=NC(=NC(=N5)NC6=CC=CC=C6S(=O)(=O)O)Cl)S(=O)(=O)O)S(=O)(=O)O)N,None
ssRNA,GGGAGAAUUCCCGCGGCGUUGGCCCAGGAUAAUAGGACGAAAUCCGAAAAAUCCGUACCCAACAUAGAACCCCCCCAGCGCUCACACGGACGCCCCAUUACGGCUAACCGAACGCCUGCAGCCCGGGAAGCUU,133.0,0.5939849624060151,Kd<100µM,100000.0,5'-GGGAGAATTCCCGCGG-N97-CTGCAGCCCGGAAGCTT-3',97.0,"0.6 ml, 0.5 M LiCl, 20 mM Tris-HCl, pH 7.6, 1 mM MgCl2",MgCl,Tris Buffers,7.6,Not applicable,"DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.
",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3NC4=CC(=C(C=C4)S(=O)(=O)O)NC5=NC(=NC(=N5)Cl)Cl)S(=O)(=O)O)N,None
ssDNA,GGTTGGTGTGGTTGG,15.0,0.6,Kd: 25-200 nM,112.5,5'-CGTACGGTCGACGCTAGC-60N-CACGTGGAGCTCGGATCC-3',60.0,"200 mM KOAc/50 mM Tris-HCl, pH 7.7/10 mM dithiothreitol",MgCl,Tris Buffers,7.4,Not applicable,Presumed minimized variant was found ,None,None
ssDNA,GGTTGG,6.0,0.6666666666666666,Kd: 25-200 nM,112.5,5'-CGTACGGTCGACGCTAGC-60N-CACGTGGAGCTCGGATCC-3',60.0,"200 mM KOAc/50 mM Tris-HCl, pH 7.7/10 mM dithiothreitol",MgCl,Tris Buffers,7.4,Not applicable,Presumed minimized variant was found ,None,TSEDHFQPFFNEKTFGAGEADCGLRPLFEKKQVQDQTEKELFESYIEGRIVEGQ...LGS
ssRNA,GGGAGCAUCAGACUUUUAAUCUGACAAUCAAGAAUUCCGUUUUCAGUCGGGAAAAACUGAACAAUCUAUGAAAGAAUUUUAUAUCUCUAUUGAAAC,96.0,0.3333333333333333,Kd: 5 nM,5.0,5'-GGGAGCAUCAGACUUUUAAUCUGACAAUCAAG-N32-AUCUAUGAAAGAAUUUUAUAUCUCUAUUGAAAC-3',32.0,"PBS 10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4",None,Tris Buffers,7.7,Not applicable,None,None,None
ssRNA,GGGAGCAUCAGACUUUUAAUCUGACAAUCAAGAAUAUCUUCCGAAGCCGAACGGGAAAACCGGCAUCUAUGAAAGAAUUUUAUCUCUAUUGAAAC,95.0,0.3894736842105263,Kd: 5 nM,5.0,5'-GGGAGCAUCAGACUUUUAAUCUGACAAUCAA-N32-AUCUAUGAAAGAAUUUUAUCUCUAUUGAAAC-3',32.0,"PBS 10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4",None,Tris Buffers,7.7,Not applicable,None,None,PISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPEN...KVL
ssRNA,GGGAGCUCAGAAUAAACGCUCAAAUCUCCUCCCGUCGAAGCUAACCUGGCCACUUCGACAUGAGGCCCGGAUCCGGC,77.0,0.5844155844155844,Kd: 23 ± 3 nM,23.0,5'-GGGAGCUCAGAAUAAACGCUCAA-N30-UUCGACAUGAGGCCCGGAUCCGGC-3',30.0,"PBS 10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4",None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssRNA,GGGAGCUCAGAAUAAACGCUCAAUCGGCGAGCUAACCAAGACACUCGCUGCACUUCGACAUGAGGCCCGGAUCCGGC,77.0,0.5844155844155844,Kd: 5.0 ± 0.5 nM,5.0,5'-GGGAGCUCAGAAUAAACGCUCAA-N30-UUCGACAUGAGGCCCGGAUCCGGC-3',30.0,"PBS 10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MVGVGGGDVEDVTPRPGGCQISGRGARGCNGIPGAAAWEAALPRRRPRRHPSVN...AKS
ssRNA,GGGAGCUCAGAAUAAACGCUCAAACCCGCGGCCUCCGAAGCUAACCAGGACACUUCGACAUGAGGCCCGGAUCCGGC,77.0,0.6103896103896104,Kd: 3.2 ± 0.5 nM,3.2,5'-GGGAGCUCAGAAUAAACGCUCAA-N30-UUCGACAUGAGGCCCGGAUCCGGC-3',30.0,"PBS 10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MVGVGGGDVEDVTPRPGGCQISGRGARGCNGIPGAAAWEAALPRRRPRRHPSVN...AKS
ssRNA,GGGAGCUCAGAAUAAACGCUCAAUGGGUGCUAACCAGGACACACCCACGCUGUUUCGACAUGAGGCCCGGAUCCGGC,77.0,0.5844155844155844,Kd: 3.0 ± 0.5 nM,3.0,5'-GGGAGCUCAGAAUAAACGCUCAA-N30-UUCGACAUGAGGCCCGGAUCCGGC-3',30.0,"PBS 10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MVGVGGGDVEDVTPRPGGCQISGRGARGCNGIPGAAAWEAALPRRRPRRHPSVN...AKS
ssRNA,GGGAGCUCAGAAUAAACGCUCAAUGGGUGCUUAACCAGGCCACACCCUGCUGUUUCGACAUGAGGCCCGGAUCCGGC,77.0,0.5844155844155844,Kd: 8.1 ± 0.8 nM,8.1,5'-GGGAGCUCAGAAUAAACGCUCAA-N30-UUCGACAUGAGGCCCGGAUCCGGC-3',30.0,"PBS 10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MVGVGGGDVEDVTPRPGGCQISGRGARGCNGIPGAAAWEAALPRRRPRRHPSVN...AKS
ssRNA,GGGAGAUGCCUGUCGAGCAUGCUGGGGGCAACGCUACAGACAAGUGCACCCAACGUAGCUAAACAGCUUUGUCGACGGG,79.0,0.5822784810126582,"Kd: exhibits biphasic binding, 0.51 ± 0.13 nM, 60 ± 52 nM",0.51,5'-GGGAGAUGCCUGUCGAGCAUGCUG-N30-GUAGCUAAACAGCUUUGUCGACGGG-3',30.0,"PBS 10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MVGVGGGDVEDVTPRPGGCQISGRGARGCNGIPGAAAWEAALPRRRPRRHPSVN...AKS
ssRNA,GGUGAAGGCAACGUAUAGGCAAGCACACUUCACC,34.0,0.5294117647058824,Kd: ~0.19 ± 0.02 nM,0.19,5'-GGGAGAUGCCUGUCGAGCAUGCUG-N30-GUAGCUAAACAGCUUUGUCGACGGG-3',30.0,"PBS 10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4",None,PBS/phosphate buffers,7.4,Truncated,None,None,MVGVGGGDVEDVTPRPGGCQISGRGARGCNGIPGAAAWEAALPRRRPRRHPSVN...AKS
ssRNA,GGGAGAUGCCUGUCGAGCAUGCUGCGUCAGAAGGCAACGUAUAGGCAAGCACACGUAGCUAAACAGCUUUGUCGACGGG,79.0,0.5569620253164557,"Kd: exhibits biphasic binding, 0.19 ± 0.02 nM, 49 ± 26 nM",0.19,5'-GGGAGAUGCCUGUCGAGCAUGCUG-N30-GUAGCUAAACAGCUUUGUCGACGGG-3',30.0,"PBS 10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MVGVGGGDVEDVTPRPGGCQISGRGARGCNGIPGAAAWEAALPRRRPRRHPSVN...AKS
ssRNA,GGGAGAUGCCUGUCGAGCAUGCUGAGGGUAACGUACUGGCAAGCUCACCUCAGCGUAGCUAAACAGCUUUGUCGACGGG,79.0,0.569620253164557,"Kd: exhibits biphasic binding, 0.13 ± 0.03 nM, 510 ± 30 nM",0.13,5'-GGGAGAUGCCUGUCGAGCAUGCUG-N30-GUAGCUAAACAGCUUUGUCGACGGG-3',30.0,"PBS = 10.1 mMNa2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MVGVGGGDVEDVTPRPGGCQISGRGARGCNGIPGAAAWEAALPRRRPRRHPSVN...AKS
ssRNA,GGGAGAUGCCUGUCGAGCAUGCUGAGGGUAACGUAUAGUCAAGACACCUCAAGUGUAGCUAAACAGCUUUGUCGACGGG,79.0,0.5189873417721519,"Kd: exhibits biphasic binding, 0.32 ± 0.07 nM, 140 ± 80 nM",0.32,5'-GGGAGAUGCCUGUCGAGCAUGCUG-N30-GUAGCUAAACAGCUUUGUCGACGGG-3',30.0,"PBS = 10.1 mMNa2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MVGVGGGDVEDVTPRPGGCQISGRGARGCNGIPGAAAWEAALPRRRPRRHPSVN...AKS
ssRNA,GGGAGAUGCCUGUCGAGCAUGCUGCAUCCGGAUCGAAGUUAGUAGGCGGAGUGGUAGCUAAACAGCUUUGUCGACGGG,78.0,0.5641025641025641,Kd: 37 ± 3.5 nM,37.0,5'-CCCGTCGACAAAGCTGTTTAGCTAC-N30-CAGCATGCTCGACAGGCATCT-3',30.0,"50 mM Tris-HCl, pH 7.7, 100 mM NaCl, 1 mM DTT, 1 mM MgCl2",MgCl,Tris Buffers,7.7,Minimum sequence requirements for high affinity binding derived from clone 16 (truncated),"5' and 3' fixed regions differ than pool non-random regions.
DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.
",None,None
ssRNA,GGGAGAUGCCUGUCGAGCAUGCUGGUGCGGCUUUGGGCGCCGUGCUUGACGUAGCUAAACAGCUUUGUCGACGGG,75.0,0.6133333333333333,Kd: 114 ± 2.0 nM,114.0,5'-CCCGTCGACAAAGCTGTTTAGCTAC-N30-CAGCATGCTCGACAGGCATCT-3',30.0,"50 mM Tris-HCl, pH 7.7, 100 mM NaCl, 1 mM DTT, 1 mM MgCl2",MgCl,Tris Buffers,7.7,Minimum sequence requirements for high affinity binding derived from clone 16 (truncated),"5' and 3' fixed regions differ than pool non-random regions.
DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.
",None,MPLLLLLLLLPSPLHPHPICEVSKVASHLEVNCDKRNLTALPPDLPKDTTILHL...HSL
ssRNA,UCCGGAUCGAAGUUAGUAGGCGGA,24.0,0.5416666666666666,Kd: 9.3 ± 1.0 nM,9.3,5'-CCCGTCGACAAAGCTGTTTAGCTAC-N30-CAGCATGCTCGACAGGCATCT-3',30.0,"1 M LiCl, 5 mM MgCl2, 25 mM HEPES (pH 7.4)",MgCl,Tris Buffers,7.7,Minimum sequence requirements for high affinity binding derived from clone 16 (truncated),"DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.
",None,MPLLLLLLLLPSPLHPHPICEVSKVASHLEVNCDKRNLTALPPDLPKDTTILHL...HSL
ssRNA,GAGCAUGCUGGUGCGGCUUUGGGCGCCGUGCUU,33.0,0.6666666666666666,Kd: 155 ± 9.0 nM,155.0,5'-CCCGTCGACAAAGCTGTTTAGCTAC-N30-CAGCATGCTCGACAGGCATCT-3',30.0,"1 M LiCl, 5 mM MgCl2, 25 mM HEPES (pH 7.4)",MgCl,Tris Buffers,7.7,Minimum sequence requirements for high affinity binding derived from clone 27 (truncated),"DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.
",None,MPLLLLLLLLPSPLHPHPICEVSKVASHLEVNCDKRNLTALPPDLPKDTTILHL...HSL
ssRNA,GUCGGCCUAUCCGACAGGCACCGCGAGAGGACCAUUAUAGUGCGCAUAACCACUUCAGUGCGAGCAAAAAUUUGG,75.0,0.5333333333333333,Kd: 88 ± 19 nM,88.0,"Original random pool: 5'-AACACTATCCGACTG-GCACC-N72-CCTTGGTCATTAGGATCC-3' (source --> Bartel, D. P., & Szostak, J. W. (1993) Science 261,1411-1418.)
mutagenized pool( 30% dopped pool): 5'-GGAACCTCTAGGTCATTA-GGAACACTATCCGACTGGCACCGCCAGCGGACAAATCCGGTGCGCATAACCACCTCAGTGCGAGCAACGATGGCC-ACGTCAGAAGGATCCAAG-3' (inside the dash are sequence of original aptamer B12.9)",72.0,"1 M LiCl, 5 mM MgCl2, 25 mM HEPES (pH 7.4)",MgCl,Other Buffers,7.4,DMS modification for probing the tertiary interaction in aptamer,"Using a doped pool for the region inside the ""- -"", 32P-labeled RNA was used to follow all selections.
DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.
The total length of the pool RNA the paper mentioned ""was 111 bases (including two new primer binding sites), with
75 mutagenized bases, and a sequence complexity of approximately 5 X 1014 molecules."" However, it did not mentioed the sequence of the new primers 
",CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]4([C@H]([C@@H]5[C@]6([C@@]([C@@H](C(=N6)C(=C7[C@@]([C@@H](C(=N7)C=C8C([C@@H](C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3],None
ssRNA,GUCGGCCUAUCCGACAGGCACCGCGAGAGGACCAUUAUAGUGCGCAUAACCACUUCAGUGCGAGCAAAAAUUUGG,75.0,0.5333333333333333,Kd: 20 ± 9 uM,20000.0,"Original random pool: 5'-AACACTATCCGACTG-GCACC-N72-CCTTGGTCATTAGGATCC-3' (source --> Bartel, D. P., & Szostak, J. W. (1993) Science 261,1411-1418.)
mutagenized pool( 30% dopped pool): 5'-GGAACCTCTAGGTCATTA-GGAACACTATCCGACTGGCACCGCCAGCGGACAAATCCGGTGCGCATAACCACCTCAGTGCGAGCAACGATGGCC-ACGTCAGAAGGATCCAAG-3' (inside the dash are sequence of original aptamer B12.9)",72.0,"20 mM Tris-acetate pH 7.4, 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2",MgCl,Other Buffers,7.4,DMS modification for probing the tertiary interaction in aptamer,"Using a doped pool for the region inside the ""- -"", 32P-labeled RNA was used to follow all selections.
DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.
",C/C/1=C/2\[C@@]([C@@H](C(=N2)/C=C\3/C([C@@H](C(=N3)/C(=C\4/[C@]([C@H](C([N-]4)[C@]5([C@@]([C@@H](C1=N5)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)(C)CCC(=O)NCC(C)O)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N.[C-]#N.[C-]#N.[Co],None
ssRNA,AACACUAUCCGACUGGCACCGCCAGCGGACAAAUCCGGUGCGCAUAACCACCUCAGUGCGAGCAACGAUGGCCUUUCUACCCAAAGAUUUUCCUUGGUCAUUAGGAUCC,109.0,0.5321100917431193,Kd: 8.8 ± 0.5 uM,8800.0,"Original random pool 5'-AACACTATCCGACTG-GCACC-N72-CCTTGGTCATTAGGATCC-3' (source --> Bartel, D. P., & Szostak, J. W. (1993) Science 261,1411-1418.)",72.0,"20 mM Tris-acetate pH 7.4, 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2",MgCl,Other Buffers,7.4,DMS modification for probing the tertiary interaction in aptamer,"DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.
",C/C/1=C/2\[C@@]([C@@H](C(=N2)/C=C\3/C([C@@H](C(=N3)/C(=C\4/[C@]([C@H](C([N-]4)[C@]5([C@@]([C@@H](C1=N5)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)(C)CCC(=O)NCC(C)O)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N.[C-]#N.[C-]#N.[Co],MHGTDAAPPHNYVAAYLWARYGFGADALMHFGAHGSLEFTPRKQAALGSNDWPD...KEK
ssRNA,AACACUAUCCGACUGGCACCGCCAGCGGACAAAUCCGGUGCGCAUAACCACCUCAGUGCGAGCAACGAUGGCCUUUCUACCCAAAGAUUUUCCUUGGUCAUUAGGAUCC,109.0,0.5321100917431193,Kd: 320 ± 90 nM,320.0,"Original random pool 5'-AACACTATCCGACTG-GCACC-N72-CCTTGGTCATTAGGATCC-3' (source --> Bartel, D. P., & Szostak, J. W. (1993) Science 261,1411-1418.)",72.0,"20 mM Tris-acetate pH 7.4, 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2",MgCl,Other Buffers,7.4,DMS modification for probing the tertiary interaction in aptamer,"DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.
",CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]4([C@H]([C@@H]5[C@]6([C@@]([C@@H](C(=N6)C(=C7[C@@]([C@@H](C(=N7)C=C8C([C@@H](C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3],None
ssRNA,GGAACCGGUGCGCAUAACCACCUCAGUGCGAGCAA,35.0,0.6,Kd: 88 ± 19 nM,87.0,"Original random pool 5'-AACACTATCCGACTG-GCACC-N72-CCTTGGTCATTAGGATCC-3' (source --> Bartel, D. P., & Szostak, J. W. (1993) Science 261,1411-1418.)",72.0,"Sepharose column conditions: 60 mg, N-hydroxysuccinimide, 190 mg, 1 -ethyl-3,3-dimethylaminopropyl carbodiimide in a 5-mi 1:1 mixture, dioxane, phosphatebuffered saline (pH 7.2)",MgCl,Other Buffers,7.4,"DMS modification for probing the tertiary interaction in aptamer
Based on the sequence data from the mutagenized pool selection, a smaller aptamer (35 nucleotides long) was made by run-off transcription of a synthetic DNA oligonucleotide (Truncation/minimal sequence)","DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.
",CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]4([C@H]([C@@H]5[C@]6([C@@]([C@@H](C(=N6)C(=C7[C@@]([C@@H](C(=N7)C=C8C([C@@H](C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3],GVDHMQTQEIISVTLQVLSLLPPYRQSISVLAGSTVEDVLKKAHELGGFTYETQ...VSW
ssRNA,GGAACCGGUGCGCAUAACCACCUCAGUGCGAGCAA,35.0,0.6,Kd: 19.7 ± 8.7 uM,19700.0,"Original random pool 5'-AACACTATCCGACTG-GCACC-N72-CCTTGGTCATTAGGATCC-3' (source --> Bartel, D. P., & Szostak, J. W. (1993) Science 261,1411-1418.)",72.0,"Sepharose column conditions: 60 mg, N-hydroxysuccinimide, 190 mg, 1 -ethyl-3,3-dimethylaminopropyl carbodiimide in a 5-mi 1:1 mixture, dioxane, phosphatebuffered saline (pH 7.2)",MgCl,Other Buffers,7.4,"DMS modification for probing the tertiary interaction in aptamer
Based on the sequence data from the mutagenized pool selection, a smaller aptamer (35 nucleotides long) was made by run-off transcription of a synthetic DNA oligonucleotide (Truncation/minimal sequence)","DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.
",C/C/1=C/2\[C@@]([C@@H](C(=N2)/C=C\3/C([C@@H](C(=N3)/C(=C\4/[C@]([C@H](C([N-]4)[C@]5([C@@]([C@@H](C1=N5)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)(C)CCC(=O)NCC(C)O)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N.[C-]#N.[C-]#N.[Co],None
5-uracil-modified-DNA,TAGAATACTCAAGCTTCGACGCAGAXACAGGCCAXGXGCAGTTTGGATCCCCGGGTAC,55.0,0.5454545454545454,Kd: 800 nM,800.0,5'-TAGAATACTCAAGCTTCGACG-N20-AGTTTGGATCCCCGGGTAC-3',20.0,"250 mM NaCl, 50 mM Tris-HCl, pH = 7.6, 5 mM MgCl2",MgCl/CaCl,Tris Buffers,7.4,Not applicable,"X denotes pentynyl dU as determined via sequencing. 5-(1-pentynyl)-2'-deoxyuridine used instead of thymidine (""X"" in sequences) it is also called 5-pentynyl-dU",None,None
5-uracil-modified-DNA,TAGAATACTCAAGCTTCGACGGXAXAXAGXAXAGXAXXGGCAGTTTGGATCCCCGGGTAC,52.0,0.5,Kd: 400 nM,400.0,5'-TAGAATACTCAAGCTTCGACG-N20-AGTTTGGATCCCCGGGTAC-3',20.0,"250 mM NaCl, 50 mM Tris-HCl, pH = 7.6, 5 mM MgCl2",MgCl/CaCl,Tris Buffers,7.4,Not applicable,"X denotes pentynyl dU as determined via sequencing. 5-(1-pentynyl)-2'-deoxyuridine used instead of thymidine (""X"" in sequences) it is also called 5-pentynyl-dU",None,MGKGDPKKPRGKMSSYAFFVQTCREEHKKKHPDASVNFSEFSKKCSERWKTMSA...DDE
5-uracil-modified-DNA,TAGAATACTCAAGCTTCGACGGACXAAACGCAXXGXGCCCCAGTTTGGATCCCCGGGTAC,56.0,0.5535714285714286,Kd: 1000 nM,1000.0,5'-TAGAATACTCAAGCTTCGACG-N20-AGTTTGGATCCCCGGGTAC-3',20.0,"20 mM HEPES, pH 7.5, 10 mM MgCl2, 0.3 mM CaCl2, 1 mM DTT, 0.05 mM ATP",MgCl/CaCl,Tris Buffers,7.4,Not applicable,"X denotes pentynyl dU as determined via sequencing. 5-(1-pentynyl)-2'-deoxyuridine used instead of thymidine (""X"" in sequences) it is also called 5-pentynyl-dU",None,MGKGDPKKPRGKMSSYAFFVQTCREEHKKKHPDASVNFSEFSKKCSERWKTMSA...DDE
ssRNA,AGUGAUACCAGCAUCGUCUUGAUGCCCUUGGCAGCACU,38.0,0.5263157894736842,Kd: 0.1 μM,100.0,Not reported (N40),40.0,"20 mM HEPES, pH 7.5, 10 mM MgCl2, 0.3 mM CaCl2, 1 mM DTT, 0.05 mM ATP",None,PBS/phosphate buffers,7.2,38-nucleotide truncated version of the TCT8-4 aptamer. ,Alternative sequence report: (Nx)AUACCA(Nx)CCUUGG(C/A)AG(Nx),None,None
ssRNA,AAGUGAUACCAGCAUCGUCUUGAUGCCCUUGGCAGCACUUCA,42.0,0.5,Kd: 0.6 μM,600.0,Not reported (N40),40.0,"PBS (10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4)",None,PBS/phosphate buffers,7.2,Not applicable,Alternative sequence report: (Nx)AUACCA(Nx)CCUUGG(C/A)AG(Nx),None,None
ssRNA,"GACGAGAAGGAGUGCUGGUUAUACUAGCGGUUAGGUCACUCGUC3'
   ",44.0,0.5227272727272727,Kd: 62-68 µM,62000.0,5'-GGAGCTCAGCCTTCACTGC-N74-GGCACCACGGTCGGATCC-3',74.0,"PBS (10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4)",MgCl,Tris Buffers,7.6,"On the basis of the similarities of the individual sequences, a 44-mer RNA was constructed","extended descriptions of the aptamer structures can be found here: https://doi.org/10.1093/nar/23.23.4769

DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.
",None,None
ssRNA,GACGAGAAGGAGCGCUGGUUCUACUAGCAGGUAGGUCACUCGUC,44.0,0.5681818181818182,Kd: 56-76 µM,56000.0,5'-GGAGCTCAGCCTTCACTGC-N74-GGCACCACGGTCGGATCC-3',74.0,"PBS (10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4)",MgCl,Tris Buffers,7.6,"On the basis of the similarities of the individual sequences, a 44-mer RNA was constructed","DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.
",C(CC(C(=O)O)N)CN=C(N)N,None
ssRNA,GGGAGAAUUCCGACCAGAGGCUUACAGAGUGUGCGUAAUGGCGUUCCCAAAUUCGGGCUGGGAACCGUUCGUUCGUGUUAUGCCCGUAGAUAUGGCAAGUCGCGGAUGCUCAGUACUACACUCUUGUGGUCAGUCACAUAUGUGCGUCUACAUGGAUCCUCA,162.0,0.5185185185185185,Kd: 7 nM,7.0,5'-GGGAGAAUUCCGACCAGAGGCUU-N120-CAUAUGUGCGUCUACAUGGAUCCUCA-3',120.0,"PBS (10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4)",MgCl/CaCl,Other Buffers,7.5,Not applicable,"Paper says RNA aptamers but reports the sequences in DNA so T's were changed to U's in the spreadsheet
DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.",None,None
ssRNA,GGGAGAAUUCCGACCAGAGGUUGUUAAGUGCGAGUUGUUUUACUCCGAUGAUACGGGGAGCGUUAGAGUCUUAUGACCUUGUUCUCCACGUCACUGUCCAAGUCACUCCGCGUCAUAGCAGUCGGAUCCUGUACAUAUGUGCGUCUACAUGGAUCCUCA,159.0,0.4968553459119497,Kd: 7 nM,7.0,5'-GGGAGAAUUCCGACCAGAGGCUU-N120-CAUAUGUGCGUCUACAUGGAUCCUCA-3',120.0,"PBS (10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4)",MgCl/CaCl,Other Buffers,7.5,Not applicable,"Paper says RNA aptamers but reports the sequences in DNA so T's were changed to U's in the spreadsheet
DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.",None,MADPAAGPPPSEGEESTVRFARKGALRQKNVHEVKNHKFTARFFKQPTFCSHCT...INV
ssRNA,GGCCGGUAGUCGCAUGGCCCAUCGCGCCCGG,31.0,0.7741935483870968,"Kd1: 0.42 ± 0.04 nM
Kd2: 182 ±94 nM
",0.42,5'-GGGAGCUCAGAAUAAACGCUCAA-30N-UUCGACAUGAGGCCCGGAUCCGGC-3',30.0,"PBS (10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4)",None,PBS/phosphate buffers,7.4,Truncated,"Most RNA ligands exhibited biphasic binding to VEGF. For those ligands, binding of RNA to VEGF is described by a model in which the RN A is assumed to be partitioned between two noninterconverting components (Ri and R2) that bind to VEGF with different affinities. R1 is associated with kd1, and R2 is associated with kd2",None,MNTNILFILFLSFKIGLVVCKGKNVNQNIDQNTEAVLPKSEIAKKQSQLIDVLK...NCV
ssRNA,GGAAGCUUGAUGGGUGACACACGUCAUGCCGAGCU,35.0,0.5714285714285714,"Kd1: 0.48 ± 0.04 nM
Kd2: 82 ± 23 nM",0.48,5'-GGGAGCUCAGAAUAAACGCUCAA-30N-UUCGACAUGAGGCCCGGAUCCGGC-3',30.0,"PBS (10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4)",None,PBS/phosphate buffers,7.4,Truncated,"Most RNA ligands exhibited biphasic binding to VEGF. For those ligands, binding of RNA to VEGF is described by a model in which the RN A is assumed to be partitioned between two noninterconverting components (Ri and R2) that bind to VEGF with different affinities. R1 is associated with kd1, and R2 is associated with kd2",None,MNTNILFILFLSFKIGLVVCKGKNVNQNIDQNTEAVLPKSEIAKKQSQLIDVLK...NCV
ssRNA,GGAAGGGAACCUGCGUCUCGGCACCUUCG,29.0,0.6551724137931034,"Kd1: 1.1 ±0.2 nM
Kd2: 180 ± 160 nM",1.1,5'-GGGAGCUCAGAAUAAACGCUCAA-30N-UUCGACAUGAGGCCCGGAUCCGGC-3',30.0,"PBS (10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4)",None,PBS/phosphate buffers,7.4,Truncated,"Most RNA ligands exhibited biphasic binding to VEGF. For those ligands, binding of RNA to VEGF is described by a model in which the RN A is assumed to be partitioned between two noninterconverting components (Ri and R2) that bind to VEGF with different affinities. R1 is associated with kd1, and R2 is associated with kd2",None,MNTNILFILFLSFKIGLVVCKGKNVNQNIDQNTEAVLPKSEIAKKQSQLIDVLK...NCV
ssRNA,GGUCAACGGUUGAGUCUGUCCCGUUCGAC,29.0,0.5862068965517241,"Kd1: 20 ± 1 nM
",20.0,5'-GGGAGCUCAGAAUAAACGCUCAA-30N-UUCGACAUGAGGCCCGGAUCCGGC-3',30.0,"PBS (10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4)",None,PBS/phosphate buffers,7.4,Truncated,"Most RNA ligands exhibited biphasic binding to VEGF. For those ligands, binding of RNA to VEGF is described by a model in which the RN A is assumed to be partitioned between two noninterconverting components (Ri and R2) that bind to VEGF with different affinities. R1 is associated with kd1, and R2 is associated with kd2",None,MNTNILFILFLSFKIGLVVCKGKNVNQNIDQNTEAVLPKSEIAKKQSQLIDVLK...NCV
ssRNA,GGCUCAAUAGUUGGAGGCCUGUCCUCGCCGUAGAGC,36.0,0.6111111111111112,"Kd1:1.8 ±0.4 nM
Kd2: 31 ± 10 nM
",1.8,5'-GGGAGCUCAGAAUAAACGCUCAA-30N-UUCGACAUGAGGCCCGGAUCCGGC-3',30.0,"PBS (10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4)",None,PBS/phosphate buffers,7.4,Truncated,"Most RNA ligands exhibited biphasic binding to VEGF. For those ligands, binding of RNA to VEGF is described by a model in which the RN A is assumed to be partitioned between two noninterconverting components (Ri and R2) that bind to VEGF with different affinities. R1 is associated with kd1, and R2 is associated with kd2",None,MNTNILFILFLSFKIGLVVCKGKNVNQNIDQNTEAVLPKSEIAKKQSQLIDVLK...NCV
ssRNA,GGAACGGUUCUGUGUGUGGACUAGCCGCGGCCGUU,35.0,0.6285714285714286,"Kd1: 1.4 ±0.2 nM
Kd2: 181 ± 57 nM",1.4,5'-GGGAGCUCAGAAUAAACGCUCAA-30N-UUCGACAUGAGGCCCGGAUCCGGC-3',30.0,"PBS (10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4)",None,PBS/phosphate buffers,7.4,Truncated,"Most RNA ligands exhibited biphasic binding to VEGF. For those ligands, binding of RNA to VEGF is described by a model in which the RN A is assumed to be partitioned between two noninterconverting components (Ri and R2) that bind to VEGF with different affinities. R1 is associated with kd1, and R2 is associated with kd2",None,MNTNILFILFLSFKIGLVVCKGKNVNQNIDQNTEAVLPKSEIAKKQSQLIDVLK...NCV
ssDNA,CTACCTGGGGGAGCATTGGGGAGGAAGGTAGCCGTGCGAAAA,42.0,0.5952380952380952,Kd: 6 ± 3 uM,6000.0,5'-AACACTATCCGACTGGCACC-N72-CCTTGGTCATTAGGATCC -3',72.0,"200 mM KOAc, 50 mM TrisHCl, pH 8.0, 6 mM MgCl2, 10 mM DTT",MgCl,Tris Buffers,7.6,The binding domain of this aptamer was localized to a 42 base sequence by deletion analysis. (Truncation),"The pool of random-sequence RNA molecules that was used in this work has been previously described (Bartel & Szostak,1993).The mutagenized pool used in the secondary selection was based on the sequence 5'-GTGCTTGGGGGAGTATTGCGGAGGAAAGCGGCCCTGCTGAAG-3', flanked by the same primer binding sites as in the original random-sequence pool.",None,MESSSSLKGSALGKLVVTSGLLHSSWSKILEIHNPPYSNHDPGLQVSKKKKDSG...KSQ
ssDNA,CCCCTGCAGGTGATTTTGCTCAAGTCAGAAGGATAAACTGTCCAGAACTTGGAATATATCAGTATCGCTAATCAGGCGGAT,81.0,0.4444444444444444,Kd: 1 nM; Ki: <0.3 nM,1.0,5'-CCCCTGCAGGTGATTTTGCTCAAGT-N35-AGTATCGCTAATCAGGCGGAT-3',35.0,"200 mM KOAc, 50 mM TrisHCl, pH 8.0, 6 mM MgCl2, 10 mM DTT",MgCl,Tris Buffers,8.0,Not applicable,None,None,None
ssDNA,CCCCTGCAGGTGATTTTGCTCAAGTCAGAAGGATAAACTGTCCAGAACTTGGA,53.0,0.4716981132075472,Kd: 4 nM; ,4.0,5'-CCCCTGCAGGTGATTTTGCTCAAGT-N35-AGTATCGCTAATCAGGCGGAT-3',35.0,"200 mM KOAc, 50 mM TrisHCl, pH 8.0, 6 mM MgCl2, 10 mM DTT",MgCl,Tris Buffers,8.0,Truncated,None,None,MGSSHHHHHHMATVKFKYKGEEKEVDISKIKKVWRVGKMISFTYDEGGGKTGRG...DED
ssDNA,CCCCTGCAGGTGATTTTGCTCAAGTTTAGCAAAGTTGAAGCCGGACTAACAAGCTCTACGAGTATCGCTAATCAGGCGGAT,81.0,0.48148148148148145,Kd: 8 nM; Ki: 4 nM,8.0,5'-CCCCTGCAGGTGATTTTGCTCAAGT-N35-AGTATCGCTAATCAGGCGGAT-3',35.0,"200 mM KOAc, 50 mM TrisHCl, pH 8.0, 6 mM MgCl2, 10 mM DTT",MgCl,Tris Buffers,8.0,Not applicable,None,None,MGSSHHHHHHMATVKFKYKGEEKEVDISKIKKVWRVGKMISFTYDEGGGKTGRG...DED
ssDNA,CCCCTGCAGGTGATTTTGCTCAAGTCAGGCGTTAGGGAAGGGCGTCGAAAGCAGGGTGGGAGTATCGCTAATCAGGCGGAT,81.0,0.5679012345679012,Kd: 5 nM; Ki: 30 nM,5.0,5'-CCCCTGCAGGTGATTTTGCTCAAGT-N35-AGTATCGCTAATCAGGCGGAT-3',35.0,"200 mM KOAc, 50 mM TrisHCl, pH 8.0, 6 mM MgCl2, 10 mM DTT",MgCl,Tris Buffers,8.0,Not applicable,None,None,MGSSHHHHHHMATVKFKYKGEEKEVDISKIKKVWRVGKMISFTYDEGGGKTGRG...DED
ssDNA,CCCCTGCAGGTGATTTTGCTCAAGTAGCCAGTCAAGTTAATGGGTGCCATGCAGAAGCAAGTATCGCTAATCAGGCGGAT,80.0,0.5,Kd: 5 nM; Ki: 13 nM,5.0,5'-CCCCTGCAGGTGATTTTGCTCAAGT-N35-AGTATCGCTAATCAGGCGGAT-3',35.0,"20 mM Tris-HCl, pH 7.9, 80 mM KCl, 10% glycerol, 1 mM MgCl2, 0.2 mM EDTA, 10 microM DTT, 0.5 mM PMSF)",MgCl,Tris Buffers,8.0,Not applicable,None,None,MGSSHHHHHHMATVKFKYKGEEKEVDISKIKKVWRVGKMISFTYDEGGGKTGRG...DED
ssDNA,CCCCTGCAGGTGATTTTGCTCAAGTTATTTGCCCCTGCAGGCCGCAGGAGTGCTAGCAGTAGTATCGCTAATCAGGCGGAT,81.0,0.5432098765432098,Kd: 11 nM;  Ki: 62 nM,11.0,5'-CCCCTGCAGGTGATTTTGCTCAAGT-N35-AGTATCGCTAATCAGGCGGAT-3',35.0,"140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 20 mM Tris acetate at pH 7.4",MgCl,Tris Buffers,8.0,Not applicable,None,None,MGSSHHHHHHMATVKFKYKGEEKEVDISKIKKVWRVGKMISFTYDEGGGKTGRG...DED
ssDNA,CCCCTGCAGGTGATTTTGCTCAAGTCGATTAGGTCCCCTGCCGCTAAACAGCGCCGCGGTAAGTATCGCTAATCAGGCGGAT,82.0,0.5609756097560976,Kd: 2 nM,2.0,5'-CCCCTGCAGGTGATTTTGCTCAAGT-N35-AGTATCGCTAATCAGGCGGAT-3',35.0,"140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 20 mM Tris acetate at pH 7.4",MgCl,Tris Buffers,8.0,Not applicable,None,None,MGSSHHHHHHMATVKFKYKGEEKEVDISKIKKVWRVGKMISFTYDEGGGKTGRG...DED
ssDNA,CCCCTGCAGGTGATTTTGCTCAAGTTACGTGAGCGTGCTGTCCCCTAAAGGTGATACGTCAGTATCGCTAATCAGGCGGAT,81.0,0.5185185185185185,Kd: 1 nM; Ki: 2.7 nM,1.0,5'-CCCCTGCAGGTGATTTTGCTCAAGT-N35-AGTATCGCTAATCAGGCGGAT-3',35.0,"140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 20 mM Tris acetate at pH 7.4",MgCl,Tris Buffers,8.0,Not applicable,None,None,MGSSHHHHHHMATVKFKYKGEEKEVDISKIKKVWRVGKMISFTYDEGGGKTGRG...DED
ssDNA,CCCCTGCAGGTGATTTTGCTCAAGTAAGCTCTTAGTTGATGCGCGGTCAAAATTTAAGCTAGTATCGCTAATCAGGCGGAT,81.0,0.4567901234567901,Kd: 4 nM; Ki: 6.5 nM,4.0,5'-CCCCTGCAGGTGATTTTGCTCAAGT-N35-AGTATCGCTAATCAGGCGGAT-3',35.0,"200 mM KOAc, 50 mM TrisHC1, pH 8.0, 6 mM MgCl2, and 10 mM DTT",MgCl,Tris Buffers,8.0,Not applicable,None,None,MGSSHHHHHHMATVKFKYKGEEKEVDISKIKKVWRVGKMISFTYDEGGGKTGRG...DED
ssRNA,GGGAGAAUUCCGACCAGAAGCUUGGACUUAUUCUCGAGCCUGCAUGUGCUAGUCGACGUUGUUUCUGCAUCUUGAAAGAUGGGGCUGUGGGUGUGGUUACUUCUACGCGGUAUGCACUGUACGCCCCAUAUGUGCGUCUACAUGGAUCCUCA,152.0,0.5131578947368421,Kd: 70 nM,70.0,5'-GGGAGAATTCCGACCAGAAGCTT-N120-CATATGTGCGTCTACATGGATCCTCA-3',120.0,"20 mM Tris x Cl, pH 7.9, 80 mM KCl, 10% glycerol, 1 mM MgCl2, 0.2 mM EDTA, 10 microM DTT, 0.5 mM PMSF)",MgCl,Tris Buffers,7.9,Not applicable,"DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.
",None,None
ssRNA,GGGAGAAUUCCGACCAGAAGCUUCGUUUGGGGUCCCACAACACAGGUCUUUGCUGGUCAUAUAUGCGUGUCCUCUAGGAAGUGCAUAUGUGCGUCUACAUGGAUCCUCA,109.0,0.5045871559633027,Kd: 4.3 ± 0.7 µM,4.3,5'-GGGAGAAUUCCGACCAGAAGCUU-N60-CAUAUGUGCGUCUACAUGGAUCCUCA-3',60.0,"140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, and 20 mM Tris acetate at pH 7.4",MgCl/CaCl,Tris Buffers,7.4,Not applicable,None,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N,None
ssRNA,GGGAGAAUUCCGACCAGAAGCUUCUGGUUAGUUUUGCACAGUGGUCGAUGCUAGACUUGGUUUAGGUAAUGAGUCCAAUAGUCCAUAUGUGCGUCUACAUGGAUCCUCA,109.0,0.45871559633027525,Kd: 3 ± 1 nM (high affinity component); 15.9 ± 0.7 µM (low affinity component),3.0,5'-GGGAGAAUUCCGACCAGAAGCUU-N60-CAUAUGUGCGUCUACAUGGAUCCUCA-3',60.0,"140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, and 20 mM Tris acetate at pH 7.4",MgCl/CaCl,Tris Buffers,7.4,Not applicable,None,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N,MARKTKEESQRTRDRILDAAEHVFLSKGVASTTMSDIADFAGVSRGAVYGHYKN...QAA
ssRNA,GGGAGAAUUCCGACCAGAAGCUUAGUAUAGCGAGGUUUAGCUACACUCGUGCUGAUCGUUUGGUACGGGACCUGCGUGUAGCCCAUAUGUGCGUCUACAUGGAUCCUCA,109.0,0.5137614678899083,Kd: 2 ± 1 nM (high affinity component); 6.0 ± 0.4 µM (low affinity component),2.0,5'-GGGAGAAUUCCGACCAGAAGCUU-N60-CAUAUGUGCGUCUACAUGGAUCCUCA-3',60.0,"140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, and 20 mM Tris acetate at pH 7.4",MgCl/CaCl,Tris Buffers,7.4,Not applicable,None,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N,MARKTKEESQRTRDRILDAAEHVFLSKGVASTTMSDIADFAGVSRGAVYGHYKN...QAA
2'-fluoro-RNA,GGGAGCUCAGAAUAAACGCUCAAUGCCUCGUGUCGAAGAAGGGUGGCGCGAGGGUAGGGUUUCGACAUGAGGCCCGGAUCCGGC,84.0,0.6071428571428571,Kd: ~2-3 μg of viral protein per ml),2000.0,5'-GCCGGATCCGGGCCTCATGTCGAA-N40-TTGAGCGTTTATTCTGAGCTCCC-3',40.0,"PBS: 10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4",MgCl,Tris Buffers,7.5,Not applicable,2'F-RNA: 2'-F-CTP and 2'-F-UTP replaced CTP and UTP. Transcribed a pool of 2'-F-RNA from unmodified RNA after 9 cycles of selection by RSV,None,None
2'-fluoro-RNA,GGGAGCUCAGAAUAAACGCUCAAUGUUAGGACCCUCGAGGGAGGUUGCGCAGGGUGGGGAGGGUUCGACAUGAGGCCCGGAUCCGGC,87.0,0.6206896551724138,Kd: ~2-3 μg of viral protein per ml),2000.0,5'-GCCGGATCCGGGCCTCATGTCGAA-N40-TTGAGCGTTTATTCTGAGCTCCC-3',40.0,"2.5 mM MgCl2/100 mM NaCl/20 mM Tris HCl, pH 7.5",MgCl,Tris Buffers,7.5,Not applicable,2'F-RNA: 2'-F-CTP and 2'-F-UTP replaced CTP and UTP. Transcribed a pool of 2'-F-RNA from unmodified RNA after 9 cycles of selection by RSV,None,MSSEAETQPPAAPVPAAAPAAAPADSKPNGGSGNGSSGLASAAPPAGGDKKVIA...GAE
2'-amino-RNA,ACCCUGAUGGUAGACGCCGGGGUG,24.0,0.6666666666666666,Kd: 2.4 ± 0.5 nM,2.4,5'-GGGAGACAAGAAUAACGCUCAA-N30-UUCGACAGGAGGCUCACAACAGGC-3',30.0,"500 mM NaCl, 50 mM Tris.HCl, pH 7.6)",None,PBS/phosphate buffers,7.4,"NX-213 is a minimal ligand derived from aptamer 24a (Truncated). [5'P] represents the 5' cap, d(tstststs), where s represents the internucleoside phosphorothioate linkage, and [3'p] represents the 3' cap, d(tstststst); all pyrimidines are aminopyrimidines; positions 1, 9, 12, 13, 16, 19-22, 24 are 2'-ome purines

Of the 14 ribopurines in this minimal ligand, 10 can be substituted with the corresponding 2'-0-methylpurine nucleotides without a reduction in binding affinity toVPF/VEGF. In fact, the 2'- O-methyl substitution at permissive positions leads to a -17-fold improvement in the binding affinity to VPF/VEGEThe higher affinity results from the reduction in the dissociation rate constant of the 2'-O-methyl-sub_x0002_stituted RNA ligand from the protein compared to the unsubstituted ligand. The 2'-O-methyl-substituted minimal ligand, which folds into a bulged hairpin motif, is also more thermally stable than the unsubstituted ligand. Nuclease resistance of the ligand is further improved by the 2'-O-methyl substitutions and the addition of short phosphorothioate caps to the 3'- and 5'-ends.",2′-amino-2′-deoxypyrimidine nucleotide RNA modifeid library,None,None
2'-amino-RNA,ACCCUGAUGGUAGACGCCGGGGUG,24.0,0.6666666666666666,Kd: 0.14 ± 0.01 nM,0.14,5'-GGGAGACAAGAAUAACGCUCAA-N30-UUCGACAGGAGGCUCACAACAGGC-3',30.0,"500 mM NaCl, 50 mM Tris.HCl, pH 7.6)",None,PBS/phosphate buffers,7.4,"NX-178 is a minimal ligand derived from aptamer 24a. [5'P] represents the 5' cap, d(tstststs), where s represents the internucleoside phosphorothioate linkage, and [3'p] represents the 3' cap, d(tstststst); all pyrimidines are aminopyrimidines; NO 2'- O-methyl substitution",2′-amino-2′-deoxypyrimidine nucleotide RNA modifeid library,None,MVSCWDTAVLPCALLGCLLLTGYCSGSKLKGPELSLKGTQHVMQAGQTLFLKCR...PPA
ssRNA,GGGAGCUCAGAAUAAACGCUCAACCAGUCUUGUGGCUUUGAAAGAGAGGAGUGUUCGACAUGAGGCCCGGAUCCGGC,77.0,0.5454545454545454,Kd: 12 nM in a buffer containing 250 mM NaCl; 2 nM in a buffer contining 50 mM NaCl,12.0,5'-GGGAGCUCAGAAUAAACGCUCAA-N30-UUCGACAUGAGGCCCGGAUCCGGC-3',30.0,"PBSM (10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, pH 7.4) containing 0.01% human serum albumin (HSA)",MgCl,Tris Buffers,8.4,Not applicable,None,None,None
ssDNA,TTGCCTAACCGTGAAGGTAAAACGATTTAGTCAAAGTGGGAGGGCGGTGGTGTTGACTGATCGATTTTATTCCA,74.0,0.44594594594594594,Kd: 0.5 µM,500.0,5‘-GGATCTTTTTGATCCGGTCGGCACC-N76-CCTTGG-N76-GGCACC-N76-CCTTGGGTCATTAGGCGA-3',76.0,"PBSM (10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, pH 7.4) containing 0.01% human serum albumin (HSA)",None,PBS/phosphate buffers,4.0,Not applicable,"DNA Library. The random-sequence DNA library used in this work was constructed according to the method of Bartel and Szostak (1993), with minor modifications. Two synthetic polynucleotides, R1 (5‘-TTGATCCGGTCGGCACC-N76- CCTTGGGTCATTAGGCGA) and, R2 (5‘-CGGGACTCTGACCTTGG-N76- GGCACCTGTCCACGCTC), were each rendered double-stranded by PCR. R1 was divided into two pools and restriction-digested, one pool with BanI (cutting at GGCACC) and the other with StyI (cutting at CCTTGG); R2 was digested with both enzymes. A 2-fold ligation was then carried out with T4 DNA ligase, to give duplexes of the form R1−R2−R1, containing a total of 228 random base pairs (bp). Ligated product (540 μg) was obtained, corresponding to 1.8 × 1015 different molecules. This library was then amplified with a large-scale (500 mL) PCR, using the primers R1P1−biotin (5‘-biotin-TCGCCTAATGACCCAAGG) and RLS (5‘-GGATCTTTTTGATCCGGTCGGCACC).",None,None
ssRNA,GGAGCUCAGCCUUCACUGCAUGAUAAACCGAUGCUGGGCGAUUCUCCUGAAGUAGGGGAAGAGUUGUCAUGUAUGGGGGCACCACGGUCGGAUCCUG,97.0,0.5567010309278351,Kd: 330 nM,3309.0,5'GGAGCUCAGCCUUCACUGC-N74-GGCACCACGGUCGGAUCC-3',74.0,"PBSM (10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, pH 7.4) containing 0.01% human serum albumin (HSA)",MgCl,Tris Buffers,7.6,"A chemical modification analysis with DMS, kethoxal and CMCT in the presence and absence of L-arginine in order to examine the secondary structure",None,C(CC(C(=O)O)N)CN=C(N)N,None
ssDNA,CCGAAGCTTAATACGACTCACTATAGGGATCCGCCTGATTAGCGATACTTGGGAGGGCGCGTTCTTCGTGGTTACTTTTAGTCCCG[3'T],87.0,0.5057471264367817,Kd: 0.147 ± 0.011 nM,0.147,5‘-CCGAAGCTTAATACGACTCACTATAGGGATCCGCCTGATTAGCGATACT-N40-ACTTGAGCAAAATCACCTGCAGGGG-3‘,40.0,"PBSM (10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, pH 7.4) containing 0.01% human serum albumin (HSA)",MgCl,PBS/phosphate buffers,7.4,Truncated versions of ligand 20,[3′T] represents a 3′-3′-linked thymidine nucleotide added to reduce 3′-exonuclease-mediated degradation,None,MNRCWALFLPLCCYLRLVSAEGDPIPEELYEMLSDHSIRSFDDLQRLLHRDSVD...LGA
ssDNA,CCGAAGCTTAATACGACTCACTATAGGGATCCGCCTGATTAGCGATACTTGGGAGGGCGCGTTCTTCGTGGTTACTTTTAGTCCCG[3'T],87.0,0.5057471264367817,Kd: 47 ± 4 nM,47.0,5‘-CCGAAGCTTAATACGACTCACTATAGGGATCCGCCTGATTAGCGATACT-N40-ACTTGAGCAAAATCACCTGCAGGGG-3‘,40.0,"PBSM (10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, pH 7.4) containing 0.01% human serum albumin (HSA)",MgCl,PBS/phosphate buffers,7.4,Truncated versions of ligand 20,[3′T] represents a 3′-3′-linked thymidine nucleotide added to reduce 3′-exonuclease-mediated degradation,None,None
ssDNA,CCGAAGCTTAATACGACTCACTATAGGGATCCGCCTGATTAGCGATACTTGGGAGGGCGCGTTCTTCGTGGTTACTTTTAGTCCCG[3'T],87.0,0.5057471264367817,Kd: 0.127 ± 0.031 nM,0.127,5‘-CCGAAGCTTAATACGACTCACTATAGGGATCCGCCTGATTAGCGATACT-N40-ACTTGAGCAAAATCACCTGCAGGGG-3‘,40.0,"PBSM (10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, pH 7.4) containing 0.01% human serum albumin (HSA)",MgCl,PBS/phosphate buffers,7.4,Truncated versions of ligand 20,[3′T] represents a 3′-3′-linked thymidine nucleotide added to reduce 3′-exonuclease-mediated degradation,None,None
ssDNA,CACAGGCTACGGCACGTAGAGCATCACCATGATCCTGTG[3'T],40.0,0.55,Kd: 0.094 ± 0.011 nM,0.094,5‘-CCGAAGCTTAATACGACTCACTATAGGGATCCGCCTGATTAGCGATACT-N40-ACTTGAGCAAAATCACCTGCAGGGG-3‘,40.0,"PBSM (10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, pH 7.4) containing 0.01% human serum albumin (HSA)",MgCl,PBS/phosphate buffers,7.4,Deduced from the knowledge of the consensus motif,[3′T] represents a 3′-3′-linked thymidine nucleotide added to reduce 3′-exonuclease-mediated degradation,None,None
ssDNA,CACAGGCTACGGCACGTAGAGCATCACCATGATCCTGTG[3'T],40.0,0.55,Kd: 72 ± 12 nM,72.0,5‘-CCGAAGCTTAATACGACTCACTATAGGGATCCGCCTGATTAGCGATACT-N40-ACTTGAGCAAAATCACCTGCAGGGG-3‘,40.0,"PBSM (10.1 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, pH 7.4) containing 0.01% human serum albumin (HSA)",MgCl,PBS/phosphate buffers,7.4,Deduced from the knowledge of the consensus motif,[3′T] represents a 3′-3′-linked thymidine nucleotide added to reduce 3′-exonuclease-mediated degradation,None,None
ssDNA,CACAGGCTACGGCACGTAGAGCATCACCATGATCCTGTG[3'T],40.0,0.55,Kd: 0.093± 0.009 nM,0.093,5‘-CCGAAGCTTAATACGACTCACTATAGGGATCCGCCTGATTAGCGATACT-N40-ACTTGAGCAAAATCACCTGCAGGGG-3‘,40.0,"500 ul, 10 mM HEPES, pH 7.4/100 mM NaCl",MgCl,PBS/phosphate buffers,7.4,Deduced from the knowledge of the consensus motif,[3′T] represents a 3′-3′-linked thymidine nucleotide added to reduce 3′-exonuclease-mediated degradation,None,None
ssDNA,CCGAAGCTTAATACGACTCACTATAGGGATCCGCCTGATTAGCGATACTTACTCAGGGCACTGCAAGCAATTGTGGTCCCAATGGGCTGAGTA[3'T],94.0,0.48936170212765956,Kd: 0.138 ± 0.009 nM,0.138,5‘-CCGAAGCTTAATACGACTCACTATAGGGATCCGCCTGATTAGCGATACT-N40-ACTTGAGCAAAATCACCTGCAGGGG-3‘,40.0,"500 ul, 10 mM HEPES, pH 7.4/100 mM NaCl",MgCl,PBS/phosphate buffers,7.4,Truncated versions of ligand 41,[3′T] represents a 3′-3′-linked thymidine nucleotide added to reduce 3′-exonuclease-mediated degradation,None,MNRCWALFLPLCCYLRLVSAEGDPIPEELYEMLSDHSIRSFDDLQRLLHRDSVD...LGA
ssDNA,CCGAAGCTTAATACGACTCACTATAGGGATCCGCCTGATTAGCGATACTTACTCAGGGCACTGCAAGCAATTGTGGTCCCAATGGGCTGAGTA[3'T],94.0,0.48936170212765956,Kd: 49 ± 8 nM,49.0,5‘-CCGAAGCTTAATACGACTCACTATAGGGATCCGCCTGATTAGCGATACT-N40-ACTTGAGCAAAATCACCTGCAGGGG-3‘,40.0,"500 ul, 10 mM HEPES, pH 7.4/100 mM NaCl",MgCl,PBS/phosphate buffers,7.40000000000001,Truncated versions of ligand 41,[3′T] represents a 3′-3′-linked thymidine nucleotide added to reduce 3′-exonuclease-mediated degradation,None,None
ssDNA,CCGAAGCTTAATACGACTCACTATAGGGATCCGCCTGATTAGCGATACTTACTCAGGGCACTGCAAGCAATTGTGGTCCCAATGGGCTGAGTA[3'T],94.0,0.48936170212765956,Kd: 0.129 ± 0.011 nM,0.129,5‘-CCGAAGCTTAATACGACTCACTATAGGGATCCGCCTGATTAGCGATACT-N40-ACTTGAGCAAAATCACCTGCAGGGG-3‘,40.0,"500 ul, 10 mM HEPES, pH 7.4/100 mM NaCl",MgCl,PBS/phosphate buffers,7.40000000000001,Truncated versions of ligand 41,[3′T] represents a 3′-3′-linked thymidine nucleotide added to reduce 3′-exonuclease-mediated degradation,None,None
2'-amino-RNA,GGAGGUCGACCUCGCGCGAGGAGGGUGGAGGGUCGUAGAGCGCGUAGGAGG,51.0,0.7058823529411765,Kd: 19-36 nM,27.5,5'-GGGAGAUACCAGCUUAUUCAAUU-N71-AGAUAGUAAGUGCAAUCU-3',71.0,"500 ul, 10 mM HEPES, pH 7.4/100 mM NaCl",None,Other Buffers,7.4,Not applicable,"Pool was not stated, but I figured it out using the figures",None,None
ssRNA,GGGAGAUACCAGCUUAUUCAAUUGCUAGGCAAUGUUUCGGUUGGAGUAAUCCGGUGGCUUGCCAUGAUUUACGUGAGUGCUGAUCCGUGAUGAGAUAGUAAGUGCAAUCU,110.0,0.45454545454545453,Kd: 19-36 nM,27.5,5'-GGGAGAUACCAGCUUAUUCAAUU-N71-AGAUAGUAAGUGCAAUCU-3',71.0,"500 ul, 10 mM HEPES, pH 7.4/100 mM NaCl",None,Other Buffers,7.4,Not applicable,"Pool was not stated, but I figured it out using the figures",None,MAGRSEDRDDALLLAVRTIRILYQSNPYPELRGTRQARRNQRRKWRARQRQIRA...GSP
ssRNA,GGGAGAUACCAGCUUAUUCAAUUGCUAGGCAAUGUUUCGGUUGGAGUAAUCCGGUGGCUUGCCAUGAUUUACGUGAGUGCUGAUCCGUGAUGAGAUAGUAAGUGCAAUCU,110.0,0.45454545454545453,Kd: 19-36 nM,27.5,5'-GGGAGAUACCAGCUUAUUCAAUU-N71-AGAUAGUAAGUGCAAUCU-3',71.0,"500 ul, 10 mM HEPES, pH 7.4/100 mM NaCl",None,Other Buffers,7.4,Not applicable,"Pool was not stated, but I figured it out using the figures",None,MAGRSEDRDDALLLAVRTIRILYQSNPYPELRGTRQARRNQRRKWRARQRQIRA...GSP
ssRNA,GGGAGAUACCAGCUUAUUCAAUUGUAUUCUCGGUGGUUUAAUCUGUGUAGAGGAGCUGACUCCUUUGGUUGGACUACGUGGAGGUUCUCUUAGAUAGUAAGUGCAAUCU,109.0,0.43119266055045874,Kd: 19-36 nM,27.5,5'-GGGAGAUACCAGCUUAUUCAAUU-N71-AGAUAGUAAGUGCAAUCU-3',71.0,"500 ul, 10 mM HEPES, pH 7.4/100 mM NaCl",None,Other Buffers,7.4,Not applicable,"Pool was not stated, but I figured it out using the figures",None,MAGRSEDRDDALLLAVRTIRILYQSNPYPELRGTRQARRNQRRKWRARQRQIRA...GSP
ssRNA,GGGAGAUACCAGCUUAUUCAAUUCAAGAAGUGGAAAUGCGCAGCGACCAUGAAACCUCGCAUGGUUCAUCGAUUGUUUGGAUAGUGUCUGUGUGAGAUAGUAAGUGCAAUCU,112.0,0.4375,Kd: 19-36 nM,27.5,5'-GGGAGAUACCAGCUUAUUCAAUU-N71-AGAUAGUAAGUGCAAUCU-3',71.0,"500 ul, 10 mM HEPES, pH 7.4/100 mM NaCl",None,Other Buffers,7.4,Not applicable,"Pool was not stated, but I figured it out using the figures",None,MAGRSEDRDDALLLAVRTIRILYQSNPYPELRGTRQARRNQRRKWRARQRQIRA...GSP
ssRNA,GGGAGAUACCAGCUUAUUCAAUUGCAGUUAACCAAGCCUGCAUACUGGAUAGACGGCUUAUCCGACUGAAUGCCUCCCGAAAGGUGCAGUUAGAUAGUAAGUGCAAUCU,109.0,0.45871559633027525,Kd: 19-36 nM,27.5,5'-GGGAGAUACCAGCUUAUUCAAUU-N71-AGAUAGUAAGUGCAAUCU-3',71.0,"500 ul, 10 mM HEPES, pH 7.4/100 mM NaCl",None,Other Buffers,7.4,Not applicable,"Pool was not stated, but I figured it out using the figures",None,MAGRSEDRDDALLLAVRTIRILYQSNPYPELRGTRQARRNQRRKWRARQRQIRA...GSP
ssRNA,GGGAGAUACCAGCUUAUUCAAUUGCGCAAACCCGAAGAAUGCCCAAAUUGAUCCAGAGCAAGUGGGAAUGAUAUAAAGUACCUGGUCCUGGAGAUAGUAAGUGCAAUCU,109.0,0.44036697247706424,Kd: 19-36 nM,27.5,5'-GGGAGAUACCAGCUUAUUCAAUU-N71-AGAUAGUAAGUGCAAUCU-3',71.0,"500 ul, 10 mM HEPES, pH 7.4/100 mM NaCl",None,Other Buffers,7.4,Not applicable,"Pool was not stated, but I figured it out using the figures",None,MAGRSEDRDDALLLAVRTIRILYQSNPYPELRGTRQARRNQRRKWRARQRQIRA...GSP
ssRNA,GGGAGAUACCAGCUUAUUCAAUUUCCAAACCCCGUUGAGAGUUGAUCCGGUCUAGGGAAUGGGAAAGAAGUAGGUAUCGAAGAGAAUGUACCCUAGAUAGUAAGUGCAAUCU,112.0,0.4375,Kd: 19-36 nM,27.5,5'-GGGAGAUACCAGCUUAUUCAAUU-N71-AGAUAGUAAGUGCAAUCU-3',71.0,"500 ul, 10 mM HEPES, pH 7.4/100 mM NaCl",None,Other Buffers,7.4,Not applicable,"Pool was not stated, but I figured it out using the figures",None,MAGRSEDRDDALLLAVRTIRILYQSNPYPELRGTRQARRNQRRKWRARQRQIRA...GSP
ssRNA,GGGAGAUACCAGCUUAUUCAAUUAGGACUCAAAUAUUCACGUUGACGUUGUCUUGGAGUGCUGAUCGGAAAACCAAUAUGAUUAAUGGGUCCUGAGAUAGUAAGUGCAAUCU,112.0,0.4017857142857143,Kd: 19-36 nM,27.5,5'-GGGAGAUACCAGCUUAUUCAAUU-N71-AGAUAGUAAGUGCAAUCU-3',71.0,"PBS, modified to contain 1 mM, Mg2+ ions (138 mM NaCl, 2.7 mM KCl, 8.1 mM NA,HPO4, 1.1 mM KH2PO4, 1 mM MgCl, pH 7.4)",None,Other Buffers,7.4,Not applicable,"Pool was not stated, but I figured it out using the figures",None,MAGRSEDRDDALLLAVRTIRILYQSNPYPELRGTRQARRNQRRKWRARQRQIRA...GSP
ssRNA,GGGAGAUACCAGCUUAUUCAAUUACGCAGCGACUGUGGUGGUGAGCGGUUGCGUAACUUGAUUUAAGCAAGUACUGCCAUGGCCGAACCUCUAAGAUAGUAAGUGCAAUCU,111.0,0.46846846846846846,Kd: 19-36 nM,27.5,5'-GGGAGAUACCAGCUUAUUCAAUU-N71-AGAUAGUAAGUGCAAUCU-3',71.0,"PBS, modified to contain 1 mM, Mg2+ ions (138 mM NaCl, 2.7 mM KCl, 8.1 mM NA,HPO4, 1.1 mM KH2PO4, 1 mM MgCl, pH 7.4)",None,Other Buffers,7.4,Not applicable,"Pool was not stated, but I figured it out using the figures",None,MAGRSEDRDDALLLAVRTIRILYQSNPYPELRGTRQARRNQRRKWRARQRQIRA...GSP
ssRNA,GGGAGAUACCAGCUUAUUCAAUUUCUAGUCAAGUUGCAAUCUCCGGUGGGGUGGUAACCGAGGAACACGUUUCGGGUGUAUAGGCUAGCGAGAUAGUAAGUGCAAUCU,108.0,0.4722222222222222,Kd: 19-36 nM,27.5,5'-GGGAGAUACCAGCUUAUUCAAUU-N71-AGAUAGUAAGUGCAAUCU-3',71.0,"PBS, modified to contain 1 mM, Mg2+ ions (138 mM NaCl, 2.7 mM KCl, 8.1 mM NA,HPO4, 1.1 mM KH2PO4, 1 mM MgCl, pH 7.4)",None,Other Buffers,7.4,Not applicable,"Pool was not stated, but I figured it out using the figures",None,MAGRSEDRDDALLLAVRTIRILYQSNPYPELRGTRQARRNQRRKWRARQRQIRA...GSP
ssRNA,GGGAGAUACCAGCUUAUUCAAUUUCUACCAGAGCGAGUGUGCUGAACGUUCUAAGGACGGGAUUGAAUCGAGAUGCGUAUACUAGGACCUUACGAGAUAGUAAGUGCAAUCU,112.0,0.44642857142857145,Kd: 19-36 nM,27.5,5'-GGGAGAUACCAGCUUAUUCAAUU-N71-AGAUAGUAAGUGCAAUCU-3',71.0,"20 mM HEPES, pH 7.4, 150 mM NaCl, 1 mM CaCl2, 1 mM MgCl2",None,Other Buffers,7.4,Not applicable,"Pool was not stated, but I figured it out using the figures",None,MAGRSEDRDDALLLAVRTIRILYQSNPYPELRGTRQARRNQRRKWRARQRQIRA...GSP
ssRNA,GGGAGAUACCAGCUUAUUCAAUUGCUUGGUACCGAGCUCGGAUCCACGUAGUAACGGGCCGCCAGUGUCUGGAAUUCGGGUCGUUCUUGAGAUAGUAAGUGCAAUCU,107.0,0.5046728971962616,Kd: 19-36 nM,27.5,5'-GGGAGAUACCAGCUUAUUCAAUU-N71-AGAUAGUAAGUGCAAUCU-3',71.0,"20 mM HEPES, pH 7.4, 150 mM NaCl, 1 mM CaCl2, 1 mM MgCl2",None,Other Buffers,7.4,Not applicable,"Pool was not stated, but I figured it out using the figures",None,MAGRSEDRDDALLLAVRTIRILYQSNPYPELRGTRQARRNQRRKWRARQRQIRA...GSP
2'-amino-RNA,GGGAGGACGAUGCGGGUGUGAAUGGUGUUGUGAGG,35.0,0.6,Kd: 30 nM,30.0,5'-GGGAGGACGAUGCGG-N40/N60-CAGACGACUCGCCCGA-3',60.0,"50 mM KCl, 2.5 mM MgCl2,10 mM Tris-HCl (pH 8.3 at 22°C)",MgCl,PBS/phosphate buffers,7.4,35-nucleotide truncate,"SELEX experiments targeting human IgE were performed using 2'-NH,-modified CTP and UTP",None,None
2'-amino-RNA,GGGAGGACGAUGCGGGUGUGGGGCG,25.0,0.76,Kd: 35 nM,35.0,5'-GGGAGGACGAUGCGG-N40/N60-CAGACGACUCGCCCGA-3',40.0,"50 mM KCl, 2.5 mM MgCl2,10 mM Tris-HCl (pH 8.3 at 22°C)",MgCl,PBS/phosphate buffers,7.4,25-nucleotide truncate,"SELEX experiments targeting human IgE were performed using 2'-NH, RNA",None,QSLEESGGRLVTPGTPLTLTCTVSGFSLSTYNIHWVRQAPGKGLEWIGVIDTGG...HHH
ssDNA,GGGGCACGTTTATCCGTCCCTCCTAGTGGCGTGCCCC,37.0,0.6756756756756757,Kd: 10 nM,10.0,5'-CTACCTACGATCTGACTAGC-N40-GCTTACTCTCATGTAGTTCC-3',40.0,"20 mM HEPES, pH 7.5, 125 mM NaCl, 1 mM MgCl2, 1 mM CaCl2, 5 mM KCl) plus 0.01% (wt/vol) human serum albumin (Sigma Chemical Co., St. Louis, MO)",MgCl,PBS/phosphate buffers,7.4,37-nucleotide truncate,Consensus sequence: TTTATCCGTTCCTCTTAGTGG,None,QSLEESGGRLVTPGTPLTLTCTVSGFSLSTYNIHWVRQAPGKGLEWIGVIDTGG...HHH
ssDNA,CTACCTACGATCTGACTAGCCAAGGTAACCAGTACAAGGTGCTAAACGTAATGGCTTCGGCTTACTCTCATGTAGTTCC,79.0,0.46835443037974683,Kd: 1.8 ± 0.2 nM,1.8,5'-CTACCTACGATCTGACTAGC-N40-GCTTACTCTCATGTAGTTCC-3',40.0,"50 mM Tris-HCl, pH 7.5, at 23 °C, 20 mM MgCl2",MgCl/CaCl,Other Buffers,7.5,Truncated at both the 5' and 3' ends (ld201t1),None,None,None
ssDNA,CTACCTACGATCTGACTAGCCATTCACCATGGCCCCTTCCTACGTATGTTCTGCGGGTGGCTTACTCTCATGTAGTTCC,79.0,0.5189873417721519,Kd: 5.5 ± 5.1 nM,5.5,5'-CTACCTACGATCTGACTAGC-N40-GCTTACTCTCATGTAGTTCC-3',40.0,"50 mM Tris-HCl, pH 7.5, at 23 °C, 20 mM MgCl2",MgCl/CaCl,Other Buffers,7.5,Truncated at both the 5' and 3' ends (ld174t1),None,None,None
ssDNA,CTACCTACGATCTGACTAGCTGGCGGTACGGGCCGTGCACCCACTTACCTGGGAAGTGAGCTTACTCTCATGTAGTTCC,79.0,0.5569620253164557,Kd: 3.1 ± 0.4 nM,3.1,5'-CTACCTACGATCTGACTAGC-N40-GCTTACTCTCATGTAGTTCC-3',40.0,"20 mM Hepes, pH 7.5, 125 mM NaCl, 1 mM MgCl2, 1 mM CaCl2, 5 mM KCl) plus 0.01% (wt/vol) human serum albumin (Sigma Chemical Co., St. Louis, MO)",MgCl/CaCl,Other Buffers,7.5,Truncated at both the 5' and 3' ends (ld196t1),None,None,None
ssDNA,CATCGCAAGCTTCCAGAGGGGACGCTGAGGCTTCTATGGTTCCGTAGAATTCCACGCG,58.0,0.5689655172413793,Kd: 1.5 uM,1500.0,5'-CATCGCAAGCTTCCAGAG-N25-CGTAGAATTCCACGCGTG-3',25.0,"20 mM Hepes, pH 7.5 / 150 mM NH4Cl / 1 mM MgCl2 / 10 ug of bovine serum albumin per ml / 1 mM 2-mercaptoethanol",MgCl,Other Buffers,7.5,Not applicable,*Pool specifies N25 but the aptamer sequence (excluding the primers) has a 26nt random region. There is an extra nucleotide ,None,None
ssDNA,CTACCGTGGTAGGGAAGGTTGGAGTGTAG,29.0,0.5517241379310345,Kd: 30 nM,30.0,5'-AGATGCCTGTCGAGCATGCT-N30-GTAGCTAAACTGCTTTGTCGACGGG-3',30.0,"50 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1 mM MgCl2 at 37°C",MgCl,Tris Buffers,7.5,The aptamer was truncated,None,None,MGKGDPKKPRGKMSSYAFFVQTCREEHKKKHPDASVNFSEFSKKCSERWKTMSA...DDE
ssDNA,TACCGTGGTAGGGAAGGTTGGAGTGTA,27.0,0.5185185185185185,Kd: 126 nM,126.0,5'-AGATGCCTGTCGAGCATGCT-N30-GTAGCTAAACTGCTTTGTCGACGGG-3',30.0,"50 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1 mM MgCl2 at 37°C",MgCl,Tris Buffers,7.5,The aptamer was truncated,None,None,MGKGDPKKPRGKMSSYAFFVQTCREEHKKKHPDASVNFSEFSKKCSERWKTMSA...DDE
ssDNA,GACCCGTGGTAGGGTAGGATGGGGTGGTC,29.0,0.6551724137931034,Kd: 0.90 nM,0.9,5'-AGATGCCTGTCGAGCATGCT-N30-GTAGCTAAACTGCTTTGTCGACGGG-3',30.0,"20 mM MgCl2, 400 mM NaCl, 100 mM his-Tris pH 6.4.",MgCl,Tris Buffers,7.5,The aptamer was truncated,None,None,MGKGDPKKPRGKMSSYAFFVQTCREEHKKKHPDASVNFSEFSKKCSERWKTMSA...DDE
ssDNA,ACCCGTGGTAGGGTAGGATGGGGTGGT,27.0,0.6296296296296297,Kd: 42 nM,42.0,5'-AGATGCCTGTCGAGCATGCT-N30-GTAGCTAAACTGCTTTGTCGACGGG-3',30.0,"20 mM MgCl2, 400 mM NaCl, 100 mM his-Tris pH 6.4.",MgCl,Tris Buffers,7.5,The aptamer was truncated,None,None,MGKGDPKKPRGKMSSYAFFVQTCREEHKKKHPDASVNFSEFSKKCSERWKTMSA...DDE
ssDNA,CAGTCCGTGGTAGGGCAGGTTGGGGTGACTTCGTGGAA,38.0,0.6052631578947368,Kd: 0.5 nM,0.5,5'-AGATGCCTGTCGAGCATGCT-N60-GTAGCTAAACTGCTTTGTCGACGGG-3',60.0,"20 mM MgCl2, 400 mM NaCl, 100 mM his-Tris pH 6.4.",MgCl,Tris Buffers,7.5,The aptamer was truncated,None,None,MGKGDPKKPRGKMSSYAFFVQTCREEHKKKHPDASVNFSEFSKKCSERWKTMSA...DDE
ssDNA,5′AGTCCGTGGTAGGGCAGGTTGGGGTGACT3′,29.0,0.6206896551724138,Kd: 0.5 nM,0.5,5'-AGATGCCTGTCGAGCATGCT-N60-GTAGCTAAACTGCTTTGTCGACGGG-3',60.0,"50 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1 mM MgCl2 at 37°C",MgCl,Tris Buffers,7.5,The aptamer was truncated,The 15-nucleotide core sequence has eight highly conserved guanine residues and forms a G-quadruplex structure. A single nucleotide within the G-quadruplex structure can direct the DNA to a distinct epitope.,None,MGKGDPKKPRGKMSSYAFFVQTCREEHKKKHPDASVNFSEFSKKCSERWKTMSA...DDE
ssDNA,GTCCGTGGTAGGGCAGGTTGGGGTGAC,27.0,0.6666666666666666,Kd: 0.7 nM,0.7,5'-AGATGCCTGTCGAGCATGCT-N60-GTAGCTAAACTGCTTTGTCGACGGG-3',60.0,"50 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1 mM MgCl2 at 37°C",MgCl,Tris Buffers,7.5,The aptamer was truncated,None,None,MGKGDPKKPRGKMSSYAFFVQTCREEHKKKHPDASVNFSEFSKKCSERWKTMSA...DDE
ssRNA,GGGAAUUCCGCGUGUGCGCCGCGGAAGACGUUGGAAGGAUAGAUACCUACAACGGGGAAUAUAGAGGCCAGCACAUAGUGAGGCCCUCCUCCCAGUCCGUUCGGGAUCCUC,111.0,0.5855855855855856,Kd: 2.8 µM,2.8,5'-GGGAATTCCGCGTGTGC-N80-GTCCGTTCGGGATCCTC-3',80.0,"0.15 M NaCl, 50 mM Tris-HCl, pH 7.4, 5 mM MgCl2, and 0.02% ascorbic acid",MgCl,Tris Buffers,7.4,The aptamer was truncated,None,C1=CC(=C(C=C1CCN)O)O,None
ssDNA,TCACGTGCATGATAGACGGCGAAGCCGTCGAGTTGCTGTGTGCCGATGCACGTGA,55.0,0.5818181818181818,Kd = 1.17 μM,1170.0,5′-TCTAACGTCAATGATAGA-N60-TTAACTTATTCGACCAAA3',60.0,"Ca2+, Mg2+ containing Dulbeco's Phosphate Buffered Saline (DPBS, Life Technologies, Gaithersburg, MD) with 0.01% human serum albumin (Sigma, St. Louis, MO)",MgCl/CaCl,Other Buffers,7.3,Not applicable,This paper has identified a mirror-image single-stranded DNA that binds the peptide hormone vasopressin Pre-SELEX modification: one preparation of l-aptamer contained a 5′ tail of two d-thymidine residues; this modification had no detectable effect on binding activity. The starting pool for the second selection had 68 nt from sequence B doped at 30% and flanked by AGGCTAGGAAGATCAATT and TTAACTTATTCGACCAAA.,None,None
ssDNA,TCACGTGCATGATAGACGGCGAAGCCGTCGAGTTGCTGTGTGCCGATGCACGTGA,55.0,0.5818181818181818,Kd = 0.85 μM ,850.0,5′-TCTAACGTCAATGATAGA-N60-TTAACTTATTCGACCAAA3',60.0,"Ca2+, Mg2+ containing Dulbeco's Phosphate Buffered Saline (DPBS, Life Technologies, Gaithersburg, MD) with 0.01% human serum albumin (Sigma, St. Louis, MO)",MgCl/CaCl,Other Buffers,7.3,Not applicable,This paper has identified a mirror-image single-stranded DNA that binds the peptide hormone vasopressin Pre-SELEX modification: one preparation of l-aptamer contained a 5′ tail of two d-thymidine residues; this modification had no detectable effect on binding activity. The starting pool for the second selection had 68 nt from sequence B doped at 30% and flanked by AGGCTAGGAAGATCAATT and TTAACTTATTCGACCAAA.,None,None
2'-amino-RNA,GGGAGGACGAUGCGGUGGUAGCGCGAUAUAGCGCUGGUAGGGUUGCCGGUGAUCAGACGACUCGCCCGA,69.0,0.6376811594202898,Kd: biphasic 1.8 nM and 750 nM,1.8,5'-GGGAGGACGAUGCGG-N40-CAGACGACUCGCCCGA-3',40.0,"Ca2+, Mg2+ containing Dulbeco's Phosphate Buffered Saline (DPBS, Life Technologies, Gaithersburg, MD) with 0.01% human serum albumin (Sigma, St. Louis, MO)",None,PBS/phosphate buffers,7.4,Truncated IFN-y ligands.,all pyrimidines modified to 2'-NH2-CMP and 2'-NH-UMP,None,MAAEPVEDNCINFVAMKFIDNTLYFIAEDDENLESDYFGKLESKLSVIRNLNDQ...NED
2'-amino-RNA,5‘GGGAAAAGCGAAUCAUACACAAGACGGCCGGCGCCAUAGCCGAGAUCCGAGGUGUUGAACGAUGACAACUCGGUGCUCCGCCAGAGACCAACCGAGAA3‘,98.0,0.5714285714285714,"Kd: 0.5 ± 0.3, Ki: 0.2 nM ",0.5,5′-GGGAAAAGCGAATCATACACAAG-N50-GCTCCGCCAGAGACCAACCGAGAA-3′,50.0,"20 mm Tris (pH 7.6), 150 mm NaCl, 5 mm MgCl2, 1 mm dithiothreitol, 100 μl final volume",CaCl,Tris Buffers,7.4,The sequences of synthetic ssdnas were derived from aptamer 5 (table 1).,RNA library contains 2'-NH2-pyrimidines and 2'-OH-purines,None,None
2'-amino-RNA,GGGAAAAGAGACGGCCGGCGCCAUAGCCGAGAUCCGAGGUGUUGCCGAGAA,51.0,0.6274509803921569,"Kd: 1.7 ± 0.2 nM, IC50: 4 nM, Ki: 0.14 nM ",1.7,5′-GGGAAAAGCGAATCATACACAAG-N50-GCTCCGCCAGAGACCAACCGAGAA-3′,50.0,"20 mm Tris (pH 7.6), 150 mm NaCl, 5 mm MgCl2, 1 mm dithiothreitol, 100 μl final volume",CaCl,Tris Buffers,7.4,"The sequences of synthetic ssdnas were derived from aptamer 5 (table 1). In turn, the sequence of aptamer 15 is determined by the synthetic template. The sequence has been trucated",RNA library contains 2'-NH2-pyrimidines and 2'-OH-purines,None,NLVNFHRMIKLTTGKEAALSYGFYGCHCGVGGRGSPKDATDRCCVTHDCCYKRL...PRC
ssRNA,GGCACGUGUAUUACCCUAGUGGUCGACGUGCC,32.0,0.59375,Kd: 3.3 µM,3300.0,5'-GGTGAGAATTCCGACCAGGATCC-N60-GTCGACGTAGAAGCTTGGGCGG-3',60.0,"20 mM Tris–HCl, pH 7.5, 0.3 M NaCl and 5 mM MgCl2",MgCl,Tris Buffers,7.5,"Turnction: We designed the 32mer RNA (designated as XBA) shown inFigure 3B, which has the common secondary structure, including the consensus sequence, of the 60mer aptamers","A single-stranded DNA (105 nt), consisting of a random sequence of 60 nt and two flanking primer-binding regions (23 and 22 nt) for PCR and reverse transcription, was chemically synthesized with a Cyclone plus DNA/RNA synthesizer (Millipore). The PCR primers, with the sequences of 5′-AGTAATACGACTCACTA_x0002_TAGGTGAGAATTCCGACCAGGATCC-3′, (the T7 promoter sequence is underlined) and 5′-CCGCCCAAGCTTCTACGTC_x0002_GAC-3′, were also synthesized

We designed the 32mer RNA (designated as XBA) shown inFigure 3B, which has the common secondary structure, including the consensus sequence, of the 60mer aptamers

DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.",None,None
ssDNA,5′GCGGGGTTGGGCGGGTGGGTTCGCTGGGCAGGGGGCGAGTG	,41.0,0.7804878048780488,Kd:  6 × 10−7 M,600.0,5′-ATAGGAGTCGACCGACCAGAA-N40-TATGTGCGTCTACATCTAGACTCAT-3',40.0,"20 mM Tris, pH 7.5/100 mM NaCl/5 mM MgCl2",MgCl,Tris Buffers,7.5,"Trunction:  Only the internal variable region of three aptamers in were used: the 41 mer of Cel#16, the 40 mer of Cel#183, and the 36 mer of Cel#202",None,C(C1C(C(C(C(O1)OC2C(OC(C(C2O)O)O)CO)O)O)O)O,None
ssDNA,5′TAGCGGGTGTGGTGGGTGGGGGAGGCATGGTTTTTGGTAA,40.0,0.575,Kd: 10−7 to 10−5 M,1000.0,5′-ATAGGAGTCGACCGACCAGAA-N40-TATGTGCGTCTACATCTAGACTCAT-3',40.0,"25 µg/ml BSA, 25 µg/ml tRNA, 5 U/ml RNAguard (Pharmacia), 1 mM PMSF, 1 mM β-mercaptoethanol, 1 µg/ml, leupeptin, antipain, aprotinin, in TNG buffer",MgCl,Tris Buffers,7.5,"Trunction:  Only the internal variable region of three aptamers in were used: the 41 mer of Cel#16, the 40 mer of Cel#183, and the 36 mer of Cel#203",None,C(C1C(C(C(C(O1)OC2C(OC(C(C2O)O)O)CO)O)O)O)O,MKNVLLLSGNENSSHLFLGEAKRTAETRHMPLNFSAASVQDLTPDMLAEQDLVL...AAV
ssDNA,5′GTCAAGGTGGGTGGGTGGGGTTGGTTGTTGTTTTGA,36.0,0.5277777777777778,Kd: 10−7 to 10−5 M,1000.0,5′-ATAGGAGTCGACCGACCAGAA-N40-TATGTGCGTCTACATCTAGACTCAT-3',40.0,"25 µg/ml BSA, 25 µg/ml tRNA, 5 U/ml RNAguard (Pharmacia), 1 mM PMSF, 1 mM β-mercaptoethanol, 1 µg/ml, leupeptin, antipain, aprotinin, in TNG buffer",MgCl,Tris Buffers,7.5,"Trunction:  Only the internal variable region of three aptamers in were used: the 41 mer of Cel#16, the 40 mer of Cel#183, and the 36 mer of Cel#204",None,C(C1C(C(C(C(O1)OC2C(OC(C(C2O)O)O)CO)O)O)O)O,MKNVLLLSGNENSSHLFLGEAKRTAETRHMPLNFSAASVQDLTPDMLAEQDLVL...AAV
ssRNA,GAAUUCAGUCGGACAGCGUCGGGUGGCCCGUGUCUGAGCGGGGACGGCCACUUGAGCGCGAUGGACGAAUAUCGUCUCCC,80.0,0.6375,Kd: 60 ± 17 nM,60.0,5'-GAATTCAGTCGGACAGCG-N40-GATGGACGAATATCGTCTCCC-3',40.0,"3 mM sodium phosphate, 3 mM MgCl2, 45 mM NaCl, 2.5 mM EDTA, 3 mM Tris-HCl (pH 7.5), 0.15 mM dithiothreitol, 12% glycerol",MgCl,PBS/phosphate buffers,7.4,Biotinylation of aptamer 2–16 was performed by in vitro transcription,"32P-phosphate labelled RNA. DNA oligonucleotides were synthesised b automated solid suupport chemsistry using O-cyanoethyl-N,N-dissopropyl-phosphoramidites . The starting pool library was a 79mer DNA of sequence. Fluorescence labelling of aptamer 2–16 was achieved by tagging the bodipy tmr-c5 fluorophore (molecular probes) to the 5′-end of the rna, DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.",None,None
ssRNA,UCAACACGGUCCCAGACGUGUUGA,24.0,0.5416666666666666,Kd: 32 ± 8 nM ,32.0,5'-GGUUACCAGCCUUCACUGC-N60-GCACCACGGUCGGUCACAC-3',60.0,"R buffer (20 mM HEPES, pH 7.3, at 208C contain-ing 20 mM sodium acetate, 140 mM potassium acetate,and 3 mM magnesium acetate)",None,Other Buffers,7.3,24-mer truncated aptamer derived from r-06 aptamer,None,None,MLAANPGKTPISLLQEYGTRIGKTPVYDLLKAEGQAHQPNFTFRVTVGDTSCTG...GSK
ssRNA,GGGAGAAUUCCGACCAGAAGCCUUCUCCUGCCGCGCGAUUUUACGCCGACAAGGGUGGCAUGAUGAUGUGUCUNUAUAUAGCAUAUGUGCGUCUACAUGGAUCCUCA,106.0,0.5094339622641509,Kd: 1.236 ± 0.051 uM,1.236,5'-GGGAGAATTCCGACCAGAAGC-N60-CATATGTGCGTCTACATGGATCCTCA-3',60.0,"1 M NaCl, 50 mM Tris–HCl, 3 mM MgCl2, pH 7.4",MgCl,Tris Buffers,7.4,Not applicable,DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.,None,None
ssRNA,GGGAGAAUUCCGACCAGAAGCUUUUAGGGCGGGACUUUUGGCCGCAAAGGUUGGUGUGAGGGUUCUCAAUAAUGGCCCAAGCAUAUGUGCGUCUACAUGGAUCCUCA,107.0,0.514018691588785,Kd: 1.446 ± 0.088 uM,1.446,5'-GGGAGAATTCCGACCAGAAGC-N60-CATATGTGCGTCTACATGGATCCTCA-3',60.0,"1 M NaCl, 50 mM Tris–HCl, 3 mM MgCl2, pH 7.4",MgCl,Tris Buffers,7.4,Not applicable,DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.,None,MSNVTKVQQIKEFMAQQGFSIKKKFGQNFLIDKNALEKIVTATEPDNNTTVLEI...VKK
ssRNA,GGGAGAAUUCCGACCAGAAGCGGCGUUCCGCAUCGGCAACUGGCGAGGAGUUGUAUUCGGCGGAAACGGGUUGAGGUCCGACAUAUGUGCGUCUACAUGGAUCCUCA,107.0,0.5700934579439252,Kd: 1.665 ± 0.101 uM,1.665,5'-GGGAGAATTCCGACCAGAAGC-N60-CATATGTGCGTCTACATGGATCCTCA-3',60.0,"20 mM Tris-HCl (pH 7.5 at 23 °C), 450 mM NaCl, 100 mM KCl, 10 mM MgCl2, 1 mM MnCl2, 5 mM CaCl2",MgCl,Tris Buffers,7.4,Not applicable,DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.,None,MSNVTKVQQIKEFMAQQGFSIKKKFGQNFLIDKNALEKIVTATEPDNNTTVLEI...VKK
ssRNA,GGGAGAAUUCCGACCAGAAGCAGUGGAAGAGCCGGGUUGGGCAUAUGUGCGUCUACAUGGAUCCUCA,67.0,0.5522388059701493,Kd: 2.946 ± 0.149 uM,2.946,5'-GGGAGAATTCCGACCAGAAGC-N20-CATATGTGCGTCTACATGGATCCTCA-3',20.0,"20 mM Tris-HCl (pH 7.5 at 23 °C), 450 mM NaCl, 100 mM KCl, 10 mM MgCl2, 1 mM MnCl2, 5 mM CaCl2",MgCl,Tris Buffers,7.4,Not applicable,DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.,None,MSNVTKVQQIKEFMAQQGFSIKKKFGQNFLIDKNALEKIVTATEPDNNTTVLEI...VKK
ssRNA,GGGAGAAUUCCGACCAGAAGCAGCGGAACGGCCGACUUCAACAUAUGUGCGUCUACAUGGAUCCUCA,67.0,0.5373134328358209,Kd: 2.786 ± 0.188 uM,2.786,5'-GGGAGAATTCCGACCAGAAGC-N20-CATATGTGCGTCTACATGGATCCTCA-3',20.0,Nitrocellulose filter binding buffer:PBS/2 mM MgCl2/0.01% HSA/1.0 mM dithiothreitol (DTT),MgCl,Tris Buffers,7.4,Not applicable,DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.,None,MSNVTKVQQIKEFMAQQGFSIKKKFGQNFLIDKNALEKIVTATEPDNNTTVLEI...VKK
ssRNA,5′GGAAGGCACGACGAAGCAAGCAGGCAACGAACACAGAAGACCGGGGGAACUACCGCGCGCGCCAGACCCAACCAGCCAGAGACC3′,84.0,0.6428571428571429,Kd: 165 μM ± 10 μM,165000.0,5′-GGAAGGCACGAC-N51-AGACCCAACCAGCCAGAGACC-3′,51.0,"300 mM NaCl, 20 mM Tris-Cl, pH 7.4, 5 mM MgCl2",MgCl,Tris Buffers,7.4,Mutants of rafl7 were constructed that replaced the uridine at position 61 with cytidine (rafl7-u61c).,DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.,None,MESSSSLKGSALGKLVVTSGLLHSSWSKILEIHNPPYSNHDPGLQVSKKKKDSG...KSQ
ssRNA,5′GGGCGCGACGAAGCAAGCAGGCAACGAACACAGAAGACCGGGGGAACUACCGCGCGCGCCC3′,61.0,0.6885245901639344,Kd: 175 μM ± 5 μM,175.0,5′-GGAAGGCACGAC-N51-AGACCCAACCAGCCAGAGACC-3′,51.0,"300 mM NaCl, 20 mM Tris-Cl, pH 7.4, 5 mM MgCl2",MgCl,Tris Buffers,7.4,Truncated and mutants of rafl7 were constructed that replaced the uridine at position 61 with cytidine (rafl7-u61c).,DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.,None,MESSSSLKGSALGKLVVTSGLLHSSWSKILEIHNPPYSNHDPGLQVSKKKKDSG...KSQ
ssRNA,GGGAGUCUGAAGUCGGACUCGAUAUCAAUUCACUUCAGACU,41.0,0.4634146341463415,Kd: 17.9 ± 2.2 nM,17.9,5'-GGGAAUGGAUCCACAUCUACGUAUUC-N30-UUCACUGCAGACUUGACGAAGCUU-3',30.0,"50 mm Tris/HCl (pH 7.8), 30 mm NaCl, 5 mm CaCl2, 10 mm dithiothreitol",MgCl,PBS/phosphate buffers,7.5,Fragmented 41-mer sequence.,None,None,None
ssRNA,GGGAAUGGAUCCACAUCUACGUAUUCAACCAAGUCUAAUGUCGGACUCGAUAUCAAUUCACUGCAGACUUGACGAAGCUU,80.0,0.4375,Kd: 21.0 ± 2.0 nM,21.0,5'-GGGAAUGGAUCCACAUCUACGUAUUC-N30-UUCACUGCAGACUUGACGAAGCUU-3',30.0,"50 mm Tris/HCl (pH 7.8), 30 mm NaCl, 5 mm CaCl2, 10 mm dithiothreitol",MgCl,PBS/phosphate buffers,7.5,Not applicable,None,None,None
ssRNA,GGGAAUGGAUCCACAUCUACGUAUUCAGUCUAGGAAGCAGUCGGACUUGUUAUCAAUUCACUGCAGACUGUACGAAGCUU,80.0,0.45,Kd: 23.4 ± 2.3 nM,23.4,5'-GGGAAUGGAUCCACAUCUACGUAUUC-N30-UUCACUGCAGACUUGACGAAGCUU-3',30.0,"2.5 mM Tris–Cl (pH 7.6), 100 mM NaCl, 2.0 mM MgCl2 or ZnCl2",MgCl,PBS/phosphate buffers,7.5,Not applicable,None,None,None
ssDNA,TAGGGAATTCGTCGACGGATCCTATGAACCAAGGGAGGGGCAGGGCGGGTAGGGTTAATAACGGATTCCGAGCGCCCAGCTCCTGCAGGTCGACGCATGCGCCG,104.0,0.6153846153846154,Kd: 1.1x10^-5 M,11000.0,5'-TAGGGAATTCGTCGACGGATCC-N59-CTGCAGGTCGACGCATGCGCCG-3',59.0,"100 mM Tris±acetate pH 8.0, 200 mM sodium acetate,50 mM potassium acetate, 25 mM magnesium acetate,5% dioxane",None,Tris Buffers,8.0,Not applicable,None,None,None
ssDNA,TAGGGAATTCGTCGACGGATCCACGAAGAAACAGGGCGCTTCGAACGAACATGGGCAGGGTGGGAAGTTTTAAAGTGGTACCTGCAGGTCGACGCATGCGCCG,103.0,0.5631067961165048,Kd: 9.1x10^-6 M,9100.0,5'-TAGGGAATTCGTCGACGGATCC-N59-CTGCAGGTCGACGCATGCGCCG-3',59.0,"100 mM Tris±acetate pH 8.0, 200 mM sodium acetate,50 mM potassium acetate, 25 mM magnesium acetate,5% dioxane",None,Tris Buffers,8.0,Not applicable,None,None,None
ssDNA,TAGGGAATTCGTCGACGGATCCCAGCGTAAGGTCGTGGGTGGTTGGGTGCCTAAGCGTATACTTACAGCGATTGATTTGGTCCTGCAGGTCGACGCATGCGCCG,104.0,0.5673076923076923,Kd: 1.2x10^-4 M,120000.0,5'-TAGGGAATTCGTCGACGGATCC-N59-CTGCAGGTCGACGCATGCGCCG-3',59.0,"100 mM Tris-acetate (pH 7.4), 200 mM NaOAc, 25 mM KOAc,10 mM Mg(OAc)2, 0.5% Triton X-100, 5% DSMO",None,Tris Buffers,8.0,Not applicable,None,None,None
ssDNA,TAGGGAATTCGTCGACGGATCCGGTGCGGGTAGGGATGAGGGCGGGTCGGGTTGAGTGTGAGCTTAGGGGTGGCGGATCTACCTGCAGGTCGACGCATGCGCCG,104.0,0.6442307692307693,Kd: 6.3x10^-6 M,6300.0,5'-TAGGGAATTCGTCGACGGATCC-N59-CTGCAGGTCGACGCATGCGCCG-3',59.0,"100 mM Tris-acetate (pH 7.4), 200 mM NaOAc, 25 mM KOAc,10 mM Mg(OAc)2, 0.5% Triton X-100, 5% DSMO",None,Tris Buffers,8.0,Not applicable,None,None,None
ssDNA,TAGGGAATTCGTCGACGGATCCCTAGAGTAACCTGTTGGGAGGGCGGGTAGGGCCCATTGAGAGGAGGACGTATTCGTCCGCCTGCAGGTCGACGCATGCGCCG,104.0,0.6153846153846154,Kd: 1.3x10^-5 M,13000.0,5'-TAGGGAATTCGTCGACGGATCC-N59-CTGCAGGTCGACGCATGCGCCG-3',59.0,"20 mM Tris-HCl (pH 7.5), 5 mM MgCl2, 100 mM KCl, 1 mM DTT, 5 μM ZnCl2, 5 μg/mL poly[d(I-C)], 100 μg/mL bovine serum albumin",None,Tris Buffers,8.0,Not applicable,None,None,None
ssDNA,TAGGGAATTCGTCGACGGATCCCAATGGGGTCGGGCGGGCCGGGTGTCATGGTGGACGGAGATGGGACGTAGAGGGCGGTCTGCAGGTCGACGCATGCGCCG,102.0,0.6666666666666666,Kd: 1.6x10^-6 M,1600.0,5'-TAGGGAATTCGTCGACGGATCC-N59-CTGCAGGTCGACGCATGCGCCG-3',59.0,"20 mM Tris-HCl (pH 7.5), 5 mM MgCl2, 100 mM KCl, 1 mM DTT, 5 μM ZnCl2, 5 μg/mL poly[d(I-C)], 100 μg/mL bovine serum albumin",None,Tris Buffers,8.0,Not applicable,None,None,None
ssDNA,TAGGGAATTCGTCGACGGATCCGCGGCAAATCAGCATACGAGTGTACAGGGACGGGACGGGTGGGTAAAAGGTGTCGCCTCAGCTGCAGGTCGACGCATGCGCCG,105.0,0.6095238095238096,Kd: 2.7x10^-6 M,2700.0,5'-TAGGGAATTCGTCGACGGATCC-N59-CTGCAGGTCGACGCATGCGCCG-3',59.0,"20 mM Tris-HCl (pH 7.5), 5 mM MgCl2, 100 mM KCl, 1 mM DTT, 5 μM ZnCl2, 5 μg/mL poly[d(I-C)], 100 μg/mL bovine serum albumin",None,Tris Buffers,8.0,Not applicable,None,None,None
ssDNA,TAGGGAATTCGTCGACGGATCCCCAACTTGGGCGGAGGGCTAACGGTGGGGGGATATTATGAGGGGTGGAGGTATTAACCATTCTGCAGGTCGACGCATGCGCCG,105.0,0.580952380952381,Kd: 9.8x10^-6 M,9800.0,5'-TAGGGAATTCGTCGACGGATCC-N59-CTGCAGGTCGACGCATGCGCCG-3',59.0,"100 mM Tris±acetate pH 8.0, 200 mM sodium acetate,50 mM potassium acetate, 25 mM magnesium acetate,5% dioxane",None,Tris Buffers,8.0,Not applicable,None,None,None
ssDNA,TAGGGAATTCGTCGACGGATCCCCGGGGATTAGAATAGTGGAGGGCCGGTGGCAAATGGGTAAGTAGGTTGAAGGGCTAAATTCTGCAGGTCGACGCATGCGCCG,105.0,0.5619047619047619,Kd: 2.2x10^-4 M,220000.0,5'-TAGGGAATTCGTCGACGGATCC-N59-CTGCAGGTCGACGCATGCGCCG-3',59.0,"100 mM Tris±acetate pH 8.0, 200 mM sodium acetate,50 mM potassium acetate, 25 mM magnesium acetate,5% dioxane",None,Tris Buffers,8.0,Not applicable,None,None,None
ssDNA,ATGGGGTCGGGCGGGCCGGGTGTC,24.0,0.7916666666666666,Kd: 1.5x10^-5 M,150000.0,5'-TAGGGAATTCGTCGACGGATCC-N59-CTGCAGGTCGACGCATGCGCCG-3',59.0,"100 mM Tris±acetate pH 8.0, 200 mM sodium acetate,50 mM potassium acetate, 25 mM magnesium acetate,5% dioxane",None,Tris Buffers,8.0,"To determine which sequence is necessary to recognize hpix, these two ssdnas were synthesized for aptamer 26 and their binding affinity to hpix was analyzed.",None,None,None
ssRNA,GGAAGAGAUGGCGACUAAAACGACUUGUCGC,31.0,0.5161290322580645,Kd: 10 uM,10000.0,5′-GGAAGAGAUGGCGAC-N50-CGGUAAGCUUGGCAC-3',50.0,"20 mM Tris-HCl (pH 7.5 at 23 °C), 450 mM NaCl, 100 mM KCl, 10 mM MgCl2, 1 mM MnCl2, and 5 mM CaCl2",MgCl/CaCl,Tris Buffers,7.5,Truncation,None,None,MNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAM...HHH
ssDNA,GGGAGGACGATGCGGTGACGTAAGAGTGTAATCGATGCAGCCTGGCAGACGACGAGCGGGA,61.0,0.6065573770491803,Kd: 560 pM,0.56,5'-GGGAGGACGATGCGG-N61-CAGACGACGAGCGGGA-3',61.0,Nitrocellulose filter binding buffer: 1×PBS/2 mM MgCl2/0.01% HSA/1.0 mM dithiothreitol (DTT),MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,GGGAGGACGATGCGGGCGAAGGCACACCGAGTTCATAGTATCCCACAGACGACGAGCGGGA,61.0,0.6229508196721312,Kd: 16 pM,0.016,5'-GGGAGGACGATGCGG-N61-CAGACGACGAGCGGGA-3',61.0,"50 mM Tris·HCl (pH 7.4), 5 mM KCl, 100 mM NaCl, 1 mM MgCl2, 0.1% NaN3",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,MVGVGGGDVEDVTPRPGGCQISGRGARGCNGIPGAAAWEAALPRRRPRRHPSVN...AKS
ssRNA,GGGAAGCUUGUACAGGGGGCAGUCAACUCGUGCGAUCGUGAAAACGGGGCAAGAUGGCCUUACAGCGGUCAAUACGGGGGUCAUCAGAUAGGGAGGCCCUCCUGGUGGUCCGUUCGGGAUCCUC,124.0,0.5967741935483871,Kd: 35 uM,35000.0,5'GGGAATTCCGCGTGTGC-N80-GTCCGTTCGGGATCCTC3',80.0,"50 mM HEPES pH 7.4, 10 mM MgCl2, 100 mM NaCl",MgCl,Tris Buffers,7.4,Mutated sequence selected from a degenerate pool derived from a previous selection,Pool comes from pervious selection paper https://pubmed.ncbi.nlm.nih.gov/9245404/,C1=CC(=CC=C1CC(C(=O)O)N)O,None
ssRNA,GGGAGAAUUCCGACCAGAAGCUUCGGGAUUUGAGGGUAGAAUGGGACUACCUUUCCUCUCUCCUUCCUCUUCU,73.0,0.5068493150684932,Kd: 11.6 nM,11.6,5'-GGGAGAAUUCCGACCAGAAG-N30-CCUUUCCUCUCUCCUUCCUCUUCU-3',30.0,"20 mM HEPES, pH 7.4, 150 mM NaCl, 2 mM CaCl2, 0.01% BSA",CaCl,Tris Buffers,7.8,Not applicable,None,None,None
ssRNA,GGGAGAAUUCCGACCAGAAGUGCUCUUAGAAUGGGACUAAGACACGGGACCCUUUCCUCUCUCCUUCCUCUUCU,74.0,0.5135135135135135,Kd: 6.3 nM,6.3,5'-GGGAGAAUUCCGACCAGAAG-N30-CCUUUCCUCUCUCCUUCCUCUUCU-3',30.0,"50 mm Tris/HCl (pH 7.8), 30 mm NaCl, 5 mm CaCl2 and 10 mm dithiothreitol",CaCl,Tris Buffers,7.8,Not applicable,None,None,None
ssRNA,GGGAGAAUUCCGACCAGAAGUACGACACGAUUGGGACGUGUCUAUGGGACCCUUUCCUCUCUCCUUCCUCUUCU,74.0,0.527027027027027,Kd: 8.9 nM,8.9,5'-GGGAGAAUUCCGACCAGAAG-N30-CCUUUCCUCUCUCCUUCCUCUUCU-3',30.0,"50 mm Tris/HCl (pH 7.8), 30 mm NaCl, 5 mm CaCl2 and 10 mm dithiothreitol",CaCl,Tris Buffers,7.8,Not applicable,None,None,None
ssRNA,GGGAGAAUUCCGACCAGAAGCUUUGGUUAUCAUGUUUAUGCGUACGGGCGCCCAUAUGUGCGUCUACAUGGAUCCUCA,78.0,0.5,Kd: 0.31 uM,0.31,5′-GGGAGAATTCCGACCAGAAGCTT-N30-ATATGTGCGTCTACATGGATCCTCA-3′,30.0,"Tris 20 mM pH 7.6, NaCl 300 mM MgCl2 5 mM",MgCl,Tris Buffers,7.6,Not applicable,None,None,None
2'-fluoro/O-Me-RNA,GGGAGGACGAUGCGGAUCGCCCUGAACCGGCCCAGCAGACUGCUGACGGCACGAUCAGACGACUCGCCCGA,71.0,0.676056338028169,Kd: 7 nM,7.0,5′-GGGAGGACGAUGCGG-N40-CCGCATCGTCCTCCC-3′,40.0,"Tris 20 mM pH 7.6, NaCl 300 mM MgCl2 5 mM",MgCl/CaCl,Other Buffers,7.0,Not applicable,"2′-Fluoropyrimidine-modified RNA. pyrimidine positions are substituted with 2′ fluorine, and 14 of 18 purine positions have been substituted with 2′ O-methyl to increase stability toward nucleases",None,None
2'-fluoro/O-Me-RNA,GAACCGGCCCAGCAGACUGCUGACGGCACGAUC3'(3'U),34.0,0.6470588235294118,Kd: 7 nM,7.0,5'-GGGAGGACGAUGCGG-N40-CCGCATCGTCCTCCC-3',40.0,"110 mM NaCl, 1 mM MgCl2, 20 mM HEPES, pH 7.0, 1 mM CaCl2, 5mM KCl",MgCl/CaCl,Other Buffers,7.0,The truncated aptamer contains a 3'-3' thymidine cap at the 3' end,"2′-Fluoropyrimidine-modified RNA; reported no loss in affinity from full sequence. All pyrimidine positions contain a 2' fluoro modification, and all purine positions are 2' O-methyl except the 3rd position A, 22nd position G, 23rd position A, and 31st position A, which are 2' hydroxy.",None,MAAMGSCLKEYDVLLDQLQKQTDLMQDTSSLLDPYIRVQGLDVPKLREHCREHP...LPR
2'-amino-RNA,UAGGGAAUUCGUCGACGGAUCCUGAACGGAGGGCGGAUGUAGAACAGGGGCUGGAAUGAUUCGGGAUUUUCUGCUGCAGGUCGACGCAUGCGCCG,95.0,0.5789473684210527,Kd: 0.25 μM,250.0,5'-TAGGGAATTCGTCGACGGATCC-N59-CTGCAGGTCGACGCATGCGCCG-3',59.0,"100 mM Tris-acetate (pH 7.4), 200 mM NaOAc, 25 mM KOAc,10 mM Mg(OAc)2, 0.5% Triton X-100, and 5% DSMO",None,Tris Buffers,7.4,Not applicable,RNA is modified with 2' amino groups (2'-AmCTP),None,None
2'-amino-RNA,UAGGGAAUUCGUCGACGGAUCCAGUUCACUCGACCAAGGCGUCCCAAGCGGAGGAUCGCAAGGAGGUGUAGACGUCUGCAGGUCGACGCAUGCGCCG,97.0,0.6082474226804123,Kd: 0.66 μM,660.0,5'-TAGGGAATTCGTCGACGGATCC-N59-CTGCAGGTCGACGCATGCGCCG-3',59.0,"100 mM Tris-acetate (pH 7.4), 200 mM NaOAc, 25 mM KOAc,10 mM Mg(OAc)2, 0.5% Triton X-100, and 5% DSMO",None,Tris Buffers,7.4,Not applicable,RNA is modified with 2' amino groups (2'-AmCTP),None,None
ssRNA,GGGGCCACCAACGACAUUGACGAAUGCGUAAAUUGCUAGGUUGAUAUAAAUAGUGCCCAUGGAUCCGCGGGUGUCGGG,78.0,0.5256410256410257,Kd: 87.4 ± 10.4 nM (WT1-ZFP) & 69.8 ± 8.4 nM (WT1[+KTS]-ZFP),87.4,5'-GGGGCCACCAACGACAUU-N20-GUUGAUAUAAAUAGUGCCCAUGGAUCCGCGGGUGUCGGG-3',20.0,"PBS binding buffer (Invitrogen, 155 mM NaCl, 1.1 mMKH2PO4, 3 mM Na2HPO4·7H2O, pH 7.4)",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssRNA,GGGGCCACCAACGACAUUGAUAUGGUGACCACCCCGGCGUUGAUAUAAAUAGUGCCCAUGGAUCCGCGGGUGUCGGG,77.0,0.5844155844155844,Kd: 13.8 ± 1.1 nM (WT1-ZFP) & 22.8 ± 2.3 nM (WT1[+KTS]-ZFP),13.8,5'-GGGGCCACCAACGACAUU-N20-GUUGAUAUAAAUAGUGCCCAUGGAUCCGCGGGUGUCGGG-3',20.0,"20 mM K±HEPES, pH 8.0, 400 mM NH4OAc, 10 mM Mg(OAc)2, 0.01% (v/v) Nonidet P-40, 5% glycerol",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssRNA,GGGGCCACCAACGACAUUAUCACCCACCCCGAGCUGGCGUUGAUAUAAAUAGUGCCCAUGGAUCCGCGGGUGUCGGG,77.0,0.5974025974025974,Kd: 17.8 ± 1.4 nM (WT1-ZFP) & 33.7 ± 4.4 nM (WT1[+KTS]-ZFP) ,17.8,5'-GGGGCCACCAACGACAUU-N20-GUUGAUAUAAAUAGUGCCCAUGGAUCCGCGGGUGUCGGG-3',20.0,"50 mM Tris^HCl, pH 7.5, 50 mM NaCl, 7 mM MgCl2",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
2'-amino-RNA,"GGAGGUCGACCUCGCGCGAGGAGGGUGGAGGGUCGUAGAGCGCGUAGGAGG3'

",51.0,0.7058823529411765,Kd: 300 to 400 nM,300.0,5′-TCGGAGAGACAAGCTTGGGTC-N40-AGAAGAGAAAGAGAAGTTAATTAAGGATCCTCAC-3′,40.0,"HBSMClT [HBSMC [HEPES buffered saline (pH 7.4), 1 mm MgCl2, 1 mm CaCl2], 0.01% I-block (Tropix Inc., Bedford, MA), 0.05% Tween 20]",MgCl,Other Buffers,7.4,"Truncated of a4 rna clone omitting any terminal primer binding sites: no difference in the binding behaviour to immobilized moenomycin was detectable, indicating that the primer binding sites are not required for moenomycin complexation",nuclease-resistant 2′-aminopyrimidine-modified RNA,None,None
2'-amino-RNA,UCUAAUACGACUCACUAUAGGGAGAGACAAGCUUGGGUCUCAUCGGAGGAGCGGUGUGGUGAGGUGACGCGGAAAAGGUAGAAGAGAAAGAGAAGUUAAUUAAGGAUCCUCAC3′,113.0,0.4778761061946903,Kd: 300 to 400 nM,300.0,5′-TCGGAGAGACAAGCTTGGGTC-N40-AGAAGAGAAAGAGAAGTTAATTAAGGATCCTCAC-3′,40.0,"HBSMClT [HBSMC [HEPES buffered saline (pH 7.4), 1 mm MgCl2, 1 mm CaCl2], 0.01% I-block (Tropix Inc., Bedford, MA), 0.05% Tween 20]",MgCl,Other Buffers,7.4,"Truncated of a4 rna clone omitting any terminal primer binding sites: no difference in the binding behaviour to immobilized moenomycin was detectable, indicating that the primer binding sites are not required for moenomycin complexation",nuclease-resistant 2′-aminopyrimidine-modified RNA,None,None
ssRNA,CCGUAAUACGACUCACUAUAGGGGAGCUCGGUACCGAAUUCAAGGYACUCUGUGCUUGUCGAUGUGYAUUGAUGGCACUUUCGAGUCAACGAGUUGACAGRACAAGUAGUCAAGCUUUGCAGAGAGGAUCCUU,130.0,0.4662,Kd: 0.085 nM and 3.3 nM via SPR,0.085,5'-CCGUAAUACGACUCACUAUAGGGGAGCUCGGUACCGAAUUC-N70-AAGCUUUGCAGAGAGGAUCCUU-3',70.0,"150 mM NaCl, 20 mM Hepes (pH 7.4), 1 mMCaCl2, 1 mM MgCl2",MgCl,Other Buffers,7.4,Not applicable,"In sequence: Y = pyrimidine, R = purine. Static region obtained from pool",None,None
ssRNA,GCAUGCUAAUACGACUCACUAUAGGAGCUCAGCCUUCACUGCUGCUUAAAGCCUAAAACAUACCAGAUCGCCACCCGCGCUUUAAUCUGGAGAGGUGAAGAAUUCGACCACCUAGGCUGCACCACAAGCUU,131.0,0.4961832061068702,Kd: ~1 μM,1000.0,5'-GCATGCGAGCTCAGCCTTCACTGCT-N74-CACCTAGGCTGCACCACAAGCTT-3',74.0,"10 mM Tris–HCl pH 7.6, 5 mM MgCl2, 250 mM NaCl",MgCl,Tris Buffers,7.6,Not applicable,None,None,None
ssDNA,5′TAGGGAATTCGTCGTCGTCGACGGATCCATGCTCGCGCCTGCTGTGTTGTTGCTTGGTTTGGTCTTTTTTTGGTTTGTTTTGGGTTCTGCAGGTCGACGCATGCGCCG3′,108.0,0.5370370370370371,Kd: 4.50×10−5 M,45000.0,5′-TAGGGAATTCGTCGTCGTCGACGGATCC-N59-CTGCAGGTCGACGCATGCGCCG-3′,59.0,"20 mM HEPES, pH 7.9, 150 mM KCl, 6 mM MgCl2, 1 mM dithiothreitol",None,Other Buffers,6.9,Not applicable,None,None,None
ssDNA,5′TAGGGAATTCGTCGTCGTCGACGGATCCGTTGGGCTACAGTACTTCCCCTTTTTTCTCTTCCTCCTTCCTATCGCTCTCCCTGCAGGTCGACGCATGCGCCG3′,102.0,0.5686274509803921,Kd: 1.94×10−5 M,1.94,5′-TAGGGAATTCGTCGTCGTCGACGGATCC-N59-CTGCAGGTCGACGCATGCGCCG-3′,59.0,"100 mM PIPES pH 6.9, 1 mM EGTA, 5 mM MgSO4, 100 mM NaCl",None,Other Buffers,6.9,Not applicable,None,None,None
2'-fluoro-RNA,5′GGGAGGACGAUGCGGGAACUCACCGGGAAGAAGCCCGUUCCGUCACAGACAUGUUCCGCAUCGUCCUCCC3′,70.0,0.6285714285714286,Kd: 180 pM,0.18,5′‐GGGAGGACGAUGCGG‐N40‐CCGCATCGTCCTCCC‐3′,40.0,"SCHMK buffer (110 mM NaCl, 1 mM MgCl2, 20 mM HEPES pH 7.0, 1 mM CaCl2, 5 mM KCl)",MgCl/CaCl,Other Buffers,7.0,Not applicable,2′-Fluoropyrimidine modified RNA containing a randomised region of 40 nucleotides was prepared by in vitro transcription from synthetic random DNA templates. ,None,None
2'-fluoro-RNA,5′GGGAGGACGAUGCGGAAAAAUCUAGGCGCUGAAGCCCCGCUUCCUUACCUUCACCCGCAUCGUCCUCCC3′,69.0,0.6086956521739131,Kd: 370 pM,0.37,5′‐GGGAGGACGAUGCGG‐N40‐CCGCATCGTCCTCCC‐3′,40.0,"SCHMK buffer (110 mM NaCl, 1 mM MgCl2, 20 mM HEPES pH 7.0, 1 mM CaCl2, 5 mM KCl)",MgCl/CaCl,Other Buffers,7.0,Not applicable,2′-Fluoropyrimidine modified RNA containing a randomised region of 40 nucleotides was prepared by in vitro transcription from synthetic random DNA templates. ,None,MEDNNMLPQFIHGILSTSHSLFTRSIQELDEGATTPYDYDDGEPCHKTSVKQIG...VGL
2'-fluoro/O-Me-RNA,GGGAGGGACGCGUCGCCGUAAUGGAUGUUUUGCUCCCUG,39.0,0.6153846153846154,Kd: 5 × 10−9 M.,5.0,5′-TCGCGCGAGTCGTCTG-40N-CCGCATCGTCCTCCC-3′,40.0,"Dulbecco's phosphate-buffered saline with MgCl2 and CaCl2 (Life Technologies, Inc.) and 0.05% bovine serum albumin",MgCl/CaCl,PBS/phosphate buffers,7.4,"Aptamer TTA1, a truncated version of aptamer TN-9, was chosen to test species cross-reactivity. Nucleotides 10–26 have been deleted. The oligonucleotide is synthesized with a 3′–3′ linkage and a 5′ primary amine incorporated by phosphoramidite coupling. TTA1.NB is a nonbinding sequence that is identical to TTA1 except that it contains a deletion in which CCCUG-3′-3′-T is replaced by 3′-3′-T.","All pyrimidines are 2′-F and all purines are 2′-OCH3
DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection..",None,None
ssRNA,5‘GGGAGAGAGGAAGAGGGAUGGGGAACAAAGCUGAAGUACUUACCCAAGAUCAUCCCGAACGACAUAACCCAGAGGUCGAU3‘,80.0,0.5125,"Kd: (Human: 2.8 ± 0.7 nM, Porcine: 83 ± 3 pM)",2.8,5‘-GGGAGAGAGGAAGAGGGAUGGG-N40-CAUAACCCAGAGGUCGAU-3‘,40.0,"10 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 1 mM DTT, 4 mM ATP",CaCl,Other Buffers,7.4,Not applicable,None,None,None
ssRNA,GCGAAUUCGGAGAGGAUACUACACGUGAUAGGACGAUUAUCGAAAAUCACCAGAUUGGACCCUGGUUAACGAUCGGAAGCUUCUGCUACAUGCAAUGG,98.0,0.46938775510204084,Kd: 10 μM,10000.0,5′-CGGAAGCTTCTGCTACATGCAATGG-N50-CACGTGTAGTATCCTCTCCC-3′,50.0,"10 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 1 mM DTT, 4 mM ATP",MgCl,Other Buffers,7.3,Not applicable,None,None,None
ssRNA,GGGAGAGGAUACUACACGUGAUAGGACGAUUAUCGAAAAUCACCAGAUUGGACCCUGGUUAACGAUCCAUUGCAUGUAGCAGAAGCUUCCG,91.0,0.4725274725274725,Kd: 10 uM,10000.0,5'-CGGAAGCTTCTGCTACATGCAATGG-N50-CACGTGTAGTATCCTCTCCC-3',50.0,"10 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 1 mM DTT, 4 mM ATP",MgCl,Other Buffers,7.3,Not applicable,None,C1=NC2=NC=NC(=C2N1)N,None
ssDNA,AATTCGCTAGCTGGAGCTTGGATTGATGTGGTGTGTGAGTGCGGTGCCC,49.0,0.5510204081632653,Kd: 45±4 μM,45000.0,5'-CGTACGGAATTCGCTAGC-N60-GGATCCGAGCTCCACGTG-3',60.0,"Tris 20 mM, pH 7.6, NaCl 300 mM and MgCl2 5 mM",MgCl,Tris Buffers,7.6,"The paper does not state the static regions were removed from the original aptamer, however the reported sequence untilized in the kd determination was the random region only. We have reported the seqeunce utilized in the kd determination.",None,C1=CC(=CC=C1CC(C(=O)N)N)O,None
ssDNA,AATTCGCTAGCCGAGCAGACGGCGTACGGAATTCGAGCTCGGTACCCGGGGATCC,55.0,0.6181818181818182,Kd: 760±21 μM,760000.0,5'-CGTACGGAATTCGCTAGC-N60-GGATCCGAGCTCCACGTG-3',60.0,"Tris 20 mM, pH 7.6, NaCl 300 mM and MgCl2 5 mM",MgCl,Tris Buffers,7.6,"The paper does not state the static regions were removed from the original aptamer, however the reported sequence untilized in the kd determination was the random region only. We have reported the seqeunce utilized in the kd determination.",None,C1=CC(=CC=C1CC(C(=O)N)N)O,MSDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTPREFVTVVLKAVFRMSEDTG...PEE
ssRNA,GGGAUGCUUCGGCAUCCCAGUCGAUGCGUAUCGCAGACUAUGUGGCUUCGGCCGUUGGAGUUGGUACCGCUUCGGCGGUACGUAAGCUUGGG,92.0,0.5978260869565217,Kd: 16 ± 1.6 nM,16.0,5'-GGGAUGCUUCGGCAUCCC-N25-GGCUUCGGCC-N10-GUACCGCUUCGGCGGUACGTAAGCTTGGG-3',35.0,50 mM Tris-Cl (pH 7.5)-100 mM KCl-50 mM NaCl-5 mM MgCl2 (5B-selection buffer),MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssRNA,GGGAUGCUUCGGCAUCCCCGAAGCCGCUAUGGACCAGUGGCGCGGCUUCGGCCCGACGGAGUGGUACCGCUUCGGCGGUACGUAAGCUUGGG,92.0,0.6739130434782609,Kd: 1.5 ± 0.2 nM,1.5,5'-GGGAUGCUUCGGCAUCCC-N25-GGCUUCGGCC-N10-GUACCGCUUCGGCGGUACGTAAGCTTGGG-3',35.0,50 mM Tris-Cl (pH 7.5)-100 mM KCl-50 mM NaCl-5 mM MgCl2 (5B-selection buffer),MgCl,Tris Buffers,7.5,Not applicable,None,None,SMSYTWTGALITPCAAEESKLPINALSNSLLRHHNMVYATTSRSAGQRQKKVTF...HHH
ssRNA,GGGAUGCUUCGGCAUCCCGCUCUGGGCCGAAUAUGGACCACGUGGCUUCGGCCGCCAGCUCGUGUACCGCUUCGGCGGUACGUAAGCUUGGG,92.0,0.6521739130434783,Kd: 10 ± 1.6 nM,10.0,5'-GGGAUGCUUCGGCAUCCC-N25-GGCUUCGGCC-N10-GUACCGCUUCGGCGGUACGTAAGCTTGGG-3',35.0,"SHMCK buffer 110 mM NaCl, 20 mM HEPES (pH 7.5 at 25°C), 1 mM MgCl2, 1 mM CaCl2, containing 0.2% (w/v) CHAPS, 0.04% (w/v) CHS, 0.1% (w/v)LM",MgCl,Tris Buffers,7.5,Not applicable,None,None,SMSYTWTGALITPCAAEESKLPINALSNSLLRHHNMVYATTSRSAGQRQKKVTF...HHH
ssRNA,CGAAGCCGCGCUAUGGACCAGUGGCGCGGCUUCG,34.0,0.7058823529411765,Kd: >>200 nM,200.0,5'-GGGAUGCUUCGGCAUCCC-N25-GGCUUCGGCC-N10-GUACCGCUUCGGCGGUACGTAAGCTTGGG-3',35.0,50 mM Tris-Cl (pH 7.5)-100 mM KCl-50 mM NaCl-5 mM MgCl2 (5B-selection buffer),MgCl,Tris Buffers,7.5,Insertion of bases (gc) and deletion of last 13 bases,None,None,SMSYTWTGALITPCAAEESKLPINALSNSLLRHHNMVYATTSRSAGQRQKKVTF...HHH
ssRNA,AAUUAACCCUCACUAAAGGGAACUGUUGUGAGUCUCAUGUCGAACUUUCCUAGCGCACAUGCGACCUCUAUGCGUAAUACGAACGUUGACGGUUUGAGCGUCUAGUCUUGUCU,113.0,0.46017699115044247,Kd: 7 ± 1.8 nM,7.0,5'-AATTAACCCTCACTAAAGGGAACTGTTGTGAGTCTCATGTCGAA-N49-TTGAGCGTCTAGTCTTGTCT-3',49.0,"20 mM HEPES–NaOH pH 7.5, 100 mM NaCl, 50 mM KCl, 10 mM MgCl2",MgCl,Other Buffers,7.5,Not applicable,None,None,None
ssRNA,5′UCGGAGAAAGGGAAGCUUGAGCAGCAGGAGGGCCGGCGUUAGGGUUAGCGAGCCGAUUGAAAGAAGAAGGAACGAGCGUACGGAUCCGAUC3′,91.0,0.5714285714285714,Kd: 0.37 μM,370.0,5′-TCGGAGAAAGGGAAGCTTGAG-N40-AGAAGAAGGAACGAGCGTACGGATCCGATC-3′,40.0,"PBS binding buffer (Invitrogen, 155 mM NaCl, 1.1 mMKH2PO4, 3 mMNa2HPO4·7H2O, pH 7.4)",None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssRNA,CGUCCCUUCGCAACCCUUUAAGACUUGGGACCCUGCUCUU,40.0,0.55,Kd: 3.6 nM,3.6,5'-GUCCC-N20-GGGAC-3',20.0,"20 mM HEPES, pH 7.4/150 mM NaCl/2 mM CaCl2/0.01% BSA",None,Other Buffers,8.0,Not applicable,None,None,None
ssRNA,GGGAGAGGAUACUACACGUGGUGUGUCAAGCCAGCCCUAGCUUGCUACCUGGGGGCCACUGACCUAUCCAUUGCAUGUAGCAGAAGCUUCCG,92.0,0.5652173913043478,Kd: 2 x 10^-5 M,20000.0,5'-GGGAGAGGAUACUACACGUG-N50-CCAUUGCAUGUAGCAGAAGCUUCCG-3',50.0,"20 mM HEPES, pH 7.4/150 mM NaCl/2 mM CaCl2/0.01% BSA",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssRNA,GGGAGAGGAUACUACACGUGGAAAGCUGAAAGUGAACGGAGUAUCACAGAGAACCCGGAAAAGUGGAGCCAUUGCAUGUAGCAGAAGCUUCCG,93.0,0.5053763440860215,Kd: 2 x 10^-5 M,20000.0,5'-GGGAGAGGAUACUACACGUG-N50-CCAUUGCAUGUAGCAGAAGCUUCCG-3',50.0,"10 mM HEPES/KOH pH 7.4, 150 mM NaCl, 4 mM KCl with CaCl2 (final 1 mM), MgCl2 (final 1 mM), Tween (final 0.05%)",MgCl,Tris Buffers,7.5,Not applicable,None,None,MPKKVLTGVVVSDKMQKTVTVLVERQFPHPLYGKVIKRSKKYLAHDPEEKYKLG...GKA
ssRNA,5′GGGAGAGCGGAAGCGUGCUGGGCCUCUGUUCCCAAGGGAAUACYGGUCGUGUUGGAUCAGGUUGGCAUAACCCAGAGGUCGAUGGAUCCCCCC3′,92.0,0.6086956521739131,Kd: 30 nM,30.0,5′-GGGAGAGCGGAAGCGUGCUGGGCC-N41-CAUAACCCAGAGGUCGAUGGAUCCCCCC-3′,41.0,"30 mM Tris–HCl pH 8.5, 40 mM ammonium sulfate, 20 mM magnesium chloride, 0.01% 2-mercaptoethanol",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssRNA,GUCGAUGUGAUAAGUAGGACGGAGGUGGUCGAU,33.0,0.5151515151515151,Kd:2–4 nM,2.0,5'-AAACAGAACAGCAGAGTGGCTGGGATG-N10-GCTAGCATC-GACCACCTCCGTCCTACTTATCACATCGACGCTAGC-N10-C-ATCCCAGCGCAGCGGTACG-3',20.0,"buffer A (20 mM NaxHyPO4 [pH 7.4], 2 mM MgCl2, 130 mM NaCl, 5 mM KCl), 0.5 mM DTT, 1 μM 32P-labeled pool RNA, 1 μM sVSG",MgCl,Other Buffers,7.9,Not applicable,None,None,None
ssRNA,UUACCGUAAGGCCUGUCUUCGUUUGACAGCGGCUUGUUGACCCUCACACUUUGUACCUGCUGCCAA,66.0,0.5151515151515151,Kd: 29–48 nM,29.0,5'-CCAAGCTTGCATGCCTGCAG-N70-GGTACCGAGCTCGAATTCCC-3,70.0,"buffer A (20 mM NaxHyPO4 [pH 7.4], 2 mM MgCl2, 130 mM NaCl, 5 mM KCl), 0.5 mM DTT, 1 μM 32P-labeled pool RNA, 1 μM sVSG",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssRNA,5′GUGACGCGACUAGUUACGGAUGCUCAACAGUAGCCAACACGAGUACUGCUUCGGCAGUGGAACCAACGUAGUAUGUUUAGCAUUCAUUCAGUUGGCGCCUCCUAUAGUGAGUCGUAUUACAU,122.0,0.47540983606557374,Kd: 28 nM,28.0,5′-GTGACGCGACTAGTTACGGA-N26-CTGCCGAAGCAG-N26-TTCATTCAGTTGGCGCCTCCTATAGTGAGTCGTATTACAT-3',52.0,"buffer A (20 mM NaxHyPO4 [pH 7.4], 2 mM MgCl2, 130 mM NaCl, 5 mM KCl), 0.5 mM DTT, 1 μM 32P-labeled pool RNA, 1 μM sVSG",MgCl,PBS/phosphate buffers,6.2,Not applicable,None,None,None
ssRNA,5′GUGACGCGACUAGUUACGGACUUUCCGaAGuGGUUGGGCUGCUUCGGCAGuGuGAAAaCGGAGAGUUCAUUCAGUUGGCGCCUCCUAUAGUGAGUCGUAUUACAU,105.0,0.5047619047619047,Kd: 60–300 nM,60.0,"5′-GTGACGCGACTAGTTACGGA-N64-TTCATTCAGTTGGCGCCTCCTATAGTGAGTCGTATTACAT-3'
5′-GTGACGCGACTAGTTACGGA-N26-CTGCCGAAGCAG-N26-TTCATTCAGTTGGCGCCTCCTATAGTGAGTCGTATTACAT-3'",58.0,"Buffer A (20 mM Tris, pH 7.6, 80 mM potassium acetate, 2.5 mM magnesium acetate, 5% glycerol), 100 Units RNase inhibitor (TaKaRa Co.)",MgCl,PBS/phosphate buffers,6.2,Not applicable,RNA transcribed from these two initial libraries was mixed together in a 1:1 ratio before the start of the selection,None,MSLQLLNPKAESLRRDAALKVNVTSAEGLQSVLETNLGPKGTLKMLVDGAGNIK...TPQ
ssRNA,5′GUGACGCGACUAGUUACGGAGAUAAGUUCCCAAGGCGGGUUGGAAGAGAUAUCAUAGGAGCUUGUCUUCAUUCAGUUGGCGCCUCCUAUAGUGAGUCGUAUUACAU,106.0,0.4716981132075472,Kd: 200 nM,200.0,5′-GTGACGCGACTAGTTACGGA-N64-TTCATTCAGTTGGCGCCTCCTATAGTGAGTCGTATTACAT-3',64.0,"Buffer A (20 mM Tris, pH 7.6, 80 mM potassium acetate, 2.5 mM magnesium acetate, 5% glycerol), 100 Units RNase inhibitor (TaKaRa Co.)",MgCl,PBS/phosphate buffers,6.2,Not applicable,None,None,MSLQLLNPKAESLRRDAALKVNVTSAEGLQSVLETNLGPKGTLKMLVDGAGNIK...TPQ
ssRNA,5′GUGACGCGACUAGUUACGGAUCUAGCAGUUCAGGUAACCACGUAAGAUACGGGUCUAGAUUCAUUCAGUUGGCGCCUCCUAUAGUGAGUCGUAUUACAU,99.0,0.46464646464646464,Kd:  250 nM,250.0,5′-GTGACGCGACTAGTTACGGA-N64-TTCATTCAGTTGGCGCCTCCTATAGTGAGTCGTATTACAT-3',64.0,"Buffer A (20 mM Tris, pH 7.6, 80 mM potassium acetate, 2.5 mM magnesium acetate, 5% glycerol), 100 Units RNase inhibitor (TaKaRa Co.)",MgCl,PBS/phosphate buffers,6.2,Not applicable,None,None,MSLQLLNPKAESLRRDAALKVNVTSAEGLQSVLETNLGPKGTLKMLVDGAGNIK...TPQ
ssRNA,5′GUGACGCGACUAGUUACGGAGGCAUCUAUAUACUGCUUCGGCAGGGAACUCUACUAAGCACCGAUGUCUUCAUUCAGUUGGCGCCUCCUAUAGUGAGUCGUAUUACAU,108.0,0.48148148148148145,Kd:  250 nM,250.0,5′-GTGACGCGACTAGTTACGGA-N26-CTGCCGAAGCAG-N26-TTCATTCAGTTGGCGCCTCCTATAGTGAGTCGTATTACAT-3',52.0,"Buffer A (20 mM Tris, pH 7.6, 80 mM potassium acetate, 2.5 mM magnesium acetate, 5% glycerol), 100 Units RNase inhibitor (TaKaRa Co.)",MgCl,PBS/phosphate buffers,6.2,Not applicable,None,None,MSLQLLNPKAESLRRDAALKVNVTSAEGLQSVLETNLGPKGTLKMLVDGAGNIK...TPQ
ssRNA,5′GUGACGCGACUAGUUACGGAAAUGAAGAUAGUCGGGACCACUUCCCUGAGUCUGCUUCGGCAGUAACUCCAAGGAGAAAGGUCGUCAUUUUCAUUCAGUUGGCGCCUCCUAUAGUGAGUCGUAUUACAU,129.0,0.4806201550387597,Kd: 500 nM,500.0,5′-GTGACGCGACTAGTTACGGA-N26-CTGCCGAAGCAG-N26-TTCATTCAGTTGGCGCCTCCTATAGTGAGTCGTATTACAT-3',52.0,"20 mM Tris, pH 7.6, 80 mM potassium acetate, 2.5 mM magnesium acetate, 5% glycerol",MgCl,PBS/phosphate buffers,6.2,Not applicable,None,None,MSLQLLNPKAESLRRDAALKVNVTSAEGLQSVLETNLGPKGTLKMLVDGAGNIK...TPQ
ssRNA,GGAAUUCUAAUACGACUCACUAUAGGGACGCAGGGACUGUACCUUCUAGGCUGGGUCAUGUGACUGUAGCGG,72.0,0.5138888888888888,Kd: 1 nM,1.0,5'-GGAATTCGGACGCAGGGACTGTA- N16 -ATGTGACTGTAGCGG-3',16.0,"5 mM, MgCl2 in PBS",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssRNA,GGAAUUCUAAUACGACUCACUAUAGGGACGCAGGGACUGUACGGUAAGUCCCCGGGCAUGUGACUGUAGCGG,72.0,0.5416666666666666,Kd: 0.46 nM,0.46,5'-GGAATTCGGACGCAGGGACTGTA- N16 -ATGTGACTGTAGCGG-3',16.0,"10 mM Tris·HCl (pH 7.5) containing 150 mM NaCl, 1 mM MgCl2, 1 mM CaCl2, 0.1% (wt/vol) BSA, 0.1% (vol/vol) Triton X-100, 0.1% (vol/vol) Tween 20",MgCl,Tris Buffers,7.5,Not applicable,None,None,MERFLTEEQQMIVDTARQITDKLIIPRRAELDEKHEFPRDILKAMAQADLFGIP...YNK
ssRNA,GGAAUUCUAAUACGACUCACUAUAGGGACGCAGGGACUGUAUGGUUUUCUGGGGUUUAUGUGACUGUAGCGG,72.0,0.4722222222222222,Kd: 1.19 nM,1.19,5'-GGAATTCGGACGCAGGGACTGTA- N16 -ATGTGACTGTAGCGG-3',16.0,"100 mM NaCl, 1 mM MgCl2, 20 mM Tris-HCl, pH 7.12",MgCl,Tris Buffers,7.5,Not applicable,None,None,MERFLTEEQQMIVDTARQITDKLIIPRRAELDEKHEFPRDILKAMAQADLFGIP...YNK
ssRNA,GGAAUUCUAAUACGACUCACUAUAGGGACGCAGGGACUGUACGGAUCAGAGUCUCCUAUGUGACUGUAGCGG,72.0,0.5,Kd: 0.1 nM,0.1,5'-GGAATTCGGACGCAGGGACTGTA- N16 -ATGTGACTGTAGCGG-3',16.0,"20 mM Tris, pH 7.4, 250 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 0.005% Triton X‐100",MgCl,Tris Buffers,7.5,Not applicable,None,None,MERFLTEEQQMIVDTARQITDKLIIPRRAELDEKHEFPRDILKAMAQADLFGIP...YNK
2'-fluoro-RNA,5′ACCGAGUCCAGAAGCUUGUAGUACUGACCCUUCCCGACGCACGGACCAGUGAUGCCAACCCACCCGCCUAGAUGGAGUUGAAUUCUCCCUAUAGUGAGUCGUAUUAC3′,107.0,0.5327102803738317,Kd: 142 ± 94 nM,142.0,5′-ACCGAGTCCAGAAGCTTGTAGTACT-N40-GCCTAGATGGAGTTGAATTCTCCCTATAGTGAGTCGTATTAC-3′,40.0,"20 mM Tris, pH 7.4, 250 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 0.005% Triton X‐100",None,PBS/phosphate buffers,7.4,Not applicable,"Two′-fluoro-pyrimidines (2′F-dCTP and 2′F-dUTP) were from TriLink BioTechnologies (San Diego, CA).[α-32P]ATP and 1 mm 2′-OH-(ATP and GTP) and 3 mm2′-F-(dCTP and dUTP), the latter to provide stability of the transcript against RNase activity
DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection..",None,None
2'-fluoro-RNA,5′ACCGAGUCCAGAAGCUUGUAGUACUCAAUACUCAAGCAAGCCCAGCCCUACCAACCCCGGAGCCUAGAUGGAGUUGAAUUCUCCCUAUAGUGAGUCGUAUUAC3′,103.0,0.49514563106796117,Kd: 400 ± 239 nM,400.0,5′-ACCGAGTCCAGAAGCTTGTAGTACT-N40-GCCTAGATGGAGTTGAATTCTCCCTATAGTGAGTCGTATTAC-3′,40.0,"PBS, 20 mm glucose (phosphate-buffered saline, pH 7.4)",None,PBS/phosphate buffers,7.4,Not applicable,"Two′-fluoro-pyrimidines (2′F-dCTP and 2′F-dUTP) were from TriLink BioTechnologies (San Diego, CA).[α-32P]ATP and 1 mm 2′-OH-(ATP and GTP) and 3 mm2′-F-(dCTP and dUTP), the latter to provide stability of the transcript against RNase activity
DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection..",None,None
2'-fluoro-RNA,5′ACCGAGUCCAGAAGCUUGUAGUACUAUCGCUACUGCGCCGGUUGCGGCUUGCGGUUGCAACGCCAGCCUAGAUGGAGUUGAAUUCUCCCUAUAGUGAGUCGUAUUAC3′,107.0,0.5233644859813084,Kd: 40 ± 14 nM,40.0,5′-ACCGAGTCCAGAAGCTTGTAGTACT-N40-GCCTAGATGGAGTTGAATTCTCCCTATAGTGAGTCGTATTAC-3′,40.0,"PBS, 20 mm glucose (phosphate-buffered saline, pH 7.4)",None,PBS/phosphate buffers,7.4,Not applicable,"Two′-fluoro-pyrimidines (2′F-dCTP and 2′F-dUTP) were from TriLink BioTechnologies (San Diego, CA).[α-32P]ATP and 1 mm 2′-OH-(ATP and GTP) and 3 mm2′-F-(dCTP and dUTP), the latter to provide stability of the transcript against RNase activity
DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection..",None,None
2'-fluoro-RNA,5′ACCGAGUCCAGAAGCUUGUAGUACUUCUCUCAGCCACGUUCUAUGUGACGCAAGCUACCCUGUAUGCCUAGAUGGAGUUGAAUUCUCCCUAUAGUGAGUCGUAUUAC3′,107.0,0.4672897196261682,Kd: 209 ± 99 nM,209.0,5′-ACCGAGTCCAGAAGCTTGTAGTACT-N40-GCCTAGATGGAGTTGAATTCTCCCTATAGTGAGTCGTATTAC-3′,40.0,"PBS, 20 mm glucose (phosphate-buffered saline, pH 7.4)",None,PBS/phosphate buffers,7.4,Not applicable,"Two′-fluoro-pyrimidines (2′F-dCTP and 2′F-dUTP) were from TriLink BioTechnologies (San Diego, CA).[α-32P]ATP and 1 mm 2′-OH-(ATP and GTP) and 3 mm2′-F-(dCTP and dUTP), the latter to provide stability of the transcript against RNase activity
DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection..",None,None
ssRNA,UAAUACGACUACUAUAGGGAGGACGAUGCGGACAGAUACGGAACUACAGAGGUCAAUUACGGUGGCCACGCCAGACGACUCGCCCGA,87.0,0.5402298850574713,Kd: 0.37 nM,0.37,5'-TAATACGACTACTATAGGGAGGACGATGCGG-N40-CAGACGACTCGCCCGA-3',40.0,"SHMCK buffer 110 mM NaCl, 20 mM Hepes (pH 7.5 at 25°C), 1 mM MgCl2, 1 mM CaCl2, containing 0.2% (w/v) CHAPS, 0.04% (w/v) CHS, and 0.1% (w/v)LM",MgCl/CaCl,Other Buffers,7.5,Not applicable,None,None,None
ssRNA,GGGAGCUCAGAAUAAACGCUCAAUGUAGAGACUUUUCGAAAAGCGUGUUCCCAAUGAGUCUAUGCAUGCAUGAGGCCCGGAUCCGGC,87.0,0.5057471264367817,Kd × 10e4: 1.0 ± 0.1 (1/s),100000.0,5'-GGGAGCUCAGAAUAAACGCUCAA-N40-GCAUGCAUGAGGCCCGGAUCCGGC-3',40.0,"40 mM Tris–HCl, pH 8, 5 mM MgCl2, 5% glycerol",MgCl,Tris Buffers,8.0,Not applicable,None,None,MSTLPKPQRKTKRNTNRRPMDVKFPGGGQIVGGVYLLPRRGPRLGVRATRKTSE...PAR
ssRNA,GGGAGCUCAGAAUAAACGCUCAAUGUAGGCUAGUACCGACCUGCGUGCCUCGCUCCUUUUCAUGCAUGCAUGAGGCCCGGAUCCGGC,87.0,0.5747126436781609,Kd × 10e4: 100 ± 6 (1/s),10000000.0,5'-GGGAGCUCAGAAUAAACGCUCAA-N40-GCAUGCAUGAGGCCCGGAUCCGGC-3',40.0,"40 mM Tris–HCl, pH 8, 5 mM MgCl2, 5% glycerol",MgCl,Tris Buffers,8.0,Not applicable,None,None,MSTLPKPQRKTKRNTNRRPMDVKFPGGGQIVGGVYLLPRRGPRLGVRATRKTSE...PAR
ssRNA,5′GGGAGGACGAUGCGGACUAGCCUCAUCAGCUCAUGUGCCCCUCCGCCUGGAUCACCAGACGACUCGCUGAGGAUCCGAGA3′,80.0,0.625,Kd: 3.1 nM,3.1,5′-GGGAGGACGATGCGG-N40-CAGACGACTCGCTGAGGATCCGAGA-3′,40.0,"20 mM Hepes, pH 7.4/150 mM NaCl/2 mM CaCl2/0.01% BSA",CaCl,Other Buffers,7.4,Not applicable,None,None,None
ssRNA,5′GAGGACGAUGCGGACUAGCCUCAUCAGCUCAUGUGCCCCUC3′,41.0,0.6097560975609756,Kd: 2.2 nM,2.2,5′-GGGAGGACGATGCGG-N40-CAGACGACTCGCTGAGGATCCGAGA-3′,40.0,"20 mM Hepes, pH 7.4/150 mM NaCl/2 mM CaCl2/0.01% BSA",CaCl,Other Buffers,7.4,41-nt truncate of aptamer 11-1,None,None,MAMSPGPLFLVFLLGLVVIPPTLSQDDSRYTKFLTQHYDAKPKGRDDRYCESMM...ISP
2'-O-Me-RNA,5′GGACUGAUGGCGCGGUCCUAUUACGCCGAAAGGGAGAGGGGAGACAGG,48.0,0.625,Kd: 2.5 nM,2.5,5′-GGAC-N40-GACAGG-3',40.0,"10 mM HEPES/KOH pH 7.4, 150 mM NaCl, 4 mM KCl with CaCl2 (final 1 mM), MgCl2 (final 1 mM) and Tween (final 0.05%)",MgCl/CaCl,Other Buffers,7.4,Not applicable,"Three complexities of a combinatorial RNA library (5′-GGAC-N40-GACAGG) of 1015 different molecules, that was obtained by in vitro transcription of a synthetic ssDNA library (5′-COMeCOMeTGTC-N40-GTCCTATAGTGAGTCGTATTAGTAGTCGC) in the presence of a 1.5-fold excess of the forward primer (5′-GCGACTACTAATACGACTCACTATAGGAC), were used as the starting library. The last two nucleotides of the 5′ terminus of the DNA library were modified with 2′-methoxy-cytidines in order to reduce the non-templated nucleotide addition at the 3′ terminus of the in vitro transcripts.",None,None
ssDNA,GCCTGTTGTGAGCCTCCTCTCGAAGCTGGTCTCTGCGGGTTGTTGCGCCGCGGCACCCTTGGCATTGAGCGTTTATTCTTGTCTCCC,87.0,0.5977011494252874,Kd: 26.5 ± 2.5 nM,26.5,5'-GCCTGTTGTGAGCCTCCTCTCGAA-N40-TTGAGCGTTTATTCTTGTCTCCC-3',40.0,"30 mM Tris–HCl pH 8.5, 40 mM ammonium sulfate, 20 mM magnesium chloride, and 0.01% 2-mercaptoethanol",None,Tris Buffers,8.5,Not applicable,None,None,None
ssDNA,CGGTCGCTCCGTGTGGCTTGGGTTGGGTGTGGCAGTGAC,39.0,0.6666666666666666,Kd: 11 ± 0.8 nM,11.0,5'-GCCTGTTGTGAGCCTCCTCTCGAA-N40-TTGAGCGTTTATTCTTGTCTCCC-3',40.0,"30 mM Tris–HCl pH 8.5, 40 mM ammonium sulfate, 20 mM magnesium chloride, and 0.01% 2-mercaptoethanol",None,Tris Buffers,8.5,Not applicable,None,None,None
ssRNA,GCAAUGGUACGGUACUUCCUUUGGAAGAUAGCUGGAGAACUAACCAAAAGUGCACGCUACUUUGCUAA,68.0,0.4411764705882353,Kd: 164 nM,164.0,5'-CAATGGTACGGTACTTCC-N25-CAAAAGTGCACGCTACTTTGCTAA-3',25.0,"30 mM Tris–HCl, pH 7.5, 150 mM NaCl, 10 mM MgCl2, 2 mM dithiothreitol, 1% bovine serum albumin",MgCl/CaCl,Other Buffers,7.35,Not applicable,Pool includes T7 promotor region,None,None
ssRNA,GCAAUGGUACGGUACUUCCAAGUGCGGGGGGGAGGUGGUGGUUCCAAAAGUGCACGCUACUUUGCUAA,68.0,0.5441176470588235,Kd: 240 nM,240.0,5'-CAATGGTACGGTACTTCC-N25-CAAAAGTGCACGCTACTTTGCTAA-3',25.0,"SHMCK, 20 mM Hepes, pH 7.35, 120 mM NaCl,
5 mM KCl, 1 mM CaCl2,1mM MgCl2 and 0.1% geletin, 0.05% Tween 20",MgCl/CaCl,Other Buffers,7.35,Not applicable,Pool includes T7 promotor region,None,MSESSWTAFGGRRAIPPNTSNAAENDPPTVELQGLVPRGFNPQDYLNVTNVHLF...PSM
ssRNA,GGGAAUUCCGCGUGUGCCAGCGAAAGUUGCGUAUGGGUCACAUCGCAGGCACAUGUCAUCUGGGCGGUCCGUUCGGGAUCCUC,83.0,0.6024096385542169,Kd: 45 nM in hrg-unbound; 400 nM in hrg-bound,45.0,5'-GGAATTCCGCGTGTGC-N49-GTCCGTTCGGGATCCTC-3',49.0,"10 mM Hepes, pH 7.4/100 mM NaCl/2.5 mM MgCl2",MgCl,Other Buffers,7.4,Not applicable,None,None,None
2'-fluoro-RNA,GAAUUCAGUCGGACAGCGGGAUGAUGCCGCACUGACGCCACGUAGGUGGCGCACAGCCGAUGGACGAAUAUCGUCUCCC,79.0,0.6075949367088608,Kd: 0.16 ± 0.02 nM,0.16,5' GAATTCAGTCGGACAGCG-N40-GATGGACGAATATCGTCTCCC-3',40.0,"buffer A (20 mM NaxHyPO4 [pH 7.4], 2 mM MgCl2, 130 mM NaCl, 5 mM KCl), 0.5 mM DTT, 1 μM 32P-labeled pool RNA, and 1 μM sVSG",MgCl,PBS/phosphate buffers,7.4,Not applicable,"Pool taken from cited article (14) here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC148414/pdf/272006.pdf, 2′ F-modified RNA aptamers showed increased serum stability. The pool was 32P-labeled.",None,None
2'-fluoro-RNA,GAAUUCAGUCGGACAGCGAGCGCGCACCUACUGUGAUGUAGAAGUCACAGCAAGGCCCGAUGGACGAAUAUCGUCUCCC,79.0,0.5569620253164557,Kd: 0.03 ± 0.05,0.03,5' GAATTCAGTCGGACAGCG-N40-GATGGACGAATATCGTCTCCC-3',40.0,"Tris–HCl buffer (50 mM pH 7.6) containing 250 mM NaCl, 5 mM MgCl2",MgCl,PBS/phosphate buffers,7.4,Not applicable,"Pool taken from cited article (14) here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC148414/pdf/272006.pdf, 2′ F-modified RNA aptamers showed increased serum stability. The pool was 32P-labeled.",None,None
2'-fluoro-RNA,GAAUUCAGUCGGACAGCGAGCGCGCACCUACUGUGAUGUAGAAGUCACAGCAAGGCCCGAUGGACGAAUAUCGUCUCCC,79.0,0.5569620253164557,Kd: 0.4 ± 0.09 nM ,0.4,5' GAATTCAGTCGGACAGCG-N40-GATGGACGAATATCGTCTCCC-3',40.0,"Tris–HCl buffer (50 mM pH 7.6) containing 250 mM NaCl, 5 mM MgCl2",MgCl,PBS/phosphate buffers,7.4,Not applicable,"Pool taken from cited article (14) here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC148414/pdf/272006.pdf, 2′ F-modified RNA aptamers showed increased serum stability. The pool was 32P-labeled.",None,None
ssRNA,5′GGGAGACAAGAAUAAAACGCUCAAACAUUGCAUCGACAGCUGCAAGGCUCCCGCCGUACAAACCUUCGACAGGAGGCUCACAACAGGC3′,88.0,0.5340909090909091,Kd: 8 μM,8000.0,5′-GGGAGACAAGAATAAAACGCTCAA-N40-TTCGACAGGAGGCTCACAACAGGC-3′,40.0,"Tris–HCl buffer (50 mM pH 7.6) containing 250 mM NaCl, 5 mM MgCl2",None,Tris Buffers,7.6,Not applicable,None,None,None
ssRNA,5′GGGAGACAAGAAUAAAACGCUCAACAGGCGUUUAGCCUCUAAGUAACAGGGGCCUCCCAUGAGCUUCGACAGGAGGCUCACAACAGGC3′,88.0,0.5340909090909091,Kd: 3 μM,3000.0,5′-GGGAGACAAGAATAAAACGCTCAA-N40-TTCGACAGGAGGCTCACAACAGGC-3′,40.0,"Tris–HCl buffer (50 mM pH 7.6) containing 250 mM NaCl, 5 mM MgCl2",None,Tris Buffers,7.6,Not applicable,None,None,MSGGSADYNSREHGGPEGMDPDGVIESNWNEIVDNFDDMNLKESLLRGIYAYGF...DLI
ssRNA,5′GGGAGACAAGAAUAAAACGCUCAAGGGGACCGCGCCCCACAUGUGAGUGAGGCCGAAACGUAGAUUCGACAGGAGGCUCACAACAGGC3′,88.0,0.5681818181818182,Kd: 44 nM,44.0,5′-GGGAGACAAGAATAAAACGCTCAA-N40-TTCGACAGGAGGCTCACAACAGGC-3′,40.0,"Tris–HCl buffer (50 mM pH 7.6) containing 250 mM NaCl, 5 mM MgCl2",None,Tris Buffers,7.6,Not applicable,None,None,MSGGSADYNSREHGGPEGMDPDGVIESNWNEIVDNFDDMNLKESLLRGIYAYGF...DLI
ssRNA,5′GGGAGACAAGAAUAAAACGCUCAAUGUGGAUGAUUUGUAUGAUCGCGCAUACAAUUCGACAGGAGGCUCACAACAGGC3′,78.0,0.46153846153846156,Kd: 1 μM,1000.0,5′-GGGAGACAAGAATAAAACGCTCAA-N40-TTCGACAGGAGGCTCACAACAGGC-3′,40.0,"Tris–HCl buffer (50 mM pH 7.6) containing 250 mM NaCl, 5 mM MgCl2",None,Tris Buffers,7.6,Not applicable,None,None,MSGGSADYNSREHGGPEGMDPDGVIESNWNEIVDNFDDMNLKESLLRGIYAYGF...DLI
ssRNA,5′GGGAGACAAGAAUAAAACGCUCAAGGGGACCGCGCCCCACAUGUGAGUGAGGCCGAAACAUAGAUUCGACAGGAGGCUCACAACAGGC3′,88.0,0.5568181818181818,Kd: 27 nM,27.0,5′-GGGAGACAAGAATAAAACGCTCAA-N40-TTCGACAGGAGGCTCACAACAGGC-3′,40.0,"Tris–HCl buffer (50 mM pH 7.6) containing 250 mM NaCl, 5 mM MgCl2",None,Tris Buffers,7.6,Not applicable,None,None,MSGGSADYNSREHGGPEGMDPDGVIESNWNEIVDNFDDMNLKESLLRGIYAYGF...DLI
ssDNA,5′GGCCTGTTGTGAGCCTCCTCCCAGAGGGAAGACTTTAGGTTCGGTTCACGTCCCGCTTATTCTTGTCTCCC3′,71.0,0.5633802816901409,Kd:150 nM,150.0,5′-GCCTGTTGTGAGCCTCCT-N34-CGCTTATTCTTGTCTCCC-3′,34.0,"Tris–HCl buffer (50 mM pH 7.6) containing 250 mM NaCl, 5 mM MgCl2",MgCl/CaCl,Tris Buffers,7.5,Not applicable,*constant region and pool type are different in the first nucliotide( constant region in sequence have an extra G base pair),None,None
5-uracil-modified-RNA,CGUGACGUGUGUGUGGGCUGUGGCAGACGUAAGGCUGAGAUUGCCGUCCGUAAUUGAGUGCGGCAGCGAGAGAGAGCAGACUCUCUCUCGUCCUCUUCUC,100.0,0.58,Kd: 1.08 μM,1080.0,5'CGTGACGTGTGTGTGGGCTG-N60-CTCTCTCTCGTCCTCTTCTC3',60.0,"Tris–HCl buffer (50 mM pH 7.6) containing 250 mM NaCl, 5 mM MgCl2",MgCl,Tris Buffers,7.12,The sequence for 10n23-6 was generated from previously identified aptamer 10n23 and was modified by a couple base pairs in the nts 46-78 region.,"The aptamer is UNH2 modified. When they are converted to C, the binding affinity decreases. (5-(3-aminopropyl)uridine triphosphate (UNH2)",None,None
ssDNA,GACGTCTTCGAATCCCCATACTGTGGCATTGGCTCAGGACGGTCTGGAGGATGGGGCTTGACGTC,65.0,0.5846153846153846,Kd: 200 ± 20 nM,200.0,5′‐TCAGCTGGACGTCTTCGAAT‐N60‐TGTCAGGAGCTCGAATTCCC‐3′,60.0,"Tris–HCl buffer (50 mM pH 7.6) containing 250 mM NaCl, 5 mM MgCl2",MgCl/CaCl,Tris Buffers,7.4,Truncated version of b12b10 (65 nts),None,None,None
ssDNA,GACGTCTTCGAATCCCCATACTGTGGCATTGGCTCAGGACGGTCTGGAGGATGGGGCTTGACGTC,65.0,0.5846153846153846,Kd: 420 nM,420.0,5′‐TCAGCTGGACGTCTTCGAAT‐N60‐TGTCAGGAGCTCGAATTCCC‐3′,60.0,"Tris–HCl buffer (50 mM pH 7.6) containing 250 mM NaCl, 5 mM MgCl2",MgCl/CaCl,Tris Buffers,7.4,Truncated version of b12b10 (65 nts),None,None,None
2'-fluoro-RNA,GGGGGAAUUCUAAUACGACUCACUAUAGGGAGAGAGGAAGAGGGAUAGGGCCGACGUGCCGCA,63.0,0.5555555555555556,Kd: 60 nM,60.0,5'-ATCGACCTCTGGGTTATG-N40-CCCATCCCTCTTCCTC-3',40.0,"10 mM Tris-HCl (pH 7.6), 10 mM MgCl2, 30 mM NH4Cl",CaCl,Other Buffers,7.4,Truncated version of m9a-9 by 60 deletions,"The contant region drived from figure 1 is 5'-GGGAGAGAGGAAGAGGGATAGGG-N40-CATAACCCAGAGGTCGATAGTACTGGATCCCCCC-3'
The pool/library in the supplement was reported in pool randon region
DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.",None,None
2'-fluoro-RNA,GGGGGAAUUCUAAUACGACUCACUAUAGGGAGAGAGGAAGAGGGAUAGGGCCGACGUGCCGCA,63.0,0.5555555555555556,Kd: >1 μM,1000.0,5'-ATCGACCTCTGGGTTATG-N40-CCCATCCCTCTTCCTC-3',40.0,"10 mM Tris-HCl (pH 7.6), 10 mM MgCl2, 30 mM NH4Cl",CaCl,Other Buffers,7.4,Truncated version of m9a-9 by 60 deletions,"The contant region drived from figure 1 is 5'-GGGAGAGAGGAAGAGGGATAGGG-N40-CATAACCCAGAGGTCGATAGTACTGGATCCCCCC-3'
The pool/library in the supplement was reported in pool randon region
DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.",None,None
ssRNA,GGGCCGGAGGUUAGCUUGCCCAUGGCAAGCAGGGCGCCACGGACCC,46.0,0.717391304347826,Kd: 30 nM,30.0,5'-GGGAGAGCGGAAGCGUGCUGGGCC-N40-CAUAACCCAGAGGUCGAUGG-3',40.0,"10 mM Tris-HCl (pH 7.6), 10 mM MgCl2, 30 mM NH4Cl",MgCl,Tris Buffers,7.5,Mutated version of an aptamer selected in 2000; also tuncated the aptamer and (separately) PEGylated,https://www.koreascience.or.kr/article/JAKO200011920816102.pdf,None,None
ssRNA,5′GCCUGUUGUGAGCCUCCUGUCGAACUGCGAUCAGCGGUAAAUUUCCGCGCAGCCUCCACGCCGCUUGAGCGUUUAUUCUUGUCUCCC3′,87.0,0.5747126436781609,Kd: 0.45 μM,450.0,5′-GCCTGTTGTGAGCCTCCTGTCGAA-N40-TTGAGCGTTTATTCTTGTCTCCC-3′,40.0,"20 mM Tris/HCl pH 7.9, 10 mM MgCl2, 300 mM NaCl, 30 mM KCl, in subsequent rounds NaCl, KCl concentrations were increased to 400, 40 mM respectively",MgCl,Tris Buffers,7.6,Not applicable,None,None,None
ssRNA,5′GCCUGUUGUGAGCCUCCUGUCGAACAGAGGCAGUACUCAUCAACCCGAGCCUUCCGUCCCUGAGUUGAGCGUUUAUUCUUGUCUCCC3′,87.0,0.5517241379310345,Kd: 2 μM,2000.0,5′-GCCTGTTGTGAGCCTCCTGTCGAA-N40-TTGAGCGTTTATTCTTGTCTCCC-3′,40.0,"20 mM Tris/HCl pH 7.9, 10 mM MgCl2, 300 mM NaCl, 30 mM KCl, in subsequent rounds NaCl, KCl concentrations were increased to 400, 40 mM respectively",MgCl,Tris Buffers,7.6,Not applicable,None,None,MNDSSPTSENIMFHQLTADTLNGSCDLPTCNNNTGEAALQLPTFSMAAKVRVII...TKE
ssRNA,5′GCCUGUUGUGAGCCUCCUGUCGAAUGGGAGGAGUGCUGCUCUCCAGGCACUCUUGUUGCUCGGAUUGAGCGUUUAUUCUUGUCUCCC3′,87.0,0.5517241379310345,Kd: 12 μM,12000.0,5′-GCCTGTTGTGAGCCTCCTGTCGAA-N40-TTGAGCGTTTATTCTTGTCTCCC-3′,40.0,"20 mM Tris–HCl, pH 7.6, 80 mM potassium acetate, 2.5 mM magnesium acetate, 1 mM DTT",MgCl,Tris Buffers,7.6,Not applicable,None,None,MNDSSPTSENIMFHQLTADTLNGSCDLPTCNNNTGEAALQLPTFSMAAKVRVII...TKE
ssDNA,5′GTACGAATTCACGAGGTTGCCAGCGGGGCCAGCCACTTCTGTCAGTGAATTCCTGCTCGTATATCTACTCGCCCGCCTGCGAGCATGGAGTCGGATCCTCTA3′,102.0,0.5686274509803921,Kd: 4.9 μM,4900.0,5′-GTACGAATTCACGAGGTTGCC-N60-AGCATGGAGTCGGATCCTCTA-3′,60.0,"PBS with 1 mM MgCl2, 10 mM DTT",MgCl,Tris Buffers,7.6,Not applicable,None,CC(=O)NC1C(CC(OC1C(C(CO)O)O)(C(=O)O)OC2C(C(OC(C2O)OC(C(CO)O)C(C(C=O)O)O)CO)O)O,MCVLFSLLLLASVFSLGQTTWGVSSPKNVQGLSGSCLLIPCIFSYPADVPVSNG...AAL
ssRNA,5′GGGAGAGCGGAAGCGUGCUGGGCCGAUAUGAAGGAGUGGAGAGGGUGGCAGCAUGGUCCGGAUCCAUAACCCAGAGGUCGAUGGAUCCCCCC3′,92.0,0.6304347826086957,Kd: 11.1 nM,11.1,5′-GGGAGAGCGGAAGCGUGCUGGGCC-N40-CAUAACCCAGAGGUCGAUGGAUCCCCCC-3′,40.0,"PBS with 1 mM MgCl2, 10 mM DTT",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssRNA,5′GGGAGAGCGGAAGCGUGCUGGGCCGAGGGAGGCGAUAUGAAGGUGUAGAGAGGCCUCCUGGACACAUAACCCAGAGGUCGAUGGAUCCCCCC3′,92.0,0.6304347826086957,Kd: 120 nM,120.0,5′-GGGAGAGCGGAAGCGUGCUGGGCC-N40-CAUAACCCAGAGGUCGAUGGAUCCCCCC-3′,40.0,"PBS with 1 mM MgCl2, 10 mM DTT",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssRNA,5‘GGGAGAAUUCCGACCAGAAGCUUACUGUCCUCCCUUCAGAGAGCGCGGGACCCUUAACUUGGGGCCCACGAACAGCUUCAGUUCCGUCUCGGCGUCAUAUGUGCGUCUACAUGGAUCCUCA3‘,121.0,0.5619834710743802,Kd: 2±11 nM,2.0,5‘-GGTAATACGACTCACTATAGGGAGAATTCCGACCAGAAGCTT-N72-CATATGTGCGTCTACATGGATCCTCA-3‘,72.0,"PBS with 1 mM MgCl2, 10 mM DTT",MgCl,Tris Buffers,7.6,Not applicable,None,None,None
ssRNA,5‘GGGAGAAUUCCGACCAGAAGCUUUCCCUGGCCCAAGAUCCUAAUAAAGUUUUUUCGGACCGGAGCGAAACCACUAUCCUCUUAAGCAAUCUGUCAUAUGUGCGUCUACAUGGAUCCUCA3‘,119.0,0.47058823529411764,Kd: 14±2 nM,14.0,5‘-GGTAATACGACTCACTATAGGGAGAATTCCGACCAGAAGCTT-N72-CATATGTGCGTCTACATGGATCCTCA-3‘,72.0,"PBS with 1 mM MgCl2, 10 mM DTT",MgCl,Tris Buffers,7.6,Not applicable,None,None,None
ssRNA,5‘GGGAGAAUUCCGACCAGAAGCUUGUACAACACAUCAUUACGGCUGCUAUUGGCUCCAAGCGUCUUUCUCCCUGGUCAAUAGUCCAGCCACCACGCAUAUGUGCGUCUACAUGGAUCCUCA3‘,120.0,0.5083333333333333,Kd: 4±15 nM,4.0,5‘-GGTAATACGACTCACTATAGGGAGAATTCCGACCAGAAGCTT-N72-CATATGTGCGTCTACATGGATCCTCA-3‘,72.0,"PBS with 1 mM MgCl2, 10 mM DTT",MgCl,Tris Buffers,7.6,Not applicable,None,None,None
ssRNA,5‘GGGAGAAUUCCGACCAGAAGCUUGACAUCUGUAAGUAAGAUUCUAUCUGCAAAGCGGUUAGGAGGGCUCGGACUCUGAUUGCCUCCCCGCACCCAUAUGUGCGUCUACAUGGAUCCUCA3‘,119.0,0.5126050420168067,Kd: 7±1 nM,7.0,5‘-GGTAATACGACTCACTATAGGGAGAATTCCGACCAGAAGCTT-N72-CATATGTGCGTCTACATGGATCCTCA-3‘,72.0,"PBS with 1 mM MgCl2, 10 mM DTT",MgCl,Tris Buffers,7.6,Not applicable,None,None,None
ssRNA,5‘GGGAGAAUUCCGACCAGAAGCUUGACAUCUGUAAGUAAGAUUCUAUCUGCAAAGCGGUUAGGGGGGCUCGGACUCUGAUUGCCUCCCCGCACCCAUAUGUGCGUCUACAUGGAUCCUCA3‘,119.0,0.5210084033613446,Kd: 294±170 nM,294.0,5‘-GGTAATACGACTCACTATAGGGAGAATTCCGACCAGAAGCTT-N72-CATATGTGCGTCTACATGGATCCTCA-3‘,72.0,"10 mM Tris, 50 mM NaCl, 1 mM EDTA at pH 7.5",MgCl,Tris Buffers,7.6,Not applicable,None,None,None
ssRNA,5‘GGGAGAAUUCCGACCAGAAGCUUGUCAGCUGCUCGCGGGAUCGAUCCAUUCGGUGGCCAUGCUCCGGAAGACGGGCCGGCUUCGCAAGACUCAGGCAUAUGUGCGUCUACAUGGAUCCUCA3‘,121.0,0.5867768595041323,Kd: 10±1 nM,10.0,5‘-GGTAATACGACTCACTATAGGGAGAATTCCGACCAGAAGCTT-N72-CATATGTGCGTCTACATGGATCCTCA-3‘,72.0,"10 mM Tris, 50 mM NaCl, 1 mM EDTA at pH 7.5",MgCl,Tris Buffers,7.6,Not applicable,None,None,None
ssDNA,GGGAGCTCAGAATAAACGCTCAATTCGGGGAGGTGGCATGGGGGGGAGGCAGTTATTCGACATGAGGCCCGGATC,75.0,0.5866666666666667,Kd: 0.13 nM,0.13,5'-GGGAGCTCAGAATAAACGCTCAA-N32-TTCGACATGAGGCCCGGATC-3',32.0,"10 mM Tris, 50 mM NaCl, 1 mM EDTA at pH 7.5",MgCl,Tris Buffers,7.9,Not applicable,None,None,None
ssDNA,GGGAGCTCAGAATAAACGCTCAAAACGCACCGGAGGGAGGACTTTGGGCCATCCTTTCGACATGAGGCCCGGATC,75.0,0.5733333333333334,Kd: 1.04 nM,1.04,5'-GGGAGCTCAGAATAAACGCTCAA-N32-TTCGACATGAGGCCCGGATC-3',32.0,"10 mM Tris, 50 mM NaCl, 1 mM EDTA at pH 7.5",MgCl,Tris Buffers,7.9,Not applicable,None,None,ADKQTHETELTFDQVKEQLTESGKKRGVLTYEEIAERMSSFEIESDQMDEYYEF...HHH
ssDNA,GGGAGCTCAGAATAAACGCTCAACGCAGGCCAGCGGGCGAGGATGGGCCACCCCTATCGACATGAGGCCCGGATC,75.0,0.64,Kd: 1.23 nM,1.23,5'-GGGAGCTCAGAATAAACGCTCAA-N32-TTCGACATGAGGCCCGGATC-3',32.0,"10 mM Tris, 50 mM NaCl, 1 mM EDTA at pH 7.5",MgCl,Tris Buffers,7.9,Not applicable,Substitution of T with A at the first position of the right constant region,None,ADKQTHETELTFDQVKEQLTESGKKRGVLTYEEIAERMSSFEIESDQMDEYYEF...HHH
ssDNA,GGGAGCTCAGAATAAACGCTCAATGGGTTGTGCAGGAGGGGGTGCCCGTTTAGGTTTCGACATGAGGCCCGGATC,75.0,0.5733333333333334,Kd: 2.23 nM,2.23,5'-GGGAGCTCAGAATAAACGCTCAA-N32-TTCGACATGAGGCCCGGATC-3',32.0,"10 mM Tris, 50 mM NaCl, 1 mM EDTA at pH 7.5",MgCl,Tris Buffers,7.9,Not applicable,None,None,ADKQTHETELTFDQVKEQLTESGKKRGVLTYEEIAERMSSFEIESDQMDEYYEF...HHH
ssDNA,GGGAGCTCAGAATAAACGCTCAAGGGTGGGCGGGAAGAGTGGGGTGGAAGAGCGTTTCGACATGAGGCCCGGATC,75.0,0.6,Kd: 0.72 nM,0.72,5'-GGGAGCTCAGAATAAACGCTCAA-N32-TTCGACATGAGGCCCGGATC-3',32.0,"10 mM Tris, 50 mM NaCl, 1 mM EDTA at pH 7.5",MgCl,Tris Buffers,7.9,Not applicable,None,None,ADKQTHETELTFDQVKEQLTESGKKRGVLTYEEIAERMSSFEIESDQMDEYYEF...HHH
ssDNA,GGGAGCTCAGAATAAACGCTCAACTTCCGACGATGTAAGTCACCACCCGGCTCAGTTCGACATGAGGCCCGGATC,75.0,0.56,Kd: 1.62 nM,1.62,5'-GGGAGCTCAGAATAAACGCTCAA-N32-TTCGACATGAGGCCCGGATC-3',32.0,"10 mM Tris, 50 mM NaCl, 1 mM EDTA at pH 7.5",MgCl,Tris Buffers,7.9,Not applicable,None,None,ADKQTHETELTFDQVKEQLTESGKKRGVLTYEEIAERMSSFEIESDQMDEYYEF...HHH
ssDNA,GGGAGCTCAGAATAAACGCTCAATGTGAGCTGGTGGGGTAGGGGGCTGCGAGAGTTTCGACATGAGGCCCGGATC,75.0,0.5866666666666667,Kd: 2.21 nM,2.21,5'-GGGAGCTCAGAATAAACGCTCAA-N32-TTCGACATGAGGCCCGGATC-3',32.0,"10 mM Tris, 50 mM NaCl, 1 mM EDTA at pH 7.5",MgCl,Tris Buffers,7.9,Not applicable,None,None,ADKQTHETELTFDQVKEQLTESGKKRGVLTYEEIAERMSSFEIESDQMDEYYEF...HHH
ssDNA,GGGAGCTCAGAATAAACGCTCAACTGCCCACCGCTGTAAGGTGTCGCCTCCGTCATTCGACATGAGGCCCGGATC,75.0,0.5866666666666667,Kd: 6.32 nM,6.32,5'-GGGAGCTCAGAATAAACGCTCAA-N32-TTCGACATGAGGCCCGGATC-3',32.0,"10 mM Tris, 50 mM NaCl, 1 mM EDTA at pH 7.5",MgCl,Tris Buffers,7.9,Not applicable,None,None,ADKQTHETELTFDQVKEQLTESGKKRGVLTYEEIAERMSSFEIESDQMDEYYEF...HHH
ssDNA,GGGAGCTCAGAATAAACGCTCAACTCGCTACAGCAAACGCAGCCTCGAGGGATGGTTCGACATGAGGCCCGGATC,75.0,0.5733333333333334,Kd: 1.43 nM,1.43,5'-GGGAGCTCAGAATAAACGCTCAA-N32-TTCGACATGAGGCCCGGATC-3',32.0,"10 mM Tris, 50 mM NaCl, 1 mM EDTA at pH 7.5",MgCl,Tris Buffers,7.9,Not applicable,None,None,ADKQTHETELTFDQVKEQLTESGKKRGVLTYEEIAERMSSFEIESDQMDEYYEF...HHH
ssDNA,GGGAGCTCAGAATAAACGCTCAAGGCATCCACGCACTGCGAACCGGTCTGGAGTGTTCGACATGAGGCCCGGATC,75.0,0.5866666666666667,Kd: 2.82 nM,2.82,5'-GGGAGCTCAGAATAAACGCTCAA-N32-TTCGACATGAGGCCCGGATC-3',32.0,"10 mM Tris, 50 mM NaCl, 1 mM EDTA at pH 7.5",MgCl,Tris Buffers,7.9,Not applicable,None,None,ADKQTHETELTFDQVKEQLTESGKKRGVLTYEEIAERMSSFEIESDQMDEYYEF...HHH
ssDNA,GGGAGCTCAGAATAAACGCTCAAGGAGTGATGCCGCCGCCTGGTTGCCTTGGGAGTTCGACATGAGGCCCGGATC,75.0,0.6,Kd: 3.56 nM,3.56,5'-GGGAGCTCAGAATAAACGCTCAA-N32-TTCGACATGAGGCCCGGATC-3',32.0,"10 mM Tris, 50 mM NaCl, 1 mM EDTA at pH 7.5",MgCl,Tris Buffers,7.9,Not applicable,None,None,ADKQTHETELTFDQVKEQLTESGKKRGVLTYEEIAERMSSFEIESDQMDEYYEF...HHH
ssDNA,GGGAGCTCAGAATAAACGCTCAAGCATCCAGCAAACGCAGCCGGTTTGGCGCCTATTCGACATGAGGCCCGGATC,75.0,0.5733333333333334,Kd: 4.00 nM,4.0,5'-GGGAGCTCAGAATAAACGCTCAA-N32-TTCGACATGAGGCCCGGATC-3',32.0,"10 mM Tris, 50 mM NaCl, 1 mM EDTA at pH 7.5",MgCl,Tris Buffers,7.9,Not applicable,None,None,ADKQTHETELTFDQVKEQLTESGKKRGVLTYEEIAERMSSFEIESDQMDEYYEF...HHH
ssDNA,GGGAGCTCAGAATAAACGCTCAAGCTACTGCTGGAGCACACCCCGACGGTGAGAGTCGACATGAGGCCCGGATC,74.0,0.5945945945945946,Kd: 4.93 nM,4.93,5'-GGGAGCTCAGAATAAACGCTCAA-N32-TTCGACATGAGGCCCGGATC-3',32.0,"10 mM Tris, 50 mM NaCl, 1 mM EDTA at pH 7.5",MgCl,Tris Buffers,7.9,Not applicable,Deletion of T at the first position of the right constant region,None,ADKQTHETELTFDQVKEQLTESGKKRGVLTYEEIAERMSSFEIESDQMDEYYEF...HHH
ssRNA,5′ACACAAUGGACGGAUUCGUAUGGGUGGGAUCGGGAAGGGCUACGAACACCGUAACGGCCGACAUGAGAG3′,69.0,0.5652173913043478,Kd: 0.33 uM,330.0,5′-GGACACAATGGACG-N40-TAACGGCCGACATGAGAG-3′,40.0,"10 mM Tris, 50 mM NaCl, 1 mM EDTA at pH 7.5",None,Tris Buffers,7.6,Not applicable,None,None,None
ssRNA,5′ACACAAUGGACGAUAUGGUAUUGAGGUGGGAAGGGGAUUGGGAUAAUUGCCAUAACGGCCGACAUGAGAG3′,70.0,0.4857142857142857,Kd: 1.8 uM,1800.0,5′-GGACACAATGGACG-N40-TAACGGCCGACATGAGAG-3′,40.0,"10 mM Tris, 50 mM NaCl, 1 mM EDTA at pH 7.5",None,Tris Buffers,7.6,Not applicable,None,None,MDPNRISEDGTHCIYRILRLHENADFQDTTLESQDTKLIPDSCRRIKQAFQGAV...DID
ssRNA,5′ACACAAUGGACGAUAGUGGUUGGGAUUGGGUGGGCGCACAAGUUGUUCCGUUAACGGCCGACAUGAGAG3′,69.0,0.5362318840579711,Kd: 5.8 uM,5800.0,5′-GGACACAATGGACG-N40-TAACGGCCGACATGAGAG-3′,40.0,"10 mM Tris, 50 mM NaCl, 1 mM EDTA at pH 7.5",None,Tris Buffers,7.6,Not applicable,None,None,MDPNRISEDGTHCIYRILRLHENADFQDTTLESQDTKLIPDSCRRIKQAFQGAV...DID
ssDNA,5′AGCAGCACAGAGGTCAGATGCGGCGCGGGGTCTTTTACAAATAGTTGTCCTAGCCACGCCTATGCGTGCTACCGTGAA3′,78.0,0.5512820512820513,Kd: 30 ± 22 nM,30.0,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"20 mM Tris, 5 mM MgCl2, 150 mM NaCl at pH 7.5",None,Tris Buffers,7.5,Not applicable,None,None,QSLEESGGRLVTPGTPLTLTCTVSGFSLSTYNIHWVRQAPGKGLEWIGVIDTGG...HHH
ssDNA,5′AGCAGCACAGAGGTCAGATGCTATGAGCAGATCCGATAGAAAGTTAATGCCCTAGAACATCCTATGCGTGCTACCGTGAA3′,80.0,0.475,Kd: 33 ± 36 nM,33.0,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"10 mM Tris, 50 mM NaCl, and 1 mM EDTA at pH 7.5",None,Tris Buffers,7.5,Not applicable,None,None,QSLEESGGRLVTPGTPLTLTCTVSGFSLSTYNIHWVRQAPGKGLEWIGVIDTGG...HHH
ssDNA,5′AGCAGCACAGAGGTCAGATGTGAAACATAGCATATTTACTTATGTCGCCTTGCCGGTTCCTATGCGTGCTACCGTGAA3′,78.0,0.47435897435897434,Kd: 23 ± 12 nM,23.0,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"10 mM Tris, 50 mM NaCl, and 1 mM EDTA at pH 7.5",None,Tris Buffers,7.5,Not applicable,None,None,QSLEESGGRLVTPGTPLTLTCTVSGFSLSTYNIHWVRQAPGKGLEWIGVIDTGG...HHH
ssDNA,5′AGCAGCACAGAGGTCAGATGAAATTTTGCACTTACTTGACGTTTCCTCGATAGCCACAAGCCTATGCGTGCTACCGTGAA3′,80.0,0.475,Kd: 39 ± 18 nM,39.0,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"20 mM Tris–HCl, pH 7.4, 150 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 0.1% Tween-20",None,Tris Buffers,7.5,Not applicable,None,None,QSLEESGGRLVTPGTPLTLTCTVSGFSLSTYNIHWVRQAPGKGLEWIGVIDTGG...HHH
ssDNA,5′AGCAGCACAGAGGTCAGATGTGGTTCGATGCTGCAAGGTGTTGTCATTTGGCATATGTTACCTATGCGTGCTACCGTGAA3′,80.0,0.4875,Kd: 25 ± 20 nM,25.0,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"10 mM Tris, 50 mM NaCl, and 1 mM EDTA at pH 7.5",None,Tris Buffers,7.5,Not applicable,None,None,QSLEESGGRLVTPGTPLTLTCTVSGFSLSTYNIHWVRQAPGKGLEWIGVIDTGG...HHH
ssDNA,5′AGCAGCACAGAGGTCAGATGAGATGGTTGACCGGTTGATGTGATTAAGGAGACGTCGATTCCTATGCGTGCTACCGTGAA3′,80.0,0.5,Kd: 23 ± 13 nM,23.0,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"25 mM HEPES, pH 7.5, 25 μM ZnCl2, 2 mM β‐mercaptoethanol, 5% glycerol, 75 mM NaCl, 0.1 mg/ml poly(dI‐dC), 0.1 mg/ml BSA",None,Tris Buffers,7.5,Not applicable,None,None,QSLEESGGRLVTPGTPLTLTCTVSGFSLSTYNIHWVRQAPGKGLEWIGVIDTGG...HHH
ssDNA,5′GAACTGAGGTGCTTTCCCAAAACCT3′,25.0,0.48,Kd: 50 nM,50.0,5′-GGGAGACAAGAATAAACGCTCAA-N25-TTCGACAGGAGGCTCACAACAGGC-′3.,25.0,"25 mM HEPES, pH 7.5, 25 μM ZnCl2, 2 mM β‐mercaptoethanol, 5% glycerol, 75 mM NaCl, 0.1 mg/ml poly(dI‐dC), 0.1 mg/ml BSA",None,PBS/phosphate buffers,9.6,Not applicable,None,None,None
ssDNA,5′GGGAGACAAGAATAAACGCTCAAGAACTGAGGTGCTTTCCCAAAACCTTTCGACAGGAGGCTCACAACAGGC5′,72.0,0.5,Kd: 666.67 nM,666.67,5′-GGGAGACAAGAATAAACGCTCAA-N25-TTCGACAGGAGGCTCACAACAGGC-′3.,25.0,"25 mM HEPES, pH 7.5, 25 μM ZnCl2, 2 mM β‐mercaptoethanol, 5% glycerol, 75 mM NaCl, 0.1 mg/ml poly(dI‐dC), 0.1 mg/ml BSA",None,PBS/phosphate buffers,9.6,Not applicable,None,None,None
ssRNA,GGGAGAGACAAGCUUGGGUCGCGUUUUGCUAUUGAUUUCUUUUAACCUGGCCUGUUUGGGCCUCUUGCUCUUCCUAGGAGU,81.0,0.49382716049382713,Kd: 115 ± 3 nM,115.0,5′-TCGGAGAGACAAGCTTGGGTC-N40-CTCTTGCTCTTCCTAGGAGT-3′,40.0,"50 mM Tris, pH 7.5, 200 mM NaCl, 5 mM MgCl2, 1 mM DTT",MgCl,PBS/phosphate buffers,7.4,Not applicable,In vitro transcription with T7 RNA polymerase yielded the corresponding RNA library,None,None
ssDNA,5′AGCAGCACAGAGGTCAGATGGTTACTGCGGGGTATGGGGACTGGTTGCGTGGCTTGGTGTCCTATGCGTGCTACCGTGAA3′,80.0,0.575,Kd: 84 ± 37 nM,84.0,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3',40.0,"8.1 mM Na2HPO4, 1.1 mM KH2PO4, 1 mM MgCl2, 2.7 mM KCl, and 40 mM NaCl at a pH of 8.0",MgCl,PBS/phosphate buffers,8.0,Not applicable,Electrophoretic selection with capillary electrophoresis (CE) is used,None,None
ssDNA,5′AGCAGCACAGAGGTCAGATGAAGCGATTGTAATCAACGCCGTAAGACCTCGAGTCGATTTCCTATGCGTGCTACCGTGAA3′,80.0,0.5,Kd: 44 ± 9 nM,44.0,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3',40.0,"0.01 M HEPES (pH 7.4), 0.15 M NaCl, 3 mM EDTA, 0.005% Tween 20",MgCl,PBS/phosphate buffers,8.0,Not applicable,Electrophoretic selection with capillary electrophoresis (CE) is used,None,QSLEESGGRLVTPGTPLTLTCTVSGFSLSTYNIHWVRQAPGKGLEWIGVIDTGG...HHH
ssDNA,5′AGCAGCACAGAGGTCAGATGCGCGCAGAATTTTGAGTCATGTACTAAGGAATTGATTGGTCCTATGCGTGCTACCGTGAA3′,80.0,0.475,Kd: 37 ± 43 nM,37.0,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3',40.0,"0.01 M HEPES (pH 7.4), 0.15 M NaCl, 3 mM EDTA, 0.005% Tween 20",MgCl,PBS/phosphate buffers,8.0,Not applicable,Electrophoretic selection with capillary electrophoresis (CE) is used,None,QSLEESGGRLVTPGTPLTLTCTVSGFSLSTYNIHWVRQAPGKGLEWIGVIDTGG...HHH
ssDNA,5′AGCAGCACAGAGGTCAGATGGTTCGTTGTAGCGCATAAAGTTTATCTCTCCCATGATTCACCTATGCGTGCTACCGTGAA3′,80.0,0.475,Kd: 27 ± 8 nM,27.0,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3',40.0,"PBS with 0.1 mg/ml tRNA, 1 mg/ml BSA in a silanized plate",MgCl,PBS/phosphate buffers,8.0,Not applicable,Electrophoretic selection with capillary electrophoresis (CE) is used,None,QSLEESGGRLVTPGTPLTLTCTVSGFSLSTYNIHWVRQAPGKGLEWIGVIDTGG...HHH
ssDNA,5′AGCAGCACAGAGGTCAGATGGGTAGGTAGCCGTGCCGGTTGTGCCATTGATTGTACAGTTCCTATGCGTGCTACCGTGAA3′,80.0,0.5375,Kd: 73 ± 29 nM,73.0,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3',40.0,"40 μl PBS with 0.1 mg/ml tRNA, 1 mg/ml BSA in a silanized plate",MgCl,PBS/phosphate buffers,8.0,Not applicable,Electrophoretic selection with capillary electrophoresis (CE) is used,None,QSLEESGGRLVTPGTPLTLTCTVSGFSLSTYNIHWVRQAPGKGLEWIGVIDTGG...HHH
ssDNA,5′AGCAGCACAGAGGTCAGATGGCCTATATTTATAAAGACAGGAGAGTAATGTCGAGCAGAACCTATGCGTGCTACCGTGAA3′,80.0,0.4625,Kd: 33 ± 10 nM	,33.0,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3',40.0,"50 mM Tris–HCl, pH 7.4, 100 mM NaCl, 1 mM MgCl 2, 1 mM DTT",MgCl,PBS/phosphate buffers,8.0,Not applicable,Electrophoretic selection with capillary electrophoresis (CE) is used,None,QSLEESGGRLVTPGTPLTLTCTVSGFSLSTYNIHWVRQAPGKGLEWIGVIDTGG...HHH
ssDNA,5′ATGACCATGACCCTCCACACACCCTACGCGTGTCAGACTGTGGCAGGGAAAC3′,52.0,0.5769230769230769,Kd: 19 pM,0.019,5′-ATGACCATGACCCTCCACAC-N12-TCAGACTGTGGCAGGGAAAC-3′,12.0,"50 mM Tris–HCl, pH 7.4, 100 mM NaCl, 1 mM MgCl 2, 1 mM DTT",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,5′ATGACCATGACCCTCCACACACCCTACGCGTGTCAGACTGTGGCAGGGAAAC3′,52.0,0.5769230769230769,Kd: 1.11 pM,0.00111,5′-ATGACCATGACCCTCCACAC-N12-TCAGACTGTGGCAGGGAAAC-3′,12.0,"21 mM Tris, 5 mM MgCl2, and 150 mM NaCl at pH 7.5",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,5′ATGACCATGACCCTCCACACATGACGATGGGATCAGACTGTGGCAGGGAAAC3′,52.0,0.5384615384615384,Kd: 18.4 pM,0.0184,5′-ATGACCATGACCCTCCACAC-N12-TCAGACTGTGGCAGGGAAAC-3′,12.0,"20 mM Tris, 5 mM MgCl2, and 150 mM NaCl at pH 7.5",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,5′ATGACCATGACCCTCCACACATGACGATGGGATCAGACTGTGGCAGGGAAAC3′,52.0,0.5384615384615384,Kd: 8.02 pM,0.008,5′-ATGACCATGACCCTCCACAC-N12-TCAGACTGTGGCAGGGAAAC-3′,12.0,"22 mM Tris, 5 mM MgCl2, and 150 mM NaCl at pH 7.5",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,5′ATGACCATGACCCTCCACACAATGCGCCGTCATCAGACTGTGGCAGGGAAAC3′,52.0,0.5576923076923077,Kd: 24.2 pM,0.0242,5′-ATGACCATGACCCTCCACAC-N12-TCAGACTGTGGCAGGGAAAC-3′,12.0,"20 mM Tris, 5 mM MgCl2, and 150 mM NaCl at pH 7.5",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,5′ATGACCATGACCCTCCACACAATGCGCCGTCATCAGACTGTGGCAGGGAAAC3′,52.0,0.5576923076923077,Kd: 7.9 pM,0.0079,5′-ATGACCATGACCCTCCACAC-N12-TCAGACTGTGGCAGGGAAAC-3′,12.0,"23 mM Tris, 5 mM MgCl2, and 150 mM NaCl at pH 7.5",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,5′ATACCAGCTTATTCAATTTGAGGCGGGTGGGTGGGTTGAATATGCTGATTACCCCATCGGAGAACGTTAAGGCGCTTCAGATAGTAAGTGCAATCT3′,96.0,0.4583333333333333,Kd: 6 ± 3 nM,6.0,5′-ATACCAGCTTATTCAATT-N60-AGATAGTAAGTGCAATCT-3′,60.0,"100 mmol L−1 NaCl/20 mmol L−1 Tris/HCl, pH 7.6/2 mmol L−1 MgCl2/5 mmol L−1 KCl/1 mmol L−1 CaCl2/0.02% Tween 20",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,C(CO)N,None
ssDNA,5′ATACCAGCTTATTCAATTTGAGGCGGGTGGGTGGGTTGAATACGCTGATCACCCCATCGGAGAACGTTAAGGCGCTTTAGATAGTAAGTGCAATCT3′,96.0,0.46875,Kd: 9 ± 5 nM,9.0,5′-ATACCAGCTTATTCAATT-N60-AGATAGTAAGTGCAATCT-3′,60.0,"100 mmol L−1 NaCl/20 mmol L−1 Tris/HCl, pH 7.6/2 mmol L−1 MgCl2/5 mmol L−1 KCl/1 mmol L−1 CaCl2/0.02% Tween 20",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,C(CO)N,MAEFGNYVIYLIMLGAVLGALASILRPESGLGREFVNGIHAIGPVFLAQAGIMV...HAA
ssDNA,5′ATACCAGCTTATTCAATTGCTGCGAGGTGGGTGGGTGGGAGCAATTGGTCCTCGCTTAGCTTCTACGGTGGGCTATCTAGATAGTAAGTGCAATCT3′,96.0,0.4895833333333333,Kd: 17 ± 4 nM,17.0,5′-ATACCAGCTTATTCAATT-N60-AGATAGTAAGTGCAATCT-3′,60.0,"100 mmol L−1 NaCl/20 mmol L−1 Tris/HCl, pH 7.6/2 mmol L−1 MgCl2/5 mmol L−1 KCl/1 mmol L−1 CaCl2/0.02% Tween 20",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,C(CO)N,MAEFGNYVIYLIMLGAVLGALASILRPESGLGREFVNGIHAIGPVFLAQAGIMV...HAA
ssDNA,5′ATACCAGCTTATTCAATTGCTGTGAGGTGGGTGGGTGGGAGCAATTGGTCCTCGCTTAGCTTCTACGGTGGGCTATCTAGATAGTAAGTGCAATCT3′,96.0,0.4791666666666667,Kd: 15 ± 4 nM,15.0,5′-ATACCAGCTTATTCAATT-N60-AGATAGTAAGTGCAATCT-3′,60.0,"100 mmol L−1 NaCl/20 mmol L−1 Tris/HCl, pH 7.6/2 mmol L−1 MgCl2/5 mmol L−1 KCl/1 mmol L−1 CaCl2/0.02% Tween 20",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,C(CO)N,MAEFGNYVIYLIMLGAVLGALASILRPESGLGREFVNGIHAIGPVFLAQAGIMV...HAA
ssDNA,5′ATACCAGCTTATTCAATTGCTGCGAGGTGGGTGGGTGGGAGCAATTGATCCTCGCTTAGCTTCTACGGTGGGCTATCTAGATAGTAAGTGCAATCT3′,96.0,0.4791666666666667,Kd: 10 ± 2 nM,10.0,5′-ATACCAGCTTATTCAATT-N60-AGATAGTAAGTGCAATCT-3′,60.0,"100 mmol L−1 NaCl/20 mmol L−1 Tris/HCl, pH 7.6/2 mmol L−1 MgCl2/5 mmol L−1 KCl/1 mmol L−1 CaCl2/0.02% Tween 20",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,C(CO)N,MAEFGNYVIYLIMLGAVLGALASILRPESGLGREFVNGIHAIGPVFLAQAGIMV...HAA
ssDNA,5′ATACCAGCTTATTCAATTGCTGCGAGGTGGGTGGGTGGGAGCAATTGGTCCTTGCTTAGCTTCTACGGTGGGCTATCTAGATAGTAAGTGCAATCT3′,96.0,0.4791666666666667,Kd: 19 ± 7 nM,19.0,5′-ATACCAGCTTATTCAATT-N60-AGATAGTAAGTGCAATCT-3′,60.0,"SHMCK (20 mM HEPES, pH 7.35, 120 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,C(CO)N,MAEFGNYVIYLIMLGAVLGALASILRPESGLGREFVNGIHAIGPVFLAQAGIMV...HAA
ssDNA,5‘AGCAGCACAGAGGTCAGATGACATGATGTTCGGACACGTGAAGGAATAGAAAGCCCTCACTTCAGCGTAGCACGCATAGG3‘,80.0,0.5125,Kd: 180 ± 70 pM,0.18,5‘-AGCAGCACAGAGGTCAGATG-N40-TTCAGCGTAGCACGCATAGG-3‘,40.0,"10 mM tris, 50 mM NaCl, and 1 mM EDTA pH 7.5",None,Tris Buffers,7.5,Not applicable,None,None,None
ssRNA,GGCGCAGGUGGGUAAAGGGGUGUGAUCGAGGGUCGAGAGGCGCC,44.0,0.6818181818181818,Kd: 40 nM,40.0,5'GGAGCTTAGACAACAGCAGCGTGC-N34-GCACGCTCAGGTGAGTCGGTTCCAC3',34.0,"20 mM Tris–HCl, pH 7.4, 150 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2 and 0.1% Tween-20",MgCl/CaCl,Tris Buffers,7.4,Truncated version of a11(unmodified aptamer),None,None,MGAAPGRRGPRLLRPPPPLLLLLLLLRPPPAALTLDPGLLPGDFAADEAGARLF...RHS
ssRNA,CGAAUGCAAGUCUGGUGAGUGUUGGGAGGGCAGUGACUUGCUUCG,45.0,0.5555555555555556,Kd: 2.8 ± 0.2  nM,2.8,5′-CCCAAGCTTACGTTCAGACCA-N60-CAATGCGATCCAATGCCCTATAGTGAGTCGTATTAGAATTCCG-3',60.0,"50 mM potassium phosphate (pH 7.4), 5 mM Mg(OAc)2, 150 mM KCl and 1 mM DTT",None,PBS/phosphate buffers,7.4,Truncated version of s23,None,None,EVQLVQSGAEVKTPGASVRVSCKASGHTFRTFDINWVRQAAGQGLEWMGWMSPN...PGK
ssRNA,GCAAGUCUGGUGAGUGUUGGGAGGGCAGUGACUUGC,36.0,0.5833333333333334,Kd:16.1 ± 3.6 nM,16.1,5′-CCCAAGCTTACGTTCAGACCA-N60-CAATGCGATCCAATGCCCTATAGTGAGTCGTATTAGAATTCCG-3',60.0,"50 mM potassium phosphate (pH 7.4), 5 mM Mg(OAc)2, 150 mM KCl and 1 mM DTT",None,PBS/phosphate buffers,7.4,Truncated version of s23,None,None,EVQLVQSGAEVKTPGASVRVSCKASGHTFRTFDINWVRQAAGQGLEWMGWMSPN...PGK
ssRNA,UAAUACGACUCACUAUAGGGAGGACGAUGCGGCAUGCGUCUGACCUACGUGCCAAGCAUUUGUGUAACCCGUCAGACGACUCGCCCGA,88.0,0.5454545454545454,"Kd: 3.5 nM, IC50 = 40.2 nM",3.5,5'-GGAGGACGATGCGG-N40-CAGACGACTCGCCCGA-3',40.0,"110 mM NaCl, 1 mM MgCl2, 20 mM HEPES, pH 7.0, 1 mM CaCl2, 5 mM KCl",MgCl/CaCl,Other Buffers,7.0,Includes t7 promoter,C” aptamers were generated by the mCXCL10 SELEX. A Potent Antagonist against Both mCXCL10 and hCXCL10 Orthologues.,None,None
ssRNA,UAAUACGACUCACUAUAGGGAGGACGAUGCGGAGUUUCUUCUGAGGUCUGAACCUUUCGAAAGCUGGCGCUCAGACGACUCGCCCGA,87.0,0.5287356321839081,Kd: 1.53 nM,1.53,5'-GGAGGACGATGCGG-N40-CAGACGACTCGCCCGA-3',40.0,"110 mM NaCl, 1 mM MgCl2, 20 mM HEPES, pH 7.0, 1 mM CaCl2, 5 mM KCl",MgCl/CaCl,Other Buffers,7.0,Includes t7 promoter,"“P” aptamers were generated by the hCXCL10 SELEX. In summary, the anti-hCXCL10 aptamers demonstrated high specificity and selectivity by functionally antagonizing hCXCL10 but not mCXCL10, hCXCL9, hCXCL11, hCCL1, or hCCL22 chemokines.",None,None
ssRNA,UAAUACGACUCACUAUAGGGAGGACGAUGCGGACUGAACCUAAUUUGAAAUUGGCUGGCGCGCAUAUUCCGUCAGACGACUCGCCCGA,88.0,0.5113636363636364,Kd: 1.76 nM,1.76,5'-GGAGGACGATGCGG-N40-CAGACGACTCGCCCGA-3',40.0,"110 mM NaCl, 1 mM MgCl2, 20 mM HEPES, pH 7.0, 1 mM CaCl2, 5 mM KCl",MgCl/CaCl,Other Buffers,7.0,Includes t7 promoter,"“P” aptamers were generated by the hCXCL10 SELEX. In summary, the anti-hCXCL10 aptamers demonstrated high specificity and selectivity by functionally antagonizing hCXCL10 but not mCXCL10, hCXCL9, hCXCL11, hCCL1, or hCCL22 chemokines.",None,None
ssDNA,5′GACCCGTAGGGCAGTGAATTCAGCCACAGTACTACCGTATAACATGATGTCAAGCAAGCTTGGACGTGTGTGCG,74.0,0.5135135135135135,Kd: 0.06 ± 0.02 nM,0.006,5′‐GACCCGTAGGGCAGTGAATTCAG‐N30‐GCAAGCTTGGACGTGTGTGCG-3',30.0,"25 mM HEPES, pH 7.5, 25 μM ZnCl2, 2 mM β‐mercaptoethanol, 5% glycerol, 75 mM NaCl, 0.1 mg/ml poly(dI‐dC) and 0.1 mg/ml BSA",None,Other Buffers,7.5,Not applicable,inconsistencies in reporting aptamer sequence,None,MQEGGFIRRRRTRSTKKSVNYNELSDDDTAVKNSKTLQLKGNSENVNDSQDEEY...FNN
ssDNA,5′GACCCGTAGGGCAGTGAATTCAGTAGTGATGTTCGTGGCGAATGATACACTTAGCAAGCTTGGACGTGTGTGCG,74.0,0.5135135135135135,Kd: 0.44 ± 0.11 nM,0.44,5′‐GACCCGTAGGGCAGTGAATTCAG‐N30‐GCAAGCTTGGACGTGTGTGCG-3',30.0,"25 mM HEPES, pH 7.5, 25 μM ZnCl2, 2 mM β‐mercaptoethanol, 5% glycerol, 75 mM NaCl, 0.1 mg/ml poly(dI‐dC) and 0.1 mg/ml BSA",None,Other Buffers,7.5,Not applicable,None,None,MQEGGFIRRRRTRSTKKSVNYNELSDDDTAVKNSKTLQLKGNSENVNDSQDEEY...FNN
ssDNA,5′GACCCGTAGGGCAGTGAATTCAGTGTATCGTATTTGGTGATGTTTGGTGTTCAGCAAGCTTGGACGTGTGTGCG,74.0,0.5,Kd: 2.1 ± 0.2 nM,2.1,5′‐GACCCGTAGGGCAGTGAATTCAG‐N30‐GCAAGCTTGGACGTGTGTGCG-3',30.0,"25 mM HEPES, pH 7.5, 25 μM ZnCl2, 2 mM β‐mercaptoethanol, 5% glycerol, 75 mM NaCl, 0.1 mg/ml poly(dI‐dC) and 0.1 mg/ml BSA",None,Other Buffers,7.5,Not applicable,None,None,MQEGGFIRRRRTRSTKKSVNYNELSDDDTAVKNSKTLQLKGNSENVNDSQDEEY...FNN
ssDNA,5′GACCCGTAGGGCAGTGAATTCAGACATGTGATGATATATCGTGTCTCGTGATAGCAAGCTTGGACGTGTGTGCG,74.0,0.5,Kd: 2.4 ± 0.4 nM,2.4,5′‐GACCCGTAGGGCAGTGAATTCAG‐N30‐GCAAGCTTGGACGTGTGTGCG-3',30.0,"25 mM HEPES, pH 7.5, 25 μM ZnCl2, 2 mM β‐mercaptoethanol, 5% glycerol, 75 mM NaCl, 0.1 mg/ml poly(dI‐dC) and 0.1 mg/ml BSA",None,Other Buffers,7.5,Not applicable,None,None,MQEGGFIRRRRTRSTKKSVNYNELSDDDTAVKNSKTLQLKGNSENVNDSQDEEY...FNN
ssDNA,5′GACCCGTAGGGCAGTGAATTCAGCGTGTCGTATTGAGTGATATGATGCACATAGCAAGCTTGGACGTGTGTGCG,74.0,0.5135135135135135,Kd: 4.1 ± 0.6 nM,4.1,5′‐GACCCGTAGGGCAGTGAATTCAG‐N30‐GCAAGCTTGGACGTGTGTGCG-3',30.0,"25 mM HEPES, pH 7.5, 25 μM ZnCl2, 2 mM β‐mercaptoethanol, 5% glycerol, 75 mM NaCl, 0.1 mg/ml poly(dI‐dC) and 0.1 mg/ml BSA",None,Other Buffers,7.5,Not applicable,None,None,MQEGGFIRRRRTRSTKKSVNYNELSDDDTAVKNSKTLQLKGNSENVNDSQDEEY...FNN
ssDNA,5′GACCCGTAGGGCAGTGAATTCAGTTACCGTGATGTATGATATGCATCCACCGTGGCAAGCTTGGACGTGTGTGCG,75.0,0.5333333333333333,Kd: 10.8 ± 1.5 nM,10.8,5′‐GACCCGTAGGGCAGTGAATTCAG‐N30‐GCAAGCTTGGACGTGTGTGCG-3',30.0,"25 mM HEPES, pH 7.5, 25 μM ZnCl2, 2 mM β‐mercaptoethanol, 5% glycerol, 75 mM NaCl, 0.1 mg/ml poly(dI‐dC) and 0.1 mg/ml BSA",None,Other Buffers,7.5,Not applicable,None,None,MQEGGFIRRRRTRSTKKSVNYNELSDDDTAVKNSKTLQLKGNSENVNDSQDEEY...FNN
ssRNA,GGGAAUGGAUCCACAUCUACGAAUUCGCAAUCCUGUAUUGAACUUCUCACUAAAACUUCACUGCAGACUUGACGAAGCUU,80.0,0.425,Kd: 70 nM,70.0,5'-GGGAAUGGAUCCACAUCUACGAA-N32-UUCACUGCAGACUUGACGAAGCUU-3',32.0,"100 mM Tris-HCl (pH 8.0), 12.5 mM EDTA, 150 mM NaCl, 1% SDS",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssRNA,5′ACCGAGUCCAGAAGCUUGUAGUACACAAGGAUGUGCCAUGCCUAGAUGGAGUUGAAUUCUCCCUAUAGUGAGUCGUAUUAC3′,81.0,0.4567901234567901,Kd: 7.1 ± 0.8 nM,7.1,5′-ACCGAGTCCAGAAGCTTGTAGTAC-N15-GCCTAGATGGAGTTGAATTCTCCCTATAGTGAGTCGTATTAC-3′,15.0,"100 mM Tris-HCl (pH 8.0), 12.5 mM EDTA, 150 mM NaCl, 1% SDS",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssRNA,GGGAGACAAGAAUAAACGCUCAAUGUUCAACCAGAGUGAAACCACUAACGGGUCAGAGCCCCUUCGACAGGAGGCUCACAACAGGC,86.0,0.5232558139534884,Kd: 11.2 nM,11.2,5'-GGGAGACAAGAATAAACGCTCAA-N40-TTCGACAGGAGGCTCACAACAGGC-3',40.0,"20 mM Tris-HCl at pH 7.6, 80 mM potassium acetate, 2.5 mM magnesium acetate, 1 mM dithiothreitol, 5% glycerol",None,Tris Buffers,7.6,Not applicable,None,None,None
ssRNA,5′GCGGAAUUCUAAUACGACUCACUAUAGGGAACAGUCCGAGCCUCACUGUUAUCCGAUAGCAGCGCGGGAUGAGGGUCAAUGCGUCAUA,88.0,0.5113636363636364,Kd: 8.56 nM,8.56,5′-GCGGAAUUCUAAUACGACUCACUAUAGGGAACAGUCCGAGCC-N30-GGGUCAAUGCGUCAUA-3,30.0,"Binding Buffer For Assay: 25 mM Tris-HCl, 50 mM KCl, 200 mM NaCl, 0.2 mM EDTA, 5% [vol/vol] glycerol, 0.5 mM DTT, pH 7.5",None,Tris Buffers,7.5,Not applicable,None,None,None
ssRNA,GGGAGAAUUCCGACCAGAAGGGUUAGCAGUCGGCAUGCGGUACAGACAGACCUUUCCUCUCUCCUUCCUCUUCU,74.0,0.5405405405405406,Kd: 188 ± 36 pM,0.188,"5'-AGGGGAGAAUUCCGACCAGAAG-N30-CCTTTCCTCTCTCCTTCCTCTTCT-2
37.5% Dopped pool:  5'-GGGAGAAUUCCGACCAGAAGGGUUAGCAGUCGGCAUGCGGUACAGACAGACCUUUCCUCUCUCCUUCCUCUUCU-3'",30.0,"0.01 M Hepes (pH 7.4), 0.15 M NaCl, 3 mM EDTA, and 0.005% Tween 20",None,Other Buffers,7.4,Not applicable,None,None,None
ssRNA,GGGAGAAUUCCGACCAGAAGGGUUAGCGGUCGUCUUAAGUAGUUUUUGGUCCUUUCCUCUCUCCUUCCUCUUCU,74.0,0.4864864864864865,Kd: 115 ± 23 pM,0.115,"5'-AGGGGAGAAUUCCGACCAGAAG-N30-CCTTTCCTCTCTCCTTCCTCTTCT-2
37.5% Dopped pool:  5'-GGGAGAAUUCCGACCAGAAGGGUUAGCAGUCGGCAUGCGGUACAGACAGACCUUUCCUCUCUCCUUCCUCUUCU-3'",30.0,"0.01 M Hepes (pH 7.4), 0.15 M NaCl, 3 mM EDTA, and 0.005% Tween 20",None,Other Buffers,7.4,Not applicable,None,None,MEAKLLVPFCMFAVLKADTICIGYHANNSTDTVDTVLEKNVTVTHSVNLLENNH...ICI
2'-O-Me-RNA,5′CAUCGAUGCUAGUCGUAACGAUCCCGAUAUGCAGUUUGAGAAGUCGCGCAUUCGCGAGAACGUUCUCUCUCCCUAUAGUGAGUCGUAUUA3′,90.0,0.4777777777777778,Kd: 3.9 nM,3.9,5′-CAUCGAUGCUAGUCGUAACGAUCC-N30-CGAGAACGUUCUCUCUCCCUAUAGUGAGUCGUAUUA-3′,30.0,PBS with 0.1 mg/ml tRNA and 1 mg/ml BSA in a silanized plate,None,PBS/phosphate buffers,7.4,Not applicable,Entirely comprised of 2′-OMe nucleotides (mrmy),None,None
2'-O-Me-RNA,5′CAUCGAUGCUAGUCGUAACGAUCCAUGCAGUUUGAGAAGUCGCGCAUCGAGAACGUUCUCUCUCCCUAUAGUGAGUCGUAUUA3′,83.0,0.46987951807228917,Kd: 2.1 nM,2.1,5′-CAUCGAUGCUAGUCGUAACGAUCC-N30-CGAGAACGUUCUCUCUCCCUAUAGUGAGUCGUAUUA-3′,30.0,40 μl PBS with 0.1 mg/ml tRNA and 1 mg/ml BSA in a silanized plate,None,PBS/phosphate buffers,7.4,Minimized version of arc224,Entirely comprised of 2′-OMe nucleotides (mrmy),None,MNTNILFILFLSFKIGLVVCKGKNVNQNIDQNTEAVLPKSEIAKKQSQLIDVLK...NCV
4'-thio-RNA,5′GGGAGAAGGGAAGUAACAGGUGGGCGCGUGAUUAUGUUUGUACGAAGACUGUGAGAAGAGGUGACGGUACCAG3′,73.0,0.5205479452054794,Kd: 4.7 nM,4.7,5′-GGGAGAAGGGAAGTAACAGG-N30-GTGAGAAGAGGTGACGGTACCAG-3′,30.0,"50 mM Tris–HCl, pH 7.4, 100 mM NaCl, 1 mM MgCl 2 and 1 mM DTT",MgCl,Tris Buffers,7.4,Not applicable,"Thio-RNA --> 4'-thio UTP & 4'- thio CTP, GTP, ATP ",None,None
ssDNA,5′ATACCAGCTTATTCAATTGATGCAGCCACCTACATTGCAGGTTTTATAATACAACTACGCGCCGTTCGCAGGCTAGTTAGATAGTAAGTGCAATCT3′,96.0,0.4166666666666667,Kd: 85.2 ± 5.3 nM,85.2,5′-ATACCAGCTTATTCAATT-N60-AGATAGTAAGTGCAATCT-3′,60.0,"20 mM HEPES-NaOH2 pH 7.4, 150 mM NaCl, 1.5 mM CaCl2, 0.5 mM MgCl2",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,None,None
ssDNA,5′ATACCAGCTTATTCAATTCTATACTCCACTTTGCTATTTCTCGGTTCCTTCACGCGCCCATCGCAGGCTGATGAATTGAGATAGTAAGTGCAATCT3′,96.0,0.4270833333333333,Kd: 56.7 ± 8.2 nM,56.7,5′-ATACCAGCTTATTCAATT-N60-AGATAGTAAGTGCAATCT-3′,60.0,"250 mM NaCl, 20 mM Tris–HCl (pH 7.4), 5 mM MgCl2",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,None,MWVTSDGYIRHQLLPENHYAEARGDWEEAYKGRYFRCAVSGYYAWLVKRPRPSW...NEL
ssDNA,5′ATACCAGCTTATTCAATTCGGGGGGTACGTGCCCGTGTTGCTCGGCGGCCCCCTCGCTTATTTTTGTGTGCCCTTTAGATAGTAAGTGCAATCT3′,94.0,0.5106382978723404,Kd: 65.5 ± 8.6 nM,65.5,5′-ATACCAGCTTATTCAATT-N60-AGATAGTAAGTGCAATCT-3′,60.0,"250 mM NaCl, 20 mM Tris–HCl (pH 7.4), 5 mM MgCl2",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,None,MWVTSDGYIRHQLLPENHYAEARGDWEEAYKGRYFRCAVSGYYAWLVKRPRPSW...NEL
ssDNA,5′ATACCAGCTTATTCAATTACAATGTCGCTCTCCGCCGCAGGAGCATTGTCTGTCTTTATGCTTCTCTTTTTTGTTGCAGATAGTAAGTGCAATCT3′,95.0,0.4105263157894737,Kd: 59.0 ± 7.5,59.0,5′-ATACCAGCTTATTCAATT-N60-AGATAGTAAGTGCAATCT-3′,60.0,"25 mmol/L HEPES (pH 7.5), 150 mmol/L NaCl, 1 mmol/L MgCl2, 2 mmol/L DTT, 40 units RNase inhibitor",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,None,MWVTSDGYIRHQLLPENHYAEARGDWEEAYKGRYFRCAVSGYYAWLVKRPRPSW...NEL
ssRNA,GGGAAGGGAUCCACAUCUACAAAUUCCUUCAUAAUAAACCCGUCCACGCCCUUCGAAGCAGUUCAGACGUCACUU,75.0,0.48,Kd: 460 nM,460.0,5′-GATAATACGACTCACTATAGGGAATGGATCCACACATCTACGA-N30-TTCGAAGCAGTTCAGACGTCACTT-3′,30.0,"(SHCMK) containing 20 mmol/l HEPES, pH 7.35, 120 mmol/l KCl, 1 mmol/l CaCl2, 1 mmol/l MgCl2",None,Tris Buffers,7.5,Not applicable,"Pool type and sequences don't match, DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.",None,None
ssRNA,GGGAAGGGAUCCAAUCUACAAAUUCGUUAACAGAAAACCUCAGUUGCUGGGUUGUUUUCACUGCAAACUUGACAAAGCUA,80.0,0.4125,Kd: 375 ± 46 nM,375.0,5′-GATAATACGACTCACTATAGGGAATGGATCCACACATCTACGA-N30-TTCGAAGCAGTTCAGACGTCACTT-3′,30.0,"10 mM Tris/HCl (pH 7.5), 500 mM NaCl, 1 mM MgCl2",None,Tris Buffers,7.5,Not applicable,None,None,GPYAGPLERQRPLKVRAKLPRQE
ssRNA,GGGAAUGGAUCCACAUCUACGAAUUCCUUACCCGUGAACCGCAGUUGCUGAGUUGUUCGAAGCAGUUCAGACGUCACUU,79.0,0.4936708860759494,Kd: 625 nM,625.0,5′-GATAATACGACTCACTATAGGGAATGGATCCACACATCTACGA-N30-TTCGAAGCAGTTCAGACGTCACTT-3′,30.0,"50 mM Tris-HCl at pH 7.5, 100 mM NaCl, 1 mM dithiothreitol [DTT], 1 mM EDTA",None,Tris Buffers,7.5,Not applicable,None,None,GPYAGPLERQRPLKVRAKLPRQE
ssRNA,GGGUUAACAGAAAACCUCAGUUGCUGGGUUGU,32.0,0.46875,Kd: 325,325.0,5′-GATAATACGACTCACTATAGGGAATGGATCCACACATCTACGA-N30-TTCGAAGCAGTTCAGACGTCACTT-3′,30.0,"50 mM Tris-HCl at pH 7.5, 100 mM NaCl, 1 mM dithiothreitol [DTT], 1 mM EDTA",None,Tris Buffers,7.5,Not applicable,None,None,GPYAGPLERQRPLKVRAKLPRQE
ssDNA,CAGCTCAGAAGCTTGATCCTGTGCGAAAAGGATGCGGGCAGCGGACTCAAGGCCATCTGACTCGAAGTCGTGCATCTGCA,80.0,0.5625,Kd: 50 ± 15 nM,50.0,5′-CAGCTCAGAAGCTTGATCCTGTG-N35-GACTCGAAGTCGTGCATCTGCA-3′,35.0,"SHMCK (20 mM HEPES, pH 7.35, 120 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2",MgCl/CaCl,Other Buffers,7.35,Not applicable,None,None,None
ssDNA,CAGCTCAGAAGCTTGATCCTGTGAGGAATGCTCATGCATAGCAAGGGCTAAACACGGCGACTCGAAGTCGTGCATCTGCA,80.0,0.525,Kd: 28 ± 9 nM,28.0,5′-CAGCTCAGAAGCTTGATCCTGTG-N35-GACTCGAAGTCGTGCATCTGCA-3′,35.0,"SHMCK (20 mM HEPES, pH 7.35, 120 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl3",MgCl/CaCl,Other Buffers,7.35,Not applicable,None,None,MTDIYIPPEGLYFRLLGFASRQVIFARNSPSPDVGLSPVNDQATDQYFSLIYGT...VTA
ssDNA,CAGCTCAGAAGCTTGATCCTGTGCGGGCGGCAAGGCCCTGACAGAGATACTGGCTCGGGACTCGAAGTCGTGCATCTGCA,80.0,0.6,Kd: 130 ± 54 nM,130.0,5′-CAGCTCAGAAGCTTGATCCTGTG-N35-GACTCGAAGTCGTGCATCTGCA-3′,35.0,"SHMCK (20 mM HEPES, pH 7.35, 120 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl4",MgCl/CaCl,Other Buffers,7.35,Not applicable,None,None,MTDIYIPPEGLYFRLLGFASRQVIFARNSPSPDVGLSPVNDQATDQYFSLIYGT...VTA
ssRNA,5′GGGAAUGGAUCCACAUCUACGAAUUCGGUUGGGUUGUCGUAGAUAGAGCGCUUCAAUUCACUGCAGACUUGACGAAGCUU3′,80.0,0.475,Kd: 290 ± 80 nM,290.0,5′-GGGAAUGGAUCCACAUCUACGAAUUC-N30-UUCACUGCAGACUUGACGAAGCUU-3′,30.0,"20 mM Tris–HCl, pH 7.7, 120 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2",MgCl/CaCl,Tris Buffers,7.7,Not applicable,aptamer inhibits polβ activity,None,None
ssRNA,5′GGGAAUGGAUCCACAUCUACGAAUUCGGUUGGGUUGUCGUAGAUAGAGCGCUUCAAUUCACUGCAGACUUGACGAAGCUU3′,80.0,0.475,Kd: 410 ± 50 nM,410.0,5′-GGGAAUGGAUCCACAUCUACGAAUUC-N30-UUCACUGCAGACUUGACGAAGCUU-3′,30.0,"20 mM Tris–HCl, pH 7.7, 120 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2",MgCl/CaCl,Tris Buffers,7.7,Not applicable,aptamer inhibits polκ activity,None,None
ssRNA,5′GGGAAUGGAUCCACAUCUACGAAUUCGGUUGGGUUGUCGUAGAUAUAGCUUAGCCAUUCACUGCAGACUUGACGAAGCUU3′,80.0,0.4625,Kd: 430 ± 130 nM,430.0,5′-GGGAAUGGAUCCACAUCUACGAAUUC-N30-UUCACUGCAGACUUGACGAAGCUU-3′,30.0,"20 mM Tris–HCl, pH 7.7, 120 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2",MgCl/CaCl,Tris Buffers,7.7,Not applicable,aptamer inhibits polβ activity,None,None
ssRNA,5′GGGAAUGGAUCCACAUCUACGAAUUCGGUUGGGUUGUCGUAGAUAUAGCUUAGCCAUUCACUGCAGACUUGACGAAGCUU3′,80.0,0.4625,Kd: 500 ± 100 nM,500.0,5′-GGGAAUGGAUCCACAUCUACGAAUUC-N30-UUCACUGCAGACUUGACGAAGCUU-3′,30.0,"20 mM Tris–HCl, pH 7.7, 120 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2",MgCl/CaCl,Tris Buffers,7.7,Not applicable,aptamer inhibits polκ activity,None,None
ssRNA,5′GGGAAUGGAUCCACAUCUACGAAUUUCGGGGGGGUUGUUCGUGGAAAAUGCUUGCGUUCACUGCAGACUUGACGAAGCUU3′,80.0,0.5,Kd: 490 ± 70 nM,490.0,5′-GGGAAUGGAUCCACAUCUACGAAUUU-N30-UUCACUGCAGACUUGACGAAGCUU-3′,30.0,"20 mM Tris–HCl, pH 7.7, 120 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2",MgCl/CaCl,Tris Buffers,7.7,Not applicable,aptamer inhibits polβ activity,None,MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIK...RSE
ssRNA,5′GGGAAUGGAUCCACAUCUACGAAUUUCGGGGGGGUUGUUCGUGGAAAAUGCUUGCGUUCACUGCAGACUUGACGAAGCUU3′,80.0,0.5,Kd: 750  ± 160 nM,750.0,5′-GGGAAUGGAUCCACAUCUACGAAUUU-N30-UUCACUGCAGACUUGACGAAGCUU-3′,30.0,"20 mM Tris–HCl, pH 7.7, 120 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2",MgCl/CaCl,Tris Buffers,7.7,Not applicable,aptamer inhibits polκ activity,None,None
ssRNA,GAGGAUCCGCCGAGUAACAGACGUCGGGGAUUGGCAAACCCCGUUUCCUUGAGCGACCCCCUUGAGGCUCGAAUUCGCCC,80.0,0.6125,"Kd: 28.9 ± 0.8 nM (VRQ), Kd: 14.6 ± 1.3 nM (ARR)",28.9,5'-GAGGATCCGCCGAGTAACAG-N40-CTTGAGGCTCGAATTCGCCC-3',40.0,"50 mM Tris, 125 mM NaCl, 5 mM MgCl2, pH 8",MgCl,Tris Buffers,8.0,Not applicable,None,None,None
ssRNA,GAGGAUCCGCCGAGUAACAGAGUAGCAACAGAAUUGGAUCCCGACCACUAAGAACCCGGCCUUGAGGCUCGAAUUCGCCC,80.0,0.5625,"Kd: 72.6 ± 3.7 nM (VRQ), Kd: 23.2 ± 0.5 nM (ARR)",72.6,5'-GAGGATCCGCCGAGTAACAG-N40-CTTGAGGCTCGAATTCGCCC-3',40.0,"Binding Buffer for Binding Assay: 0.01 M HEPES, pH 7.4, 0.15 M NaCl, 3 mM EDTA, 0.005% (v/v) surfactant P20",MgCl,Tris Buffers,8.0,Not applicable,None,None,None
ssRNA,GAGGAUCCGCCGAGUAACAGUGCCAUGAGUGAAAUAAAACCAUCCGGAACUAAGACUGCGCUUGAGGCUCGAAUUCGCCC,80.0,0.525,Kd: 55.3 ± 1.4 nM (VRQ),55.3,5'-GAGGATCCGCCGAGTAACAG-N40-CTTGAGGCTCGAATTCGCCC-3',40.0,"Binding Buffer for Binding Assay: 0.01 M HEPES, pH 7.4, 0.15 M NaCl, 3 mM EDTA, 0.005% (v/v) surfactant P20",MgCl,Tris Buffers,8.0,Not applicable,None,None,None
ssRNA,GAGGAUCCGCCGAGUAACAGCGUGCAGGUACUAGCUCCACCCCGAGGGGGCACAUCAUUUCUUGAGGCUCGAAUUCGCCC,80.0,0.6,Kd: 20 nM,20.0,5-GAGGATCCGCCGAGTAACAG-N40-CTTGAGGCTCGAATTCGCCC-3,40.0,"“BB”, 50 mM Tris, 125 mM NaCl, 5 mM MgCl2, pH 8",MgCl,Tris Buffers,8.0,Not applicable,None,None,None
ssRNA,AGGGAGGACGAUGCGGGGUGCUUCGAGCGUAGGAAGAAAGCCGGGGGCUGCAGAUAAUGUAUAGCCAGACGACGGA,76.0,0.5921052631578947,Kd: ~4nM,4.0,5'-AGGGAGGACGATGCG-N49-CAGACGACGGA-3',49.0,"4.5 g/L glucose, 5 mM MgCl2 in Dulbecco's PBS (Sigma), yeast tRNA (0.1 mg/mL) (Sigma), BSA (1 mg/mL)",None,Tris Buffers,8.0,Not applicable,T7 Promoter: AATACGACTCACTATAG. 32P-labeled RNA,None,None
ssRNA,AGGGAGGACGAUGCGGGAUGGACGCUUAUCCGCAUAGAGGUUUACUACUUCGGAGACUGCCGAUACAGACGACGGA,76.0,0.5526315789473685,Kd: ~16 nM,16.0,5'-AGGGAGGACGATGCG-N49-CAGACGACGGA-3',49.0,"4.5 g/L glucose, 5 mM MgCl2 in Dulbecco's PBS (Sigma), yeast tRNA (0.1 mg/mL) (Sigma), BSA (1 mg/mL)",None,Tris Buffers,8.0,Not applicable,T7 Promoter: AATACGACTCACTATAG. 32P-labeled RNA,None,MSLLDPRQFLLPAFYLDPTTQALLAQAASTSPCNKISSSSSFRISDILEQSPNN...NSE
ssDNA,5′GGGAGACAAGAATAAACGCTCAAGGGCGTGGTGGGTGGGGTACTAATAATGTGCGTTTGTTCGACAGGAGGCTCACAACAGGC3′,83.0,0.5301204819277109,Kd: 1.3 ± 0.3 nM,1.3,5′-GGGAGACAAGAATAAACGCTCAA-N36-TTCGACAGGAGGCTCACAACAGGC-3′,36.0,"4.5 g/L glucose, 5 mM MgCl2 in Dulbecco's PBS (Sigma), yeast tRNA (0.1 mg/mL) (Sigma), BSA (1 mg/mL)",None,PBS/phosphate buffers,8.0,Not applicable,None,None,None
ssDNA,5′GGGAGACAAGAATAAACGCTCAATTGGGGTCTGCTCGGGATTGCGGAGAACGTGAATCTTTCGACAGGAGGCTCACAACAGGC3′,83.0,0.5301204819277109,Kd: 23.5 ± 6.7 nM ,23.5,5′-GGGAGACAAGAATAAACGCTCAA-N36-TTCGACAGGAGGCTCACAACAGGC-3′,36.0,"4.5 g/L glucose, 5 mM MgCl2 in Dulbecco's PBS (Sigma), yeast tRNA (0.1 mg/mL) (Sigma), BSA (1 mg/mL)",None,PBS/phosphate buffers,8.0,Not applicable,None,None,None
ssRNA,GGGAGCUCAGCCUUCACUGC-CUACGCGGGCGUUUACGUAACGGCUUAUGGGGAGCUGAGCGCUUGACCGUGGUAGUGCUAAGCAGUAAACGAG-GGCACCACGGUCGGAUCCAC,113.0,0.6017699115044248,Kd: 10 nM,10.0,5'-TCGAGCTCAGCCTTCACTGC–N74-GGCACCACGGTCGGATCCAC-3',74.0,"Selection buffer (SB), composed, 10 mM HEPES, pH 7.0, 120 mM NaCl, 5 mM KCl, 5 mM MgCl2, binding buffer (BB): (10 mM TRIS, pH 8.5,120 mM NaCl, 5 mM KCl, 20 mM CaCl2)",MgCl,Tris Buffers,7.5,Not applicable,The aptamer sequence was obtained from the fiigure 5. (there is potential for error since the quality of figure was not great),None,None
ssRNA,GGGAGCUCAGCCUUCACUGCACUCCGGCUGGUGGACGCGGUACGAGCAAUUUGUACCGGAUGGAUGUUCGGGCAGCGGUGUGGCAGGGAUGAGCGGCACCACGGUCGGAUCCAC,114.0,0.6403508771929824,Kd: 44 ± 6 nM,44.0,5'-TCGAGCTCAGCCTTCACTGC–N74-GGCACCACGGTCGGATCCAC-3',74.0,"Selection buffer (SB), composed, 10 mM HEPES, pH 7.0, 120 mM NaCl, 5 mM KCl, 5 mM MgCl2, binding buffer (BB): (10 mM TRIS, pH 8.5,120 mM NaCl, 5 mM KCl, 20 mM CaCl2)",MgCl,Tris Buffers,7.5,Not applicable,requires 5 mM MgCl2 ion for its recognition,None,None
ssRNA,5′GGGAUAGGAUCCACAUCUACGUAUUACGCAACGCCGGGCCACUACGCGAAUGGCAAGCCCGUCGACUUCACUGCAGACUUGACGAAGCUU3′ ,90.0,0.5555555555555556,Kd: 280 nM,280.0,5′-GGGATAGGATCCACATCTACGTATTA–N40-TTCACTGCAGACTTGACGAAGCTT-3′,40.0,"Selection buffer (SB), composed, 10 mM HEPES, pH 7.0, 120 mM NaCl, 5 mM KCl, 5 mM MgCl2, binding buffer (BB): (10 mM TRIS, pH 8.5,120 mM NaCl, 5 mM KCl, 20 mM CaCl2)",MgCl,PBS/phosphate buffers,7.4,Not applicable,Doped pool for affinity maturation (M-selection),None,None
ssRNA,5′GGGAUAGGAUCCACAUCUACGUAUUAGUACACGUCGGCCACCUACGCGAAGUGGAAGCCUCAUUUGUUCACUGCAGACUUGACGAAGCUU3′,90.0,0.5,Kd: 360 nM,360.0,5′-GGGATAGGATCCACATCTACGTATTA–N40-TTCACTGCAGACTTGACGAAGCTT-3′,40.0,"Selection buffer (SB), composed, 10 mM HEPES, pH 7.0, 120 mM NaCl, 5 mM KCl, 5 mM MgCl2, binding buffer (BB): (10 mM TRIS, pH 8.5,120 mM NaCl, 5 mM KCl, 20 mM CaCl2)",MgCl,PBS/phosphate buffers,7.4,Not applicable,Doped pool for affinity maturation (M-selection),None,None
ssRNA,5′GGGAGAAUUCCGACCAGAAGGGUUAAGCAGUCGGCAUGCGGUACAGACAGACCUUUCCUCUCUCCUUCCUCUUCU,75.0,0.5333333333333333,Kd: 188 pM,0.188,5′-GGGAGAATTCCGACCAGAAG-N30-CCTTTCCTCTCTCCTTCCTCTTCT-3′.,30.0,"Selection buffer (SB), composed, 10 mM HEPES, pH 7.0, 120 mM NaCl, 5 mM KCl, 5 mM MgCl2, binding buffer (BB): (10 mM TRIS, pH 8.5,120 mM NaCl, 5 mM KCl, 20 mM CaCl2)",None,Other Buffers,7.4,Not applicable,None,None,None
ssDNA,ATAGGAGTCACGACGACCAGAACCGTAGGTTCGGGGTCGGAGTGGTCCGGAAGGTGGCGTGGTATGTGCGTCTACCTCTTGACTAAT,87.0,0.5632183908045977,Kd: 105 ± 41 nM,105.0,5'-ATAGGAGTCACGACGACCAGAA-N40-TATGTGCGTCTACCTCTTGACTAAT-3',40.0,"20 mM HEPES pH 7.35, 120 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2",MgCl/CaCl,Other Buffers,7.3,Not applicable,None,None,None
ssDNA,ATAGGAGTCACGACGACCAGAACCGTAGGTTCGGGGTCGGAGTGGTCCGGAAGATGGCGTGGTATGTGCGTCTACCTCTTGACTAAT,87.0,0.5517241379310345,Kd: 80 ± 38 nM,80.0,5'-ATAGGAGTCACGACGACCAGAA-N40-TATGTGCGTCTACCTCTTGACTAAT-3',40.0,"20 mM HEPES pH 7.35, 120 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2",MgCl/CaCl,Other Buffers,7.3,Not applicable,None,None,MSDYTGPGIYTISPFHAPDMELDIWKGEKKEGTQVKLYKKAPTAANHQFQIVYA...AAA
ssDNA,ATAGGAGTCACGACGACCAGAACCGTAGGTTCGGGGCGGAGTGGTCCGGAAGGTGGCGTGGTATGTGCGTCTACCTCTTGACTAAT,86.0,0.5697674418604651,Kd: 58 ± 19 nM,58.0,5'-ATAGGAGTCACGACGACCAGAA-N40-TATGTGCGTCTACCTCTTGACTAAT-3',40.0,"20 mM HEPES pH 7.35, 120 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2",MgCl/CaCl,Other Buffers,7.3,Not applicable,None,None,MSDYTGPGIYTISPFHAPDMELDIWKGEKKEGTQVKLYKKAPTAANHQFQIVYA...AAA
ssRNA,GGGCCAGGCAGCGAGAGAUAAGCAGAAGAAGUAUGUGACCAUGCUCCAGAGAGCAACUUCACAUGCGUAGCCAAACCGACCACACGCGUCCGAGA,95.0,0.5578947368421052,Kd: 2.47 nM,2.47,5′-GGAGGACGTGCAGGGCCA-N60-CCACACGCGTCCGAGACAC-3′,60.0,"100 mM NaCl, 5 mM MgCl2, pH 7.4",MgCl/CaCl,Other Buffers,7.4,Not applicable,"Doped pool with random region doped at 30% of the following nucleotides: GGCAGCGAAAGCAGAAGAAGTATGTGACCATGCTTCGGCAACTTCACATGCGTAGCCAAACCGA

More about target: Chinese hamster ovary (CHO-K1) cells ectopically expressing human transforming growth factor-beta type III receptor (TβRIII)",None,None
ssRNA,5′GGGACAGGGCUAGCAGUAGGAUUGGGUGAGGGGAUGUGCUGUGGAGGCAAAGCUUCCG3′,58.0,0.603448275862069,Kd: 4.00 ± 0.13 μM,4000.0,5′-GGGACAGGGCTAGC-N30-GAGGCAAAGCTTCCG-3′,30.0,"100 mM NaCl, 5 mM MgCl2, pH 7.4",MgCl,Tris Buffers,7.4,Not applicable,SELEX was done with the DNA pool that was transcribed into RNA for selection. The final aptamer is RNA,None,None
ssRNA,5′GGGACAGGGCUAGCUUAGUGCUAUGUGAGAAAAGGGUGUGGGGGGAGGCAAAGCUUCCG3′,59.0,0.576271186440678,Kd: 2.50 ± 0.06 μM,2500.0,5′-GGGACAGGGCTAGC-N30-GAGGCAAAGCTTCCG-3′,30.0,"100 mM NaCl, 5 mM MgCl2, pH 7.4",MgCl,Tris Buffers,7.4,Not applicable,SELEX was done with the DNA pool that was transcribed into RNA for selection. The final aptamer is ssDNA,None,None
ssRNA,GGACGCGUGGUACCAGGCCGAUCUAUGGACGCUAUAGGCACACCGGAUACUUUAACGAUUGGCUAAGCUUCCGCGGGGAUC,81.0,0.5679012345679012,Kd: ~5.0 nM,5.0,5'-GGACGCGCGUGGUACC-N50-GCUUCCGCGGGGAUC-3',50.0,"25 mmol/L HEPES (pH 7.5), 150 mmol/L NaCl, 1 mmol/L MgCl2, 2 mmol/L DTT, and 40 units RNase inhibitor",MgCl,Other Buffers,7.5,Not applicable,None,None,None
ssRNA,5′ACCGAGUCCAGAAGCUUGUAGUACUCGGCGAACUACCUAACCCCCCACAAUUGUAUUAUCGCCCGCCUAGAUGGCAGUUGAAUUCUCCCUAUAGUGAGUCGUAUUAC3′,107.0,0.48598130841121495,Kd: 37 ± 5 nM,37.0,5′-ACCGAGTCCAGAAGCTTGTAGTACT-N40-GCCTAGATGGCAGTTGAATTCTCCCTATAGTGAGTCGTATTAC-3′,40.0,"EMSA binding buffer: 1 pmol BSA, Streptavidin, ANEPIII (5 µL total volume each)",MgCl/CaCl,Other Buffers,7.4,Not applicable,None,None,None
ssDNA,5′CGGGGATCCGGAATTCTCCTCACAGGCGAAAATTTGTGGATATAGAGGGTTACTCGGATGTATGTCGACGAAGCTTGCG3′,79.0,0.5063291139240507,Kd: 21.73 nM,21.73,5′-CGGGGATCCGGAATTCTCCTCACA-N35-GTATGTCGACGAAGCTTGCG-3′,35.0,"EMSA binding buffer: 1 pmol BSA, Streptavidin, ANEPIII (5 µL total volume each)",MgCl/CaCl,Other Buffers,7.35,Not applicable,None,None,None
ssRNA,GAAUUCGUCGACGGAUCCGCAGUGCGUCUUGGGUUGUGAGCUCCCGGCUCGCAUUGUGAGGUGGAGGGGGACGUGCUGCAGGUCGACGCAUGCGCCG,97.0,0.6494845360824743,Kd: 50±10 μM,50000.0,5′-GAATTCGTCGACGGATCC-N58-CTGCAGGTCGACGCATGCGCCG-3′,58.0,"EMSA binding buffer: 1 pmol BSA, Streptavidin, ANEPIII (5 µL total volume each)",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,CAGCTCAGAAGCTTGATCCTGTGAGCGAAAATCCGGAGTAGAGGAGCAGCTGGGTGCTGACTCGAAGTCGTGCATCTGCA,80.0,0.55,Kd: 76 ± 28 nM,76.0,5′-CAGCTCAGAAGCTTGATCCTGTG-N35-GACTCGAAGTCGTGCATCTGCA-3,35.0,"EMSA binding buffer: 1 pmol BSA, Streptavidin, ANEPIII (5 µL total volume each)",MgCl/CaCl,Other Buffers,7.35,Not applicable,None,None,None
ssDNA,5′CAGCTCAGAAGCTTGATCCTGTGCAGCCGGGGGACAAGCGCGTTGGCCAGATCATCCGACTCGAAGTCGTGCATCTGCA,79.0,0.5949367088607594,Kd: 89 ± 32,89.0,5′-CAGCTCAGAAGCTTGATCCTGTG-N35-GACTCGAAGTCGTGCATCTGCA-3,35.0,"EMSA binding buffer: 1 pmol BSA, Streptavidin, ANEPIII (5 µL total volume each)",MgCl/CaCl,Other Buffers,7.35,Not applicable,None,None,None
ssDNA,5′CAGCTCAGAAGCTTGATCCTGTGCGAAAAGGATGCGGGCAGCGGACTCAAGGCCATCTGACTCGAAGTCGTGCATCTGCA,80.0,0.5625,Kd: 50 ± 15,50.0,5′-CAGCTCAGAAGCTTGATCCTGTG-N35-GACTCGAAGTCGTGCATCTGCA-3,35.0,"EMSA binding buffer: 1 pmol BSA, Streptavidin, ANEPIII (5 µL total volume each)",MgCl/CaCl,Other Buffers,7.35,Not applicable,None,None,None
ssDNA,5′CAGCTCAGAAGCTTGATCCTGTGCGGGGCAAAGAGGTCCGAATTTGAAGGCTCCCCTGGACTCGAAGTCGTGCATCTGCA,80.0,0.5625,Kd: 104 ± 47,104.0,5′-CAGCTCAGAAGCTTGATCCTGTG-N35-GACTCGAAGTCGTGCATCTGCA-3,35.0,"EMSA binding buffer: 1 pmol BSA, Streptavidin, ANEPIII (5 µL total volume each)",MgCl/CaCl,Other Buffers,7.35,Not applicable,None,None,None
ssDNA,5′CAGCTCAGAAGCTTGATCCTGTGAAGGGCTGATGAGGGGCGTAGCGGCTTGTTCGTAAGACTCGAAGTCGTGCATCTGCA,80.0,0.55,Kd: 81 ± 26,81.0,5′-CAGCTCAGAAGCTTGATCCTGTG-N35-GACTCGAAGTCGTGCATCTGCA-3,35.0,"EMSA binding buffer: 1 pmol BSA, Streptavidin, ANEPIII (5 µL total volume each)",MgCl/CaCl,Other Buffers,7.35,Not applicable,None,None,None
ssDNA,5′CAGCTCAGAAGCTTGATCCTGTGAGGAATGCTCATGCATAGCAAGGGCTAAACACGGCGACTCGAAGTCGTGCATCTGCA,80.0,0.525,Kd: 28 ± 9 nM,28.0,5′-CAGCTCAGAAGCTTGATCCTGTG-N35-GACTCGAAGTCGTGCATCTGCA-3,35.0,"EMSA binding buffer: 1 pmol BSA, Streptavidin, ANEPIII (5 µL total volume each)",MgCl/CaCl,Other Buffers,7.35,Not applicable,None,None,None
ssDNA,5′CAGCTCAGAAGCTTGATCCTGTGCGATCGAATGAAAGCTGCTGGATTGTCGCTATCCTGACTCGAAGTCGTGCATCTGCA,80.0,0.5125,Kd: 67 ± 29,67.0,5′-CAGCTCAGAAGCTTGATCCTGTG-N35-GACTCGAAGTCGTGCATCTGCA-3,35.0,"EMSA binding buffer: 1 pmol BSA, Streptavidin, ANEPIII (5 µL total volume each)",MgCl/CaCl,Other Buffers,7.35,Not applicable,None,None,None
ssDNA,5′CAGCTCAGAAGCTTGATCCTGTGCGGGCGGCAAGGCCCTGACAGAGATACTGGCTCGGGACTCGAAGTCGTGCATCTGCA,80.0,0.6,Kd: 130 ± 54,130.0,5′-CAGCTCAGAAGCTTGATCCTGTG-N35-GACTCGAAGTCGTGCATCTGCA-3,35.0,"EMSA binding buffer: 1 pmol BSA, Streptavidin, ANEPIII (5 µL total volume each)",MgCl/CaCl,Other Buffers,7.35,Not applicable,None,None,None
ssDNA,5′ATACCAGTCTATTCAATTGGGCCCTTTTCTGTGTCTTTCTGTGCCCTTAGATAGTATGTGCAATCA3′,66.0,0.4090909090909091,Kd: 1.13 × 10−7 M,113.0,5′-ATACCAGTCTATTCAATT-30N-AGATAGTATGTGCAATCA-3′,30.0,4% skim milk in PBS containing 0.5% Tween 20 (PBS-T) buffer,None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssRNA,5′GGGACGCGUGGUACCGACGGAGGCUUGUUUAUGUAGGGAUGUAAGGGGAUGGGCAAUGUGGCGACAGCUUCCGCGGGGAUC3′,81.0,0.6049382716049383,"Kd: 43 nM for Ca2+ bound, 79 nM for Ca2+ unbound",43.0,5′-CGGAATTCGGGACGCGTGGTACC-N50-AAGCTTCCGCGGGGATCCAA-3′,50.0,"30 mM Tris (pH 7.5 at 25 °C), 150 mM NaCl, 1 mM MgCl2, 1 mM DTT, 5 mM EGTA, or 1 mM CaCl2",MgCl/CaCl,Tris Buffers,7.5,Not applicable,"Aptamer-2, does not discriminate between the calcium-bound dimeric conformation and the calcium-deficient conformation of the protein. The paper given fixed region which has less nucleotides than the given pool (5′-Fixed region: GGGACGCGTGGTACC, 3′-fixed region: AGCTTCCGCGGGGAT). The given fixed region is used to construct the aptamer sequence. 
Since this is an RNA aptamer sequence, All the thymine converted to Uridine.
DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.",None,None
ssRNA,5′GGGACGCGUGGUACCAAAGAGGCUGCGCGGAAGUGAGGGUGUUGGUUACGAAGGUUGGUGUGUGAAGCUUCCGCGGGGAUC3′,81.0,0.6049382716049383,Kd: 190 nM for Ca2+ bound,190.0,5′-CGGAATTCGGGACGCGTGGTACC-N50-AAGCTTCCGCGGGGATCCAA-3′,50.0,"30 mM Tris (pH 7.5 at 25 °C), 150 mM NaCl, 1 mM MgCl2, 1 mM DTT, 5 mM EGTA, or 1 mM CaCl2",MgCl/CaCl,Tris Buffers,7.5,Not applicable,"Aptamer-12, selected for the active conformation of the protein, binds strongly to the calcium-bound dimeric conformation and not to the calcium-deficient conformation. The paper given fixed region which has less nucleotides than the given pool (5′-Fixed region: GGGACGCGTGGTACC, 3′-fixed region: AGCTTCCGCGGGGAT). The given fixed region is used to construct the aptamer sequence. 
All the thymine converted to Uridine.
DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.",None,None
ssRNA,GGGCCAAGCUUGCAUGCCUGCAGUUGGUUACGCGUACAGUGAAACUCGGAAAGUUGAAGGGCCAAAUGGGAACGGUACCGAGCUCAGGUUCCC,93.0,0.5591397849462365,Kd: 1.15E-08 M,11.5,5'-GGGCCAAGCTTGCATGCCTGCAG-N60-GGTACCGAGCTCAGGTTCCC-3',60.0,"25 mm sodium acetate, 25 mm sodium phosphate buffer (Buffer A), pH 3.6, containing 250 mm NaCl",None,PBS/phosphate buffers,3.6,Not applicable,None,None,None
ssRNA,GGGCCAAGCUUGCAUGCCUGCAGAAAAAUAAAGUGUGUACACUAAAUUGCUAGCCCCCGGAAAGAAGGUCAACAAAAGUCAGUGGUACCGAGCUCAGGUUCCC,103.0,0.49514563106796117,Kd: 7.48E-09 M,7.48,5'-GGGCCAAGCTTGCATGCCTGCAG-N60-GGTACCGAGCTCAGGTTCCC-3',60.0,"25 mm sodium acetate, 25 mm sodium phosphate buffer (Buffer A), pH 3.6, containing 250 mm NaCl",None,PBS/phosphate buffers,3.6,Not applicable,None,None,MSRSVALAVLALLSLSGLEAIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSD...RDM
ssRNA,GGGCCAAGCUUGCAUGCCUGCAGGCAAACGGGGGCGUUUCGGCGGAGGAGUGGGAAGAAAAACGAGAGAAGAGUUGGAACGGGUACCGAGCUCAGGUUCCC,101.0,0.6039603960396039,Kd: 2.21E-08 M,22.1,5'-GGGCCAAGCTTGCATGCCTGCAG-N60-GGTACCGAGCTCAGGTTCCC-3',60.0,"25 mm sodium acetate, 25 mm sodium phosphate buffer (Buffer A), pH 3.6, without NaCl, at pH 2.5",None,PBS/phosphate buffers,3.6,Not applicable,None,None,MSRSVALAVLALLSLSGLEAIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSD...RDM
ssDNA,CAGGTCCATCGAGTGGTAGGAGTAGTTATTGGAGGGGTGGGCGGGAAGCGACGATTGTGGGTCGCACTGCTCCTGAACGTAC,82.0,0.5853658536585366,Kd: 39 nM,39.0,5'-CAGGTCCATCGAGTGGTAGGA-N40-TCGCACTGCTCCTGAACGTAC-3',40.0,"BP-T (20 mM Tris–HCl [pH 7.4], 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 0.05% [v/v] Tween 20)",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,CAGGTCCATCGAGTGGTAGGAGGTGCGAAATTGGGGGGGTGGGGTAGCGGTGTTGAGCACATCGCACTGCTCCTGAACGTAC,82.0,0.5975609756097561,Kd: 29 nM,29.0,5'-CAGGTCCATCGAGTGGTAGGA-N40-TCGCACTGCTCCTGAACGTAC-3',40.0,"20 mM Tris–HCl [pH 7.4], 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 0.05% [v/v] Tween 20",MgCl,Tris Buffers,7.5,Not applicable,None,None,MNKNKNIGIILAGGVGSRMGLGYPKQFSKIAGKTALEHTLAIFQEHKEIDEIII...LYK
2'-fluoro-RNA,GGGCCGUUCGAACACGAGCAUGUUGUCUACGUUGUAGAAGCUGUUAUGGUAGGUACUUCCACGAGGUAUCAACGGAGUUGGUGGACAGUACUCAGGUCAUCCUAGG,106.0,0.5094339622641509,Kd: 142 nM via format protein chip assay (Biacore),142.0,5'-GGGCCGTTCGAACACGAGCATG-N60-GGACAGTACTCAGGTCATCCTAGG-3',60.0,"20 mM Tris–HCl [pH 7.4], 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 0.05% [v/v] Tween 20",None,Other Buffers,7.4,"Using the same sol–gel materials as those used for the protein chips [22], we immobilized the 2′-F modified (for protection of aptamers against RNases) aptamers (2′F-9-14 , 2′F-9-15, and 2′F-9-19) along with the core and NS5 proteins as diagnostic controls","Protein info: A fusion protein including the N-terminal amino acids 2–114 of the core antigen with the C-terminal His tag was bacterially expressed, and the resulting core(2-114)-His6 proteins were purified using Ni-NTA affinity chromatography",None,None
2'-fluoro-RNA,GGGCCGUUCGAACACGAGCAUGGAUCGAGGAUGGGAACACCCAGUAGGAGGAUGGGCAUGGCCGGACCCAAAAUUAGCAGUGGGACAGUACUCAGGUCAUCCUAGG,106.0,0.5754716981132075,Kd: 224 nM via format protein chip assay (Biacore),224.0,5'-GGGCCGTTCGAACACGAGCATG-N60-GGACAGTACTCAGGTCATCCTAGG-3',60.0,"Tris–Cl (50 mM pH 7.5), Triton X-100 (0.05% w/v), NaCl (0.5 M), imidazole (20 mM)",None,Other Buffers,7.4,"Using the same sol–gel materials as those used for the protein chips [22], we immobilized the 2′-F modified (for protection of aptamers against RNases) aptamers (2′F-9-14 , 2′F-9-15, and 2′F-9-19) along with the core and NS5 proteins as diagnostic controls","Protein info: A fusion protein including the N-terminal amino acids 2–114 of the core antigen with the C-terminal His tag was bacterially expressed, and the resulting core(2-114)-His6 proteins were purified using Ni-NTA affinity chromatography",None,MDAPEESIRMTSDPQSKIYVQNPDTHIHLEQSPSAKSGNGRALVLCSVSVACLS...ATV
ssRNA,GGGCGAAUUCAACUGCCAUCUAGGCAGUAACCAGGAGUUAGUAGGACAAGUUUCGUCC,58.0,0.5,Kd: 0.419 ± 0.221 nM & IC50: 121 ± 7 nM,0.419,5'-GGGCGAAUUCAACUGCCAUCUAGGC-N50-AGUACUACAAGCUUCUGGACUCGGU-3',50.0,"Tris–Cl (50 mM pH 7.5), Triton X-100 (0.05% w/v), NaCl (0.5 M), imidazole (20 mM)",MgCl/CaCl,Other Buffers,7.4,"An1444 was reduced to a 58 nt long, functional aptamer (an58) (the original 99 nt an1444 was truncated from both 5‘ and 3‘ directions)",None,None,None
ssDNA,GATCGGGTGTGGGTGGCGTAAAGGGAGCATCGGACA,36.0,0.6111111111111112,Kd: 0.2,0.2,5'TGGTGGCTGTAGGTCA-N30-CGTTGTCCGATGCTC,30.0,"Selection buffer (SB), composed of 10 mM HEPES, pH 7.0, 120 mM NaCl, 5 mM KCl, and 5 mM MgCl2; binding buffer (BB): (10 mM TRIS, pH 8.5,120 mM NaCl, 5 mM KCl, and 20 mM CaCl2)",MgCl/CaCl,Tris Buffers,7.0,"Removing the forward primer in 1.12 and a section of the 5′-nonconsensus sequence. Further removal of three bases from the 3′-end, (aptamers 1.12.2 and 1.12.8) resulted in a significant increase in binding affinity","The library was designed with 30 random nucleotides, flanked with two constant regions for primer annealing. The primers were as follows: reverse, Biotin_x0002_CGTTGTCCGATGCTC; and forward, Cy3-TGGTGGCTGTAGGTCA",None,None
ssDNA,GATCGGGTGTGGGTGGCGTAAAGGGAGCATCGG,33.0,0.6363636363636364,Kd: 0.2,0.2,5'TGGTGGCTGTAGGTCA-N30-CGTTGTCCGATGCTC,30.0,"Selection buffer (SB), composed of 10 mM HEPES, pH 7.0, 120 mM NaCl, 5 mM KCl, and 5 mM MgCl2; binding buffer (BB): (10 mM TRIS, pH 8.5,120 mM NaCl, 5 mM KCl, and 20 mM CaCl2)",MgCl/CaCl,Tris Buffers,7.0,"Removing the forward primer in 1.12 and a section of the 5′-nonconsensus sequence. Further removal of three bases from the 3′-end, (aptamers 1.12.2 and 1.12.8) resulted in a significant increase in binding affinity","The library was designed with 30 random nucleotides, flanked with two constant regions for primer annealing. The primers were as follows: reverse, Biotin_x0002_CGTTGTCCGATGCTC; and forward, Cy3-TGGTGGCTGTAGGTCA",None,MTTPTPTTLKHHATTILTTLVNDRQTAAIEHLLHPTITLKHNDLPAMSKSELIA...GEM
ssDNA,GATCGGGTGTGGGTGGCGTAAAGGGAGCAT,30.0,0.6,Kd: 1.6,1.6,5'TGGTGGCTGTAGGTCA-N30-CGTTGTCCGATGCTC,30.0,"Selection buffer (SB), composed of 10 mM HEPES, pH 7.0, 120 mM NaCl, 5 mM KCl, and 5 mM MgCl2; binding buffer (BB): (10 mM TRIS, pH 8.5,120 mM NaCl, 5 mM KCl, and 20 mM CaCl2)",MgCl/CaCl,Tris Buffers,7.0,Removing the forward primer in 1.12 and a section of the 5′ nonconsensus sequence. Removal of nucleotide from 3'-end,"The library was designed with 30 random nucleotides, flanked with two constant regions for primer annealing. The primers were as follows: reverse, Biotin_x0002_CGTTGTCCGATGCTC; and forward, Cy3-TGGTGGCTGTAGGTCA",None,MTTPTPTTLKHHATTILTTLVNDRQTAAIEHLLHPTITLKHNDLPAMSKSELIA...GEM
ssDNA,GATCGGGTGTGGGTGGCGTAAAGGGAGCATCG,32.0,0.625,Kd: 0.4,0.4,5'TGGTGGCTGTAGGTCA-N30-CGTTGTCCGATGCTC,30.0,"Selection buffer (SB), composed of 10 mM HEPES, pH 7.0, 120 mM NaCl, 5 mM KCl, and 5 mM MgCl2; binding buffer (BB): (10 mM TRIS, pH 8.5,120 mM NaCl, 5 mM KCl, and 20 mM CaCl2)",MgCl/CaCl,Tris Buffers,7.0,Removing the forward primer in 1.12 and a section of the 5′ nonconsensus sequence. Removal of nucleotide from 3'-end,"The library was designed with 30 random nucleotides, flanked with two constant regions for primer annealing. The primers were as follows: reverse, Biotin_x0002_CGTTGTCCGATGCTC; and forward, Cy3-TGGTGGCTGTAGGTCA",None,MTTPTPTTLKHHATTILTTLVNDRQTAAIEHLLHPTITLKHNDLPAMSKSELIA...GEM
ssDNA,5′CGTACGGAATTCGCTAGCCGACGCGCGTTGGTGGTGGATGGTGTGTTACACGTGTTGTGGATCCGAGCTCCACGTG3′,76.0,0.5921052631578947,Kd: 9.61 ± 0.3 nM,9.61,5′-CGTACGGAATTCGCTAGC-N40-GGATCCGAGCTCCACGTG-3′,40.0,"NaCl (100 mM), Tris–HCl (20 mM pH 7.6), MgCl2(2 mM), KCl(5 mM), CaCl2(1 mM), Tween 20 (0.02%)",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,None,None
ssDNA,5′CGTACGGAATTCGCTAGCACGTTGACGCTGGTGCCCGGTTGTGGTGCGAGTGTTGTGTGGATCCGAGCTCCACGTG3′,76.0,0.6052631578947368,Kd: 12.08 ± 2.25 nM,12.08,5′-CGTACGGAATTCGCTAGC-N40-GGATCCGAGCTCCACGTG-3′,40.0,"NaCl (100 mM), Tris–HCl (20 mM pH 7.6), MgCl2(2 mM), KCl(5 mM), CaCl2(1 mM), Tween 20 (0.02%)",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,None,MEGMNMGSSMNMDAMSSASKTVASSMASMSMDAMSSASKTILSSMSSMSMEAMS...THN
ssDNA,5′CGTACGGAATTCGCTAGCCGAGTTGAGCCGGGCGCGGTACGGGTACTGGTATGTGTGGGGATCCGAGCTCCACGTG3′,76.0,0.631578947368421,Kd: 56.84 ± 3.62 nM,56.84,5′-CGTACGGAATTCGCTAGC-N40-GGATCCGAGCTCCACGTG-3′,40.0,"NaCl (100 mM), Tris–HCl (20 mM pH 7.6), MgCl2(2 mM), KCl(5 mM), CaCl2(1 mM), Tween 20 (0.02%)",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,None,MEGMNMGSSMNMDAMSSASKTVASSMASMSMDAMSSASKTILSSMSSMSMEAMS...THN
ssDNA,5′GGGAGACAAGAATAAACGCTCAAGAAGTGAAAATGACAGAACACAACATTCGACAGGAGGCTCACAACAGGC,72.0,0.4583333333333333,Kd: 47.3 ± 0.984 nM,47.3,5′-GGGAGACAAGAATAAACGCTCAA-N25-TTCGACAGGAGGCTCACAACAGGC-3',25.0,"NaCl (100 mM), Tris–HCl (20 mM pH 7.6), MgCl2(2 mM), KCl(5 mM), CaCl2(1 mM), Tween 20 (0.02%)",MgCl,Other Buffers,7.4,Not applicable,Selection was done using affinity chromatography,None,None
ssDNA,5′GGGAGACAAGAATAAACGCTCAAGGCTATAGCACATGGGTAAAACGACTTCGACAGGAGGCTCACAACAGGC,72.0,0.5,Kd: 85.2 ± 0.986 nM,85.2,5′-GGGAGACAAGAATAAACGCTCAA-N25-TTCGACAGGAGGCTCACAACAGGC-3',25.0,"NaCl (100 mM), Tris–HCl (20 mM pH 7.6), MgCl2(2 mM), KCl(5 mM), CaCl2(1 mM), Tween 20 (0.02%)",MgCl,Other Buffers,7.4,Not applicable,Selection was done using affinity chromatography,None,None
ssDNA,5′GGGAGACAAGAATAAACGCTCAACAAACAATCAAACAGCAGTGGGGTGTTCGACAGGAGGCTCACAACAGGC,72.0,0.5,Kd: 83.0 ± 0.981 nM,83.0,5′-GGGAGACAAGAATAAACGCTCAA-N25-TTCGACAGGAGGCTCACAACAGGC-3',25.0,"NaCl (100 mM), Tris–HCl (20 mM pH 7.6), MgCl2(2 mM), KCl(5 mM), CaCl2(1 mM), Tween 20 (0.02%)",MgCl,Other Buffers,7.4,Not applicable,Selection was done using affinity chromatography,None,None
ssDNA,5′GGGAGACAAGAATAAACGCTCAATACTGCATGCACACCACTTCAACTATTCGACAGGAGGCTCACAACAGGC,72.0,0.4861111111111111,Kd: 69.0 ± 0.974 nM,69.0,5′-GGGAGACAAGAATAAACGCTCAA-N25-TTCGACAGGAGGCTCACAACAGGC-3',25.0,"NaCl (100 mM), Tris–HCl (20 mM pH 7.6), MgCl2(2 mM), KCl(5 mM), CaCl2(1 mM), Tween 20 (0.02%)",MgCl,Other Buffers,7.4,Not applicable,Selection was done using affinity chromatography,None,None
2'-fluoro-RNA,GGGAGAGAGGAAGAGGGAUGGGACUCGAACAUUUCCACUAACCAACCAUACUAAAGCACCGCCAUAACCCAGAGGUCGAUAGUACUGGAUCCCCCC3′,96.0,0.53125,Kd: 2.8 nM,2.8,5'-GGGAGAGAGGAAGAGGGAUGGG-N40-CAUAACCCAGAGGUCGAUAGUACUGGAUCCCCCC-3′,40.0,"20 mM HEPES, pH 7.4, 50 mM [round 1] - 150 mM [round 7] NaCl, 2 mM CaCl2, 0.05% CHAPS",CaCl,Other Buffers,7.4,Not applicable,"in pool type N40 represents 40 random nucleotides with equimolar 2′-hydroxy ATP, 2′-hydroxy GTP, 2′-fluoro CTP, and 2′-fluoro UTP content
RNA aptamers are promising tools with which to study the angiopoietins in vitro and in vivo. The use of 2′-modified nucleotides confers resistance to nuclease degradation, and 2′-fluoro-modified RNAs have plasma half-lives of greater than 12 h [37]. The in vivo circulating half-life of these aptamers can be improved further by the addition of PEG or cholesterol moieties to their 5′ ends [38]. The full-length ANG9-4 aptamer (96 nucleotides) can be transcribed in vitro in quantities sufficient for cell culture and some small animal models. However, chemical synthesis, with or without 5′ modification, is inefficient for RNAs greater than 60 nucleotides in length. Work is ongoing to truncate and modify the full-length aptamer for large-scale synthesis and application in animal models.",None,None
ssDNA,TAATACGACTCACTATAGGGAATTCTATCCGGGTACCAAACTGAATACTGGGAATCAATTCCCTATAGTGAGTCGTATTAGCTAGTAAGCTTGCCGT,97.0,0.41237113402061853,Kd: 228.4 nM and 7485.3 nM *this Kd was determined with affinity test on entire n round pool,228.4,5'-TAATACGACTCACTATAGGGAATTCTATCCGGGTA-N25-GCTAGTAAGCTTGCCGT-3',25.0,"EMSA binding buffer: 1 pmol BSA, Streptavidin and ANEPIII (5 µL total volume each)",None,Other Buffers,7.4,Not applicable,None,None,None
ssDNA,TAATACGACTCACTATAGGGAATTCTATCCGGGTAAAGCTGGCCACCGGAATACTGGAAATCTGGATCCCT3GCTAGTAAGCTTGCCGT,88.0,0.4772727272727273,Kd: 228.4 nM and 7485.3 nM *this Kd was determined with affinity test on entire n round pool,228.4,5'-TAATACGACTCACTATAGGGAATTCTATCCGGGTA-N25-GCTAGTAAGCTTGCCGT-3',25.0,"1XBB: 0.5M NaCl, 20 mM Tris HCl, 2 mM MgCl2, pH 7.2–7.4",None,Other Buffers,7.4,Not applicable,None,None,MKLSLLLVISASMLIDGLVNADGYIRGSNGCKISCLWGNEGCNKECKGFGAYYG...GKK
ssDNA,TAATACGACTCACTATAGGGAATTCTATCCGGGTATAGGGAATTCTATCCGGGCTAGTTTCGAAGCCGTAAGACTGGAGATCTGGATCCCTGCTAGTAAGCTTGCCGT,108.0,0.4722222222222222,Kd: 228.4 nM and 7485.3 nM *this Kd was determined with affinity test on entire n round pool,228.4,5'-TAATACGACTCACTATAGGGAATTCTATCCGGGTA-N25-GCTAGTAAGCTTGCCGT-3',25.0,"1XBB: 0.5M NaCl, 20 mM Tris HCl, 2 mM MgCl2, pH 7.2–7.4",None,Other Buffers,7.4,Not applicable,None,None,MKLSLLLVISASMLIDGLVNADGYIRGSNGCKISCLWGNEGCNKECKGFGAYYG...GKK
ssDNA,TAATACGACTCACTATAGGGAATTCTATCCGGGTAGCTTCCAAACTGAATACTGGGATTCAATTCCCTATAGTGAGTCGTATTAGCTAGTAAGCTTGCCGT,101.0,0.4158415841584158,Kd: 228.4 nM and 7485.3 nM *this Kd was determined with affinity test on entire n round pool,228.4,5'-TAATACGACTCACTATAGGGAATTCTATCCGGGTA-N25-GCTAGTAAGCTTGCCGT-3',25.0,"1XBB: 0.5M NaCl, 20 mM Tris HCl, 2 mM MgCl2, pH 7.2–7.4",None,Other Buffers,7.4,Not applicable,None,None,MKLSLLLVISASMLIDGLVNADGYIRGSNGCKISCLWGNEGCNKECKGFGAYYG...GKK
ssDNA,TAATACGACTCACTATAGGGAATTCTATCCGGGTACCAAACTAGCTACTGGGAATCAATTCCCTATAGTGAGTCGTATTAGCTAGTAAGCTTGCCGT,97.0,0.422680412371134,Kd: 228.4 nM and 7485.3 nM *this Kd was determined with affinity test on entire n round pool,228.4,5'-TAATACGACTCACTATAGGGAATTCTATCCGGGTA-N25-GCTAGTAAGCTTGCCGT-3',25.0,"0.5 M NaCl, 10 mM Tris HCl, 1 mM MgCl2 in sterile deionized nuClease-free water (NFW) at pH 7.2–7.4",None,Other Buffers,7.4,Not applicable,None,None,MKLSLLLVISASMLIDGLVNADGYIRGSNGCKISCLWGNEGCNKECKGFGAYYG...GKK
ssDNA,TAATACGACTCACTATAGGGAATTCTATCCGGGTACCAAACTAGCTACCGGGATACAATTCCCTATAGTGAGTCGTATTAGCTAGTAAGCTTGCCGT,97.0,0.4329896907216495,Kd: 228.4 nM and 7485.3 nM *this Kd was determined with affinity test on entire n round pool,228.4,5'-TAATACGACTCACTATAGGGAATTCTATCCGGGTA-N25-GCTAGTAAGCTTGCCGT-3',25.0,"50 mM Tris–Cl, pH 7.4, 5 mM KCl, 100 mM NaCl, 1 mM MgCl2",None,Other Buffers,7.4,Not applicable,None,None,MKLSLLLVISASMLIDGLVNADGYIRGSNGCKISCLWGNEGCNKECKGFGAYYG...GKK
ssDNA,TAATACGACTCACTATAGGGAATTCTATCCGGGTAACGGCTTCCAAACTAGCTACCCGGATAGAATTCCCTATAGTGAGTCGTATTAAGGCTAGTAAGCTTGCCGT,106.0,0.44339622641509435,Kd: 228.4 nM and 7485.3 nM *this Kd was determined with affinity test on entire n round pool,228.4,5'-TAATACGACTCACTATAGGGAATTCTATCCGGGTA-N25-GCTAGTAAGCTTGCCGT-3',25.0,"50 mM Tris–Cl, pH 7.4, 5 mM KCl, 100 mM NaCl, 1 mM MgCl2",None,Other Buffers,7.4,Not applicable,None,None,MKLSLLLVISASMLIDGLVNADGYIRGSNGCKISCLWGNEGCNKECKGFGAYYG...GKK
ssDNA,TAATACGACTCACTATAGGGAATTCTATCCGGGTACGGCTTCCAAACTAGCTACCGGGATTGAATTCCCTATAGTGAGTCGTATTAGCTAGTAAGCTTGCCGT,103.0,0.44660194174757284,Kd: 228.4 nM and 7485.3 nM *this Kd was determined with affinity test on entire n round pool,228.4,5'-TAATACGACTCACTATAGGGAATTCTATCCGGGTA-N25-GCTAGTAAGCTTGCCGT-3',25.0,"20 mM Tris (pH 7.5), 5 mM MgCl2, 100 mM NaCl",None,Other Buffers,7.4,Not applicable,None,None,MKLSLLLVISASMLIDGLVNADGYIRGSNGCKISCLWGNEGCNKECKGFGAYYG...GKK
ssDNA,TAATACGACTCACTATAGGGAATTCTATCCGGGTAAAGCTGGCCACCGGAAGACTGGAGATCTGGATCCCTGCTAGTAAGCTTGCCGT,88.0,0.5,Kd: 228.4 nM and 7485.3 nM *this Kd was determined with affinity test on entire n round pool,228.4,5'-TAATACGACTCACTATAGGGAATTCTATCCGGGTA-N25-GCTAGTAAGCTTGCCGT-3',25.0,"EMSA binding buffer: 1 pmol BSA, Streptavidin and ANEPIII (5 µL total volume each)",None,Other Buffers,7.4,Not applicable,None,None,MKLSLLLVISASMLIDGLVNADGYIRGSNGCKISCLWGNEGCNKECKGFGAYYG...GKK
ssDNA,TAATACGACTCACTATAGGGAATTCTATCCGGGTAAAGCTGACTACCTATCTACTGGTCTTCTGGGTCCCTGCTAGTAAGCTTGCCGT,88.0,0.4659090909090909,Kd: 228.4 nM and 7485.3 nM *this Kd was determined with affinity test on entire n round pool,228.4,5'-TAATACGACTCACTATAGGGAATTCTATCCGGGTA-N25-GCTAGTAAGCTTGCCGT-3',25.0,"EMSA binding buffer: 1 pmol BSA, Streptavidin and ANEPIII (5 µL total volume each)",None,Other Buffers,7.4,Not applicable,None,None,MKLSLLLVISASMLIDGLVNADGYIRGSNGCKISCLWGNEGCNKECKGFGAYYG...GKK
ssDNA,TAATACGACTCACTATAGGGAATTCTATCCGGGTACGGCTTCGAAACTAGCCCGGATAGAATTCCCTATAGTGAGTCGTATTAGCTAGTAAGCTTGCCGT,100.0,0.45,Kd: 228.4 nM and 7485.3 nM *this Kd was determined with affinity test on entire n round pool,228.4,5'-TAATACGACTCACTATAGGGAATTCTATCCGGGTA-N25-GCTAGTAAGCTTGCCGT-3',25.0,"EMSA binding buffer: 1 pmol BSA, Streptavidin and ANEPIII (5 µL total volume each)",None,Other Buffers,7.4,Not applicable,None,None,MKLSLLLVISASMLIDGLVNADGYIRGSNGCKISCLWGNEGCNKECKGFGAYYG...GKK
ssDNA,GGTATTGAGGGTCGCATCTGGCTTTCCTTTCTTCTCACTCCCCTGTTCTCTTCGTCTCTTGTTGATGGCTCTAACTCTCCTCT,83.0,0.4939759036144578,Kd: 48 nM,48.0,5'-GGTATTGAGGGTCGCATC-N45-GATGGCTCTAACTCTCCTCT-3',45.0,"Selection Buffer: 50 mM NaH2PO4, pH 8.0, 150 mM NaCl, 5 mM KCl, 1 mM MgCl2, 0.005% (v/v) Tween-20",MgCl,PBS/phosphate buffers,8.0,Not applicable,None,None,None
ssDNA,GGTATTGAGGGTCGCATCTGGCTTTTCTTTCTTCTCACTCCCCTGTTCTCTTCGTCTCTTGTTGATGGCTCTAACTCTCCTCT,83.0,0.4819277108433735,Kd: 30 nM,30.0,5'-GGTATTGAGGGTCGCATC-N45-GATGGCTCTAACTCTCCTCT-3',45.0,"Selection Buffer: 50 mM NaH2PO4, pH 8.0, 150 mM NaCl, 5 mM KCl, 1 mM MgCl2, 0.005% (v/v) Tween-21",MgCl,PBS/phosphate buffers,8.0,Not applicable,None,None,VQLQESGGGLVQPGGSLRLSCAASGRTFSSYNMGWFRQAPGKGREFVASITSSG...TVS
ssDNA,GGTATTGAGGGTCGCATCGTTTTGTTACAGTTCGTTTCTTTTCCCTGTCTTGTTTTGTTGTCTGATGGCTCTAACTCTCCTCT,83.0,0.43373493975903615,Kd: 20 nM,20.0,5'-GGTATTGAGGGTCGCATC-N45-GATGGCTCTAACTCTCCTCT-3',45.0,"Selection Buffer: 50 mM NaH2PO4, pH 8.0, 150 mM NaCl, 5 mM KCl, 1 mM MgCl2, 0.005% (v/v) Tween-22",MgCl,PBS/phosphate buffers,8.0,Not applicable,None,None,VQLQESGGGLVQPGGSLRLSCAASGRTFSSYNMGWFRQAPGKGREFVASITSSG...TVS
ssDNA,GGTATTGAGGGTCGCATCTTTCTGTCTTGTGTTACTTGTTTGTCCGGTTTCTTTTCTCCCCCCGATGGCTCTAACTCTCCTCT,83.0,0.4819277108433735,Kd: 56 nM,56.0,5'-GGTATTGAGGGTCGCATC-N45-GATGGCTCTAACTCTCCTCT-3',45.0,"Selection Buffer: 50 mM NaH2PO4, pH 8.0, 150 mM NaCl, 5 mM KCl, 1 mM MgCl2, 0.005% (v/v) Tween-23",MgCl,PBS/phosphate buffers,8.0,Not applicable,None,None,VQLQESGGGLVQPGGSLRLSCAASGRTFSSYNMGWFRQAPGKGREFVASITSSG...TVS
ssDNA,GGTATTGAGGGTCGCATCTTTCTGTCTTGTGTTACTTGTTTGTCCGGTTTCTTTTCTCCCCCTGATGGCTCTAACTCTCCTCT,83.0,0.46987951807228917,Kd: 33 nM,33.0,5'-GGTATTGAGGGTCGCATC-N45-GATGGCTCTAACTCTCCTCT-3',45.0,"20 mM Tris-HCl (pH 7.5), 100 mM NaCl",MgCl,PBS/phosphate buffers,8.0,Not applicable,None,None,VQLQESGGGLVQPGGSLRLSCAASGRTFSSYNMGWFRQAPGKGREFVASITSSG...TVS
ssDNA,GGTATTGAGGGTCGCATCTCCTTTTGTGTGTTTTTTTTATTGTTTTTTTTTTGTTTTTGATGGCTCTAACTCTCCTCT,78.0,0.34615384615384615,Kd: 19 nM,19.0,5'-GGTATTGAGGGTCGCATC-N45-GATGGCTCTAACTCTCCTCT-3',45.0,"Selection Buffer: 50 mM NaH2PO4, pH 8.0, 150 mM NaCl, 5 mM KCl, 1 mM MgCl2, 0.005% (v/v) Tween-25",MgCl,PBS/phosphate buffers,8.0,Not applicable,None,None,VQLQESGGGLVQPGGSLRLSCAASGRTFSSYNMGWFRQAPGKGREFVASITSSG...TVS
ssDNA,GGTATTGAGGGTCGCATCGTTTCTTCCTTTGGCCTTTCTTCCGTCTTTCTGTTGTTCTTACCTGATGGCTCTAACTCTCCTCT,83.0,0.46987951807228917,Kd: 79 nM,79.0,5'-GGTATTGAGGGTCGCATC-N45-GATGGCTCTAACTCTCCTCT-3',45.0,"Selection Buffer: 50 mM NaH2PO4, pH 8.0, 150 mM NaCl, 5 mM KCl, 1 mM MgCl2, 0.005% (v/v) Tween-26",MgCl,PBS/phosphate buffers,8.0,Not applicable,None,None,VQLQESGGGLVQPGGSLRLSCAASGRTFSSYNMGWFRQAPGKGREFVASITSSG...TVS
ssDNA,GGTATTGAGGGTCGCATCTCCTTTTGTTGTTTATTCTCTGTTCTCTGTTCCTGTACTCTTTATCCGATGGCTCTAACTCTCCTCT,85.0,0.43529411764705883,Kd: 18 nM,18.0,5'-GGTATTGAGGGTCGCATC-N45-GATGGCTCTAACTCTCCTCT-3',45.0,"4.5 g/L glucose, 5 mmol/L MgCl2 in Dulbecco PBS, yeast tRNA (0.1 g/L, Sigma–Aldrich), FBS (100 mL/L), BSA (1 g/L, Fisher)",MgCl,PBS/phosphate buffers,8.0,Not applicable,None,None,VQLQESGGGLVQPGGSLRLSCAASGRTFSSYNMGWFRQAPGKGREFVASITSSG...TVS
ssDNA,GGGAATTCGAGCTCGGTACCATCTGTGTAAGGGGTAAGGGGTGGGGGTGGGTACGTCTAGCTGCAGGCATGCAAGCTTGG,80.0,0.5875,Kd: 20 nM,20.0,5'-GGGAATTCGAGCTCGGTACC-N40-CCAAGCTTGCATGCCTGCAG-'3,40.0,"4.5 g/L glucose, 5 mmol/L MgCl2 in Dulbecco PBS, yeast tRNA (0.1 g/L, Sigma–Aldrich), FBS (100 mL/L), BSA (1 g/L, Fisher)",MgCl/CaCl,Tris Buffers,7.4,Not applicable,Inconsistency in reporting aptamer sequence (reverse primer region in aptamer sequence does not match the reported pool type),None,None
ssDNA,ACCATCTGTGTAAGGGGTAAGGGGTGGGGGTGGGTACGTCT,41.0,0.5853658536585366,Kd: 272 nM        ,272.0,5'-GGGAATTCGAGCTCGGTACC-N40-CTGCAGGCATGCAAGCTTGG-3',40.0,"4.5 g/L glucose, 5 mmol/L MgCl2 in Dulbecco PBS, yeast tRNA (0.1 g/L, Sigma–Aldrich), FBS (100 mL/L), BSA (1 g/L, Fisher)",MgCl/CaCl,Tris Buffers,7.4,Truncated sequence 10.10V was obtained by removing primer sequences that were predicted by mfold as not being involved in the secondary structure of the randomized region,None,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O,None
ssDNA,5′CCGAAGCTTAATACGACTCACTATAGGGATCCGCCTGATTAGCGATACTAGCGCCGGTGGTGGGGGTTGTTGTTACGCGGTATTATACTTGAGCAAAATCACCTGCAGGGG3′,111.0,0.5135135135135135,Kd: 5.4 μM,5400.0,5′-CCGAAGCTTAATACGACTCACTATAGGGATCCGCCTGATTAGCGATACT-N40-ACTTGAGCAAAATCACCTGCAGGGG-3′,40.0,"4.5 g/L glucose, 5 mmol/L MgCl2 in Dulbecco PBS, yeast tRNA (0.1 g/L, Sigma–Aldrich), FBS (100 mL/L), BSA (1 g/L, Fisher)",None,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,5′CCGAAGCTTAATACGACTCACTATAGGGATCCGCCTGATTAGCGATACTCGAGGCGTGTGCAAGGCGTGTTGTTCAAAGGTGTGTGTGTACTTGAGCAAAATCACCTGCAGGGG3′,114.0,0.5087719298245614,Kd: 0.56 μM,560.0,5′-CCGAAGCTTAATACGACTCACTATAGGGATCCGCCTGATTAGCGATACT-N40-ACTTGAGCAAAATCACCTGCAGGGG-3′,40.0,"4.5 g/L glucose, 5 mmol/L MgCl2 in Dulbecco PBS, yeast tRNA (0.1 g/L, Sigma–Aldrich), FBS (100 mL/L), BSA (1 g/L, Fisher)",None,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,ACGCTCGGATGCCACTACAGAGTGATGGTTGTTATCTGGCCTCAGAGGTTCTCGGGTGTGGTCACTCATGGACGTGCTGGTGAC,84.0,0.5595238095238095,Kd: 10.34 ± 0.96 nM,10.34,5'-ACGCTCGGATGCCACTACAG-N45-CTCATGGACGTGCTGGTGAC-3',45.0,"4.5 g/L glucose, 5 mmol/L MgCl2 in Dulbecco PBS, yeast tRNA (0.1 g/L, Sigma–Aldrich), FBS (100 mL/L), BSA (1 g/L, Fisher)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,ACAGGAGTGATGGTTGTTATCTGGCCTCAGAGGTTCTCGGGTGTGGTCACTCCTG,55.0,0.5454545454545454,Kd: 9.79 ± 0.30 nM,9.79,5'-ACGCTCGGATGCCACTACAG-N45-CTCATGGACGTGCTGGTGAC-3',45.0,"4.5 g/L glucose, 5 mmol/L MgCl2 in Dulbecco PBS, yeast tRNA (0.1 g/L, Sigma–Aldrich), FBS (100 mL/L), BSA (1 g/L, Fisher)",MgCl,PBS/phosphate buffers,7.4,Optimized truncated version of tls1 aptamer,None,None,None
ssDNA,ACGCTCGGATGCCACTACAGTGGGAATATTAGTACCGTTATTCGGACTCCGCCATGACAATCTGGCTCATGGACGTGCTGGTGAC,85.0,0.5294117647058824,Kd: 10.9 ± 1.8 nM,10.9,5'-ACGCTCGGATGCCACTACAG-N45-CTCATGGACGTGCTGGTGAC-3',45.0,"20 uM HEPES, pH 7.4, 150 uL NaCl, 2 uM CaCl2, 0.01% bovine serum albumin",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,ACGCTCGGATGCCACTACAGACGGTGGTCGTACACGGCCATTTTATTCCCGGAATATTTGTCAACCTCATGGACGTGCTGGTGAC,85.0,0.5294117647058824,Kd: 33.9 ± 2.3 nM,33.9,5'-ACGCTCGGATGCCACTACAG-N45-CTCATGGACGTGCTGGTGAC-3',45.0,"20 uM HEPES, pH 7.4, 150 uL NaCl, 2 uM CaCl2, 0.01% bovine serum albumin",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,ACGCTCGGATGCCACTACAGATACGGCCTGGGTCTTTATTCGCCCCGAATATTTCTTAACGTCGGCTCATGGACGTGCTGGTGAC,85.0,0.5411764705882353,Kd: 157.0 ± 16.9 nM,157.0,5'-ACGCTCGGATGCCACTACAG-N45-CTCATGGACGTGCTGGTGAC-3',45.0,"4.5 g/liter glucose, 5 mM MgCl2, 0.1 mg/ml tRNA, 1mg/ml BSA, all dissolved in Dulbecco's PBS with magnesium chloride, calcium chloride",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,ACGCTCGGATGCCACTACAGTGCGCCCAAAGTTCCCATATTGCTTCCCTGTTGGTGAGTGCCGATCTCATGGACGTGCTGGTGAC,85.0,0.5647058823529412,Kd: 68.1 ± 7.6 nM,68.1,5'-ACGCTCGGATGCCACTACAG-N45-CTCATGGACGTGCTGGTGAC-3',45.0,"4.5 g/liter glucose, 5 mM MgCl2, 0.1 mg/ml tRNA, 1mg/ml BSA, all dissolved in Dulbecco's PBS with magnesium chloride, calcium chloride",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,AGTCCATTTTATTCCTGAATATTTGTTAACCTCATGGAC,39.0,0.3333333333333333,Kd: 7.38 ± 0.28 nM,7.38,5'-ACGCTCGGATGCCACTACAG-N45-CTCATGGACGTGCTGGTGAC-3',45.0,"4.5 g/liter glucose, 5 mM MgCl2, 0.1 mg/ml tRNA, 1mg/ml BSA, all dissolved in Dulbecco's PBS with magnesium chloride, calcium chloride",MgCl,PBS/phosphate buffers,7.4,Optimized truncated version of tls9 aptamer (sequence not. Provided),None,None,None
ssDNA,ACAGCATCCCCATGTGAACAATCGCATTGTGATTGTTACGGTTTCCGCCTCATGGACGTGCTG,63.0,0.5079365079365079,Kd: 4.51 ± 0.39 nM,4.51,5'-ACGCTCGGATGCCACTACAG-N45-CTCATGGACGTGCTGGTGAC-3',45.0,"4.5 g/liter glucose, 5 mM MgCl2, 0.1 mg/ml tRNA, 1mg/ml BSA, all dissolved in Dulbecco's PBS with magnesium chloride, calcium chloride",MgCl,PBS/phosphate buffers,7.4,Optimized truncated version of tls11 aptamer (sequence not provided),None,None,None
ssDNA,CCTTCGTTGTCTGCCTTCGTAGCGGATCGAATTACGCGTTAACGGCAACCGATAACGGGACCGATTGCACACCCTTCAGAATTCGCACCA,90.0,0.5333333333333333,Kd: 102 ± 39.7,102.0,5'-CCTTCGTTGTCTGCCTTCGT-N50-ACCCTTCAGAATTCGCACCA-3',50.0,"4.5 g/liter glucose, 5 mM MgCl2, 0.1 mg/ml tRNA, 1mg/ml BSA, all dissolved in Dulbecco's PBS with magnesium chloride, calcium chloride",MgCl,Tris Buffers,7.6,Not applicable,boronic acid-labeled,C(C(C(C(C(CO)O)O)O)O)O,None
ssDNA,CCTTCGTTGTCTGCCTTCGTTAGGACCGCAGACATCGACGCAGGGAAATTCCGCAAGTCCAGCCAAATGCCACCCTTCAGAATTCGCACCA,91.0,0.5494505494505495,Kd: 6.4±0.81 nM,6.4,5'-CCTTCGTTGTCTGCCTTCGT-N50-ACCCTTCAGAATTCGCACCA-3',50.0,"4.5 g/liter glucose, 5 mM MgCl2, 0.1 mg/ml tRNA, 1mg/ml BSA, all dissolved in Dulbecco's PBS with magnesium chloride, calcium chloride",MgCl,Tris Buffers,7.6,Not applicable,boronic acid-labeled,C(C(C(C(C(CO)O)O)O)O)O,MPFDGMFTHAMTKELNTALVGGRISKIHEPFQNEVILTVRSNRKNVPVLLSAHP...LRQ
ssDNA,CCTTCGTTGTCTGCCTTCGTAGTCGACTCTGACGCATGGACGTATCCTGTGCGTATGCATTATGAAGCACACCCTTCAGAATTCGCACCA,90.0,0.5111111111111111,Kd: 17.1±2.1 nM,17.1,5'-CCTTCGTTGTCTGCCTTCGT-N50-ACCCTTCAGAATTCGCACCA-3',50.0,"BSA binding buffer E (20 mM HEPES, pH 7.4, 50 mM NaCl, 2 mM CaCl2, 0.1% bovine serum albumin [BSA]), CHAPS binding buffer E (20 mM HEPES, pH 7.4, 50 mM NaCl, 2 mM CaCl2, 0.05% CHAPS), CHAPS binding buffer F (20 mM HEPES, pH 7.4, 150 mM NaCl, 2 mM CaCl2, 0.05% CHAPS)",MgCl,Tris Buffers,7.6,Not applicable,boronic acid-labeled,C(C(C(C(C(CO)O)O)O)O)O,MPFDGMFTHAMTKELNTALVGGRISKIHEPFQNEVILTVRSNRKNVPVLLSAHP...LRQ
ssRNA,5′CUGCAGUUCGGGUAGCACAGACCAUACGGGAGAGAAACUUGUGCAACCCGGGGCUAC3′,57.0,0.5789473684210527,Kd: 78.2 nM ± 2.6 nM,78.2,5′-CTGCAGTTCGGGTAGCACA-N20-TGTGCAACCCGGGGCTAC-3′,20.0,"BSA binding buffer E (20 mM HEPES, pH 7.4, 50 mM NaCl, 2 mM CaCl2, 0.1% bovine serum albumin [BSA]), CHAPS binding buffer E (20 mM HEPES, pH 7.4, 50 mM NaCl, 2 mM CaCl2, 0.05% CHAPS), CHAPS binding buffer F (20 mM HEPES, pH 7.4, 150 mM NaCl, 2 mM CaCl2, 0.05% CHAPS)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssRNA,GGUUCGGGUAGCACAGACCAUACGGGAGAGAAACUUGUGCAACCCGGGGCU,51.0,0.5882352941176471,Kd: 101.2 nM ± 7.2 nM,101.2,5′-CTGCAGTTCGGGTAGCACA-N20-TGTGCAACCCGGGGCTAC-3′,20.0,PBS/3 mM MgCl2,MgCl,PBS/phosphate buffers,7.4,"Truncated variant of c13 consisting of 51 nt, termed c13.51",None,None,MADLEAVLADVSYLMAMEKSKATPAARASKRIVLPEPSIRSVMQKYLEDRGEVT...NGL
ssDNA,CGTACGGAATTCGCTAGCGGGCAGCGGTGGTGTGGCGGGATCTGGGGTTgtgcGGTGTGGATCCGAGCTCCACGTG,76.0,0.6578947368421053,Kd: 357.8 nM,357.8,5'-CGTACGGAATTCGCTAGC-N40-GGATCCGAGCTCCACGTG-3',40.0,"20 mm HEPES, 0.05 m NaCl, 2 mm CaCl2, 0.01% (w/v) bovine serum albumin, pH 7.4",MgCl/CaCl,Tris Buffers,7.6,Not applicable,"ssDNA aptamers were identified by modified SELEX method by employing tosylactivated magnetic beads (TMB) coated with OTC, TET, and DOX,respectively, as targets and counter targets
The T/GTGCT conserved motif was specifically found in TGS-aptamers, which is predicted to be crucial for group specificity because this motif was absent in aptamers specific for OTC as reported in our previous studies.",None,None
ssDNA,CGTACGGAATTCGCTAGCGGAGGAACGGGTTCCAGTGTGGGGTCTATCGGGGCgtgcGGGATCCGAGCTCCACGTG,76.0,0.6447368421052632,Kd: 197 nM,197.0,5'-CGTACGGAATTCGCTAGC-N40-GGATCCGAGCTCCACGTG-3',40.0,"50 mM Tris–HCl (pH 7.6), 300 mM NaCl, 30 mM KCl, 5 mM MgCl2, 3.5 mM 8-OHdG",MgCl/CaCl,Tris Buffers,7.6,Not applicable,"ssDNA aptamers were identified by modified SELEX method by employing tosylactivated magnetic beads (TMB) coated with OTC, TET, and DOX,respectively, as targets and counter targets
The T/GTGCT conserved motif was specifically found in TGS-aptamers, which is predicted to be crucial for group specificity because this motif was absent in aptamers specific for OTC as reported in our previous studies.",None,None
ssDNA,CGTACGGAATTCGCTAGCCGGGAGGGCGGGGTGTGGTATGTATTGAGCGTGGTCCGTGGGATCCGAGCTCCACGTG,76.0,0.631578947368421,Kd: 424.8 nM,424.8,5'-CGTACGGAATTCGCTAGC-N40-GGATCCGAGCTCCACGTG-3',40.0,"50 mM Tris–HCl (pH 7.6), 300 mM NaCl, 30 mM KCl, 5 mM MgCl2, 3.5 mM 8-OHdG",MgCl/CaCl,Tris Buffers,7.6,Not applicable,"ssDNA aptamers were identified by modified SELEX method by employing tosylactivated magnetic beads (TMB) coated with OTC, TET, and DOX,respectively, as targets and counter targets",None,None
ssDNA,CGTACGGAATTCGCTAGCCCCCCGGCAGGCCACGGCTTGGGTTGGTCCCACTGCGCGTGGATCCGAGCTCCACGTG,76.0,0.6842105263157895,Kd: 63.6 nM,63.6,5'-CGTACGGAATTCGCTAGC-N40-GGATCCGAGCTCCACGTG-3',40.0,"50 mM Tris–HCl (pH 7.6), 300 mM NaCl, 30 mM KCl, 5 mM MgCl2, 3.5 mM 8-OHdG",MgCl/CaCl,Tris Buffers,7.6,Not applicable,"ssDNA aptamers were identified by modified SELEX method by employing tosylactivated magnetic beads (TMB) coated with OTC, TET, and DOX,respectively, as targets and counter targets",None,None
ssDNA,CGTACGGAATTCGCTAGCGGGCGGACGCTAGGTGGTGATGCTgtgcTACACGTGTTGTGGATCCGAGCTCCACGTG,76.0,0.6052631578947368,Kd: 483.5 nM,483.5,5'-CGTACGGAATTCGCTAGC-N40-GGATCCGAGCTCCACGTG-3',40.0,"NaCl (100 mM), Tris–HCl (20 mM, pH 7.6), MgCl2(2 mM), KCl(5 mM), CaCl2(1 mM), and Tween 20 (0.02%)",MgCl/CaCl,Tris Buffers,7.6,Not applicable,"ssDNA aptamers were identified by modified SELEX method by employing tosylactivated magnetic beads (TMB) coated with OTC, TET, and DOX,respectively, as targets and counter targets
The T/GTGCT conserved motif was specifically found in TGS-aptamers, which is predicted to be crucial for group specificity because this motif was absent in aptamers specific for OTC as reported in our previous studies.",None,None
ssDNA,CGTACGGAATTCGCTAGCGGGGGCACACATGTAGgtgcTGTCCAGGTGTGGTTGTGGTGGATCCGAGCTCCACGTG,76.0,0.6052631578947368,Kd: 100.6 nM,100.6,5'-CGTACGGAATTCGCTAGC-N40-GGATCCGAGCTCCACGTG-3',40.0,"NaCl (100 mM), Tris–HCl (20 mM, pH 7.6), MgCl2(2 mM), KCl(5 mM), CaCl2(1 mM), and Tween 20 (0.02%)",MgCl/CaCl,Tris Buffers,7.6,Not applicable,"ssDNA aptamers were identified by modified SELEX method by employing tosylactivated magnetic beads (TMB) coated with OTC, TET, and DOX,respectively, as targets and counter targets
The T/GTGCT conserved motif was specifically found in TGS-aptamers, which is predicted to be crucial for group specificity because this motif was absent in aptamers specific for OTC as reported in our previous studies.",None,None
ssDNA,CGTACGGAATTCGCTAGCGGGCGGGGgtgcTGGGGGAATGGAgtgcTGCgtgcTGCGGGGATCCGAGCTCCACGTG,76.0,0.6842105263157895,Kd: 70.7 nM,70.7,5'-CGTACGGAATTCGCTAGC-N40-GGATCCGAGCTCCACGTG-3',40.0,"NaCl (100 mM), Tris–HCl (20 mM, pH 7.6), MgCl2(2 mM), KCl(5 mM), CaCl2(1 mM), and Tween 20 (0.02%)",MgCl/CaCl,Tris Buffers,7.6,Not applicable,"ssDNA aptamers were identified by modified SELEX method by employing tosylactivated magnetic beads (TMB) coated with OTC, TET, and DOX,respectively, as targets and counter targets
The T/GTGCT conserved motif was specifically found in TGS-aptamers, which is predicted to be crucial for group specificity because this motif was absent in aptamers specific for OTC as reported in our previous studies.",None,None
ssDNA,5′ATACCAGTCTATTCAATTGGGCGGGGACTGTCGGGATGTGTGTGGGCCAGATAGTATGTGCAATCA3′,66.0,0.5,Kd: 500 nM,500.0,5′-ATACCAGTCTATTCAATT-N30-AGATAGTATGTGCAATCA-3′,30.0,"TBSE (10 mM Tris/HCl, pH 7.0, 100 mM NaCl, 0.05 mM EDTA)",None,Tris Buffers,7.0,Not applicable,ssDNA library was labeled with FITC at the 5' end.,None,None
ssDNA,5′ATACCAGTCTATTCAATTGGGCCCGTCCGTATGGTGGGTGTGCTGGCCAGATAGTATGTGCAATCA3′,66.0,0.5,Kd: 130 nM,130.0,5′-ATACCAGTCTATTCAATT-N30-AGATAGTATGTGCAATCA-3′,30.0,"TBSE (10 mM Tris/HCl, pH 7.0, 100 mM NaCl, 0.05 mM EDTA)",None,Tris Buffers,7.0,Not applicable,ssDNA library was labeled with FITC at the 5' end.,None,XVRPFLEVHERSACQARETLVPILQEYPDEISDIFRPSCVAVLRCSGCCTDESL...KPR
ssRNA,GGGAAUGGAUCCACAUCUACGAAUUCACCGUAGAUGAUGGAUGUGCGGUAGAGUCUUUCACUGCAGACUUGACGAAGCUU,80.0,0.475,Kd: 0.23 nM ± 0.09,0.23,5′-GGGAATGGATCCACATCTACGAATTC-N30-TTCACTGCAGACTTGACGAAGCTT-3′,30.0,"20 mM Tris (pH 7.5), 5 mM MgCl2, and 100 mM NaCl",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssRNA,5′GGGAGGUGGAACUGAAGGAGACAAUCCAUUCAUCUCUCGAAUGAGGAAGUAGCCCAAGAGGAGGAGGAGGAUGAGCACUUCGCAAUCGCUCUACGCA3′,97.0,0.5257731958762887,Kd: 82 ± 21 nM,82.0,5′-GGGAGGUGGAACUGAAGGAGA-N55-ACUUCGCAAUCGCUCUACGCA-3′,55.0,20 mM Tris-HCl (pH 7.5) and 100 mM NaCl,None,Tris Buffers,7.5,Not applicable,None,None,None
ssRNA,GGGAUGUUCUAGGCGGUUGAUGAUAGCGUAUGCCACUCUCCUGGGACCCCCCGCCGGAUGGCCACAUCCAGAGUAGCAUAAUUGAUCCGA,90.0,0.5666666666666667,Kd: 21.6 μM,21600.0,5′-GGGATGTTCTAGGCCGGTTGATGA-N40-CATCCAGAGTAGCATAATTTGATCCGA-3′,40.0,"HEPES (20 mM), MgCl2 (5 mM), NaCl (125 mM) at pH 7.3",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssRNA,GGGAUGUUCUAGGCGGUUGAUGAUUUGGGGUGUCGGGCGAUUUUUAGGGUUGGGCCAGGCCGUCAUCCAGAGUAGCAUAAUUGAUCCGA,89.0,0.5280898876404494,Kd: 10.9 μM,10900.0,5′-GGGATGTTCTAGGCCGGTTGATGA-N40-CATCCAGAGTAGCATAATTTGATCCGA-3′,40.0,"10 mM HEPES (pH 7.6), 1 mM EDTA, 2 mM dithiothreitol, 50 mM KCl, 0.05% Triton X-100, 5% glycerol",MgCl,Tris Buffers,7.5,Not applicable,None,None,MAVIPESAWKHPDYVDDGLSGVCNGLEQPRKQQRSDLNGPVDNNNIPETKKVAS...LYI
ssDNA,5′ATCGTCTGCTCCGTCCAATAGTGCATTGAAACTTCTGCATCCTCGTTTGGTGTGAGGTCGTGC,63.0,0.5079365079365079,Kd: 7.3 ± 1.4 nM,7.3,5′-ATCGTCTGCTCCGTCCAATA-N45-TTTGGTGTGAGGTCGTGC-3',45.0,"4.5 g/L glucose, 5 mmol/L MgCl2 in Dulbecco PBS, yeast tRNA (0.1 g/L; Sigma–Aldrich), FBS (100 mL/L), BSA (1 g/L; Fisher)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′ATCGTCTGCTCCGTCCAATACCTGCATATACACTTTGCATGTGGTTTGGTGTGAGGTCGTGC,62.0,0.5,Kd: 3.6 ± 0.48 nM,3.6,5′-ATCGTCTGCTCCGTCCAATA-N45-TTTGGTGTGAGGTCGTGC-3',45.0,"4.5 g/L glucose, 5 mmol/L MgCl2 in Dulbecco PBS, yeast tRNA (0.1 g/L; Sigma–Aldrich), FBS (100 mL/L), BSA (1 g/L; Fisher)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′ATCGTCTGCTCCGTCCAATAGCGTGCATTGGTTTACTGCATCCGTGAAACTGGGCTTTGGTGTGAGGTCGTGC,73.0,0.5342465753424658,Kd: 4.1 ± 0.59 nM,4.1,5′-ATCGTCTGCTCCGTCCAATA-N45-TTTGGTGTGAGGTCGTGC-3',45.0,"4.5 g/L glucose, 5 mmol/L MgCl2 in Dulbecco PBS, yeast tRNA (0.1 g/L; Sigma–Aldrich), FBS (100 mL/L), BSA (1 g/L; Fisher)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′ATCGTCTGCTCCGTCCAATAAACCTGCATAATTTATAAGTCTAGACTGCTGCATTTGGTGTGAGGTCGTGC,71.0,0.4507042253521127,Kd: 6.5 ± 0.94 nM,6.5,5′-ATCGTCTGCTCCGTCCAATA-N45-TTTGGTGTGAGGTCGTGC-3',45.0,"4.5 g/L glucose, 5 mmol/L MgCl2 in Dulbecco PBS, yeast tRNA (0.1 g/L; Sigma–Aldrich), FBS (100 mL/L), BSA (1 g/L; Fisher)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′ATCGTCTGCTCCGTCCAATAGCCTCACCCTGCATAATTTATAGACTACACTTAGGAATCGCTGCATTTGGTGTGAGGTCGTGC,83.0,0.4819277108433735,Kd: 4.1 ± 0.44 nM,4.1,5′-ATCGTCTGCTCCGTCCAATA-N45-TTTGGTGTGAGGTCGTGC-3',45.0,"4.5 g/L glucose, 5 mmol/L MgCl2 in Dulbecco PBS, yeast tRNA (0.1 g/L; Sigma–Aldrich), FBS (100 mL/L), BSA (1 g/L; Fisher)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′ATCGTCTGCTCCGTCCAATAGGACCGATAGGAACCACGGACTGCATGTTTCTGCATTTGACGTGGTTTGGTGTGAGGTCGTGC,83.0,0.5301204819277109,Kd: 6.5 ± 1.3 nM,6.5,5′-ATCGTCTGCTCCGTCCAATA-N45-TTTGGTGTGAGGTCGTGC-3',45.0,"4.5 g/L glucose, 5 mmol/L MgCl2 in Dulbecco PBS, yeast tRNA (0.1 g/L; Sigma–Aldrich), FBS (100 mL/L), BSA (1 g/L; Fisher)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′ATCGTCTGCTCCGTCCAATATCCGAGCAAGAACTCATATTGCATTATTTATAGCTACGCGCTGCATTTGGTGTGAGGTCGTGC,83.0,0.46987951807228917,Kd: 11.7 ± 2.9 nM,11.9,5′-ATCGTCTGCTCCGTCCAATA-N45-TTTGGTGTGAGGTCGTGC-3',45.0,"4.5 g/L glucose, 5 mmol/L MgCl2 in Dulbecco PBS, yeast tRNA (0.1 g/L; Sigma–Aldrich), FBS (100 mL/L), BSA (1 g/L; Fisher)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′ATCGTCTGCTCCGTCCAATATGATGACACCTGCATAATTTATAGTGAGTCTTGATTCACGCTGCATTTGGTGTGAGGTCGTGC,83.0,0.4578313253012048,Kd: 2.7 ± 6.2 nM,2.7,5′-ATCGTCTGCTCCGTCCAATA-N45-TTTGGTGTGAGGTCGTGC-3',45.0,"4.5 g/L glucose, 5 mmol/L MgCl2 in Dulbecco PBS, yeast tRNA (0.1 g/L; Sigma–Aldrich), FBS (100 mL/L), BSA (1 g/L; Fisher)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
2'-fluoro-RNA,GGGAGGACGAUGCGGUACCAAGAUCCCACAACUAGCCGACCACAAUUGCCGGCCACAGACGACUCGCUGAGGAUCCGAGA,80.0,0.6,Kd: 33 nM,33.0,5'-GGGAGGACGATGCGG-N40-CAGACGACTCGCTGAGGATCCGAGA-3',40.0,"20 uM HEPES, pH 7.4; 150 uL NaCl; 2 uM CaCl2; 0.01% bovine serum albumin",CaCl,Other Buffers,7.4,Not applicable,"pyrimidines were 2'-fluoro-modified to improve stability; the article explicitly states the selection of RNA aptamers but only reports the sequence and pool type as DNA. Pool in vitro transcription with 2′-fluoro CTP and UTP, 2′-hydroxy GTP and ATP, and mutant T7 RNA polymerase that efficiently incorporates modified nucleotides",None,None
2'-fluoro-RNA,GGGAGGACGAUGCGGACCAAAAUCAACGCAAAGAGCGCGCCUGCACGUCACCUCACAGACGACUCGCUGAGGAUCCGAGA,80.0,0.6,Kd: 50 nM,50.0,5'-GGGAGGACGATGCGG-N40-CAGACGACTCGCTGAGGATCCGAGA-3',40.0,"20 uM HEPES, pH 7.4; 150 uL NaCl; 2 uM CaCl2; 0.01% bovine serum albumin",CaCl,Other Buffers,7.4,Not applicable,"pyrimidines were 2'-fluoro-modified to improve stability; the article explicitly states the selection of RNA aptamers but only reports the sequence and pool type as DNA. Pool in vitro transcription with 2′-fluoro CTP and UTP, 2′-hydroxy GTP and ATP, and mutant T7 RNA polymerase that efficiently incorporates modified nucleotides",None,None
ssDNA,ATCCAGAGTGACGCAGCATGCCCTAGTTACTACTACTCTTTTTAGCAAACGCCCTCGCTTTGGACACGGTGGCTTAGT,78.0,0.5,Kd: 4.5± 1.6 nM,4.5,5′-FITC- ATCCAGAGTGACGCAGCA-N45-TGGACACGGTGGCTTAGT-3′,45.0,"TBSE (10 mM Tris/HCl, 100 mM NaCl, 0.05 mM EDTA, pH 7.0)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,ATCCAGAGTGACGCAGCATGCTCATCCACGATTCTGGCGAATTTAGTGCCTGTCTTTTTCTCTTGGACACGGTGGCTTAGT,81.0,0.49382716049382713,Kd: 6.1 + 2.1 nM,6.1,5′-FITC- ATCCAGAGTGACGCAGCA-N45-TGGACACGGTGGCTTAGT-3′,45.0,"TBSE (10 mM Tris/HCl, 100 mM NaCl, 0.05 mM EDTA, pH 7.0)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,ATCCAGAGTGACGCAGCACACACAACCTGCTCATAAACTTTACTCTGCTCGAACCATCTCTGGACACGGTGGCTTAGT,78.0,0.5,Kd: 184.5 ± 20.2 nM,184.6,5′-FITC- ATCCAGAGTGACGCAGCA-N45-TGGACACGGTGGCTTAGT-3′,45.0,"TBSE (10 mM Tris/HCl, 100 mM NaCl, 0.05 mM EDTA, pH 7.0)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,ATCCAGAGTGACGCAGCAGGCATAGATGTGCAGCTCCAAGGAGAAGAAGGAGTTCTGTGTATTGGACACGGTGGCTTAGT,80.0,0.5125,Kd: 106.1 ± 15.4 nM,106.1,5′-FITC- ATCCAGAGTGACGCAGCA-N45-TGGACACGGTGGCTTAGT-3′,45.0,"TBSE (10 mM Tris/HCl, 100 mM NaCl, 0.05 mM EDTA, pH 7.0)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,ATCCAGAGTGACGCAGCAGATCAGTCTATCTTCTCCTGATGGGTTCCTATTTATAGGTGAAGCTGGACACGGTGGCTTAGT,81.0,0.48148148148148145,Kd: 256.0 ± 72.0 nM,256.0,5′-FITC- ATCCAGAGTGACGCAGCA-N45-TGGACACGGTGGCTTAGT-3′,45.0,"4.5 g/liter glucose, 5 mM MgCl2, 0.1 mg/ml tRNA and 1mg/ml BSA, all dissolved in Dulbecco's PBS with magnesium chloride and calcium chloride",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,ATCCAGAGTGACGCAGCACAAAGTCTCTTCGGCGCGAATCAGTTCATCTTTCCCTGATGGGGGTGGACACGGTGGCTTAGT,81.0,0.5432098765432098,Kd: 204.6 ± 48.4 nM,204.6,5′-FITC- ATCCAGAGTGACGCAGCA-N45-TGGACACGGTGGCTTAGT-3′,45.0,"4.5 g/liter glucose, 5 mM MgCl2, 0.1 mg/ml tRNA and 1mg/ml BSA, all dissolved in Dulbecco's PBS with magnesium chloride and calcium chloride",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssRNA,5′GGGAGGACGAUGCGGAUCAACUCACCGUAGGUCUAGUGAGAACUUCAAGUCUACUCAGACGACUCGCUGAGGAUCC3′,76.0,0.5394736842105263,Kd: 177 pM,0.177,5′-GGGAGGACGATGCGG-N40-CAGACGACTCGCTGAGGATCC-3′,40.0,"BSA binding buffer E (20 mM Hepes, pH 7.4, 50 mM NaCl, 2 mM CaCl2, and 0.1% bovine serum albumin [BSA]); CHAPS binding buffer E (20 mM Hepes, pH 7.4, 50 mM NaCl, 2 mM CaCl2, and 0.05% CHAPS); CHAPS binding buffer F (20 mM Hepes, pH 7.4, 150 mM NaCl, 2 mM CaCl2, and 0.05% CHAPS)",CaCl,Other Buffers,7.4,Not applicable,Different buffers were used during different rounds of selection,None,None
ssRNA,5′GGGAGGACGAUGCGGAGCGACUGACGAUCUUGAGUAAACCGCUCAUCCACGUAGUCAGACGACUCGCUGAGGAUCC3′,76.0,0.5789473684210527,Kd: 920 pM,0.92,5′-GGGAGGACGATGCGG-N40-CAGACGACTCGCTGAGGATCC-3′,40.0,"BSA binding buffer E (20 mM Hepes, pH 7.4, 50 mM NaCl, 2 mM CaCl2, and 0.1% bovine serum albumin [BSA]); CHAPS binding buffer E (20 mM Hepes, pH 7.4, 50 mM NaCl, 2 mM CaCl2, and 0.05% CHAPS); CHAPS binding buffer F (20 mM Hepes, pH 7.4, 150 mM NaCl, 2 mM CaCl2, and 0.05% CHAPS)",CaCl,Other Buffers,7.4,Not applicable,Different buffers were used during different rounds of selection,None,MAPLRPLLILALLAWVALADQESCKGRCTEGFNVDKKCQCDELCSYYQSCCTDY...GHL
ssDNA,GCAATGGTACGGTACTTCCTGTGGCGAGGTAGGTGGGGTGTGTGTGTATCCAAAAGTGCACGCTACTTTGCTAA,74.0,0.5135135135135135,Kd: 111.0 ± 36.9 nM,111.0,5'-GCAATGGTACGGTACTTCC-N30-CAAAAGTGCACGCTACTTTGCTAA-3',30.0,PBS binding buffer,None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
2'-fluoro-RNA,5′GAGAG(2′FC)(2′FC)(2′FC)(2′FC)AG(2′FC)GAGA(2′FU)AA(2′FU)A(2′FC)(2′FU)(2′FU)GG(2′FC)(2′FC)(2′FC)(2′FC)G(2′FC)(2′FU)(2′FC)(2′FU)(2′FU)idU,37.0,0.5675675675675675,Kd: 1.1 ± 0.2 nM,1.1,5′-GGGAGAGAGGAAGAGGGATGGG-N40-CATAACCCAGAGGTCGATAGTACTGGATCCCCCC-3′,40.0,"10 mM Tris-HCl, pH 7.5, 50 mM NaCl, 1 mM EDTA, 10 μM ZnCl2",CaCl,Other Buffers,7.4,The lead molecule was systematically shortened to obtain a truncated version (RNA11F7t) that retained binding activity. In parallel studies point mutations were introduced to yield RNAMUT with a greatly reduced ability to bind Xa. Ribooligonucleotides were chemically synthesized by Dharmacon Research and supplied desalted after deprotection form 2′-hydroxylated purines. ,"2′FC is 2′-flurocytosine, 2′FU is 2′flurouracil, and idT denotes inverted deoxythymidine. The 2′-fluoro derivatives of cytidine triphosphate and uridine triphosphate (TriLink Biotechnologies) were incorporated into RNA libraries by in vitro transcription as described",None,None
ssDNA,5′TAGGGAATTCGTCGACGGATCCGCGGGCGATCGGCGGGGGGTGCGTGCGCTCTGTGCCAGGGGGTGGGACAGATCATATGGGGGTGCTCTGCAGGTCGACGCATGCGCCG3′,110.0,0.6818181818181818,Kd: 0.1 μmol/L,1000.0,5′-TAGGGAATTCGTCGACGGATCC-N60-CTGCAGGTCGACGCATGCGCCG-3′,60.0,"50 mM Tris–HCl (pH 7.6), 300 mM NaCl, 30 mM KCl, and 5 mM MgCl2, 3.5 mM 8-OHdG",MgCl,Tris Buffers,7.6,Not applicable,None,None,None
ssDNA,5′GGTAATACGACTCACTATAGGGAGATACCAGCTTATTCAATTTTACAGAACAACCAACGTCGTCTCCGGGTACTTCTTCATCGAGATAGTAAGTGCAATCT3′,101.0,0.4158415841584158,Kd: 4.95± 0.31 nM,4.95,5′-GGTAATACGACTCACTATAGGGAGATACCAGCTTATTCAATT-N40-AGATAGTAAGTGCAATCT-3′,40.0,"50 mM HEPES, 150 mM NaCl, 0.5 mM MgCl2, 0.5 mM CaCl2",MgCl/CaCl,Other Buffers,7.4,Not applicable,None,None,None
ssDNA,5′GGTAATACGACTCACTATAGGGAGATACCAGCTTATTCAATTTTACAGAACAACCAACGTCGTCTCCGGGTACTTCTTCATCGAGATAGTAAGTGCAATCT3′,101.0,0.4158415841584158,Kd: 7.05 ± 0.91 nM ,7.05,5′-GGTAATACGACTCACTATAGGGAGATACCAGCTTATTCAATT-N40-AGATAGTAAGTGCAATCT-3′,40.0,"50 mM HEPES, 150 mM NaCl, 0.5 mM MgCl2, 0.5 mM CaCl2",MgCl/CaCl,Other Buffers,7.4,Not applicable,None,None,None
ssRNA,GGGAGAGCGGAAGCGUGCUGGGCCUGUCGUUCGCUGUCUUGCUACGUUACGUUACACGGUUGGCAUAACCCAGAGGUCGAUGG,83.0,0.5903614457831325,Kd: 1.65 ± 0.41 nM,1.65,5′-GGGAGAGCGGAAGCGUGCUGGGCC-N40-CAUAACCCAGAGGUCGAUGGAUCCCCCC-3′,40.0,"30 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10 mM MgCl2, 2 mM DTT, 1% BSA",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,5′ATACCAGCTTATTCAATTACACACCGAGACCGCACTTGTACTCCCTAGCCGCCTCCGTAGATAGTAAGTGCAATCT3′,76.0,0.47368421052631576,Kd: 100.64 nM,100.64,5′-ATACCAGCTTATTCAATT-N40-AGATAGTAAGTGCAATCT-3′,40.0,"100 mM NaCl, 20 mM Tris–HCl pH 7.6, 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2, 0.02% Tween 20",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,None,None
ssDNA,5′ATACCAGCTTATTCAATTGGCAGTAGGTGTACATGCAAAGCCAGTGTGGGTCCCTGTGTAGATAGTAAGTGCAATCT3′,77.0,0.44155844155844154,Kd: 166.34 nM,166.34,5′-ATACCAGCTTATTCAATT-N40-AGATAGTAAGTGCAATCT-3′,40.0,"100 mM NaCl, 20 mM Tris–HCl pH 7.6, 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2, 0.02% Tween 20",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,None,None
ssDNA,5′ATACCAGCTTATTCAATTGCCCGGCAACAGGTTGTGACATGCCAGTGCGAGACCGCCCGAGATAGTAAGTGCAATCT3′,77.0,0.5064935064935064,Kd: 148.73 nM,148.73,5′-ATACCAGCTTATTCAATT-N40-AGATAGTAAGTGCAATCT-3′,40.0,"100 mM NaCl, 20 mM Tris–HCl pH 7.6, 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2, 0.02% Tween 20",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,None,None
ssDNA,5′ATACCAGCTTATTCAATTGCAACGTGGCGGTCAGTCAGCGGGTGGTGGGTTCGGTCCAGATAGTAAGTGCAATCT3′,75.0,0.5066666666666667,Kd: 42.7 nM,42.7,5′-ATACCAGCTTATTCAATT-N40-AGATAGTAAGTGCAATCT-3′,40.0,"100 mM NaCl, 20 mM Tris–HCl pH 7.6, 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2, 0.02% Tween 20",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,None,None
ssDNA,5′TAATACGACTCACTATAGCAATGGTACGGTACTTCCTATAACGCCCGTGTTGCTCGGTTATCAAAAGTGCACGCTACTTTG3′,81.0,0.4444444444444444,Kd: 69.277 ± 4.323 nM,69.277,5′-TAATACGACTCACTATAGCAATGGTACGGTACTTCC-N25-CAAAAGTGCACGCTACTTTG-3′,25.0,"50 mM Tris HCl, pH 8.0, 50 mM NaCl, 10% glycerol, 10 mM β‐mercaptoethanol, 20 mM imidazole, 0.5% Nonidet P40, 1 mM phenylmethylsulfonyl fluoride, 0.5 mg/ml, lysozyme",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′TAATACGACTCACTATAGCAATGGTACGGTACTTCCAGATACGCtCGTGTTGCTCGATAGCCAAAAGTGCACGCTACTTTG3′,81.0,0.4567901234567901,Kd: 94.228 ± 5.443 nM,94.228,5′-TAATACGACTCACTATAGCAATGGTACGGTACTTCC-N25-CAAAAGTGCACGCTACTTTG-3′,25.0,5 mM of MgCl2 in PBS,MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,MWVTSDGYIRHQLLPENHYAEARGDWEEAYKGRYFRCAVSGYYAWLVKRPRPSW...NEL
ssDNA,5′TAATACGACTCACTATAGCAATGGTACGGTACTTCCCGACGCACCGATCGCAGGTTCGGGACAAAAGTGCACGCTACTTTG3′,81.0,0.5061728395061729,Kd: 104.265 ± 5.688 nM,104.265,5′-TAATACGACTCACTATAGCAATGGTACGGTACTTCC-N25-CAAAAGTGCACGCTACTTTG-3′,25.0,"200 μl, 0.05% BSA in DPBS",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,MWVTSDGYIRHQLLPENHYAEARGDWEEAYKGRYFRCAVSGYYAWLVKRPRPSW...NEL
ssDNA,5′AGCCTCGTCTGTTCTCCCGGGGTGGTGGGTTCTTTTTGTGGTATTGGTGTGGGGGGCAGGGAAGACAAGCAGACGT3′,76.0,0.5789473684210527,"Kd: 55 nM for MT32 protein & 83 nM for PSA‐H protein, both via SPR",55.0,5′‐AGCCTCGTCTGTTCTCCC‐40N‐GGGAAGACAAGCAGACGT‐3′,40.0,"200 μl, 0.05% BSA in DPBS",None,PBS/phosphate buffers,7.5,Not applicable,None,None,None
ssDNA,5′AGCCTCGTCTGTTCTCCCAGCAAGGTTTGGTGTTGGTTGGTTGCTGGTTTTGGTTTCGGGAAGACAAGCAGACGT3′,75.0,0.52,"Kd: 8.0 nM for PSA‐H protein & 290 nM for MT32 protein, both via SPR",8.0,5′‐AGCCTCGTCTGTTCTCCC‐40N‐GGGAAGACAAGCAGACGT‐3′,40.0,"PBS‐T solution: 10 mM Na2HPO4,2mMKH2PO4, 2.7 mM KCl, 137 mM NaCl, and 0.05% Triton‐X; pH 7.5 containing 0.1 µg/ml dIdC and 1 µg/ml BSA",None,PBS/phosphate buffers,7.5,Not applicable,None,None,None
ssDNA,AGCAGCACAGAGGTCAGTTCGTCCATTATTCTGGTAGCGTTGAACAACATTCAACACGCCCCTATGCGTGCTACCGTGAA,80.0,0.5,Kd: 27 μM,27000.0,5′-AGCAGCACAGAGGTCAGTTC-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"50 mM Tris/Cl, pH 8.0, 150 mM NaCl, 1.5 mM MgCl2, 2 mM dithiothreitol (DTT), 1% (w/v) BSA",None,Other Buffers,7.4,Not applicable,None,None,None
ssDNA,AGCAGCACAGAGGTCAGTTCGTCGAATCAGCACCTCTGCATAGGTTACGTTTATACTGCGCCTATGCGTGCTACCGTGAA,80.0,0.5125,Kd: 36 μM,36000.0,5′-AGCAGCACAGAGGTCAGTTC-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"1× BB, 50 mM Tris–HCl (pH 7.4), 5 mM KCl, 100 mM NaCl, 1 mM MgCl2",None,Other Buffers,7.4,Not applicable,None,None,QIQLVQSGPELKKPGETVRISCKASDYSFMTSGMQWVQQMPGKGLKWIGWLNTQ...RDC
ssDNA,AGCAGCACAGAGGTCAGTTCAGCGTCCTCTGCATAGTGATTTACGCTATGTGTACAGTGCCCTATGCGTGCTACCGTGAA,80.0,0.5125,Kd: 124 μM,124000.0,5′-AGCAGCACAGAGGTCAGTTC-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"1× BB, 50 mM Tris–HCl (pH 7.4), 5 mM KCl, 100 mM NaCl, 1 mM MgCl2",None,Other Buffers,7.4,Not applicable,None,None,QIQLVQSGPELKKPGETVRISCKASDYSFMTSGMQWVQQMPGKGLKWIGWLNTQ...RDC
ssDNA,AGCAGCACAGAGGTCAGTTCCATGACTCTGCATAGGTCTAATGAAACTAGTTCTTATTTACCTATGCGTGCTACCGTGAA,80.0,0.4375,Kd: 52 μM,52000.0,5′-AGCAGCACAGAGGTCAGTTC-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"1× BB, 50 mM Tris–HCl (pH 7.4), 5 mM KCl, 100 mM NaCl, 1 mM MgCl2",None,Other Buffers,7.4,Not applicable,None,None,QIQLVQSGPELKKPGETVRISCKASDYSFMTSGMQWVQQMPGKGLKWIGWLNTQ...RDC
ssDNA,AGCAGCACAGAGGTCAGTTCCAAGTCGTACGACACAGGGTAATCCTGTTTGGTAAAACGACCTATGCGTGCTACCGTGAA,80.0,0.5,Kd: 51 μM,51000.0,5′-AGCAGCACAGAGGTCAGTTC-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"1× BB, 50 mM Tris–HCl (pH 7.4), 5 mM KCl, 100 mM NaCl, 1 mM MgCl2",None,Other Buffers,7.4,Not applicable,None,None,QIQLVQSGPELKKPGETVRISCKASDYSFMTSGMQWVQQMPGKGLKWIGWLNTQ...RDC
ssDNA,AGCAGCACAGAGGTCAGTTCTTATGTCGAACTAAATTTGGCCTGACCAAGCCGAATTTGACCTATGCGTGCTACCGTGAA,80.0,0.475,Kd: 63 μM,63000.0,5′-AGCAGCACAGAGGTCAGTTC-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"1× BB, 50 mM Tris–HCl (pH 7.4), 5 mM KCl, 100 mM NaCl, 1 mM MgCl2",None,Other Buffers,7.4,Not applicable,None,None,QIQLVQSGPELKKPGETVRISCKASDYSFMTSGMQWVQQMPGKGLKWIGWLNTQ...RDC
ssDNA,TGTGTGTGAGACTTCGTTCCGGCGATGGGGTAGGGGGTGTGGAGGGGCCGGACGGAGGGGCAGCAAGGCATCAGAGGTAT,80.0,0.6375,Kd: 0.9 μM,900.0,5'-TGTGTGTGAGACTTCGTTCC-N40-CAGCAAGGCATCAGAGGTAT-3',40.0,"1× BB, 50 mM Tris–HCl (pH 7.4), 5 mM KCl, 100 mM NaCl, 1 mM MgCl2",None,PBS/phosphate buffers,7.4,Not applicable,None,None,QIQLVQSGPELKKPGETVRISCKASDYSFMTSGMQWVQQMPGKGLKWIGWLNTQ...RDC
ssDNA,TGTGTGTGAGACTTCGTTCCCCCGGTCGGTGGGGTAGGGGGCGTGGAGTCACCGGGGGGGCAGCAAGGCATCAGAGGTAT,80.0,0.65,Kd: 6 μM,6000.0,5'-TGTGTGTGAGACTTCGTTCC-N40-CAGCAAGGCATCAGAGGTAT-3',40.0,"1× BB, 50 mM Tris–HCl (pH 7.4), 5 mM KCl, 100 mM NaCl, 1 mM MgCl2",None,PBS/phosphate buffers,7.4,Not applicable,None,None,QIQLVQSGPELKKPGETVRISCKASDYSFMTSGMQWVQQMPGKGLKWIGWLNTQ...RDC
ssRNA,GAAGCUUGGGAAUUCGAGCUCCUGACAGCAGGACCCUCACCUCGGUGAUGAUGGAGGGGCGCAAGGUUAACCGCCUCAGGGUCCUCGAUUCGAAGACGUCCAGCUGAUCUAGAUUCUAUAGUGUCACCUAAAU,133.0,0.5338345864661654,"Kd: 39.1 ± 7.6 μM (if purified with a G-25 column without denaturing and renaturing subsequent to in vitro transcription), 3.5 ± 1.5 μM (if purified using 6% polyacrylamide-7M urea gel) ",39100.0,5'-GAAGCUUGGGAAUUCGAGCUCCUGACA-N60-AUUCGAAGACGUCCAGCUGAUCUAGAUUCUAUAGUGUCACCUAAAU-3',60.0,"1× BB, 50 mM Tris–HCl (pH 7.4), 5 mM KCl, 100 mM NaCl, 1 mM MgCl2",MgCl,PBS/phosphate buffers,7.4,Not applicable,*pool static regions determined by sequences,None,None
ssRNA,GGACAGCAGGACCCUCACCUCGGUGAUGAUGGAGGGGCGCAAGGUUAACCGCCUCAGGGUCCUCGACUCGAAGACGUCCAGCUGAUCC,88.0,0.625,Kd: 26.9 ± 2.2 uM,26900.0,5'-GAAGCUUGGGAAUUCGAGCUCCUGACA-N60-AUUCGAAGACGUCCAGCUGAUCUAGAUUCUAUAGUGUCACCUAAAU-3',60.0,"1× BB, 50 mM Tris–HCl (pH 7.4), 5 mM KCl, 100 mM NaCl, 1 mM MgCl2",MgCl,PBS/phosphate buffers,7.4,"Tuncation. To elucidate the interaction between the ASR probe and the RNA aptamer, we systematically modified both the ASR structure and the aptamer sequence and identified the structural elements important for binding affinity and fluorescence activation. A rationally designed ASR analogue displayed a 33-fold improvement in the binding affinity compared to the original ASR probe.",*pool static regions determined by sequences,None,None
ssDNA,5′CTTCTGCCCGCCTCCTTCCGATTGAAAGGTCTGTTTTTGGGGTTGGTTTGGGTCAATAGGAGACGAGATAGGCGGACACT3′,80.0,0.525,Kd: 82 ± 32 nM,82.0,5′-CTTCTGCCCGCCTCCTTCC-N39-GGAGACGAGATAGGCGGACACT-3′,39.0,"1× BB, 50 mM Tris–HCl (pH 7.4), 5 mM KCl, 100 mM NaCl, 1 mM MgCl2",MgCl,Tris Buffers,7.4,Not applicable,WGA lectin-mediated affinity chromatographic SELEX,None,None
ssRNA,GGGAAUGGAUCCACAUCUACGAAUUCUACCGUUAUUGGUGUCACCGAAGAUGUUAUUCACUGCAGACUUGACGAAGCUU,79.0,0.4430379746835443,Kd: 20.9 ± 0.19 nM,20.9,5'-GGGAAUGGAUCCACAUCUACGAAUUC-N30-UUCACUGCAGACUUGACGAAGC-3′,30.0,"25 mM Tris-HCl, 100 mM NaCl, 25 mM KCl, 10 mM MgCl2, 5% DMSO, pH 8.0",MgCl,Other Buffers,7.4,Not applicable,None,None,None
ssRNA,GGGAAUGGAUCCACAUCUACGAAUUCUUCCGUUAUUGGAGCCAAGUCGUAUCCCGAUUCACUGCAGACUUGACGAAGCUU,80.0,0.475,Kd: 33.2 ± 0.19 nM,33.2,5'-GGGAAUGGAUCCACAUCUACGAAUUC-N30-UUCACUGCAGACUUGACGAAGC-3′,30.0,"SB: 20 mM HEPES, pH 7.4, 150 mM NaCl, 5 mM MgCl2, 5 mM KCl",MgCl,Other Buffers,7.4,Not applicable,None,None,MGNITADNSSMSCTIDHTIHQTLAPVVYVTVLVVGFPANCLSLYFGYLQIKARN...RLA
ssRNA,GGAAUGGAUCCACAUCUACGAAUUCGCAUUGUCCGCACGCAAAGCAUUAUUGUGAUUCACUGCAGACUUGACGAAGCUU,79.0,0.45569620253164556,Kd: 90.4 ± 2.35 nM,90.4,5'-GGGAAUGGAUCCACAUCUACGAAUUC-N30-UUCACUGCAGACUUGACGAAGC-3′,30.0,"SB: 20 mM HEPES, pH 7.4, 150 mM NaCl, 5 mM MgCl2, 5 mM KCl",MgCl,Other Buffers,7.4,Not applicable,None,None,MGNITADNSSMSCTIDHTIHQTLAPVVYVTVLVVGFPANCLSLYFGYLQIKARN...RLA
ssRNA,GGGAUCCACAUCUACGAAUUCUACCGUUAUUGGUGUCACCGAAGAUGUUAUUCC,54.0,0.4444444444444444,Kd: 186 ± 5.05 nM,186.0,5'-GGGAAUGGAUCCACAUCUACGAAUUC-N30-UUCACUGCAGACUUGACGAAGC-3′,30.0,"(0.1 mg mL−1 yeast tRNA, 1 mg mL−1 BSA, 4.5 g L−1glucose, 5 mM MgCl2 in phosphate buffered saline, pH 7.4",MgCl,Other Buffers,7.4,Tructated aptamer derived from c1 and c2,None,None,MGNITADNSSMSCTIDHTIHQTLAPVVYVTVLVVGFPANCLSLYFGYLQIKARN...RLA
ssRNA,GGAUCUACGAAUUCUACCGUUAUUGGUGUCACCGAAGAUCC,41.0,0.4634146341463415,Kd: 252 ± 7.04 nM,252.0,5'-GGGAAUGGAUCCACAUCUACGAAUUC-N30-UUCACUGCAGACUUGACGAAGC-3′,30.0,"(0.1 mg mL−1 yeast tRNA, 1 mg mL−1 BSA, 4.5 g L−1glucose, 5 mM MgCl2 in phosphate buffered saline, pH 7.4",MgCl,Other Buffers,7.4,Tructated aptamer derived from c1 and c2,None,None,MGNITADNSSMSCTIDHTIHQTLAPVVYVTVLVVGFPANCLSLYFGYLQIKARN...RLA
ssRNA,GGGAUCCACAUCUACGAAUUCUUCCGUUAUUGGAGCCAAGUCGUAUCCCGAUUCC,55.0,0.4909090909090909,Kd: 221 ± 4.84 nM,221.0,5'-GGGAAUGGAUCCACAUCUACGAAUUC-N30-UUCACUGCAGACUUGACGAAGC-3′,30.0,"(SHCMK) containing 20 mmol/L HEPES (N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid), pH 7.35, 1 mmol/L MgCl2, 1 mmol/L CaCl2,, 120 mmol/L KCl",MgCl,Other Buffers,7.4,Tructated aptamer derived from c1 and c2,None,None,MGNITADNSSMSCTIDHTIHQTLAPVVYVTVLVVGFPANCLSLYFGYLQIKARN...RLA
ssRNA,GGCGAAUUCUUCCGUUAUUGGAGCCAAGUCGCC,33.0,0.5454545454545454,Kd: 196 ± 2.98 nM,196.0,5'-GGGAAUGGAUCCACAUCUACGAAUUC-N30-UUCACUGCAGACUUGACGAAGC-3′,30.0,"(SHCMK) containing 20 mmol/L HEPES (N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid), pH 7.35, 1 mmol/L MgCl2, 1 mmol/L CaCl2,, 120 mmol/L KCl",MgCl,Other Buffers,7.4,Tructated aptamer derived from c1 and c2,None,None,MGNITADNSSMSCTIDHTIHQTLAPVVYVTVLVVGFPANCLSLYFGYLQIKARN...RLA
ssDNA,ATACCAGTCTATTCAATTGCACTCTGTGGGGGTGGACGGGCCGGGTAGATAGTATGTGCAATCA,64.0,0.5,Kd: 1.0 nM,1.0,5'-ATACCAGTCTATTCAATT-N30-AGATAGTATGTGCAATCA-3',30.0,"1× BB, 50 mM Tris-HCl (pH 7.4), 5 mM KCl, 100 mM NaCl, 1 mM MgCl2",None,Other Buffers,8.0,Not applicable,None,None,None
ssDNA,ATACCAGTCTATTCAATTGCACTCTGTGGGGGTGGACGGGCCGGGTAGATAGTATGTGCAATCA,64.0,0.5,Kd: 20 nM,20.0,5'-ATACCAGTCTATTCAATT-N30-AGATAGTATGTGCAATCA-3',30.0,"50 mM Tris-HCl (pH 7.5), 5 mM KCl, 100 mM NaCl, 1 mM MgCl2, 250 mM sucrose, 0.1% sodium azide",None,Other Buffers,8.0,Not applicable,None,None,None
ssDNA,TGTGGGGGTGGACGGGCCGGGTAGA,25.0,0.72,Kd: 1.4 nM,1.4,5'-ATACCAGTCTATTCAATT-N30-AGATAGTATGTGCAATCA-3',30.0,"50 mM Tris-HCl (pH 7.5), 5 mM KCl, 100 mM NaCl, 1 mM MgCl2, 250 mM sucrose, 0.1% sodium azide.",None,Other Buffers,8.0,Not applicable,truncated version of Vap7,None,None
ssDNA,TGTGGGGGTGGACGGGCCGGGTAGA,25.0,0.72,Kd: 1.1 nM,1.1,5'-ATACCAGTCTATTCAATT-N30-AGATAGTATGTGCAATCA-3',30.0,"50 mM Tris-HCl (pH 7.5), 5 mM KCl, 100 mM NaCl, 1 mM MgCl2, 250 mM sucrose, 0.1% sodium azide.",None,Other Buffers,8.0,Not applicable,truncated version of Vap7,None,None
ssDNA,AGCACGTTGGTTAGGTCAGGTTTGGGTTTCGTGC,34.0,0.5294117647058824,Kd: 1.757±0.174 uM,1757.0,5'-ACTGGAGCTCTCACACACGA-N45-GTCCAGTCCAGTGTCCAGCA-3',45.0,"(1× TGK) 25 mM Tris, 192 mM glycine, 5 mM potassium phosphate (pH 8.3)",MgCl,PBS/phosphate buffers,7.4,"Truncated (there is a g–t wobble base pair in the stem of trp3a, and thus we truncated trp3a from this base pair to obtain trp3a-1.)",None,C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N,None
ssDNA,5′ATACCAGCTTATTCAATTACAGTAGTGAGGGGTCCGTCGTGGGGTAGTTGGGTCGTGGAGATAGTAAGTGCAATCT3′,76.0,0.47368421052631576,Kd: 3.0 uM,3000.0,5′-ATACCAGCTTATTCAATT-N40-AGATAGTAAGTGCAATCT-3′,40.0,"(1× TGK) 25 mM Tris, 192 mM glycine, 5 mM potassium phosphate (pH 8.3)",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,None
ssDNA,5′ATACCAGCTTATTCAATTGCGAACGACTTCATAAAATGCTATAAGGTTGCCCTCTGTCAGATAGTAAGTGCAATCT3′,76.0,0.3815789473684211,Kd: 5.2 uM,5200.0,5′-ATACCAGCTTATTCAATT-N40-AGATAGTAAGTGCAATCT-3′,40.0,"(1× TGK) 25 mM Tris, 192 mM glycine, 5 mM potassium phosphate (pH 8.3)",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,MVLRGVRVVELAGLAPGPFCGMVLADFGAEVVRVNRLGSTGENFLARGKRSLAL...ANL
ssDNA,5′ATACCAGCTTATTCAATTGGATCGGCGACGTGGGTGTCGTGATTCGGGGTGAGATAGTAAGTGCAATCT3′,69.0,0.4782608695652174,Kd: 3.2 uM,3200.0,5′-ATACCAGCTTATTCAATT-N40-AGATAGTAAGTGCAATCT-3′,40.0,"(1× TGK) 25 mM Tris, 192 mM glycine, 5 mM potassium phosphate (pH 8.3)",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,MVLRGVRVVELAGLAPGPFCGMVLADFGAEVVRVNRLGSTGENFLARGKRSLAL...ANL
ssDNA,5′ATACCAGCTTATTCAATTCCACAGACCCTTAGCTTTCCTATTATTCTGCGCGACGCTGAGATAGTAAGTGCAATCT3′,76.0,0.42105263157894735,Kd: 1.5 uM,1500.0,5′-ATACCAGCTTATTCAATT-N40-AGATAGTAAGTGCAATCT-3′,40.0,"0.1 g/L yeast tRNA (Invitrogen, NY, USA), 4.5 g/L glucose, 1.0 g/L bovine serum albumin (Solarbio, Beijing, China), 5 mmol/L MgCl2 in Dullbecco's PBS",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,None
ssDNA,5′ATACCAGCTTATTCAATTACAGCGTGGGCGGTGTCGGATTTTCGTATGGATGGGGATGAGATAGTAAGTGCAATCT3′,76.0,0.4473684210526316,Kd: 3.8 uM,3800.0,5′-ATACCAGCTTATTCAATT-N40-AGATAGTAAGTGCAATCT-3′,40.0,"0.1 g/L yeast tRNA (Invitrogen, NY, USA), 4.5 g/L glucose, 1.0 g/L bovine serum albumin (Solarbio, Beijing, China), 5 mmol/L MgCl2 in Dullbecco's PBS",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,MAKKTSGRGKLPPGPTPLPVIGNILQIGIKDISKSLTNLSKVYGPVFTLYFGLK...HHH
ssDNA,AGCAGCACAGAGGTCAGATGGCAGCTAAGCAGGCGGCTCACAAAACCATTCGCATGCGGCCCTATGCGTGCTACCGTGAA,80.0,0.575,Kd: 2.8 ± 0.3 nM,2.8,5'-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3',40.0,"0.1 g/L yeast tRNA (Invitrogen, NY, USA), 4.5 g/L glucose, 1.0 g/L bovine serum albumin (Solarbio, Beijing, China), 5 mmol/L MgCl2 in Dullbecco's PBS",None,Other Buffers,7.5,Not applicable,None,None,None
ssDNA,AGCAGCACAGAGGTCAGATGGCGGGTCGGTTGCTCGCTTCGCCCGATCGGTCTAAGGGTGCCTATGCGTGCTACCGTGAA,80.0,0.6125,Kd: 47.1 ± 16.3 nM,47.1,5'-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3',40.0,"0.1 g/L yeast tRNA (Invitrogen, NY, USA), 4.5 g/L glucose, 1.0 g/L bovine serum albumin (Solarbio, Beijing, China), 5 mmol/L MgCl2 in Dullbecco's PBS",None,Other Buffers,7.5,Not applicable,None,None,EVKVVESGGGLVQPGGSLRLSCATSGFTFSDFYMEWVRQPPGKRLEWIAASRNK...VSA
ssDNA,AGCAGCACAGAGGTCAGATGGCACCTTGATGACATGATAGTCGTTGTGTATGCAGTTGGCCCTATGCGTGCTACCGTGAA,80.0,0.5125,Kd: 52.1 ± 12.7 nM,52.1,5'-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3',40.0,"0.1 g/L yeast tRNA (Invitrogen, NY, USA), 4.5 g/L glucose, 1.0 g/L bovine serum albumin (Solarbio, Beijing, China), 5 mmol/L MgCl2 in Dullbecco's PBS",None,Other Buffers,7.5,Not applicable,None,None,EVKVVESGGGLVQPGGSLRLSCATSGFTFSDFYMEWVRQPPGKRLEWIAASRNK...VSA
ssDNA,5′AGCAGCACAGAGGTCAGATGACTTCAGTGAGTTGTCCCACGGTCGGCGAGTCGGTGGTAGCCTATGCGTGCTACCGTGAA3′,80.0,0.575,Kd: 0.766 μM,766.0,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"SELEX Buffer: 137 mM NaCl, 8.1 mM Na2HPO4, 2.68 mM KCl, 1.47 mM KH2PO4, 0.9 mM CaCl2, 5.3 mM MgCl2, 4.5 g/L glucose, pH 7.4",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,None,None
ssDNA,5′AGCAGCACAGAGGTCAGATGCACCAAGCGCAGGGAATTACATTGAAGTGTGGGATTGGCTCCTATGCGTGCTACCGTGAA3′,80.0,0.525,Kd: 20.03 μM,20030.0,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"(20 mM HEPES, pH 7.4, 150mM NaCl, 2 mM CaCl2, 0.01% BSA",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,None,MRDHTDEKSEAAGNDDGHVRIGGLPAFDPDDPAENAVINRLVGNWHRRAAVKRE...VTR
ssDNA,5′AGCAGCACAGAGGTCAGATGACTGAGGGCACGGACAGGAGGGGGAGAGATGGCGTGAGGTCCTATGCGTGCTACCGTGAA3′,80.0,0.6,Kd: 1.16 μM,11600.0,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"20 mM (4-(2-hydroxyethyl)-1-piperazine ethane sulfonic acid) (HEPES) pH 7.5, 100 mM NaCl, 2 mM CaCl2, 0.01% bovine serum albumin (BSA)",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,None,MRDHTDEKSEAAGNDDGHVRIGGLPAFDPDDPAENAVINRLVGNWHRRAAVKRE...VTR
ssDNA,5′AGCAGCACAGAGGTCAGATGATGCGGGTATATGGTGCGAGAAAACAAGGGGCATACTGGACCTATGCGTGCTACCGTGAA3′,80.0,0.525,Kd: 2.2 μM,2200.0,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"100 mM NaCl, 20 mM Tris–HCl (pH 7.6), 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2, 0.02% Tween 20",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,None,MRDHTDEKSEAAGNDDGHVRIGGLPAFDPDDPAENAVINRLVGNWHRRAAVKRE...VTR
ssRNA,5′UAAUACGACUCACUAUAGGGAGCAGGAGAGAGGUCAGAUGGGUCUAGCCGGAGGAGUCAGUAAUCGGUAGACCCAUCUGACCUCUCUCCUGCUCCC3′,96.0,0.5416666666666666,Kd: 48.5 pM,0.0485,5′‐TAATACGACTCACTATAGGGAGCAGGAGAGAGGTCAGATG‐N30‐CATCTGACCTCTCTCCTGCTCCC‐3′,30.0,"100 mM NaCl, 20 mM Tris–HCl (pH 7.6), 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2, 0.02% Tween 20",None,Tris Buffers,8.0,Not applicable,None,None,None
ssDNA,5′GCGTCGACAAGCTTTCTAGATCGATTTCCTTAGTTGTCTTCCTTAGTTGTCTTCCTTAGTTGTCTTCCTTAGTGAGGAATTCGGATCCCTCGAGCG3′,96.0,0.4583333333333333,Kd: 80 ± 7 nM,80.0,5′-GCGTCGACAAGCTTTCTAGA-N35-GAATTCGGATCCCTCGAGCG-3′,35.0,"100 mM NaCl, 20 mM Tris–HCl (pH 7.6), 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2, 0.02% Tween 20",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,5′GGAGGGAAAAGTTATCAGGCCACTGCGGGGGTCTATACGTGAGGAAGAAGTGGGCAGGTCGATTAGTTTTGGAGTACTCGCTCC3′,84.0,0.5357142857142857,Kd: 45 ± 28 nM,45.0,5′-GGAGGGAAAAGTTATCAGGC-N40-GATTAGTTTTGGAGTACTCGCTCC-3′,40.0,"100 mM NaCl, 20 mM Tris–HCl (pH 7.6), 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2, 0.02% Tween 20",None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′GGAGGGAAAAGTTATCAGGCTGGATGGTAGCTCGGTCGGGGTGGGTGGGTTGGCAAGTCTGATTAGTTTTGGAGTACTCGCTCC3′,84.0,0.5476190476190477,Kd: 0.09 ± 0.04 nM,0.09,5′-GGAGGGAAAAGTTATCAGGC-N40-GATTAGTTTTGGAGTACTCGCTCC-3′,40.0,"100 mM NaCl, 20 mM Tris–HCl (pH 7.6), 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2, 0.02% Tween 20",None,PBS/phosphate buffers,7.4,Not applicable,referenced as CLN3 is https://doi.org/10.1371/journal.pone.0142412,None,None
ssRNA,GGGAUACCAGCUUAUUCAAUUUGAUUCCAUCUUCCUGGACUGUCGAAAAUUCAGUAUCGGGAGGUUACGUAUUUGGUUUAUAGAUAGUAAGUGCAAUCU,99.0,0.3838383838383838,Kd: 110 nM,110.0,5′-GGGAUACCAGCUUAUUCAAUU-N60-AGAUAGUAAGUGCAAUCU-3′,60.0,"200 ul (30 mM Tris-HCl, ph 7.5, 150 mM NaCl, 1.5 mM MgCl2, 2mM dithiothreitol, 1% BSA)",MgCl,Tris Buffers,7.5,Truncated to: 5'-gggtcttccthhacthtchaaaattcagtatcgggaggttacgtatttggtttatagatagtaa-3',None,None,None
ssDNA,5′GCAATGGTACGGTACTTCCGGATGCGGAAACTGGCTAATTGGTGAGGCTGGGGCGGTCGTGCAGCAAAAGTGCACGCTACTTTGCTAA3′,88.0,0.5454545454545454,Kd: 4.93 ± 0.30 nM,4.93,5′-GCAATGGTACGGTACTTCC-N45-CAAAAGTGCACGCTACTTTGCTAA-3′,45.0,"50 mM Tris/Cl, pH 8.0, 150 mM NaCl, 1.5 mM MgCl2, 2 mM dithiothreitol (DTT) and 1% (w/v) BSA",MgCl,Tris Buffers,8.0,Not applicable,None,None,None
ssDNA,5′AGCAGCACAGAGGTCAGATGGGGGGAAGACACAGAGAAAGGCCGGGGTGAAGTGTAGAGGCCTATGCGTGCTACCGTGAA3′,80.0,0.575,Kd: 9.1 ± 0.6 nM,9.1,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"Hank's Buffer with 0.1 mg/mL salmon sperm DNA, 1 mg/mL, BSA",MgCl,Tris Buffers,7.4,Not applicable,"This aptamer was noted as ""particulalry promising."" A total of 10^8 cells, containing an equal number of cells of each M-type: Streptococcus pyogenes clinical isolates corresponding to M-types M1, M2, M3, M4, M5, M6, M11, M12, M28, M41, M49, M59, M75, M77, M82, M83, M89, M91, M92, and M114. One of the recommended aptamers for this article. 5' fam addition",None,None
ssDNA,TTCACGGTAGCACGCATAGGGACAGCAAGCCCAAGCTGGGTGTGCAAGGTGAGGAGTGGGCATCTGACCTCTGTGCTGCT,80.0,0.5875,Kd: 9.6 ± 0.3 nM,9.6,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"Hank's Buffer with 0.1 mg/mL salmon sperm DNA, 1 mg/mL, BSA",MgCl,Tris Buffers,7.4,Not applicable,"This aptamer was noted as ""particulalry promising."" A total of 10^8 cells, containing an equal number of cells of each M-type: Streptococcus pyogenes clinical isolates corresponding to M-types M1, M2, M3, M4, M5, M6, M11, M12, M28, M41, M49, M59, M75, M77, M82, M83, M89, M91, M92, and M114. One of the recommended aptamers for this article. 5' fam addition",None,SLSKDDTAQLKITNIEGGPTVTLYKIGEGVYNTNGDSFINFKYAEGVSLTETGP...STG
ssDNA,CCCCACGAATCGTTACTCTGGTCCTCTATTTCTCCTCCCC,40.0,0.55,Kd: 4 ± 1 nM,4.0,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"1× BB; 50 mM Tris–HCl (pH 7.4), 5 mM KCl, 100 mM NaCl, 1 mM MgCl2",MgCl,Tris Buffers,7.4,Primer regions removed (no primer version of 20a8p),"A total of 10^8 cells, containing an equal number of cells of each M-type: Streptococcus pyogenes clinical isolates corresponding to M-types M1, M2, M3, M4, M5, M6, M11, M12, M28, M41, M49, M59, M75, M77, M82, M83, M89, M91, M92, and M114. 5' fam addition",None,SLSKDDTAQLKITNIEGGPTVTLYKIGEGVYNTNGDSFINFKYAEGVSLTETGP...STG
ssDNA,CACACGCTGAAGAAACTGAGGTCGTAGGTTTTCTTCGGG,39.0,0.5128205128205128,Kd: 13 ± 1 nM,13.0,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"20 mM HEPES pH 7.5, 150 mM NaCl, 2 mM CaCl2, 3 mM MgCl2",MgCl,Tris Buffers,7.4,Primer region removed (no primer version of 20a9),"A total of 10^8 cells, containing an equal number of cells of each M-type: Streptococcus pyogenes clinical isolates corresponding to M-types M1, M2, M3, M4, M5, M6, M11, M12, M28, M41, M49, M59, M75, M77, M82, M83, M89, M91, M92, and M114. 5' fam addition",None,SLSKDDTAQLKITNIEGGPTVTLYKIGEGVYNTNGDSFINFKYAEGVSLTETGP...STG
ssDNA,AGCAGCACAGAGGTCAGATGCACACGCTGAAGAAACTGAGGTCGTAGGTTTTCTTCGGGCCTATGCGTGCTACCGTGAA,79.0,0.5316455696202531,Kd: 9.1 ± 0.8nM,9.1,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"1× BB; 50 mM Tris–HCl (pH 7.4), 5 mM KCl, 100 mM NaCl, 1 mM MgCl2",MgCl,Tris Buffers,7.4,Not applicable,"A total of 10^8 cells, containing an equal number of cells of each M-type: Streptococcus pyogenes clinical isolates corresponding to M-types M1, M2, M3, M4, M5, M6, M11, M12, M28, M41, M49, M59, M75, M77, M82, M83, M89, M91, M92, and M114. 5' fam addition",None,SLSKDDTAQLKITNIEGGPTVTLYKIGEGVYNTNGDSFINFKYAEGVSLTETGP...STG
ssDNA,TTCACGGTAGCACGCATAGGGCCCGACACTCGTCCACCCGATACCTCTCATGTGTCCCCATCTGACCTCTGTGCTGCT,78.0,0.5897435897435898,Kd: 25 ± 3 nM,25.0,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"1× BB; 50 mM Tris–HCl (pH 7.4), 5 mM KCl, 100 mM NaCl, 1 mM MgCl2",MgCl,Tris Buffers,7.4,Not applicable,"A total of 10^8 cells, containing an equal number of cells of each M-type: Streptococcus pyogenes clinical isolates corresponding to M-types M1, M2, M3, M4, M5, M6, M11, M12, M28, M41, M49, M59, M75, M77, M82, M83, M89, M91, M92, and M114. 5' fam addition",None,SLSKDDTAQLKITNIEGGPTVTLYKIGEGVYNTNGDSFINFKYAEGVSLTETGP...STG
ssDNA,AGCAGCACAGAGGTCAGATGGGCATGGGGAAGAGAAAGCGGGATAACTTCGTTACCGGGCCCTATGCGTGCTACCGTGAA,80.0,0.5625,Kd: 17 ± 1 nM,17.0,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"1× BB; 50 mM Tris–HCl (pH 7.4), 5 mM KCl, 100 mM NaCl, 1 mM MgCl2",MgCl,Tris Buffers,7.4,Not applicable,"A total of 10^8 cells, containing an equal number of cells of each M-type: Streptococcus pyogenes clinical isolates corresponding to M-types M1, M2, M3, M4, M5, M6, M11, M12, M28, M41, M49, M59, M75, M77, M82, M83, M89, M91, M92, and M114. 5' fam addition",None,SLSKDDTAQLKITNIEGGPTVTLYKIGEGVYNTNGDSFINFKYAEGVSLTETGP...STG
2'-fluoro-RNA,GGGAGGACGAUGCGGAAUUGAGGGACCACGCGCUGCUUGUUGUGAUAAGCAGUUUGUCGGAUGGCAGACGACUCGCCCGA,80.0,0.5875,Kd: 52 nM,52.0,5'-GGGAGGACGATGCGG-N50-CAGACGACTCGCCCGA-3',50.0,"Low-salt RNA binding buffer (10 mM HEPES pH 7.4, 50 mM NaCl, 1 mM CaCl2, 1 mM MgCl2, 2.7 mM KCl, 10 mM DTT, 0.01% BSA and a high-salt RNA binding buffer (10 mM HEPES pH 7.4, 150 mM NaCl, 1 mM CaCl2, 1 mM MgCl2, 2.7 mM KCl, 10 mM DTT, 0.01% BSA)",MgCl/CaCl,Other Buffers,7.4,Not applicable,"2'F-modified: Typically, prepare 20 μL of reaction containing 1 μg of purified DNA template, 2 μL 10 x buffer, 2 μL dATP, 2 μL dGTP, 2 μL 2'-F-dCTP, 2 μL 2'-F-dUTP, 2 μL DTT and 2 μL T7 RNA polymerase at room temperature and then incubate at 37°C for 6 h.",None,None
ssDNA,5′GGGCCGTTCGAACACGAGCATGCCGGTGGGTGGTCAGGTGGGATAGCGTTCCGCGTATGGCCCAGCGCATCACGGGTTCGCACCAGGACAGTACTCAGGTCATCCTAGG3′,109.0,0.6330275229357798,Kd: 8.3 nM ,8.3,5′-GGGCCGTTCGAACACGAGCATG-N60-GGACAGTACTCAGGTCATCCTAG-3′,60.0,"Hanks buffer with 0.1 mg/ml salmon sperm DNA, 1 mg/ml, BSA",MgCl,Tris Buffers,8.0,Not applicable,None,CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,None
ssDNA,5′GGGCCGTTCGAACACGAGCATGCCGGTGGGTGGTCAGGTGGGATAGCGTTCCGCGTATGGCCCAGCGCATCACGGGTTCGCACCAGGACAGTACTCAGGTCATCCTAGG3′,109.0,0.6330275229357798,Kd: 208 mM,208000000.0,5′-GGGCCGTTCGAACACGAGCATG-N60-GGACAGTACTCAGGTCATCCTAGG-3′,60.0,"25 mM Tris-HCl, 100 mM NaCl, 25 mM KCl, 10 mM MgCl2, and 5% DMSO, pH 8.0",MgCl,Tris Buffers,8.0,Not applicable,None,None,None
ssDNA,5′GGGCCGTTCGAACACGAGCATGCCGGTGGGTGGTCAGGTGGGATAGCGTTCCGCGTATGGCCCAGCGCATCACGGGTTCGCACCAGGACAGTACTCAGGTCATCCTAGG3′,109.0,0.6330275229357798,Kd: 139 mM,139000000.0,5′-GGGCCGTTCGAACACGAGCATG-N60-GGACAGTACTCAGGTCATCCTAGG-3′,60.0,"25 mM Tris-HCl, 100 mM NaCl, 25 mM KCl, 10 mM MgCl2, and 5% DMSO, pH 8.0",MgCl,Tris Buffers,8.0,Not applicable,None,None,None
ssDNA,5′GGGCCGTTCGAACACGAGCATGCCGGTGGGTGGTCAGGTGGGATAGCGTTCCGCGTATGGCCCAGCGCATCACGGGTTCGCACCAGGACAGTACTCAGGTCATCCTAGG3′,109.0,0.6330275229357798,Kd: 139 mM,139000000.0,5′-GGGCCGTTCGAACACGAGCATG-N60-GGACAGTACTCAGGTCATCCTAGG-3′,60.0,"50 mM Tris/Cl (pH 8.0), 150 mM NaCl, 1.5 mM MgCl2, 2 mM DTT, 1% (w/v) BSA",MgCl,Tris Buffers,8.0,Not applicable,None,None,None
ssDNA,5′CGTACGGTCGACGCTAGCGGCGACCCCCGGGCTACCAGACAATGTACGCAGCAAGAGTGACGGTCGTACCTCGGAGTCCACGTGGAGCTCGGATCC3′,96.0,0.6458333333333334,Kd: 44 ± 7 nM,44.0,5′-CGTACGGTCGACGCTAGC-N60-CACGTGGAGCTCGGATCC-3′,60.0,"0.2 mg/ml yeast tRNA, 2 mg/ml bovine serum albumin in washing buffer (4.5 g/l glucose, 5 mM MgCl2 in Dulbecco's phosphate-buffered saline (PBS))",MgCl/CaCl,Other Buffers,7.35,Not applicable,None,None,None
ssDNA,5′CGTACGGTCGACGCTAGCACACTCTTTTGCTCGTGTTTTTGCCTGTTACATAAAATGAATCAGTGGATGTTTCCTTCTCACGTGGAGCTCGGATCC3′,96.0,0.4791666666666667,Kd: 36 ± 8 nM,36.0,5′-CGTACGGTCGACGCTAGC-N60-CACGTGGAGCTCGGATCC-3′,60.0,"0.2 mg/ml yeast tRNA, 2 mg/ml bovine serum albumin in washing buffer (4.5 g/l glucose, 5 mM MgCl2 in Dulbecco's phosphate-buffered saline (PBS))",MgCl/CaCl,Other Buffers,7.35,Not applicable,None,None,WMTGHHHHHHDDYRQKWEWKVGTGLNGFGNVLNDLTNGGTKLTITVTGNKPILL...ITA
ssDNA,5′CGTACGGTCGACGCTAGCGGCGGCCGTGAAATTTGCCAAATGCCGTCTTGGCTTTCGCCCAATGTATCCTGGGTGTTCCACGTGGAGCTCGGATCC3′,96.0,0.59375,Kd: 43 ± 6 nM,43.0,5′-CGTACGGTCGACGCTAGC-N60-CACGTGGAGCTCGGATCC-3′,60.0,"0.2 mg/ml yeast tRNA, 2 mg/ml bovine serum albumin in washing buffer (4.5 g/l glucose, 5 mM MgCl2 in Dulbecco's phosphate-buffered saline (PBS))",MgCl/CaCl,Other Buffers,7.35,Not applicable,None,None,WMTGHHHHHHDDYRQKWEWKVGTGLNGFGNVLNDLTNGGTKLTITVTGNKPILL...ITA
ssDNA,5′CGTACGGTCGACGCTAGCGGAGACCGTACCATCTGTTCGTGGAAGCGCTTTGCTCGTCCATTAGCCTTGTGCTCGTGCCACGTGGAGCTCGGATCC3′,96.0,0.6041666666666666,Kd: 25 ± 4 nM,25.0,5′-CGTACGGTCGACGCTAGC-N60-CACGTGGAGCTCGGATCC-3′,60.0,"20 mM Tris-HCl buffer (pH 7.40), MgCl2 (1 mM), NaCl (10 mM)",MgCl/CaCl,Other Buffers,7.35,Not applicable,None,None,WMTGHHHHHHDDYRQKWEWKVGTGLNGFGNVLNDLTNGGTKLTITVTGNKPILL...ITA
ssDNA,ATAGGAGTCACGACGACCAGAATAGAGATATGACAGCGGGGAAGGTTAAGAGGCGCTAGGAGTATGTGCGTCTACCTCTTGACTAAT3′,87.0,0.4827586206896552,Kd: 21.45 ± 2.62 nM,21.45,5′-ATAGGAGTCACGACGACCAGAA-N40-TATGTGCGTCTACCTCTTGACTAAT-3′,40.0,"20 mM Tris-HCl buffer (pH 7.40), MgCl2 (1 mM), NaCl (10 mM)",MgCl,Tris Buffers,7.4,Not applicable,None,None,None
ssDNA,ATAGGAGTCACGACGACCAGAATCTAAAAATGGGCAAAGAAACAGTGACTCGTTGAGATACTTATGTGCGTCTACCTCTTGACTAAT3′,87.0,0.41379310344827586,Kd: 16.88 ± 1.92 nM,16.88,5′-ATAGGAGTCACGACGACCAGAA-N40-TATGTGCGTCTACCTCTTGACTAAT-3′,40.0,"20 mM Tris-HCl buffer (pH 7.40), MgCl2 (1 mM), NaCl (10 mM)",MgCl,Tris Buffers,7.4,Not applicable,None,None,MDCNNFYASCEKLFRPDLKDTPVVVLSNNDGCVVARSREAKLLGIKMGVPVFQI...RVK
ssDNA,CGTAGAATTCATGAGGACGTTACGTACCGACTTCGTATGCCAACAGCCCTTTATCCACCTCAGCTAAGCTTACCAGTGCGAT,82.0,0.4878048780487805,Kd: 43.8±13.7 nM,43.8,5′-CGTAGAATTCATGAGGACGTT-N40-AGCTAAGCTTACCAGTGCGAT-3′,40.0,"20 mM Tris-HCl buffer (pH 7.40), MgCl2 (1 mM), NaCl (10 mM)",MgCl,Tris Buffers,7.5,Not applicable,"Cell-based SELEX, a modification of the usual SELEX technique using live cells",None,None
ssDNA,5′TCTCGGACGCGTGTGGTCGGCGACGCACCGATCGCAGGTTCGGGATTTTCGGGTGGGAGTTGTGGGGGGGGGTGGGAGGGTTCTCGCTGCCTGGCCCTAGAGTG3′,104.0,0.6730769230769231,Kd: 13.1 ± 67.2 nM,13.1,5′-TCTCGGACGCGTGTGGTCGG-N45-CTCGCTGCCTGGCCCTAGAGTG-3′,45.0,"200 µL, 1×PBS buffer containing 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4 and 2.0 mM KH2PO4, pH 7.4",None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,TCTCGGACGCGTGTGGTCGGCGGGTGGGAGTTGTGGGGGGGGGTGGGAGGGTTCTCGCTGCCTGGCCCTAGAGTG,75.0,0.7066666666666667,Kd: 19.1 ± 5.1 nM,19.1,5′-TCTCGGACGCGTGTGGTCGG-N45-CTCGCTGCCTGGCCCTAGAGTG-3′,45.0,"200 µL, 1×PBS buffer containing 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4 and 2.0 mM KH2PO4, pH 7.4",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MEKISVSTFLLLVALSYSLAKDTTVKPGAKKDPKASSPKLPQTLSRGWGDQLIW...TEL
ssDNA,GTGCAGTCAAAGACGTCCGGGGTGGGTGGGGGGCACGTGTGGGGGCGGCCAGGGTGCTGACCATGAAGTGCGATTGCC,78.0,0.6794871794871795,Kd: 3.4 ± 0.7 nM,3.4,5'-GTGCAGTCAAAGACGTCC-N40-GACCATGAAGTGCGATTGCC-3',40.0,"PBS with 0.5 μg/mL poly dA:dT and 50 μg/mL bovine serum albumin (BSA), pH 7.4.",None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,GTGCAGTCAAAGACGTCCACTCCGTCATCTTTAGTGGCCCCAATGTCGTTATCACCGAGGCAATCGCACTTCATGGTC,78.0,0.5256410256410257,Kd: 7.1 nM,7.1,5'-GTGCAGTCAAAGACGTCC-N40-GGCAATCGCACTTCATGGTC-'3,40.0,"500 μl of 50 mM NaH2PO4, 300 mM NaCl, and 20 mM imidazole (pH 8.0)",None,PBS/phosphate buffers,8.0,Not applicable,"Selected aptamer sequences were synthesized and labeled with biotin (5′), while amplicons containing enriched aptamer pool were amplified by pcr with 5′-biotin-labeled forward primer (bio-wp18: biotingtgcagtcaaagacgtcc)",None,None
ssDNA,GTGCAGTCAAAGACGTCCCACTCCGTCACTTTAGTGGATCTTTATAAAACCGATGCTGGGCAATCGCACTTCATGGTC,78.0,0.48717948717948717,Kd: 22.3 nM,22.3,5'-GTGCAGTCAAAGACGTCC-N40-GGCAATCGCACTTCATGGTC-'3,40.0,"500 μl of 50 mM NaH2PO4, 300 mM NaCl, and 20 mM imidazole (pH 8.0)",None,PBS/phosphate buffers,8.0,Not applicable,"Selected aptamer sequences were synthesized and labeled with biotin (5′), while amplicons containing enriched aptamer pool were amplified by pcr with 5′-biotin-labeled forward primer (bio-wp18: biotingtgcagtcaaagacgtcc)",None,None
ssDNA,GTGCAGTCAAAGACGTCCGCCACTCCGTCACTTTAGTGGTTTTTTTTATAAATGCTTCGGCAATCGCACTTCATGGTC,78.0,0.46153846153846156,Kd: 16 nM,16.0,5'GTGCAGTCAAAGACGTCC-N40-GGCAATCGCACTTCATGGTC'5,40.0,"500 μl of 50 mM NaH2PO4, 300 mM NaCl, and 20 mM imidazole (pH 8.0)",None,PBS/phosphate buffers,8.0,Not applicable,"Selected aptamer sequences were synthesized and labeled with biotin (5′), while amplicons containing enriched aptamer pool were amplified by pcr with 5′-biotin-labeled forward primer (bio-wp18: biotingtgcagtcaaagacgtcc)",None,None
ssDNA,GTGCAGTCAAAGACGTCCTACTCCGTCACTTTAGTGGATATAACAACCTCCCTATGGGGGCAATCGCACTTCATGGTC,78.0,0.5,Kd: 3.7 nM,3.7,5'GTGCAGTCAAAGACGTCC-N40-GGCAATCGCACTTCATGGTC'6,40.0,"Electrophoresis buffer: (A) 25 mM trizma base, 192 mM glycine, 5 mM K2HPO4 (TGK pH 8.3), (B) 8.1 mM Na2HPO4, 1.1 mM KH2PO4, 1 mM MgCl2, 2.7 mM KCl, 40 mM NaCl (PBS pH 7.4)",None,PBS/phosphate buffers,8.0,Not applicable,"Selected aptamer sequences were synthesized and labeled with biotin (5′), while amplicons containing enriched aptamer pool were amplified by pcr with 5′-biotin-labeled forward primer (bio-wp18: biotingtgcagtcaaagacgtcc)",None,None
ssDNA,5′CTTCTGCCCGCCTCCTTCCTGTCACAATTTCCCCCCTCGCACATTTTGCAAGTAACTGAGGAGACGAGATAGGCGGACACT3′,81.0,0.5432098765432098,"Kd: 0.87 ± 0.07 μM via NECEEM, Kd: 1.90 ± 0.53 μM via Fluorescence intensity",870.0,5′-CTTCTGCCCGCCTCCTTCC-N40-GGAGACGAGATAGGCGGACACT-3′,40.0,"Electrophoresis buffer: (A) 25 mM trizma base, 192 mM glycine, 5 mM K2HPO4 (TGK pH 8.3), (B) 8.1 mM Na2HPO4, 1.1 mM KH2PO4, 1 mM MgCl2, 2.7 mM KCl, 40 mM NaCl (PBS pH 7.4)",None,Tris Buffers,8.3,Not applicable,5'-FAM: Fuorescent label modified primers (IDT),None,None
ssDNA,5′CTTCTGCCCGCCTCCTTCCTGGGTGGCCTCCCGTTTATTCGAGATTTGGTTGAATTTGTGGAGACGAGATAGGCGGACACT3′,81.0,0.5432098765432098,"Kd: 0.41 ± 0.13 μM via NECEEM, Kd: 1.18 ± 0.39 μM via Fluorescence intensity",410.0,5′-CTTCTGCCCGCCTCCTTCC-N40-GGAGACGAGATAGGCGGACACT-3′,40.0,"Electrophoresis buffer: (A) 25 mM trizma base, 192 mM glycine, 5 mM K2HPO4 (TGK pH 8.3), (B) 8.1 mM Na2HPO4, 1.1 mM KH2PO4, 1 mM MgCl2, 2.7 mM KCl, 40 mM NaCl (PBS pH 7.4)",None,Tris Buffers,8.3,Not applicable,5'-FAM: Fuorescent label modified primers (IDT),None,MRWGCLCRFLWLWACLSYTQAVPIQRVQDDTKTLIKTIITRINGLSHTQSVSPK...PSC
ssDNA,5′CTTCTGCCCGCCTCCTTCCGTTAATGGGGGATCTCGCGGCCGTTCTTGTTGCTTATACAGGAGACGAGATAGGCGGACACT3′,81.0,0.5679012345679012,"Kd: 0.32 ± 0.50 μM via NECEEM, Kd: 1.50 ± 0.25 μM via Fluorescence intensity",320.0,5′-CTTCTGCCCGCCTCCTTCC-N40-GGAGACGAGATAGGCGGACACT-3′,40.0,"Electrophoresis buffer: (A) 25 mM trizma base, 192 mM glycine, 5 mM K2HPO4 (TGK pH 8.3), (B) 8.1 mM Na2HPO4, 1.1 mM KH2PO4, 1 mM MgCl2, 2.7 mM KCl, 40 mM NaCl (PBS pH 7.4)",None,Tris Buffers,8.3,Not applicable,5'-FAM: Fuorescent label modified primers (IDT),None,MRWGCLCRFLWLWACLSYTQAVPIQRVQDDTKTLIKTIITRINGLSHTQSVSPK...PSC
ssDNA,5′CTTCTGCCCGCCTCCTTCCTCTATAAACTCTGTCCGGTTTTATAATAATAACATTTTACGGAGACGAGATAGGCGGACACT3′,81.0,0.4444444444444444,"Kd: 1.47 ± 0.14 μM via NECEEM, Kd: 3.00 ± 0.80 μM via Fluorescence intensity",1470.0,5′-CTTCTGCCCGCCTCCTTCC-N40-GGAGACGAGATAGGCGGACACT-3′,40.0,"Electrophoresis buffer: (A) 25 mM trizma base, 192 mM glycine, 5 mM K2HPO4 (TGK pH 8.3), (B) 8.1 mM Na2HPO4, 1.1 mM KH2PO4, 1 mM MgCl2, 2.7 mM KCl, 40 mM NaCl (PBS pH 7.4)",None,Tris Buffers,8.3,Not applicable,5'-FAM: Fuorescent label modified primers (IDT),None,MRWGCLCRFLWLWACLSYTQAVPIQRVQDDTKTLIKTIITRINGLSHTQSVSPK...PSC
ssDNA,ATCCAGAGTGACGCAGCAACCGATAACAAGTCTCGTTGTGTTTGCCGGGTGGGTTTTGTTGTTTGGACACGGTGGCTTAGT,81.0,0.5061728395061729,Kd: 33 ± 1.2 nM,33.0,5'-ATCCAGAGTGACGCAGCA-N45-TGGACACGGTGGCTTAGT-3',45.0,"Electrophoresis buffer: (A) 25 mM trizma base, 192 mM glycine, 5 mM K2HPO4 (TGK pH 8.3), (B) 8.1 mM Na2HPO4, 1.1 mM KH2PO4, 1 mM MgCl2, 2.7 mM KCl, 40 mM NaCl (PBS pH 7.4)",MgCl,Other Buffers,7.4,Not applicable,None,None,None
ssDNA,ATCCAGAGTGACGCAGCACTTGTTTGCGTGTTTTTTTCGTTGTCTTGTCGGGGTCTTGTGGTTTGGACACGGTGGCTTAGT,81.0,0.49382716049382713,Kd: 39 ± 2.4 nM,39.0,5'-ATCCAGAGTGACGCAGCA-N45-TGGACACGGTGGCTTAGT-3',45.0,"Electrophoresis buffer: (A) 25 mM trizma base, 192 mM glycine, 5 mM K2HPO4 (TGK pH 8.3), (B) 8.1 mM Na2HPO4, 1.1 mM KH2PO4, 1 mM MgCl2, 2.7 mM KCl, 40 mM NaCl (PBS pH 7.4)",MgCl,Other Buffers,7.4,Not applicable,None,None,None
ssDNA,ATCCAGAGTGACGCAGCAGGGGCCGATTGGTGGTACTGCCATCGTCGTTCTTCAGGCGTTAGTTGGACACGGTGGCTTAGT,81.0,0.5679012345679012,Kd: 31 ± 2.1 nM,31.0,5'-ATCCAGAGTGACGCAGCA-N45-TGGACACGGTGGCTTAGT-3',45.0,"0.1 g/L yeast tRNA (Invitrogen, NY, USA), 4.5 g/L glucose, 1.0 g/L bovine serum albumin (Solarbio, Beijing, China), and 5 mmol/L MgCl2 in Dullbecco's PBS",MgCl,Other Buffers,7.4,Not applicable,None,None,None
ssDNA,ATCCAGAGTGACGCAGCACAGCATTCAGTCCACTACACGGTTCCTCCTTTCATCTCATAAATTTGGACACGGTGGCTTAGT,81.0,0.48148148148148145,Kd: 28 ± 2.3 nM,28.0,5'-ATCCAGAGTGACGCAGCA-N45-TGGACACGGTGGCTTAGT-3',45.0,"0.1 g/L yeast tRNA (Invitrogen, NY, USA), 4.5 g/L glucose, 1.0 g/L bovine serum albumin (Solarbio, Beijing, China), and 5 mmol/L MgCl2 in Dullbecco's PBS",MgCl,Other Buffers,7.4,Not applicable,None,None,None
ssDNA,ATCCAGAGTGACGCAGCAGGGGCTGAGTTTCTTTGTCGGTCTTTTCATGGTTGGTTCTCTTTTTGGACACGGTGGCTTAGT,81.0,0.49382716049382713,Kd: 28 ± 1.9 nM,28.0,5'-ATCCAGAGTGACGCAGCA-N45-TGGACACGGTGGCTTAGT-3',45.0,"0.1 g/L yeast tRNA (Invitrogen, NY, USA), 4.5 g/L glucose, 1.0 g/L bovine serum albumin (Solarbio, Beijing, China), and 5 mmol/L MgCl2 in Dullbecco's PBS",MgCl,Other Buffers,7.4,Not applicable,None,None,None
ssDNA,ATACCAGCTTATTCAATTTGCACCACTTATTGTTACTAATCTGAGATAGTAAGTGCAATCT,61.0,0.32786885245901637,Kd: 1.2 μM,1200.0,5'-ATACCAGCTTATTCAATT-N25-AGATAGTAAGTGCAATCT-3',25.0,"SELEX Buffer: 137 mM NaCl, 8.1 mM Na2HPO4, 2.68 mM KCl, 1.47 mM KH2PO4, 0.9 mM CaCl2, 5.3 mM MgCl2, and 4.5 g/L glucose, pH 7.4",MgCl/CaCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssRNA,5′UCGGGCGAGUCGUCUGGGGAGGACGAUGCGGAAAAAAGAACACUUCCGAUUAGGGCCCACCCUAACGGCCGCAGGGGAGGACGAUGCGGCCGCAUCGUCCUCCCUA3′,106.0,0.6320754716981132,Kd: 1.7 nM,1.7,5′-TCGGGCGAGTCGTCTG-N40-CCGCATCGTCCTCCCTA-3′,40.0,"20 mM (4-(2-hydroxyethyl)-1-piperazine ethane sulfonic acid) (HEPES) pH 7.5, 100 mM NaCl, 2 mM CaCl2, and 0.01% bovine serum albumin (BSA)",CaCl,Other Buffers,7.5,Not applicable,None,None,None
ssRNA,5′UCGGGCGAGUCGUCUGGGGAGGACGAUGCGGAACGGGACCACCCAUGCCAGGGGACCACCUCAGGCAGCGCCAGACGACGGGAGGACGAUGCGGCCGCAUCGUCCUCCCUA3′,111.0,0.6936936936936937,Kd: 10 nM,10.0,5′-TCGGGCGAGTCGTCTG-N40-CCGCATCGTCCTCCCTA-3′,40.0,"20 mM (4-(2-hydroxyethyl)-1-piperazine ethane sulfonic acid) (HEPES) pH 7.5, 100 mM NaCl, 2 mM CaCl2, and 0.01% bovine serum albumin (BSA)",CaCl,Other Buffers,7.5,Not applicable,None,None,MPVQAAQWTEFLSCPICYNEFDENVHKPISLGCSHTVCKTCLNKLHRKACPFDQ...FCR
ssDNA,5′ATACCAGCTTATTCAATTAGCGAGGGCGGTGTCCAACAGCGGTTTTTTCACGAGGAGGTTGGCGGTGGAGATAGTAAGTGCAATCT3′,86.0,0.4883720930232558,Kd: 0.05 nM and 17.8 nM,0.05,5′-ATACCAGCTTATTCAATT-N50-AGATAGTAAGTGCAATCT-3′,50.0,"100 mM NaCl, 20 mM Tris–HCl (pH 7.6), 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2 and 0.02% Tween 20",MgCl/CaCl,Tris Buffers,7.6,Not applicable,"The following forward and reverse primers were used for amplification and cloning using forward primer: 5′-ATACCAGCTTATTCAATT-3′, reverse primer: 5′-AGATTGCACTTACTATCT-3′, fluorescein-labeled forward primer: 5′-fluorescein-ATACCAGCTTATTCAATT-3′ and modified reverse primer: 5′-poly-dA20-hexaethylene glycol (HEGL)-AGATTGCACTTACTATCT-3′.",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,None
ssDNA,5′AGCGAGGGCGGTGTCCAACAGCGGTTTTTTCACGAGGAGGTTGGCGGTGG3′,50.0,0.62,Kd: 8.2 nM,8.2,5′-ATACCAGCTTATTCAATT-N50-AGATAGTAAGTGCAATCT-3′,50.0,"100 mM NaCl, 20 mM Tris–HCl (pH 7.6), 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2 and 0.02% Tween 20",MgCl/CaCl,Tris Buffers,7.6,Not applicable,"The following forward and reverse primers were used for amplification and cloning using forward primer: 5′-ATACCAGCTTATTCAATT-3′, reverse primer: 5′-AGATTGCACTTACTATCT-3′, fluorescein-labeled forward primer: 5′-fluorescein-ATACCAGCTTATTCAATT-3′ and modified reverse primer: 5′-poly-dA20-hexaethylene glycol (HEGL)-AGATTGCACTTACTATCT-3′.",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,MKSAKGIENLAFVPSSPDILRRLSASPSQIEVSALSSDPQRENSQPQELQKPQE...KEG
ssDNA,5′GGTGGCTGTTGGTCGAGGCTTATTAGTGTAGTCAATGGAGGCAGGCGACG3′,50.0,0.56,Kd: 44.0 nM,44.0,5′-ATACCAGCTTATTCAATT-N50-AGATAGTAAGTGCAATCT-3′,50.0,"100 mM NaCl, 20 mM Tris–HCl (pH 7.6), 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2 and 0.02% Tween 20",MgCl/CaCl,Tris Buffers,7.6,Not applicable,"The following forward and reverse primers were used for amplification and cloning using forward primer: 5′-ATACCAGCTTATTCAATT-3′, reverse primer: 5′-AGATTGCACTTACTATCT-3′, fluorescein-labeled forward primer: 5′-fluorescein-ATACCAGCTTATTCAATT-3′ and modified reverse primer: 5′-poly-dA20-hexaethylene glycol (HEGL)-AGATTGCACTTACTATCT-3′.",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,MKSAKGIENLAFVPSSPDILRRLSASPSQIEVSALSSDPQRENSQPQELQKPQE...KEG
ssDNA,5′CACCTAATACGACTCACTATAGCGGATCCGACACGGCATGGTGGGCGTCGTGCTGGCTCGAACAAGCTTGC3′,71.0,0.5774647887323944,Kd: 9.4 nM,9.4,5′-CACCTAATACGACTCACTATAGCGGATCCGA-N40-CTGGCTCGAACAAGCTTGC-3′,40.0,"20 mM Tris–HCl, 50 mM NaCl, 5 mM KCl, 5 mM MgCl2, pH 8.0",MgCl,Tris Buffers,8.0,Not applicable,Fam conjugated to 5' end of aptamer,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)C,None
ssDNA,5′CACCTAATACGACTCACTATAGCGGATCCGAGCGGGCGGTTGTATAGCGGCTGGCTCGAACAAGCTTGC3′,69.0,0.5652173913043478,Kd: 13.4 nM,13.4,5′-CACCTAATACGACTCACTATAGCGGATCCGA-N40-CTGGCTCGAACAAGCTTGC-3′,40.0,"20 mM Tris–HCl, 50 mM NaCl, 5 mM KCl, 5 mM MgCl2, pH 8.0",MgCl,Tris Buffers,8.0,Not applicable,Fam conjugated to 5' end of aptamer,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)C,MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKI...KHW
ssDNA,TTTAGTTGGGGTTCAGTTG,19.0,0.42105263157894735,Kd: 9.8 nM,9.8,5′-CACCTAATACGACTCACTATAGCGGATCCGA-N40-CTGGCTCGAACAAGCTTGC-3′,40.0,"D-PBS(+) supplemented with 1 mg/ml bovine serum albumin (BSA). To decrease non-specific binding, the binding buffer was supplemented with 20% FBS, 1 mg/ml BSA after round 6.",MgCl,Tris Buffers,8.0,Truncated: The ssDNA was shortened based on the common sequence,"Fam conjugated to 5' end of aptamer. The paper reported two common sequences for the AMP18, the manuscript version of sequence is: AMP18 (21-mer 5′-TTAGTTGGGGTTCAGTTGG-3′) ",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)C,MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKI...KHW
ssDNA,AACCGCCCAAATCCCTAAGAGTCTGCACTTGTCATTTTGTATATGTATTTGGTTTTTGGCTCTCACAGACACACTACACACGCACA,86.0,0.43023255813953487,Kd: 18.9 nM,18.9,5'-AACCGCCCAAATCCCTAAGAGTC-N40-CACAGACACACTACACACGCACA-3',40.0,"D-PBS(+) supplemented with 1 mg/ml bovine serum albumin (BSA), To decrease non-specific binding, the binding buffer was supplemented with 20% FBS, 1 mg/ml BSA after round 6.",None,Other Buffers,7.2,Not applicable,None,None,None
ssDNA,AACCGCCCAAATCCCTAAGAGTCTGCACTTGTCATTTTGTATATGTATTTGGTTTTTGGCTCTCACAGACACACTACACACGCACA,86.0,0.43023255813953487,Kd: 316 nM,316.0,5'-AACCGCCCAAATCCCTAAGAGTC-N40-CACAGACACACTACACACGCACA-3',40.0,"D-PBS(+) supplemented with 1 mg/ml bovine serum albumin (BSA), To decrease non-specific binding, the binding buffer was supplemented with 20% FBS, 1 mg/ml BSA after round 6.",None,Other Buffers,7.2,Not applicable,None,None,None
ssRNA,GGGAGGACGAUGCGGGGACCUAUGCAGUAGCCAGUGUGGACUGGGCUGCCCCCCCCAGACGACUCGCCCGA,71.0,0.6901408450704225,Kd: 1.5 ± 0.02 nM,1.5,5'-GGGAGGACGAUGCGG-N40-CAGACGACUCGCCCGA-3',40.0,"D-PBS(+) supplemented with 1 mg/ml bovine serum albumin (BSA), To decrease non-specific binding, the binding buffer was supplemented with 20% FBS, 1 mg/ml BSA after round 6.",MgCl/CaCl,Other Buffers,7.5,Not applicable,None,None,None
ssDNA,5′ATACCAGCTTATTCAATTGGGCACAGACGGAAGATGAGAATTGTGGGGCTTAGTATAGTGAGGTGCGTGTAGATAGTAAGTGCAATCT3′,88.0,0.4318181818181818,Kd: 2.5±0.5 nM,2.5,5′-ATACCAGCTTATTCAATT-N52-AGATAGTAAGTGCAATCT-3′,52.0,"D-PBS(+) supplemented with 1 mg/ml bovine serum albumin (BSA), To decrease non-specific binding, the binding buffer was supplemented with 20% FBS, 1 mg/ml BSA after round 6.",None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′ATACCAGCTTATTCAATTGGGCGGGGAGTAGGGAGAGGGGTTTCCATCGGCGACAGAGGAGTTATGTGTGTAGATAGTAAGTGCAATCT3′,89.0,0.48314606741573035,Kd: 7.1±0.4 nM,7.1,5′-ATACCAGCTTATTCAATT-N52-AGATAGTAAGTGCAATCT-3′,52.0,"D-PBS(+) supplemented with 1 mg/ml bovine serum albumin (BSA), To decrease non-specific binding, the binding buffer was supplemented with 20% FBS, 1 mg/ml BSA after round 6.",None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′ATACCAGCTTATTCAATTGGGGAGGGAGACACAGTCATGGAGCAGTTATTAGGGTGTACCGGGTGTAGTAGATAGTAAGTGCAATCT3′,87.0,0.4482758620689655,Kd: 1.6±0.4 nM,1.6,5′-ATACCAGCTTATTCAATT-N52-AGATAGTAAGTGCAATCT-3′,52.0,"D-PBS(+) supplemented with 1 mg/ml bovine serum albumin (BSA), To decrease non-specific binding, the binding buffer was supplemented with 20% FBS, 1 mg/ml BSA after round 6.",None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′ATACCAGCTTATTCAATTGGGGGACACGGAGGTGGTGGAAAGGCTAAGATTTGATGATGAGTAGTGTGGTAGATAGTAAGTGCAATCT3′,88.0,0.4318181818181818,Kd: 6.9±0.2 nM,6.9,5′-ATACCAGCTTATTCAATT-N52-AGATAGTAAGTGCAATCT-3′,52.0,"D-PBS(+) supplemented with 1 mg/ml bovine serum albumin (BSA), To decrease non-specific binding, the binding buffer was supplemented with 20% FBS, 1 mg/ml BSA after round 6.",None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′AACCGCCCAAATCCCTAAGAGTCGGACTGCAACCTATGCTATCGTTGATGTCTGTCCAAGCAACACAGACACACTACACACGCACA3′,86.0,0.5,Kd: 38.3 nM,38.3,5′-AACCGCCCAAATCCCTAAGAGTC-N40-CACAGACACACTACACACGCACA-3′,40.0,Hanks buffer with 0.1 mg/ml salmon sperm DNA and 1 mg/ml of BSA,None,Other Buffers,7.2,Not appilcable,None,None,None
ssDNA,5′CGTACGGAATTCGCTAGCCGACGCACAGTCGCTGGTGCGTACCTGGTTGCCGTTGTGTGGATCCGAGCTCCACGTG3′,76.0,0.618421052631579,Kd: 4.7 nM,4.7,5′-CGTACGGAATTCGCTAGC-N40-GGATCCGAGCTCCACGTG-3′,40.0,"20 mM Tris–HCl, 50 mM NaCl, 5 mM KCl, 1 mM MgCl2, pH 7.2",MgCl,Tris Buffers,7.2,Not applicable,None,None,None
ssDNA,GCAATGGTACGGTACTTCCGCGGTCCGGGGTGGGTGGGTGGTGGGGGGTGCGGGGGGGCGGCCGCAAAAGTGCACGCTACTTTGCTAA,88.0,0.6704545454545454,Kd: 18.91 ± 3.95 nM,18.91,5'-GCAATGGTACGGTACTTCC-N45-CAAAAGTGCACGCTACTTTGCTAA-3',45.0,"50 mM Tris/Cl (pH 8.0), 150 mM NaCl, 1.5 mM MgCl2, 2 mM DTT and 1% (w/v) BSA",MgCl,Tris Buffers,8.0,Not applicable,None,None,None
ssDNA,CATCTGCAGTGTGGCACCATGGAATACGACATTGTTGGCTGTTCTTGGTTATGCGGTTTTTCGTGCTGAGCGTGAATTCGC,81.0,0.49382716049382713,Kd: 96.37 nM,96.37,5′-CATCTGCAGTGTGGCACCATG-N40-CGTGCTGAGCGTGAATTCGC-3′,40.0,"4.5 g/l glucose, 5 mM MgCl2 in Dulbecco's PBS (Sigma, St. Louis, MO). One mg/mL BSA (Fisher, Waltham, MA), 0.1 mg/mL t-RNA",MgCl/CaCl,PBS/phosphate buffers,7.35,Not applicable,None,None,MALTFHTALYFTIVGLSFAASDARHVQWCTISHLEQKKCNDLVGSCNVPDITLA...LFQ
ssDNA,ACGCTCGGATGCCACTACAGGACAGGGCACCACCATAGTACCTGTACTACCCAGCCGAGGCTCATGGACGTGCTGGTGAC,80.0,0.6,Kd: 103.61 ± 35.05 nM,103.61,5′-ACGCTCGGATGCCACTACAG-N40-CTCATGGACGTGCTGGTGAC-3′,40.0,"Tris/Triton buffer (50 mmol/l Tris pH 8.0, 2 mmol/l EDTA, 100 mmol/l NaCl, 0.5% Triton X-100)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
"2',4'-BNA/LNA-DNA",5′TCGCCTTGCCGGATCGCAGACtCttAACAGGACAAGtGAAACAAACCCGCTGGTCCGTGAGCCTGACACC3′,70.0,0.5714285714285714,Kd: 23nM,23.0,5′-TCGCCTTGCCGGATCGCAGA-N30-TGGTCCGTGAGCCTGACACC-3′,30.0,"Tris/Triton buffer (50 mmol/l Tris pH 8.0, 2 mmol/l EDTA, 100 mmol/l NaCl, 0.5% Triton X-100)",MgCl,Tris Buffers,7.4,Not applicable,"DNA library contained B/L thymidines (t's) instead of the natural thymidines in the non-primer region and 8 B/L nucleotides placed at intervals of two residues in the primer region. 2′,4′-BNA/LNA library was enzymatically prepared from 70-mer oligodeoxyribonucleotides (ODNs) comprising the variable region (30 bases) flanked by the forward and reverse primer regions (20 bases each) 2′,4′-BNA/LNA -->2'-O,4'-C-methylene bridged/locked nucleic acid",None,None
"2',4'-BNA/LNA-DNA",5′TCGCCTTGCCGGATCGCAGACtCttGACAGGACtCAtGCACGGGGGGGCtTGGTCCGTGAGCCTGACACC3′,70.0,0.6428571428571429,Kd: 27nM,27.0,5′-TCGCCTTGCCGGATCGCAGA-N30-TGGTCCGTGAGCCTGACACC-3′,30.0,"Tris/Triton buffer (50 mmol/l Tris pH 8.0, 2 mmol/l EDTA, 100 mmol/l NaCl, 0.5% Triton X-100)",MgCl,Tris Buffers,7.4,Not applicable,"DNA library contained B/L thymidines (t's) instead of the natural thymidines in the non-primer region and 8 B/L nucleotides placed at intervals of two residues in the primer region. 2′,4′-BNA/LNA library was enzymatically prepared from 70-mer oligodeoxyribonucleotides (ODNs) comprising the variable region (30 bases) flanked by the forward and reverse primer regions (20 bases each) 2′,4′-BNA/LNA -->2'-O,4'-C-methylene bridged/locked nucleic acid",None,MGKGDPKKPRGKMSSYAFFVQTCREEHKKKHPDASVNFSEFSKKCSERWKTMSA...DDE
"2',4'-BNA/LNA-DNA",5′TCGCCTTGCCGGATCGCAGACtCttGACAGGACACAtGCACGCGGGGGCtTGGTCCGTGAGCCTGACACC3′,70.0,0.6428571428571429,Kd: 20nM,20.0,5′-TCGCCTTGCCGGATCGCAGA-N30-TGGTCCGTGAGCCTGACACC-3′,30.0,"Tris/Triton buffer (50 mmol/l Tris pH 8.0, 2 mmol/l EDTA, 100 mmol/l NaCl, 0.5% Triton X-100)",MgCl,Tris Buffers,7.4,Not applicable,"DNA library contained B/L thymidines (t's) instead of the natural thymidines in the non-primer region and 8 B/L nucleotides placed at intervals of two residues in the primer region. 2′,4′-BNA/LNA library was enzymatically prepared from 70-mer oligodeoxyribonucleotides (ODNs) comprising the variable region (30 bases) flanked by the forward and reverse primer regions (20 bases each) 2′,4′-BNA/LNA -->2'-O,4'-C-methylene bridged/locked nucleic acid",None,MGKGDPKKPRGKMSSYAFFVQTCREEHKKKHPDASVNFSEFSKKCSERWKTMSA...DDE
"2',4'-BNA/LNA-DNA",5′TCGCCTTGCCGGATCGCAGACTCTTAACAGGACTCATGCACGGGGGGGCTTGGTCCGTGAGCCTGACACC3′,70.0,0.6285714285714286,Kd: 18nM,18.0,5′-TCGCCTTGCCGGATCGCAGA-N30-TGGTCCGTGAGCCTGACACC-3′,30.0,"Tris/Triton buffer (50 mmol/l Tris pH 8.0, 2 mmol/l EDTA, 100 mmol/l NaCl, 0.5% Triton X-100)",MgCl,Tris Buffers,7.4,Modified nucleoside triphosphates with corresponding foreign functionalities (ATS tail),"DNA library contained B/L thymidines (t's) instead of the natural thymidines in the non-primer region and 8 B/L nucleotides placed at intervals of two residues in the primer region. 2′,4′-BNA/LNA library was enzymatically prepared from 70-mer oligodeoxyribonucleotides (ODNs) comprising the variable region (30 bases) flanked by the forward and reverse primer regions (20 bases each) 2′,4′-BNA/LNA -->2'-O,4'-C-methylene bridged/locked nucleic acid",None,MGKGDPKKPRGKMSSYAFFVQTCREEHKKKHPDASVNFSEFSKKCSERWKTMSA...DDE
"2',4'-BNA/LNA-DNA",5′TCGCCTTGCCGGATCGCAGACtCttAACAGGACtCAtGCACGGGGGGGCtTGGTCCGTGAGCCTGACACC3′,70.0,0.6285714285714286,Kd: 4.2nM,4.2,5′-TCGCCTTGCCGGATCGCAGA-N30-TGGTCCGTGAGCCTGACACC-3′,30.0,"Tris/Triton buffer (50 mmol/l Tris pH 8.0, 2 mmol/l EDTA, 100 mmol/l NaCl, 0.5% Triton X-100)",MgCl,Tris Buffers,7.4,Modified nucleoside triphosphates with corresponding foreign functionalities (ATS tail),"DNA library contained B/L thymidines (t's) instead of the natural thymidines in the non-primer region and 8 B/L nucleotides placed at intervals of two residues in the primer region. 2′,4′-BNA/LNA library was enzymatically prepared from 70-mer oligodeoxyribonucleotides (ODNs) comprising the variable region (30 bases) flanked by the forward and reverse primer regions (20 bases each) 2′,4′-BNA/LNA -->2'-O,4'-C-methylene bridged/locked nucleic acid",None,None
ssDNA,5′AGATTGCACTTACTATCTATACCAGCTTATTCAATTCCCAAATTGCCACCACTTACAGCATGATAACATACTACATCTTTTCATCAAGATAGTAAGTGCAATCTAATTGAATAAGCTGGTAT3′,122.0,0.3360655737704918,Kd: 460.12 (±101.99) nM,460.0,5′-AGATTGCACTTACTATCT-N50-AATTGAATAAGCTGGTAT-3′,50.0,"Tris/Triton buffer (50 mmol/l Tris pH 8.0, 2 mmol/l EDTA, 100 mmol/l NaCl, 0.5% Triton X-100)",MgCl,PBS/phosphate buffers,7.4,Not applicable,"Utilized modified SELEX methodology called SRC-SELEX, which enables the selection of aptamers to distinguish the cells activated by stimulus of healthy cells or cells isolated from diseased tissue.",None,None
ssDNA,GGTCACCAACAACAGGGAGCGCTACGCGAAGGGTCAATGTGACGTCATGCGGATGTGTGG,60.0,0.5833333333333334,Kd: 77 nM,77.0,5′-ATACCAGCTTATTCAATT-N60-AGATAGTAAGTGCAATCT-3′,60.0,"50 mM Tris, pH 7.5, 150 mM NaCl, 2 mM MgCl2",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,5′AGTATACGTATTACCTGCAGCGAGGGAAGAAGGGCCAGCACAGATCAGATCAATCGCTCCGCGATATCTCGGAGATCTTGC3′,81.0,0.5185185185185185,Kd: 35.7 ± 8.02 μM,35700.0,5′-AGTATACGTATTACCTGCAGC-N40-CGATATCTCGGAGATCTTGC-3′,40.0,"1xPBST, 0.05%Tween20 in 1xPBS",None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′TCGCACATTCCGCTTCTACCGGGGGGGTCGAGCTGAGTGGATGCGAATCTGTGGGTGGGCTTCGCACACACGGACTTACG3′,80.0,0.6125,Kd: 419 ± 63 nM,419.0,5′-TCGCACATTCCGCTTCTACC-N40-TTCGCACACACGGACTTACG-3′,40.0,"Binding buffer was prepared by adding 1 mg/mL bovine serum albumin (BSA, Sigma), 0.1 mg/mL Herring Sperm DNA (Invitrogen) to washing buffer (0.01 M PBS (contain 8 g NaCl, 0.2 g KCl, 3.58 g Na2HPO4·12H2O, 0.272 g KH2PO4 per 1 L ddH2O. pH = 7.4)",MgCl,PBS/phosphate buffers,8.3,Not applicable,None,None,None
ssDNA,5′TCGCACATTCCGCTTCTACCGGGGGGGTGAGACATCGGGCATGTTCATGGGTGGGGGGTATTCGCACACACGGACTTACG3′,80.0,0.6,Kd: 1770 ± 140 nM,1770.0,5′-TCGCACATTCCGCTTCTACC-N40-TTCGCACACACGGACTTACG-3′,40.0,"4.5 g/l glucose, 5 mM MgCl2, 2 mg/ml BSA, 0.2 mg/ml yeast tRNA dissolved in PBS buffer",MgCl,PBS/phosphate buffers,8.3,Not applicable,None,None,None
ssDNA,5′TCGCACATTCCGCTTCTACCGCCGCACAATCGGGTTGGGCAGGGAGGGCACGTGTGGCGCTTCGCACACACGGACTTACG3′,80.0,0.6375,Kd: 1210 ± 60 nM,1210.0,5′-TCGCACATTCCGCTTCTACC-N40-TTCGCACACACGGACTTACG-3′,40.0,"10 mM HEPES, pH 7.4, 150 mM NaCl",MgCl,PBS/phosphate buffers,8.3,Not applicable,None,None,None
ssDNA,TCGGCAACAAGGTCACCCGGAGAAGATCGGTGGTCAAACTGCATAGGTAGTCCAGAAGCC3′,60.0,0.55,Kd: 7.8 ± 6.1 nM,7.8,5′-CTCCTCTGACTGTAACCACG-N40-GCATAGGTAGTCCAGAAGCC-3′,40.0,500 μl DPBS buffer,None,PBS/phosphate buffers,7.4,Trucated by removing the first 20 bases,aptamer can be used as affitity probe in flow cytometry or biosensors,None,MSHNDTIVAQATPPGRGGVGILRISGLKARDVAQEVLGKLPKPRHADYLPFKDV...IGK
ssDNA,CTCCTCTGACTGTAACGTACCAAAATGTTGGATTGGATGTTGTACTGGGTTGCATAGGTAGTCCAGAAGCC,71.0,0.4647887323943662,Kd: 53 ± 7 nM (affinity for 80nt),53.0,5′-CTCCTCTGACTGTAACCACG-N40-GCATAGGTAGTCCAGAAGCC-3′,40.0,"20 mM sodium phosphate, pH 7.5, 500 mM NaCl, 20 mM imidazole",None,PBS/phosphate buffers,7.4,Not applicable,aptamer has good antibacterial potential,None,MSHNDTIVAQATPPGRGGVGILRISGLKARDVAQEVLGKLPKPRHADYLPFKDV...IGK
ssDNA,TACCAAAATGTTGGATTGGATGTTGTACTGGGTTGCATAGGTAGTCCAGAAGCC,54.0,0.4444444444444444,Kd: 6.3 ± 0.58 nM (affinity for 60nt),6.3,5′-CTCCTCTGACTGTAACCACG-N40-GCATAGGTAGTCCAGAAGCC-3′,40.0,500 μl DPBS buffer,None,PBS/phosphate buffers,7.4,Truncated by removing the first 25 bases,aptamer has good antibacterial potential,None,MSHNDTIVAQATPPGRGGVGILRISGLKARDVAQEVLGKLPKPRHADYLPFKDV...IGK
ssDNA,5′CTCCTCTGACTGTAACCACGCACAAAGGCTCGCGCATGGTGTGTACGTTCTTACAGAGGTGCATAGGTAGTCCAGAAGCC3′,80.0,0.5375,Kd: 28 ± 3.8 nM,28.0,5′-CTCCTCTGACTGTAACCACG-N40-GCATAGGTAGTCCAGAAGCC-3′,40.0,500 μl DPBS buffer,None,PBS/phosphate buffers,7.4,Not applicable,aptamer has good antibacterial potential,None,MSHNDTIVAQATPPGRGGVGILRISGLKARDVAQEVLGKLPKPRHADYLPFKDV...IGK
ssDNA,5′CTCCTCTGACTGTAACCACGCACAAAGGCTCGCGCATGGTGTGTACGTTCTTACAGAGGT,60.0,0.5333333333333333,Kd: 7.1 ± 0.62 nM,7.1,5′-CTCCTCTGACTGTAACCACG-N40-GCATAGGTAGTCCAGAAGCC-3′,40.0,500 μl DPBS buffer,None,PBS/phosphate buffers,7.4,Trucated by removing the last 20 bases,aptamer has good antibacterial potential,None,MSHNDTIVAQATPPGRGGVGILRISGLKARDVAQEVLGKLPKPRHADYLPFKDV...IGK
ssDNA,5′CTCCTCTGACTGTAACCACGAACGATTCAAGAACTGTTGGTTGTCGGCTTATTTTCGGCA3′,60.0,0.4666666666666667,Kd: 6.9 ± 0.4 nM,6.9,5′-CTCCTCTGACTGTAACCACG-N40-GCATAGGTAGTCCAGAAGCC-3′,40.0,"30 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1.5 mM MgCl2, 2mM DTT, 1% BSA",None,PBS/phosphate buffers,7.4,Trucated by removing the last 20 bases,aptamer can be used as affitity probe in flow cytometry or biosensors,None,MSHNDTIVAQATPPGRGGVGILRISGLKARDVAQEVLGKLPKPRHADYLPFKDV...IGK
ssDNA,5′CTCCTCTGACTGTAACCACGTGCCGCTAAACGCCGGCTCATCGTTATGCTTTTCATTGCAGCATAGGTAGTCCAGAAGCC3′,80.0,0.525,Kd: 56 ± 7.1 nM,56.0,5′-CTCCTCTGACTGTAACCACG-N40-GCATAGGTAGTCCAGAAGCC-3′,40.0,"30 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1.5 mM MgCl2, 2mM DTT, 1% BSA",None,PBS/phosphate buffers,7.4,Not applicable,aptamer can be used as affitity probe in flow cytometry or biosensors,None,MSHNDTIVAQATPPGRGGVGILRISGLKARDVAQEVLGKLPKPRHADYLPFKDV...IGK
ssDNA,5′CTCCTCTGACTGTAACCACGGAGTTAATCAATACAAGGCGGGAACATCCTTGGCGGTGCCGCATAGGTAGTCCAGAAGCC3′,80.0,0.5375,Kd: 37 ± 2.7 nM,37.0,5′-CTCCTCTGACTGTAACCACG-N40-GCATAGGTAGTCCAGAAGCC-3′,40.0,"30 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1.5 mM MgCl2, 2mM DTT, 1% BSA",None,PBS/phosphate buffers,7.4,Not applicable,aptamer can be used as affitity probe in flow cytometry or biosensors,None,None
ssDNA,5′GAGTTAATCAATACAAGGCGGGAACATCCTTGGCGGTGCC3′,40.0,0.525,Kd: 5.3 ± 0.4 nM,5.3,5′-CTCCTCTGACTGTAACCACG-N40-GCATAGGTAGTCCAGAAGCC-3′,40.0,500 μl DPBS buffer,None,PBS/phosphate buffers,7.4,Trucated by removing the first 20 bases and the last 20 bases,aptamer can be used as affitity probe in flow cytometry or biosensors,None,MSSPSSAPTLIAPSPAARAADGRIRTYEVRTFGCQMNVHDSERLSGSLESAGYV...VEA
ssDNA,5′GCCTCTAAGGCTCACCTTGAAGCGCCCGGACTAAGCTGCTCGCATAGGTAGTCCAGAAGCC3′,61.0,0.5901639344262295,Kd: 13 ± 1.1 nM,13.0,5′-CTCCTCTGACTGTAACCACG-N40-GCATAGGTAGTCCAGAAGCC-3′,40.0,500 μl DPBS buffer,None,PBS/phosphate buffers,7.4,Trucated by removing the first 20 bases,aptamer can be used as affitity probe in flow cytometry or biosensors,None,MSSPSSAPTLIAPSPAARAADGRIRTYEVRTFGCQMNVHDSERLSGSLESAGYV...VEA
ssDNA,5′CTCCTCTGACTGTAACCACGGTGGTTTGATCACTATTGGGCCTTTGTGATGTCGGTAGTCGCATAGGTAGTCCAGAAGCC3′,80.0,0.5125,Kd: 15.4 ±1.8 nM,15.4,5′-CTCCTCTGACTGTAACCACG-N40-GCATAGGTAGTCCAGAAGCC-3′,40.0,500 μl DPBS buffer,None,PBS/phosphate buffers,7.4,Not applicable,aptamer has good antibacterial potential,None,MSSPSSAPTLIAPSPAARAADGRIRTYEVRTFGCQMNVHDSERLSGSLESAGYV...VEA
ssDNA,5′CTCCTCTGACTGTAACCACGGTGGTTTGATCACTATTGGGCCTTTGTGATGTCGGTAGT3′,59.0,0.4915254237288136,Kd: 4.5 ± 0.4 nM,4.5,5′-CTCCTCTGACTGTAACCACG-N40-GCATAGGTAGTCCAGAAGCC-3′,40.0,500 μl DPBS buffer,None,PBS/phosphate buffers,7.4,Trucated by removing the last 20 bases,aptamer has good antibacterial potential,None,MSSPSSAPTLIAPSPAARAADGRIRTYEVRTFGCQMNVHDSERLSGSLESAGYV...VEA
ssDNA,5′CTCCTCTGACTGTAACCACGGTGGGAGAGATGCTATACAATCTTGTAAGGCGATGGACCG3′,60.0,0.5166666666666667,Kd: 51 ± 4.3 nM,51.0,5′-CTCCTCTGACTGTAACCACG-N40-GCATAGGTAGTCCAGAAGCC-3′,40.0,"Binding buffer (1 L Dulbecco's phosphate buffered saline (DPBS) containing 4.5 g, glucose, 1 g BSA (Sigma), 100 mg yeast tRNA (Invitrogen), 5 ml, 1 M MgCl2)",None,PBS/phosphate buffers,7.4,Trucated by removing the last 20 bases,aptamer has good antibacterial potential,None,MSSPSSAPTLIAPSPAARAADGRIRTYEVRTFGCQMNVHDSERLSGSLESAGYV...VEA
ssDNA,CAGCTCAGAAGCTTGATCCTGTGTAACTCAATAAGCTAGGTGGGTGGGGGACACTACCCGGGGGTGGTTGGGTGACTCGAAGTCGTGCATCTGCA,95.0,0.5578947368421052,Kd: 450 ± 360 nM,450.0,5'-CAGCTCAGAAGCTTGATCCTGTG-N50-GACTCGAAGTCGTGCATCTGCA-3',50.0,"binding buffer (20 mM HEPES, 150 mM NaCl, 2 mM KCl, 2 mM MgCl2, 2 mM CaCl2, pH 7.4)",None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,CAGCTCAGAAGCTTGATCCTGTGCAACTCAATAAGCTAGGTGGGTGGGGGACACTACCCGGGGGTGGTTGGGTGACTCGAAGTCGTGCATCTGCA,95.0,0.5684210526315789,Kd: 214 ± 82 nM,214.0,5'-CAGCTCAGAAGCTTGATCCTGTG-N50-GACTCGAAGTCGTGCATCTGCA-3',50.0,"D-PBS(+) supplemented with 1 mg/ml bovine serum albumin (BSA); To decrease non-specific binding, the binding buffer was supplemented with 20% FBS and 1 mg/ml BSA after round 6.",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MESNLSGLVPAAGLVPALPPAVTLGLTAAYTTLYALLFFSVYAQLWLVLLYGHK...PQT
ssDNA,CAGCTCAGAAGCTTGATCCTGTGTAACTCAATAAGCTAGGTGGGTGGGGGACACTGCCCGGGGGTGGTTGGGTGACTCGAAGTCGTGCATCTGCA,95.0,0.5684210526315789,Kd: 111 ± 41 nM,111.0,5'-CAGCTCAGAAGCTTGATCCTGTG-N50-GACTCGAAGTCGTGCATCTGCA-3',50.0,"D-PBS(+) supplemented with 1 mg/ml bovine serum albumin (BSA); To decrease non-specific binding, the binding buffer was supplemented with 20% FBS and 1 mg/ml BSA after round 6.",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MESNLSGLVPAAGLVPALPPAVTLGLTAAYTTLYALLFFSVYAQLWLVLLYGHK...PQT
ssDNA,CAGCTCAGAAGCTTGATCCTGTGCAACTCAATAAGCTAGGTGGGTGGGGGACACTGCCCGGGGGTGGTTGGGTGACTCGAAGTCGTGCATCTGCA,95.0,0.5789473684210527,Kd: 27 ± 1 nM,27.0,5'-CAGCTCAGAAGCTTGATCCTGTG-N50-GACTCGAAGTCGTGCATCTGCA-3',50.0,"D-PBS(+) supplemented with 1 mg/ml bovine serum albumin (BSA); To decrease non-specific binding, the binding buffer was supplemented with 20% FBS and 1 mg/ml BSA after round 6.",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MESNLSGLVPAAGLVPALPPAVTLGLTAAYTTLYALLFFSVYAQLWLVLLYGHK...PQT
ssDNA,CAGCTCAGAAGCTTGATCCTGTGTAACTCAATAAGCTAGGTGGGTGGGGGACACTATCCGGGGGTGGTTGGGTGACTCGAAGTCGTGCATCTGCA,95.0,0.5473684210526316,Kd: 20 ± 8 nM,20.0,5'-CAGCTCAGAAGCTTGATCCTGTG-N50-GACTCGAAGTCGTGCATCTGCA-3',50.0,"BSA dissolved in binding buffer (20 mM HEPES, 120 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, pH 7.3",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MESNLSGLVPAAGLVPALPPAVTLGLTAAYTTLYALLFFSVYAQLWLVLLYGHK...PQT
ssDNA,CAGCTCAGAAGCTTGATCCTGTGTAACTCAATAAGCTAGGTGGGTGGGGGACACTACTCGGGGGTGGTTGGGTGACTCGAAGTCGTGCATCTGCA,95.0,0.5473684210526316,Kd: 19 ± 1 nM,19.0,5'-CAGCTCAGAAGCTTGATCCTGTG-N50-GACTCGAAGTCGTGCATCTGCA-3',50.0,"1 L, Dulbecco's phosphate-buffered saline (DPBS, Invitrogen Co., USA), 100 mg transfer ribonuCleic acid (Sigma Co., USA), 4.5 g, glucose, 5 mL, 1 M MgCl2",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MESNLSGLVPAAGLVPALPPAVTLGLTAAYTTLYALLFFSVYAQLWLVLLYGHK...PQT
ssDNA,CAGCTCAGAAGCTTGATCCTGTGCAACTCAATAAGCTAGGTGGGTGGGGGACACTACTCGGGGGTGGTTGGGTGACTCGAAGTCGTGCATCTGCA,95.0,0.5578947368421052,Kd: 50 ± 21 nM,50.0,5'-CAGCTCAGAAGCTTGATCCTGTG-N50-GACTCGAAGTCGTGCATCTGCA-3',50.0,"1 L, Dulbecco's phosphate-buffered saline (DPBS, Invitrogen Co., USA), 100 mg transfer ribonuCleic acid (Sigma Co., USA), 4.5 g, glucose, 5 mL, 1 M MgCl2",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MESNLSGLVPAAGLVPALPPAVTLGLTAAYTTLYALLFFSVYAQLWLVLLYGHK...PQT
ssDNA,CAGCTCAGAAGCTTGATCCTGTGTAACTCAGTAAGCTAGGTGGGTGGGGGACACTATCCGGGGGTGGTTGGGTGACTCGAAGTCGTGCATCTGCA,95.0,0.5578947368421052,Kd: 141 ± 59 nM,141.0,5'-CAGCTCAGAAGCTTGATCCTGTG-N50-GACTCGAAGTCGTGCATCTGCA-3',50.0,"1 L, Dulbecco's phosphate-buffered saline (DPBS, Invitrogen Co., USA), 100 mg transfer ribonuCleic acid (Sigma Co., USA), 4.5 g, glucose, 5 mL, 1 M MgCl2",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MESNLSGLVPAAGLVPALPPAVTLGLTAAYTTLYALLFFSVYAQLWLVLLYGHK...PQT
ssDNA,CAGCTCAGAAGCTTGATCCTGTGTAACTCAATAGGCTAGGTGGGTGGGGGACACTACCAGGGGGTGGTTGGGTGACTCGAAGTCGTGCATCTGCA,95.0,0.5578947368421052,Kd: 195 ± 131 nM,195.0,5'-CAGCTCAGAAGCTTGATCCTGTG-N50-GACTCGAAGTCGTGCATCTGCA-3',50.0,"1 L, Dulbecco's phosphate-buffered saline (DPBS, Invitrogen Co., USA), 100 mg transfer ribonuCleic acid (Sigma Co., USA), 4.5 g, glucose, 5 mL, 1 M MgCl2",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MESNLSGLVPAAGLVPALPPAVTLGLTAAYTTLYALLFFSVYAQLWLVLLYGHK...PQT
ssDNA,CAGCTCAGAAGCTTGATCCTGTGCGATGGCGGTGGGTGGGGGACAAATTTGGGGGGCGTTGGGTGTTTGTGGTGACTCGAAGTCGTGCATCTGCA,95.0,0.5789473684210527,Kd: 64 ± 10 nM,64.0,5'-CAGCTCAGAAGCTTGATCCTGTG-N50-GACTCGAAGTCGTGCATCTGCA-3',50.0,"1 L, Dulbecco's phosphate-buffered saline (DPBS, Invitrogen Co., USA), 100 mg transfer ribonuCleic acid (Sigma Co., USA), 4.5 g, glucose, 5 mL, 1 M MgCl2",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MESNLSGLVPAAGLVPALPPAVTLGLTAAYTTLYALLFFSVYAQLWLVLLYGHK...PQT
ssDNA,CAGCTCAGAAGCTTGATCCTGTGGGTGGTGGGGAGGGGGTTGCTGGGTCGCGACTAGGAAACTCATGCGGTAAGACTCGAAGTCGTGCATCTGCA,95.0,0.5789473684210527,Kd: 370 ± 311 nM,370.0,5'-CAGCTCAGAAGCTTGATCCTGTG-N50-GACTCGAAGTCGTGCATCTGCA-3',50.0,"1 L, Dulbecco's phosphate-buffered saline (DPBS, Invitrogen Co., USA), 100 mg transfer ribonuCleic acid (Sigma Co., USA), 4.5 g, glucose, 5 mL, 1 M MgCl2",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MESNLSGLVPAAGLVPALPPAVTLGLTAAYTTLYALLFFSVYAQLWLVLLYGHK...PQT
ssDNA,CAGCTCAGAAGCTTGATCCTGTGTTCCGCAATGGCCCTCGATTACTGTCCCTACCACATGAGTTTCCCACATCGACTCGAAGTCGTGCATCTGCA,95.0,0.5263157894736842,Kd: 153 ± 52 nM,153.0,5'-CAGCTCAGAAGCTTGATCCTGTG-N50-GACTCGAAGTCGTGCATCTGCA-3',50.0,"1 L, Dulbecco's phosphate-buffered saline (DPBS, Invitrogen Co., USA), 100 mg transfer ribonuCleic acid (Sigma Co., USA), 4.5 g, glucose, 5 mL, 1 M MgCl2",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MESNLSGLVPAAGLVPALPPAVTLGLTAAYTTLYALLFFSVYAQLWLVLLYGHK...PQT
ssRNA,CCCUCCUACAUAGGG,15.0,0.6,Kd: 83.2 ± 82.9 nM,83.2,5′-GGAGACAAGAATAAACGCTCAA-N40-TTCGACAGGAGGCTCACAACAGGC-3' ,40.0,100 μl Dulbecco's PBS (2.5 mM MgCl2),MgCl,PBS/phosphate buffers,7.39999999999999,Cd133-a aptamer was truncated to 15 nucleotides,None,None,None
ssRNA,CCCUCCUACAUAGGG,15.0,0.6,Kd: 33.9 ± 12.5 nM,33.9,5′-GGAGACAAGAATAAACGCTCAA-N40-TTCGACAGGAGGCTCACAACAGGC-3' ,40.0,100 μl Dulbecco's PBS (2.5 mM MgCl2),MgCl,PBS/phosphate buffers,7.39999999999999,Cd133-a aptamer was truncated to 15 nucleotides,None,None,None
ssRNA,5′CAGAACGUAUACUAUUCUG,19.0,0.3684210526315789,Kd: 145.1 ± 75.4,145.1,5′-GGAGACAAGAATAAACGCTCAA-N40-TTCGACAGGAGGCTCACAACAGGC-3' ,40.0,100 μl Dulbecco's PBS (2.5 mM MgCl2),MgCl,PBS/phosphate buffers,7.39999999999999,Cd133-b aptamer was truncated to 19 nucleotides,None,None,None
ssRNA,5′CAGAACGUAUACUAUUCUG,19.0,0.3684210526315789,Kd: 52.3 ± 15.8 nM,52.3,5′-GGAGACAAGAATAAACGCTCAA-N40-TTCGACAGGAGGCTCACAACAGGC-3' ,40.0,100 μl Dulbecco's PBS (2.5 mM MgCl2),MgCl,PBS/phosphate buffers,7.39999999999999,Cd133-b aptamer was truncated to 19 nucleotides,None,None,None
ssDNA,ATCCAGAGTGACGCAGCAATCCAGACGTGACGCAGCATGCGGTTGGTTGCGGTTGGGCATGATGTATTTCTGTGTGGACACGGTGGCTTAGTATGGACACGGTGGCTTAGT,111.0,0.5405405405405406,kD: 160 ± 50 nM,150.0,5'-ATCCAGAGTGACGCAGCA-N40-TGGACACGGTGGCTTAGT-3',40.0,"4.5 g/L glucose, 5 mL MgCl2, 1.0 g/L bovine serum albumin and 100 mg/L tRNA",MgCl,Other Buffers,7.4,Not applicable,None,None,None
ssDNA,GAATTCAGTCGGACAGCGATGGACGAATATCGTCTCCCAGTGAATTCAGTCGGACAGCGGATGGACGAATATCGTCTCCC,80.0,0.525,Kd: 47 ± 3 nM,47.0,5′-GAATTCAGTCGGACAGCG-N40-GATGGACGAATATCGTCTCCC-3′,40.0,"50 mM Tris-HCl (pH 7.4), 100 mM NaCl, 5 mM KCl, 1 mM MgCl2, and 0.1% NaN3",MgCl,Tris Buffers,7.4,Not applicable,"Unclear if the primer/static-regions are part of the aptamer. This UTexas Aptamer DB includes them as part of the aptamer, but the Apta-Index does not.

The FITC-labeled forward primer (5'-C12-FITC-GAATTCAGTCGGACAGCG-3') and biotin-labeled reverse primer (5'-Bio-GGGAGACGATATTCGTCCATC-3') were used in PCR to get the double-labeled DNA and measure the concentration of the ssDNA in fluorescence analysis.",None,None
ssRNA,5’GGGCAGAGGCACCGCGAACAAAACGCAAGACAGAGUGCCGACAAGAGCACUACAAGCUUCUGCCC,65.0,0.5846153846153846,Kd:16 nM,16.0,5'- GGGAGAAUUCAACUGCCAUCUAGGC-N50-AGUACUACAAGCUUCUGGACUCGGU-3',50.0,"0.5 mg/mL BSA, 0.5 mg/mL salmon sperm DNA, 1 mM CaCl2, 1 mM MgCl2 in PBS, 95C for 5 mins",MgCl,Other Buffers,7.6,Not applicable,None,None,None
ssRNA,GGGAGAAUUCAACUGCCAUCUAGGCACACGCGAGAUAGAGCGAGGCCUCCAAAAAUGGCCACGCCAGGAAGCAGUACUACAAGCUUCUGGACUCGGU,97.0,0.5463917525773195,Kd: 21 nM,21.0,5'- GGGAGAAUUCAACUGCCAUCUAGGC-N50-AGUACUACAAGCUUCUGGACUCGGU-3',50.0,"0.5 mg/mL BSA, 0.5 mg/mL salmon sperm DNA, 1 mM CaCl2, 1 mM MgCl2 in PBS, 95C for 5 mins",MgCl,Other Buffers,7.6,Not applicable,None,None,FPAXV
ssRNA,GGGAGAAUUCAACUGCCAUCUAGGCGACCCAGGGCCGGGACGCAAAGCAGCCAAAACAGACGGCCCCAGUCAGGGAGUUACUACAAGCUUCUGGACUCGGU,101.0,0.5841584158415841,Kd: 30 nM,30.0,5'- GGGAGAAUUCAACUGCCAUCUAGGC-N50-AGUACUACAAGCUUCUGGACUCGGU-3',50.0,"0.5 mg/mL BSA, 0.5 mg/mL salmon sperm DNA, 1 mM CaCl2, 1 mM MgCl2 in PBS, 95C for 5 mins",MgCl,Other Buffers,7.6,Not applicable,None,None,FPAXV
ssDNA,5′ATACCAGCTTATTCAATTGGCCACAACCCAACGACACTGACTGTACTGAATAATGTCTGTCAAACATCCGCGTGGTGAGATAGTAAGTGCAATCT,95.0,0.43157894736842106,Kd: 180.4 nM,180.4,5′-ATACCAGCTTATTCAATT-N60-AGATAGTAAGTGCAATCT-3,60.0,"50 mM Tris, pH 7.5, 150 mM NaCl, 2 mM MgCl2",MgCl,Tris Buffers,7.5,Not applicable,Not applicable,None,None
ssDNA,5′ATACCAGCTTATTCAATTCACCACCACAACACACGCACAGCTAGGACCGGTCGTAGGTATATCTGTTGTTCATGCGCGAGATAGTAAGTGCAATCT,96.0,0.4583333333333333,Kd: 57.41 nM,57.41,5′-ATACCAGCTTATTCAATT-N60-AGATAGTAAGTGCAATCT-3,60.0,"50 mM Tris, pH 7.5, 150 mM NaCl, 2 mM MgCl2",MgCl,Tris Buffers,7.5,Not applicable,Not applicable,None,None
ssDNA,5′ATACCAGCTTATTCAATTGGCATCAGGCAACAACCGATGGTCCGGCCACCCTAACAACCAGCCCACCCACCACCCCGCCGAGATAGTAAGTGCAATCT,98.0,0.5408163265306123,Kd: 88.78 nM,88.78,5′-ATACCAGCTTATTCAATT-N60-AGATAGTAAGTGCAATCT-3,60.0,"50 mM Tris, pH 7.5, 150 mM NaCl, 2 mM MgCl2",MgCl,Tris Buffers,7.5,Not applicable,Not applicable,None,None
ssDNA,5′ATACCAGCTTATTCAATTCACAGCGTGACACGGCAACCCACCCACCAGCCCCGTCAACGACCTATACCTGTGCTGCGCAAGATAGTAAGTGCAATCT,97.0,0.5154639175257731,Kd: 87.4 nM,87.4,5′-ATACCAGCTTATTCAATT-N60-AGATAGTAAGTGCAATCT-3,60.0,"50 mM Tris, pH 7.5, 150 mM NaCl, 2 mM MgCl2",MgCl,Tris Buffers,7.5,Not applicable,Not applicable,None,None
ssDNA,5′ATACCAGCTTATTCAATTCACCAACGGACATCAGTACCCACCCGCCAGCCCCAACATCATGCCCATTCTGCGTGTCGAGATAGTAAGTGCAATCT,95.0,0.49473684210526314,Kd: 176.3 nM,176.3,5′-ATACCAGCTTATTCAATT-N60-AGATAGTAAGTGCAATCT-3,60.0,"50 mM Tris, pH 7.5, 150 mM NaCl, 2 mM MgCl2",MgCl,Tris Buffers,7.5,Not applicable,Not applicable,None,None
ssDNA,ACGCTCGGATGCCACTACAGTGCCACTACAGCTGGTTCGGTTTGGTGACTTCGTTCTTCGTTGTGGTGCTTAGTGGCCTCATGGACGTGCTGGTGAC3′,97.0,0.5567010309278351,Kd: 73.59±11.01 nM,73.59,5'-ACGCTCGGATGCCACTACAG-N45-CTCATGGACGTGCTGGTGAC-3′,45.0,"Binding buffer was prepared by adding 1 mg/mL bovine serum albumin (BSA, Sigma) and 0.1 mg/mL Herring Sperm DNA (Invitrogen) to washing buffer (0.01 M PBS (contain 8 g NaCl, 0.2 g KCl, 3.58 g Na2HPO4·12H2O, 0.272 g KH2PO4 per 1 L ddH2O. pH = 7.4)",None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,ACGCTCGGATGCCACTACAGTGCCACTAAGCTGGTTCGGTTTGGTGACTTCGTTCTTCGTTGTGGTGCTTAGTGGCCTCATGGACGTGCTGGTGAC3′,96.0,0.5520833333333334,Kd: 173.1±44.67 nM,173.1,5'-ACGCTCGGATGCCACTACAG-N45-CTCATGGACGTGCTGGTGAC-3′,45.0,"Binding buffer was prepared by adding 1 mg/mL bovine serum albumin (BSA, Sigma) and 0.1 mg/mL Herring Sperm DNA (Invitrogen) to washing buffer (0.01 M PBS (contain 8 g NaCl, 0.2 g KCl, 3.58 g Na2HPO4·12H2O, 0.272 g KH2PO4 per 1 L ddH2O. pH = 7.4)",None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′GCCTGTTGTGAGCCTCCTAACGATTTGGATTTGGGGTGGAGGGTATGGTTTGTGCTGGCGTTCTCATTTCCCATGCTTATTCTTGTCTCCC3′,91.0,0.5054945054945055,Kd: 98±16 nM,98.0,5′-GCCTGTTGTGAGCCTCCTAAC-N50-CATGCTTATTCTTGTCTCCC-3′,50.0,"3 mM MgCl2 in phosphate buffered saline (PBS), pH 7.5, 1 mg bovine serum albumin (BSA)/mL",MgCl,PBS/phosphate buffers,7.5,Not applicable,"The author mentioned that the SDA aptamer is also highly selective for p-selectin based on sequence homologies and supporting binding affinity tests, although the SELEX procedure was solely conducted on the E-selectin.",None,None
ssDNA,5′ACGCTCGGATGCCACTACAGGGGGGTGGTCCTGAGGGTGGTGTGGTTGGTTTGGTTTCCTCATGGACGTGCTGGTGAC,78.0,0.6025641025641025,Kd: 16.49 ± 0.40 nM,16.49,5′-ACGCTCGGATGCCACTACAG-N40-CTCATGGACGTGCTGGTGAC-3′,40.0,"CE Buffer (30 mM NaH2PO4) at a pH, 7.5.",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssRNA,UCUAAUACGACUCACUAUAGGAGCUCAGCCUUCACUGCGAGAUUGUUCUGACCGAGUUGCCUAGCAGGGCAACCGCUGGAACUUGAAGUCGGUAAUGCGAGCGGAAAGCCUUGGCACCACGGUCGGAUCCUG,132.0,0.5454545454545454,Kd: 170 pM,0.17,5'-GGAGCTCAGCCTTCACTGC-N74-GGCA CCACGGTCGGATCCTG-3',74.0,"CE Buffer (30 mM NaH2PO4) at a pH, 7.5.",None,Other Buffers,7.4,Not applicable,Specificity of aptamers for the HAs of different subtypes of influenza A virus were measured and reported,None,GLFGAIAGFIEGGWQGMVDGWYGYHHSNEQGSGYAADKESTQKAIDGVTNKVNS...VPR
2'-fluoro-RNA,GGGCAACCGCUGGAACUUGAAGUCGGUAAUGCGUGCGGAAAGCCC,45.0,0.6,Kd: 110 pM,0.11,5'-GGAGCTCAGCCTTCACTGC-N74-GGCA CCACGGTCGGATCCTG-3',74.0,"CE Buffer (30 mM NaH2PO4) at a pH, 7.5.",None,Other Buffers,7.4,Not applicable,"Shortened version of aptamer 8-3. Was able to retain full-length aptamer's affinity.the presence of 2′F UTP, 2′OH CTP, 2′OH ATP and 2′OH GTP to generate 2′-fluoro-U aptamer 8-3S, and in the presence of 2′OH UTP, 2′F CTP, 2′OH ATP and 2′OH GTP to generate 2′-fluoro-C aptamer 8-3S.2′-fluoro modifications to pyrimines to improve the stability of the aptamer in the presence of endoribonucleases",None,GLFGAIAGFIEGGWQGMVDGWYGYHHSNEQGSGYAADKESTQKAIDGVTNKVNS...VPR
ssRNA,GGGAGAAUUCCGACCAGAAGCAAGUAGUUGGCGCCUACUAUAGAAAUACGCCUUUCCUCUCUCCUUCCUCUUCU,74.0,0.4864864864864865,Kd: 110 ± 2.6 nM,110.0,5'-GGGAGAAUUCCGACCAGAAG-N30-CCUUUC­CUCUCUCCUUCCUCUUCU-3',30.0,Phosphate buffered saline (PBS),None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,GAATGGATCCACATCCATGGATGGGCAATGCGGGGTGGAGAATGGTTGCCGCACTTCGGCTTCACTGCAGACTTGACGAAGCTTGACGAA,90.0,0.5444444444444444,Kd: 16.1 ± 0.6 μM,16100.0,5'-GAATGGATCCACATCCATGG-N40-TTCACTGCAGACTTGACGAAGCTTGACGAA-3',40.0,"50 mM Tris (Promega, ≥99.9 %), 137 mM NaCl (Sigma >99.5 %), 5 mM MgCl2 (Fluka, ≥98 %), pH 7.4",MgCl,Tris Buffers,7.4,Not applicable,None,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,None
ssDNA,5′CCGCCCAAATCCCTAAGAGAAGACTGTAATGACATCAAACCAGACACACTACACACGCA3′,59.0,0.4745762711864407,Kd: 74.5 nM,74.5,5′-TGCGTGTGTAGTGTGTCTG-N21-CTCTTAGGGATTTGGGCGG-3′,21.0,Phosphate buffered saline (PBS),None,PBS/phosphate buffers,7.4,Not applicable,aptamer can bind to both natural and paraformaldehyde-fixed IFN-γ,None,None
ssDNA,ACCGACCGTGCTGGACTCTGGACTGTTGTGGTATTATTTTTGGTTGTGCAGTATGAGCGAGCGTTGCG,68.0,0.5147058823529411,Kd: 34.5 nM,34.5,5′-ACCGACCGTGCTGGACTCT-N30-AGTATGAGCGAGCGTTGCG-3′,30.0,"50 mM HEPES, 50 mM NaCl, 5 mM KCl, 5 mM MgCl2, pH 7.2",MgCl,Other Buffers,7.2,Not applicable,None,None,None
2'-fluoro-RNA,GGGGGCUUAUCAUUCCAUUUAGUGUUAUGAUAACCUUCCCAUCA,44.0,0.4090909090909091,Kd: 92.2 μM,92.2,5'-GGGAGAGCGGAAGCGTGCTGGGCC-N40-CATAACCCAGAGGTCGATGGATCCCCCC-3,40.0,"30 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1.5 mM MgCl2, 2mM DTT, and 1% BSA",MgCl,Tris Buffers,7.5,Not applicable,This aptamer was originally labelled as 8A-1F2R.,None,None
2'-fluoro-RNA,GGGGGCUUAUCAUUCCAUUUAGUGUUAUGAUAACC,35.0,0.4,Kd: 1.72 pM,1.72,5'-GGGAGAGCGGAAGCGTGCTGGGCC-N40-CATAACCCAGAGGTCGATGGATCCCCCC-3,40.0,"30 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1.5 mM MgCl2, 2mM DTT, and 1% BSA",MgCl,Tris Buffers,7.5,Truncated form of 8a-44; truncated to cut costs and filter out bases not essential for binding,None,None,MEDFNMESDSFEDFWKGEDLSNYSYSSTLPPFLLDAAPCEPESLEINKYFVVII...TTL
2'-fluoro-RNA,GGGUUAUCAUUCCAUUUAGUGUUAUGAUAA,30.0,0.3,Kd: 1.22 μM,1.22,5'-GGGAGAGCGGAAGCGTGCTGGGCC-N40-CATAACCCAGAGGTCGATGGATCCCCCC-3,40.0,"30 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1.5 mM MgCl2, 2mM DTT, and 1% BSA",MgCl,Tris Buffers,7.5,Truncated form of 8a-44; truncated to cut costs and filter out bases not essential for binding,None,None,MEDFNMESDSFEDFWKGEDLSNYSYSSTLPPFLLDAAPCEPESLEINKYFVVII...TTL
ssDNA,GACGATAGCGGTGACGGCACAGACGGACGTGACATGCTTGACCAACTCGCCGTATGCCGCTTCCGTCCGTCGCTC,75.0,0.6266666666666667,Kd: 390 ± 86 nM,390.0,5'-GACGATAGCGGTGACGGCACAGACG-N25-CGTATGCCGCTTCCGTCCGTCGCTC-3',25.0,PBS (pH 7.4),None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,GACGATAGCGGTGACGGCACAGACGTTTATTACCATTATGCCTATGTAACGTATGCCGCTTCCGTCCGTCGCTC,74.0,0.527027027027027,Kd: >1000 nM,1000.0,5'-GACGATAGCGGTGACGGCACAGACG-N25-CGTATGCCGCTTCCGTCCGTCGCTC-3',25.0,"10 μg yeast tRNA, 100 μg BSA in 100 μL SHMCK buffer (20 mM HEPES, 120 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2, pH 7.4)",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MVDTEMPFWPTNFGISSVDLSVMDDHSHSFDIKPFTTVDFSSISAPHYEDIPFT...DLY
ssDNA,AGCCTCGTCTGTTCTCCCGGCAGTGTGGGCGAATCTATGCGTACCGTTCGATATCGTGGGGAAGACAAGCAGACGT,76.0,0.5657894736842105,Kd: 290 ± 150 nM,290.0,5'-AGCCTCGTCTGTTCTCCC-N40-GGGAAGACAAGCAGACGT-3',40.0,"10 μg yeast tRNA, 100 μg BSA in 100 μL SHMCK buffer (20 mM HEPES, 120 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2, pH 7.4)",None,PBS/phosphate buffers,7.4,Not applicable,"The forward primer, SELF, 5'-AGCCTCGTCTGTTCTCCC-3', and reverse primer, SELR, 5'-BIOTIN-ACGTCTGCTTGTCTTCCC-3', were also synthesized and prepared for the selection procedure.",None,None
ssDNA,AGCCTCGTCTGTTCTCCCGGCGCATGATCATTCGGTGGGTAAGGTGGTGGTAACGTTGGGGAAGACAAGCAGACGT,76.0,0.5657894736842105,Kd: 110 ± 50 nM,110.0,5'-AGCCTCGTCTGTTCTCCC-N40-GGGAAGACAAGCAGACGT-3',40.0,"10 μg yeast tRNA, 100 μg BSA in 100 μL SHMCK buffer (20 mM HEPES, 120 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2, pH 7.4)",None,PBS/phosphate buffers,7.4,Not applicable,"The forward primer, SELF, 5'-AGCCTCGTCTGTTCTCCC-3', and reverse primer, SELR, 5'-BIOTIN-ACGTCTGCTTGTCTTCCC-3', were also synthesized and prepared for the selection procedure.",None,MTTPTPTTLKHHATTILTTLVNDRQTAAIEHLLHPTITLKHNDLPAMSKSELIA...GEM
ssDNA,GAGGCAGCACTTCACACGATCTGTATTCCGTGAATAACTTAGCTGGTAATGGCGTTCGTTCCGCTGCGTAATGACTGTAGTGATG,85.0,0.4823529411764706,Ka: 1.47 nM,1.47,5′-GAGGCAGCACTTCACACGATCTG-N40-CTGCGTAATGACTGTAGTGATG-3',40.0,"10 μg yeast tRNA, 100 μg BSA in 100 μL SHMCK buffer (20 mM HEPES, 120 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2, pH 7.4)",MgCl/CaCl,Other Buffers,7.4,Not applicable,None,None,None
ssDNA,GAAAAGTTATCAGGCCTGGATGGTAGCTCGGTCGGGGTGGGTGGGTTGGCAAGTCTGATT,60.0,0.55,Kd: 0.10 nM,0.1,5'-GGAGGGAAAAGTTATCAGGC-N40-TGATTAGTTTTGGAGTACTCGCTCC-3',40.0,Dulbecco's PBS,None,PBS/phosphate buffers,7.4,Trancated version of cln3 by the deletion of 25 bases in the primer region,"Initially found selected in Boltz, A., Piater, B., Toleikis, L., Guenther, R., Kolmar, H., & Hock, B. (2011). Bi-specific aptamers mediating tumor cell lysis. The Journal of biological chemistry, 286(24), 21896–21905. https://doi.org/10.1074/jbc.M111.238261",None,None
2'-fluoro-RNA,GGAGGGAAAAGUUAUCAGGCCGCUAGUUACCAGGUGUAGCUGACCAAGCGGAUGUGUGUUGAUUAGUUUUGGAGUACUCGCUCC,84.0,0.5,Kd: 1.03 ± 0.15 nM,1.03,5'-GGAGGGAAAAGTTATCAGGC-N40-TGATTAGTTTTGGAGTACTCGCTCC-3',40.0,"Tris−HCl buffer supplemented only with NaCl (50 mM Tris−HCl, 150 mM NaCl, 0.01% (v/v) Tween 20, pH 7.5)",None,PBS/phosphate buffers,7.4,Not applicable,"2´-fluoro-CTP (fCTP), 2´-fluoro-UTP (fUTP)",None,MKAPAVLAPGILVLLFTLVQRSNGECKEALAKSEMNVNMKYQLPNFTAETPIQN...GLK
2'-fluoro-RNA,GGAGGGAAAAGUUAUCAGGCCCGCUAGUUACCAGGUGUAGCUGACCAAGCGGAUGUGUGUUGAUU,65.0,0.5076923076923077,Kd: 3.83 ± 2.40 nM,3.83,5'-GGAGGGAAAAGTTATCAGGC-N40-TGATTAGTTTTGGAGTACTCGCTCC-3',40.0,Dulbecco's PBS,None,PBS/phosphate buffers,7.4,Truncated version of cln64 by the deletion of 20 bases from the primer region,"2´-fluoro-CTP (fCTP), 2´-fluoro-UTP (fUTP)",None,MKAPAVLAPGILVLLFTLVQRSNGECKEALAKSEMNVNMKYQLPNFTAETPIQN...GLK
ssDNA,ACGCTCGGATGCCACTACAGTTGGTTTTTTTTTGTTATTTAGAGTAAAAACCTTGTGTGTAGTGACTCATGGACGTGCTGGTGAC,85.0,0.4235294117647059,Kd: 127.4 ± 18.65 nM.,127.4,5′-ACGCTCGGATGCCACTACAG-N45-CTCATGGACGTGCTGGTGAC-3′,45.0,"BSA dissolved in binding buffer (20 mM HEPES, 120 mM NaCl, 5 mM KCl, 1 mM CaCl2, and 1 mM MgCl2, pH 7.3",MgCl/CaCl,Other Buffers,7.3,Not applicable,None,None,None
ssDNA,GGCAGGAAGACAAACAGCGGTCTGACTGGGTAGCAGTAGAAGGCGTCGGTCCCGGGGGTCTGTGGTGCTGT,71.0,0.6197183098591549,Kd: 27.4 ± 4.9 nM,27.4,5'-GGCAGGAAGACAAACA-N40-GGTCTGTGGTGCTGT-3',40.0,"1 L of Dulbecco's phosphate-buffered saline (DPBS, Invitrogen Co., USA), 100 mg transfer ribonucleic acid (Sigma Co., USA), 4.5 g of glucose, and 5 mL of 1 M MgCl2",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,GGCAGGAAGACAAACACCCGGGACCGACGCCTTCTACTGCTACCCAGTCAGACCGCGGTCTGTGGTGCTGT,71.0,0.6197183098591549,Kd: 157.2 ± 44.4 nM,157.2,5'-GGCAGGAAGACAAACA-N40-GGTCTGTGGTGCTGT-3',40.0,"1 L of Dulbecco's phosphate-buffered saline (DPBS, Invitrogen Co., USA), 100 mg transfer ribonucleic acid (Sigma Co., USA), 4.5 g of glucose, and 5 mL of 1 M MgCl2",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,GGCAGGAAGACAAACACACAGCCGCACACACAGAACTCCAGGATCTTACCGCCTCAGGTCTGTGGTGCTGT,71.0,0.5633802816901409,Kd: 48.6 ± 6.8 nM,48.6,5'-GGCAGGAAGACAAACA-N40-GGTCTGTGGTGCTGT-3',40.0,"1 L of Dulbecco's phosphate-buffered saline (DPBS, Invitrogen Co., USA), 100 mg transfer ribonucleic acid (Sigma Co., USA), 4.5 g of glucose, and 5 mL of 1 M MgCl2",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,GGCAGGAAGACAAACATGAGGCGGTAAGATCCTGGAGTTCTGTGTGTGCGGCTGTTGGGTCTGTGGTGCTGT,72.0,0.5555555555555556,Kd: 44.8 ± 10.2 nM,44.8,5'-GGCAGGAAGACAAACA-N40-GGTCTGTGGTGCTGT-3',40.0,"1 × PBS (137 mM NaCl, 2.7 mM KCl, 6.5 mM Na2HPO4, 1.5 mM KH2PO4) supplemented with 3 mM MgCl2",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,GGCAGGAAGACAAACACGCAACAACATACGAAGCCACACAAAAAAAAACACAACCAGGTCTGTGGTGCTGT,71.0,0.4647887323943662,Kd: 13.2 ± 3.8 nM,13.2,5'-GGCAGGAAGACAAACA-N40-GGTCTGTGGTGCTGT-3',40.0,"1 × PBS (137 mM NaCl, 2.7 mM KCl, 6.5 mM Na2HPO4, 1.5 mM KH2PO4) supplemented with 3 mM MgCl2",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,GGCAGGAAGACAAACATGGTTGTGTTTTTTTTTGTGTGGCTTCGTATGTTGTTGCGGGTCTGTGGTGCTGT,71.0,0.4647887323943662,Kd: 28.5 ± 8.5 nM,28.5,5'-GGCAGGAAGACAAACA-N40-GGTCTGTGGTGCTGT-3',40.0,"1 × PBS (137 mM NaCl, 2.7 mM KCl, 6.5 mM Na2HPO4, 1.5 mM KH2PO4) supplemented with 3 mM MgCl2",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,GGCAGGAAGACAAACACCAAAAAAACACCAAAAACAAAACCACGGTCTGTGGTGCTGT,58.0,0.4482758620689655,Kd: 12.3 ± 4.5 nM,12.3,5'-GGCAGGAAGACAAACA-N40-GGTCTGTGGTGCTGT-3',40.0,"1 × PBS (137 mM NaCl, 2.7 mM KCl, 6.5 mM Na2HPO4, 1.5 mM KH2PO4) supplemented with 3 mM MgCl2",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,GGCAGGAAGACAAACAGTGGTTTTGTTTTTGGTGTTTTTTTGGGGTCTGTGGTGCTGT,58.0,0.4482758620689655,Kd: 34.4 ± 6.6 nM,34.4,5'-GGCAGGAAGACAAACA-N40-GGTCTGTGGTGCTGT-3',40.0,"1 L of Dulbecco's phosphate-buffered saline (DPBS, Invitrogen Co., USA), 100 mg transfer ribonucleic acid (Sigma Co., USA), 4.5 g of glucose, and 5 mL of 1 M MgCl2",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssRNA,ACCGAGUCCAGAAGCUUGUAGUACUGCUGGAGCAUUUAUGGAUGAACCUUGGACGGAAGCCUAGAUGGAGUUGAAUUCUCCCUAUAGUGAGUCGUAUUAC,100.0,0.46,Kd: 133.9 ± 12.78 nM,133.9,5'-ACCGAGTCCAGAAGCTTGTAGTACT-N35-GCCTAGATGGAGTTGAATTCTCCCTATAGTGAGTCGTATTAC-3',35.0,"20 mM HEPES-NaOH, pH 7.4, 150 mM NaCl, 1.5 mM CaCl2, 0.5 mM MgCl2, 10% yeast tRNA (Sigma)",MgCl/CaCl,Other Buffers,7.4,Not applicable,TUBO is a cloned cell line established from a mammary carcinoma of the Her2-neu transgenic mice also on the Balb/c background. TUBO is considered to be a nonmetastatic cell line,None,None
ssRNA,GGGUUACCUAGGUGUAGAUGCUCUUCAUUGUAACUUCUCAUAAUUUCCCGAGGCUUUUACUUUCGGGGUCCUAAGUGACGUCUGAACUGCUUCGAA3' ,96.0,0.4479166666666667,Kd: 115 ± 22 nM,115.0,5'-GGGTTACCTAGGTGTAGATGCT-N50-AAGTGACGTCTGAACTGCTTCGAA-3' ,50.0,"20 mmol/l HEPES pH 7.4, 150 mmol/l NaCl, 5 mmol/l MgCl2",MgCl,Other Buffers,7.4,Not applicable,"*primer regions (constant region shown in figure 3) on aptamer do not match pool cited
DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.",None,None
ssRNA,GGGUUACCUAGGAGGAGAUGCUACAUUACCUAAGUAAGAUUACGGCUUCGAGUUUAGAGACCUCUCCCUGGUAAGUGACGUCUGAACUGCUUCGAA,96.0,0.46875,Kd: 93 ±19 nM,93.0,5'-GGGTTACCTAGGTGTAGATGCT-N50-AAGTGACGTCTGAACTGCTTCGAA-3' ,50.0,"Dulbecco's phosphate buffered saline with CaCl2, MgCl2 (DPBS)",MgCl,Other Buffers,7.4,Not applicable,"*primer regions on aptamer do not match pool cited
DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.",None,PQITLWKRPLVTIRIGGQLKEALLDTGADDTVLEEMNLPGKWKPKMIGGIGGFI...LNF
ssRNA,GGGUUACCUAGGAGGAGAUGCUCUUAAGUGUAACUUCUCAUAACAUCCGGAGGCUUUUACUUCCGGGGACCUAAGUGACGUCUGAACUGCUUCGAA,96.0,0.4791666666666667,Kd: 17 ± 3 nM,17.0,"Doped Pool: 80% dopped pool: 5'GGGUUACCUAGGUGUAGAUGCUCUUCAUUGUAACUUCUCAUAAUUUCCCGAGGCUUUUACUUUCGGGGUCCUAAGUGACGUCUGAACUGCUUCGAA3' 
Doped pools were generated starting with the PR10.1 sequence with 20% mutations at each position across the variable 50-nucleotide region. 5'-GGGTTACCTAGGTGTAGATGCT-N50-AAGTGACGTCTGAACTGCTTCGAA-3' ",50.0,"Dulbecco's phosphate buffered saline with CaCl2, MgCl2 (DPBS)",MgCl,Other Buffers,7.4,Not applicable,"*primer regions on aptamer do not match pool cited
DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.
The doped PR10.1, PR10.9, and PR10.13 RNA pools were synthesized to contain 80% WT residues and 20% non-WT residues across the 50-nt random region such that at each position there was an 80% chance that the correct nucleotide would be present and a 20% chance that one of the remaining three nucleotide would be presen",None,PQITLWKRPLVTIRIGGQLKEALLDTGADDTVLEEMNLPGKWKPKMIGGIGGFI...LNF
ssRNA,GGGUUACCUAGGAGGAGAUGCUCUUAAGUGUAACUUCUCGUAAUUCCCAAGGCUUUUACCUCGGGGUCCUAAGUGACGUCUGAACUGCUUCGAA,94.0,0.4787234042553192,Kd: 2.2 ± 0.2 nM,2.2,"Doped Pool: 80% dopped pool: 5'GGGUUACCUAGGUGUAGAUGCUCUUCAUUGUAACUUCUCAUAAUUUCCCGAGGCUUUUACUUUCGGGGUCCUAAGUGACGUCUGAACUGCUUCGAA3' 
Doped pools were generated starting with the PR10.1 sequence with 20% mutations at each position across the variable 50-nucleotide region. 5'-GGGTTACCTAGGTGTAGATGCT-N50-AAGTGACGTCTGAACTGCTTCGAA-3' ",50.0,"Dulbecco's phosphate buffered saline with CaCl2, MgCl2 (DPBS)",MgCl,Other Buffers,7.4,Not applicable,"*primer regions on aptamer do not match pool cited
DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.
The doped PR10.1, PR10.9, and PR10.13 RNA pools were synthesized to contain 80% WT residues and 20% non-WT residues across the 50-nt random region such that at each position there was an 80% chance that the correct nucleotide would be present and a 20% chance that one of the remaining three nucleotide would be presen",None,PQITLWKRPLVTIRIGGQLKEALLDTGADDTVLEEMNLPGKWKPKMIGGIGGFI...LNF
ssRNA,GGGUUACCUAGGAGGAGAUGCUUUGACCUAAGGUAAGAUAACGGCUUCGAGUUCAGAGACCUCGCCCUGGUAAGUGACGUCUGAACUGCUUCGAA,95.0,0.5052631578947369,Kd: 4.3 ± 0.2 nM,4.3,"Doped Pool: 80% dopped pool: 5'GGGUUACCUAGGAGGAGAUGCUACAUUACCUAAGUAAGAUUACGGCUUCGAGUUUAGAGACCUCUCCCUGGUAAGUGACGUCUGAACUGCUUCGAA3' 
Doped pools were generated starting with the PR10.1 sequence with 20% mutations at each position across the variable 50-nucleotide region. 5'-GGGTTACCTAGGTGTAGATGCT-N50-AAGTGACGTCTGAACTGCTTCGAA-3' ",50.0,"Dulbecco's phosphate buffered saline with CaCl2, MgCl2 (DPBS)",MgCl,Other Buffers,7.4,Not applicable,"*primer regions on aptamer do not match pool cited
DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.
The doped PR10.1, PR10.9, and PR10.13 RNA pools were synthesized to contain 80% WT residues and 20% non-WT residues across the 50-nt random region such that at each position there was an 80% chance that the correct nucleotide would be present and a 20% chance that one of the remaining three nucleotide would be presen",None,PQITLWKRPLVTIRIGGQLKEALLDTGADDTVLEEMNLPGKWKPKMIGGIGGFI...LNF
ssDNA,GCGGATGAAGACTGGTGTGGACAGTTCTACGAGGATTACGCTGTTACTAAGTGTGGGGGCCCTAAATACGACGAAC,76.0,0.5131578947368421,Kd: 5.4 ± 1.1 nM,5.4,5'-GCGGATGAAGACTGGTCT-40N-GTTGCTCGTATTTAGGGC-3',40.0,"Dulbecco's phosphate buffered saline with CaCl2, MgCl2 (DPBS)",MgCl,Tris Buffers,7.4,Not applicable,None,None,None
ssDNA,GCGGATGAAGACTGGTGTCCAGAGTGAACACAAAGAAATTGAAATACGTAAGCTCCGGGCCCTAAATACGAGCAAC,76.0,0.47368421052631576,Kd: 6.0 ± 2.6 nM,6.0,5'-GCGGATGAAGACTGGTCT-40N-GTTGCTCGTATTTAGGGC-3',40.0,"Dulbecco's phosphate buffered saline with CaCl2, MgCl2 (DPBS)",MgCl,Tris Buffers,7.4,Not applicable,None,None,None
ssDNA,GTTGCTCGTATTTAGGGCGGCCCCCTCCTCCCTCCCCCACCCGACACTATTCCCCCCCACACCAGTCTTCATCCGC,76.0,0.6447368421052632,Kd: 10.8 ± 2.7 nM,10.8,5'-GCGGATGAAGACTGGTCT-40N-GTTGCTCGTATTTAGGGC-3',40.0,"Dulbecco's phosphate buffered saline with CaCl2, MgCl2 (DPBS)",MgCl,Tris Buffers,7.4,Not applicable,*primer regions on aptamer do not match pool cited,None,None
ssDNA,5′CACACACGGAACCCCGACAACATACATACGGTGAGGGTGG3′,40.0,0.575,Kd: 7±1 nM,7.0,5'-TTCACGGTAGCACGCATAGG-N40-CATCTGACCTCTGTGCTGCT-3',40.0,"Dulbecco's phosphate buffered saline with CaCl2, MgCl2 (DPBS)",None,Tris Buffers,8.0,Primer region removed for this aptamer,None,None,None
ssDNA,5′TTCACGGTAGCACGCATAGGCACACACGGAACCCCGACAACATACATACGGTGAGGGTGGCATCTGACCTCTGTGCTGCT3′,80.0,0.5625,Kd: 12 ± 1 nM,12.0,5'-TTCACGGTAGCACGCATAGG-N40-CATCTGACCTCTGTGCTGCT-3',40.0,"Dulbecco's phosphate buffered saline with CaCl2, MgCl2 (DPBS)",None,Tris Buffers,8.0,Not applicable,None,None,MAISGVPVLGFFIIAVLMSAQESWAIKEEHVIIQAEFYLNPDQSGEFMFDFDGD...GPL
ssDNA,5′GGGGAGGAGAAAAAGAGGACCAGAGTAACGATTCGTGGGG3′,40.0,0.55,Kd: 71 ± 23 nM,71.0,5'-TTCACGGTAGCACGCATAGG-N40-CATCTGACCTCTGTGCTGCT-3',40.0,"Dulbecco's phosphate buffered saline with CaCl2, MgCl2 (DPBS)",None,Tris Buffers,8.0,Primer region removed for this aptamer,None,None,MAISGVPVLGFFIIAVLMSAQESWAIKEEHVIIQAEFYLNPDQSGEFMFDFDGD...GPL
ssDNA,5′TTCACGGTAGCACGCATAGGGGGGAGGAGAAAAAGAGGACCAGAGTAACGATTCGTGGGGCATCTGACCTCTGTGCTGCT3′,80.0,0.55,Kd: 44 ± 8 nM,44.0,5'-TTCACGGTAGCACGCATAGG-N40-CATCTGACCTCTGTGCTGCT-3',40.0,"Dulbecco's phosphate buffered saline with CaCl2, MgCl2 (DPBS)",None,Tris Buffers,8.0,Not applicable,None,None,MAISGVPVLGFFIIAVLMSAQESWAIKEEHVIIQAEFYLNPDQSGEFMFDFDGD...GPL
ssDNA,5′TTCACGGTAGCACGCATAGGGGGGAGGAGAAAAGAGGACCAGAGTAACGATTCGTGGGGCATCTGACCTCTGTGCTGCT3′,79.0,0.5569620253164557,Kd: 20 ± 3 nM,20.0,5'-TTCACGGTAGCACGCATAGG-N40-CATCTGACCTCTGTGCTGCT-3',40.0,"Dulbecco's phosphate buffered saline with CaCl2, MgCl2 (DPBS)",None,Tris Buffers,8.0,Not applicable,None,None,MAISGVPVLGFFIIAVLMSAQESWAIKEEHVIIQAEFYLNPDQSGEFMFDFDGD...GPL
ssDNA,5′CGCTCGGATGCCACTACAGTGCTAATCTCAAGGGTCGTTCCCGATCACCGAGTCTGAGGCTGG3′,63.0,0.5873015873015873,Kd: 24.9 ± 3.6 nM @37C,24.9,5′-CCAGCCTCAGACTCGGTGA-N25-TGTAGTGGCATCCGAGCG-3′,25.0,"Dulbecco's phosphate buffered saline with CaCl2, MgCl2 (DPBS)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′CGCTCGGATGCCACTACAGGAACTAACACACTACTGAACCGTGCTCACCGAGTCTGAGGCTGG3′,63.0,0.5714285714285714,Kd: 20.9 ± 3.5 nM @ 37C,20.9,5′-CCAGCCTCAGACTCGGTGA-N25-TGTAGTGGCATCCGAGCG-3′,25.0,"Dulbecco's phosphate buffered saline with CaCl2, MgCl2 (DPBS)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′CGCTCGGATGCCACTACAGCACTCACCTCAAGGGTTCCGTGTCACCGAGTCTGAGGCTGG3′,60.0,0.6166666666666667,Kd: 23.1 ± 5.3 nM @37C,23.1,5′-CCAGCCTCAGACTCGGTGA-N25-TGTAGTGGCATCCGAGCG-3′,25.0,"50 mM Tris–HCl (pH 8), 80 mM KCl, 2 mM MgCl2, 1 mM DTT",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′CGCTCGGATGCCACTACAGGGACTAAGCACACTACTGTTCACGGTCACCGAGTCTGAGGCTGG3′,63.0,0.5873015873015873,Kd: 11.9 ± 1.4 nM @37C,11.9,5′-CCAGCCTCAGACTCGGTGA-N25-TGTAGTGGCATCCGAGCG-3′,25.0,"50 mM Tris–HCl (pH 8), 80 mM KCl, 2 mM MgCl2, 1 mM DTT",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′CGCTCGGATGCCACTACAGCCAGCGTGGATATGGGTTCCACTGGTCACCGAGTCTGAGGCTGG3′,63.0,0.6190476190476191,Kd: 65.5 ± 18.1 nM @37 ,65.5,5′-CCAGCCTCAGACTCGGTGA-N25-TGTAGTGGCATCCGAGCG-3′,25.0,"50 mM Tris–HCl (pH 8), 80 mM KCl, 2 mM MgCl2, 1 mM DTT",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′CGCTCGGATGCCACTACAGTACACACTGGTCTCAAGGGTGTGAGTCACCGAGTCTGAGGCTGG3′,63.0,0.5873015873015873,Kd: 178.9 ± 30.1 nM @37C,178.9,5′-CCAGCCTCAGACTCGGTGA-N25-TGTAGTGGCATCCGAGCG-3′,25.0,"Dulbecco's phosphate buffered saline, glucose (4.5 g/L), 5 mM MgCl2, bovine serum albumin (1 mg/mL) and Transfer ribonucleotide acid (tRNA) (0.1 mg/mL)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′CGCTCGGATGCCACTGTTGAGGTGTATTGTACACGTGGGGTTACACACCGAGTCTGAGGCTGG3′,63.0,0.5714285714285714,Kd: 30.0 ± 11.2 nM @37C,30.0,5′-CCAGCCTCAGACTCGGTGA-N25-TGTAGTGGCATCCGAGCG-3′,25.0,"DPBS (pH 7.0 ~7.4), Ca2+, Mg2+, 1 mM CaCl2, 2.7 mM KCl, 1.47 mM KH2PO4, 1 mM MgCl2, 136.9 mM NaCl, 2.13 mM Na2HPO4, yeast tRNA",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′CGCTCGGATGCCACTACAGCATATATCCTCCCCCCATGCGTGGTCACCGAGTCTGAGGCTGG,62.0,0.6129032258064516,Kd: 26.1 ± 6.5 nM @37C,26.1,5′-CCAGCCTCAGACTCGGTGA-N25-TGTAGTGGCATCCGAGCG-3′,25.0,"1X binding buffer (1X BB, 5 mM MgCl2 in Dulbecco's phosphate buffered saline, pH 7.4 ± 0.2)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssRNA,GGGUCGUGUCGGAUCCUGCGAAGGGGGGCAGAGGUUUGACGCGAGAAAGCUUCUAAGGUAACGAU,65.0,0.5692307692307692,Kd: 52.7nM,52.7,5'-ATCGTTACCTTAGAAGCTT-N30-GGATCCGACACGACCCTATAGTGAGTCGTATTA-3',30.0,"1X binding buffer (1X BB, 5 mM MgCl2 in Dulbecco's phosphate buffered saline, pH 7.4 ± 0.2)",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssRNA,GGGUCGUGUCGGAUCCGUGAGUUUUUCGCGGCGAAGACAAGGCUCGAAGCUUCUAAGGUAACGAU,65.0,0.5384615384615384,Kd: 38 nM,38.0,5'-ATCGTTACCTTAGAAGCTT-N30-GGATCCGACACGACCCTATAGTGAGTCGTATTA-3',30.0,"1X binding buffer (1X BB, 5 mM MgCl2 in Dulbecco's phosphate buffered saline, pH 7.4 ± 0.2)",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssRNA,GGGUCGUGUCGGAUCCAGGCACGACGCAUAGCCUUGGGAGCGAGGAAAGCUUCUAAGGUAACGAU,65.0,0.5692307692307692,Kd: 16.5 nM,16.5,5'-ATCGTTACCTTAGAAGCTT-N30-GGATCCGACACGACCCTATAGTGAGTCGTATTA-3',30.0,"RSB-100 buffer (10 mM Tris-HCl, 5 mM MgCl2, 100 mM NaCl, 0.01% NP-40, pH 7.5), 25C for 30 minutes",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,5′GCTGTGTGACTCCTGCAACCTGTATGGGGGTTGGGCGGGTGGGCTGGTGGTGCGCGAGGTTGCAGCTGTATCTTGTCTCC3′,80.0,0.625,Kd: 82 ± 19 nM,82.0,5′- GCTGTGTGACTCCTGCAA-N43-GCAGCTGTATCTTGTCTCC-3′,43.0,"0.5 mg/mL BSA, 0.5 mg/mL salmon sperm DNA, 1 mM CaCl2, and 1 mM MgCl2 in 1× PBS, 95C for 5 mins",MgCl/CaCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′GCTGTGTGACTCCTGCAATGACCAGACGGGGTGGGTGGGCGGGCTGTCGGCTGGTCCTCGTGCAGCTGTATCTTGTCTCC3′,80.0,0.6375,Kd: 46 ± 4 nM,46.0,5′- GCTGTGTGACTCCTGCAA-N43-GCAGCTGTATCTTGTCTCC-3′,43.0,"0.5 mg/mL BSA, 0.5 mg/mL salmon sperm DNA, 1 mM CaCl2, and 1 mM MgCl2 in 1× PBS, 95C for 5 mins",MgCl/CaCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′GCTGTGTGACTCCTGCAAGACGCCGGGTTGGGTGGGTGGGAAGGGCGTCGCTCCCTCTTCGGCAGCTGTATCTTGTCTCC3′,80.0,0.6375,Kd: 69 ± 27 nM,69.0,5′- GCTGTGTGACTCCTGCAA-N43-GCAGCTGTATCTTGTCTCC-3′,43.0,"50 mM Tris pH7.4, 5 mM KCl, 100 mM NaCl, 1 mM MgCl2, 0.02% Tween 20, 0.1 mg/ml yeast tRNA, 1 mg/ml BSA",MgCl/CaCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,CTCCTCTGACTGTAACCACGCGGAAAGCATCAGGGTTGAGCATAGGTAGTCCAGAAGCCA,60.0,0.5333333333333333,Kd: 365.3 ± 24.14 nM,365.3,5′-CTCCTCTGACTGTAACCACG-N20-GCATAGGTAGTCCAGAAGCCA-3′,20.0,"Phosphate-buffered saline (PBS), 0.05% Tween 20, 1% bovine serum albumin",MgCl,Tris Buffers,8.0,Not applicable,None,None,None
ssDNA,ATACCAGCTTATTCAATTCGATGGTAAGTGAGGTTCGTCCCTTTAATAAACTCGATTAGGATCTCGTGAGGTGTGCTCTACAATCGTAATCAGTTAG,97.0,0.4020618556701031,Kd: 56.9 ± 11.3 nM,56.9,5′-ATACCAGCTTATTCAATT-N10-TGAGGCTCGATC-N40-ACAATCGTAATCAGTTAG-3′,50.0,"Phosphate-buffered saline (PBS), 0.05% Tween 20, 1% bovine serum albumin",MgCl/CaCl,Tris Buffers,7.6,Not applicable,5′fluorescein (FAM) labeled,None,None
ssDNA,ATACCAGCTTATTCAATTGCAGGGTATCTGAGGCTTGATCTACTAAATGTCGTGGGGCATTGCTATTGGCGTTGATACGTACAATCGTAATCAGTTAG,98.0,0.41836734693877553,Kd: 0.11 ± 0.06 nM,0.11,5′-ATACCAGCTTATTCAATT-N10-TGAGGCTCGATC-N40-ACAATCGTAATCAGTTAG-3′,50.0,"20-mM Tris-Cl, pH 7.5, 120-mM NaCl, 5-mM KCl, 1-mM MgCl2, 1-mM CaCl2",MgCl/CaCl,Tris Buffers,7.6,Not applicable,5′fluorescein (FAM) primers,None,MRAISSLAGPRALAAFGRNDIRGTYRDPLLVMLVIAPVIWTTGVALLTPLFTEM...KHA
ssDNA,ATACCAGCTTATTCAATTAGTTGTGTATTGAGGTTTGATCTAGGCATAGTCAACAGAGCACGATCGATCTGGCTTGTTCTACAATCGTAATCAGTTAG,98.0,0.3877551020408163,Kd: 0.20 ± 0.09 nM,0.2,5′-ATACCAGCTTATTCAATT-N10-TGAGGCTCGATC-N40-ACAATCGTAATCAGTTAG-3′,50.0,"20-mM Tris-Cl, pH 7.5, 120-mM NaCl, 5-mM KCl, 1-mM MgCl2, 1-mM CaCl2",MgCl/CaCl,Tris Buffers,7.6,Not applicable,5′fluorescein (FAM) primers,None,MRAISSLAGPRALAAFGRNDIRGTYRDPLLVMLVIAPVIWTTGVALLTPLFTEM...KHA
2'-fluoro-RNA,5′UAAUACGACUCACUAUAGGGAGACAAGAAUAAACGCUCAAAAAAUGCAUGGAGCGAAGGUGUGGGGGAUACCAACCGCGCCGUGUUGAGCGUUUAUUCUUGUCUCCCUAUAGUGAGUCGUAUUA3′,124.0,0.45161290322580644,Kd: 4.13 nM,4.13,5′-TAATACGACTCACTATAGGGAGACAAGAATAAACGCTCAA-N45-TTGAGCGTTTATTCTTGTCTCCCTATAGTGAGTCGTATTA-3′,45.0,"20-mM Tris-Cl, pH 7.5, 120-mM NaCl, 5-mM KCl, 1-mM MgCl2, 1-mM CaCl2",None,Other Buffers,7.4,Not applicable,"2'-Fluoro-Pyrimidine modified nucleotides. 
To select high affinity aptamers for CA125 biomarker, we performed an in vitro protein SELEX by using human CA125 recombinant protein as target, with a C-terminal His tag as modification.",None,None
ssDNA,5′CCGTCAGCCGAGGACCACACTTGGTTGCTGAATCCCCTCGTCTTGGCTTTCTTTTGGGTGCAATGAAT3′,68.0,0.5294117647058824,Kd: 5.09 ±1.43 nM,5.09,5′-CCGTCAGCCGAGGACCACAC-N40-TTGGGTGCAATGAAT-3′,40.0,"20-mM Tris-Cl, pH 7.5, 120-mM NaCl, 5-mM KCl, 1-mM MgCl2, 1-mM CaCl2",None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′CGTACGGAATTCGCTAGCGGGCGGACGCTAGGTGGTGATGCTGTGCTACACGTGTTGTGGATCCGAGCTCCACGTG3′,76.0,0.6052631578947368,Kd: 4.60 ± 1.17 μM,4600.0,5′-CGTACGGAATTCGCTAGC-N40-GGATCCGAGCTCCACGTG-3′,40.0,HEPES (0.1 M) at pH 8.02,None,Other Buffers,8.0,Not applicable,None,[Pd+2],None
ssDNA, 5’GTGACGCTCCTAACGCTGACTCAGGTGCAGTTCTCGACTCGGTCTTGATGTGGGTCCTGTCCGTCCGAACCAATC3’,75.0,0.5733333333333334,Kd: 17.41 ± 4.32 nM ,500.0,5′-GTGACGCTCCTAACGCTGAC-N35-CTGTCCGTCCGAACCAATC-3′,35.0,CE Buffer (30 mM NaH2PO4) at a pH of 7.5.,None,PBS/phosphate buffers,7.5,Not applicable,None,None,None
ssDNA,5′GTGACGCTCCTAACGCTGACGTGACGCTCCTAACGCTGACGGCCCGTCAATCCCCGCGTATCCATTGGTCCTTTACCTGTCCGTCCGAACCAATCCCTGTCCGTCCGAACCAATC3′,115.0,0.591304347826087,Kd: 4.8 μM,4800.0,5′-GTGACGCTCCTAACGCTGAC-N35-CCTGTCCGTCCGAACCAATC-3′,35.0,CE Buffer (30 mM NaH2PO4) at a pH of 7.5.,None,PBS/phosphate buffers,7.5,Not applicable,None,None,MKWVVSIFLIFLLNVTESRTMHNNPYGIASVLNSSQCSAEVNLIDLATIFFAQF...LGV
ssDNA,GACGCTTACTCAGGTGTGACTCGCGGGTGCCTTAAAGTGTAGGTGGGAGGGGGATGATTATGTACGATCAAGTCGAAGGACGCAGAGAAGTCTC,94.0,0.5319148936170213,Kd: 71.2 nM,71.2,5'-GACGCTTACTCAGGTGTGACTCG-N50-CGAAGGACGCAGAGAAGTCTC-3',50.0,"21 mM HEPES, 120 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 0.02% Tween 20, pH 7.4",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,GACGCTTACTCAGGTGTGACTCGGAAGGTGGAGCGGTTAGGATACTAGCGAATGAAGACACGTTAGCTGATCTCGAAGGACGCAGAGAAGTCTC,94.0,0.5212765957446809,Kd: 77.5 nM,77.5,5'-GACGCTTACTCAGGTGTGACTCG-N50-CGAAGGACGCAGAGAAGTCTC-3',50.0,"4.5 g/L glucose, 5 mM MgCl2, in Phosphate‐buffered saline (PBS) with yeast tRNA (0.1 mg/mL), bovine serum albumin (BSA, 1 mg/mL)",MgCl,Tris Buffers,7.5,Not applicable,None,None,MSSVTGSGITSGFIDLATYDNLERAMYGGSDATTYFVKEHYPVGWFTKLPSLAA...PIL
ssDNA,GACGCTTACTCAGGTGTGACTCGAGTGGGTAAGGTCTGGTGGATTGTGGACGGGGGGCGGGGCAGTGGCTTGACGAAGGACGCAGAGAAGTCTC,94.0,0.6063829787234043,Kd: 80.7 nM,80.7,5'-GACGCTTACTCAGGTGTGACTCG-N50-CGAAGGACGCAGAGAAGTCTC-3',50.0,"4.5 g/L glucose, 5 mM MgCl2, in Phosphate‐buffered saline (PBS) with yeast tRNA (0.1 mg/mL), bovine serum albumin (BSA, 1 mg/mL)",MgCl,Tris Buffers,7.5,Not applicable,None,None,MSSVTGSGITSGFIDLATYDNLERAMYGGSDATTYFVKEHYPVGWFTKLPSLAA...PIL
ssDNA,GACGCTTACTCAGGTGTGACTCGTGTGCGGGGGAGGGGAGTGGCGCTGTTGGTGCGGGTATAGCGCGTGGTGTCGAAGGACGCAGAGAAGTCTC,94.0,0.6276595744680851,Kd: 53.8 nM,53.8,5'-GACGCTTACTCAGGTGTGACTCG-N50-CGAAGGACGCAGAGAAGTCTC-3',50.0,"4.5 g/L glucose, 5 mM MgCl2, in Phosphate‐buffered saline (PBS) with yeast tRNA (0.1 mg/mL), bovine serum albumin (BSA, 1 mg/mL)",MgCl,Tris Buffers,7.5,Not applicable,None,None,MSSVTGSGITSGFIDLATYDNLERAMYGGSDATTYFVKEHYPVGWFTKLPSLAA...PIL
ssDNA,CTGTATGCCTCCTGTACGAGCGGTGATTCTTGTCCAGCCCTGTATGCCTCCTGTACGAGCGGTGATTCTTGTCCA,75.0,0.5466666666666666,Kd: 3.648 nM,3.648,5′-GACAAGAATCACCGCTC-N40-CGTACAGGAGGCATACAG-3′,40.0,"Phosphate buffer 0.1 M pH 7 containing 5 mM, MgCl2",MgCl/CaCl,Other Buffers,7.4,Not applicable,The highest affinity aptamer against rhCTGF developed by Li et al.; Included the constant regions. Biotin modified at the 5' end,None,None
ssDNA,5′GGACAAGAATCACCGCTCCCCGTACAGGAGGCATACAGA3′,39.0,0.5641025641025641,Kd: 7.376 nM,7.376,5′-GACAAGAATCACCGCTC-N40-CGTACAGGAGGCATACAG-3′,40.0,"10 μg yeast tRNA and 100 μg BSA in 100 μL SHMCK buffer (20 mM Hepes, 120 mM NaCl, 5 mM KCl, 1 mM MgCl2 and 1 mM CaCl2, pH 7.4)",MgCl/CaCl,Other Buffers,7.4,Not applicable,"The synthetic aptamer characterized as c-ap11 only consisted of the core, random region due to mutations and deletions during amplification. Biotin was used to label the 3' end of this aptamer",None,None
ssDNA,5′GGACAAGAATCACCGCTCGTACAGGAGGCATACAGA3′,36.0,0.5277777777777778,Kd: 3.893 nM,3.893,5′-GACAAGAATCACCGCTC-N40-CGTACAGGAGGCATACAG-3′,40.0,"10 μg yeast tRNA and 100 μg BSA in 100 μL SHMCK buffer (20 mM Hepes, 120 mM NaCl, 5 mM KCl, 1 mM MgCl2 and 1 mM CaCl2, pH 7.4)",MgCl/CaCl,Other Buffers,7.4,Not applicable,"The synthetic aptamer characterized as c-ap12 only consisted of the core, random region due to mutations and deletions during amplification. Biotin was used to label the 5' end of this aptamer",None,None
ssDNA,5′CTGTATGCCTCCTGTACGGGGAGCGGTGATTCTTGTCCA3′,39.0,0.5641025641025641,Kd: 5.561 nM,5.561,5′-GACAAGAATCACCGCTC-N40-CGTACAGGAGGCATACAG-3′,40.0,"100 mM, NaCl, 20 mM, Tris–HCl, 2 mM, MgCl2, 5 mM, KCl, 1 mM, CaCl2, 0.02 % aqueous solution, Tween 20, pH 7.6",MgCl/CaCl,Other Buffers,7.4,Not applicable,"The synthetic aptamer characterized as c-ap14 only consisted of the core, random region due to mutations and deletions during amplification. Biotin was used to label the 5' end of this aptamer",None,None
ssDNA,CTGTATGCCTCCTGTACGAGCGGTGATTCTTGTCCA3′,36.0,0.5277777777777778,Kd: 5.234 nM,5.234,5′-GACAAGAATCACCGCTC-N40-CGTACAGGAGGCATACAG-3′,40.0,"101 mM, NaCl, 20 mM, Tris–HCl, 2 mM, MgCl2, 5 mM, KCl, 1 mM, CaCl2, 0.02 % aqueous solution, Tween 20, pH 7.6",MgCl/CaCl,Other Buffers,7.4,Not applicable,"The synthetic aptamer characterized as c-ap15 only consisted of the core, random region due to mutations and deletions during amplification. Biotin was used to label the 5' end of this aptamer",None,None
ssDNA,5′GGCACGTACGCGTCCTGTATGCCTCCTGTACGGGGG3′,36.0,0.6666666666666666,Kd: 9.734 nM,9.734,5′-GACAAGAATCACCGCTC-N40-CGTACAGGAGGCATACAG-3′,40.0,"100 mM NaCl, 20 mM Tris-HCl, 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2 at pH 7.6",MgCl/CaCl,Other Buffers,7.4,Not applicable,"The synthetic aptamer characterized as c-ap18 only consisted of the core, random region due to mutations and deletions during amplification. Biotin was used to label the 5' end of this aptamer",None,None
ssDNA,ATCCAGAGTGACGCAGCAAGCACTCAATATTCCCTGGACACGGTGGCTTAGT,52.0,0.5192307692307693,Kd: 57 nM,57.0,5'-ATCCAGAGTGACGCAGCA-N16-TGGACACGGTGGCTTAGT3',16.0,"0.01% yeast tRNA, 0.1% BSA, 0.45% glucose, 5 mM MgCl2, in Dulbecco's Phosphate-Buffered Saline",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,CATGCTTCCCCAGGGAGATGGTTTGCCGGTGGGCAGGTTTAGGGTCTGCTCGGGATTGCGGAGGAACATGCGTCGCAAACGAGGAACATGCGTCGCAAAC,100.0,0.59,Kd: 122.7 ± 20.6 nM,122.7,"5'-CATGCTTCCCCAGGGAGATG-N40-GAGGAACATGCGTCGCAAAC-3""",40.0,"Tris−HCl buffer supplemented only with NaCl (50 mM Tris−HCl, 150 mM NaCl, 0.01% (v/v) Tween 20; pH 7.5)",None,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,5′AGCGTCGAATACCACTACAGGGGATGCGAAGTTCCGCGGTCGAGTATATGATACATCCATCTAATGGAGCTCGTGGTCAG3′,80.0,0.5125,Kd: 47.83 ± 4.99 nM,47.83,5′-AGCGTCGAATACCACTACAG-N40-CTAATGGAGCTCGTGGTCAG-3′,40.0,"5 mM MgCl2, 0.1 mg/mL yeast tRNA in PBS, pH 7.4",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssRNA,GGGAUAUCCUUCAUGAUUCGGAAAAGCGUAACCGCGGCCAAUCAUGCAUGAAGCGUUCCAUAUUUUU,67.0,0.44776119402985076,Kd: 11.6 ± 2.3 nM,11.6,5′-TA2TACGACTCACTATAG3ATATC2TC2ATGAT-N10-G-TA2-N9-ATCATGCATGA2GCGT2C2ATAT5-3',19.0,"Selection buffer for KpnI (10 mM HEPES pH 7.5, 100 mM NaCl, 1 mM CaCl2)",CaCl,Other Buffers,7.5,Not applicable,"The structured RNA libraries (Figure ​(Figure1A)1A) used for selection were 67-nt in length with a potential tetraloop (GUAA) flanked by two random regions: 10 nt upstream and 9 nt downstream of the tetraloop. 

The synthetic DNA template for the selection pool was 5′-TA2TACGACTCACTATAG3ATATC2TC2ATGATN10G-TA2N9ATCATGCATGA2GCGT2C2ATAT5 where N indicates any base. Nucleotides in the random region were synthesized from a mixture of phosphoramidites adjusted for the relative coupling efficiency of each monomer. The library template was amplified by PCR using primers LJM-4485 5′-TA2TACGACTCACTATAG3ATATC2 and LJM-4486 5′A5TATG2A2CGCT2CATGCAT.",None,None
ssRNA,GGGAUAUCCUUCAUGGUGUGAUUAAACGUAAUCUCAAUCGAUCAUGCAUGAAGCGUUCCAUAUUUUU,67.0,0.373134328358209,Kd: 28.7 ± 5.2 nM,28.7,5′-TA2TACGACTCACTATAG3ATATC2TC2ATGAT-N10-G-TA2-N9-ATCATGCATGA2GCGT2C2ATAT5-3',19.0,"20 mM Tris at pH 7.5 with 150 mM NaCl, 1 mM MgCl2, 2.7 mM KCl, 0.005% NP-40",CaCl,Other Buffers,7.5,Not applicable,"The structured RNA libraries (Figure ​(Figure1A)1A) used for selection were 67-nt in length with a potential tetraloop (GUAA) flanked by two random regions: 10 nt upstream and 9 nt downstream of the tetraloop. 

The synthetic DNA template for the selection pool was 5′-TA2TACGACTCACTATAG3ATATC2TC2ATGATN10G-TA2N9ATCATGCATGA2GCGT2C2ATAT5 where N indicates any base. Nucleotides in the random region were synthesized from a mixture of phosphoramidites adjusted for the relative coupling efficiency of each monomer. The library template was amplified by PCR using primers LJM-4485 5′-TA2TACGACTCACTATAG3ATATC2 and LJM-4486 5′A5TATG2A2CGCT2CATGCAT.",None,None
ssRNA,GGGAUAUCCCUACAUGAUAAUCGGGUGAGUAAGGCCUAAACAUCAUGCAUGAAGCGUUCCAUAUUUUU,68.0,0.4117647058823529,Kd: 419 ± 46.6 nM,419.0,5′-TA2TACGACTCACTATAG3ATATC2TC2ATGAT-N10-G-TA2-N9-ATCATGCATGA2GCGT2C2ATAT5-3',19.0,"20 mM Tris at pH 7.5 with 150 mM NaCl, 1 mM MgCl2, 2.7 mM KCl, 0.005% NP-40",CaCl,Other Buffers,7.5,Not applicable,"The structured RNA libraries (Figure ​(Figure1A)1A) used for selection were 67-nt in length with a potential tetraloop (GUAA) flanked by two random regions: 10 nt upstream and 9 nt downstream of the tetraloop. 

The synthetic DNA template for the selection pool was 5′-TA2TACGACTCACTATAG3ATATC2TC2ATGATN10G-TA2N9ATCATGCATGA2GCGT2C2ATAT5 where N indicates any base. Nucleotides in the random region were synthesized from a mixture of phosphoramidites adjusted for the relative coupling efficiency of each monomer. The library template was amplified by PCR using primers LJM-4485 5′-TA2TACGACTCACTATAG3ATATC2 and LJM-4486 5′A5TATG2A2CGCT2CATGCAT.",None,None
ssRNA,GGGAUAUCCUUCAUGAUUCGGAAAAGCGUAACCGCGGCCGAUCAUGCAUGAAGCGUUCCAUAUUUUU,67.0,0.4626865671641791,Kd: 18.6 ± 4.5 nM,18.6,5′-TA2TACGACTCACTATAG3ATATC2TC2ATGATN10G-TA2-N9-ATCATGCATGA2GCGT2C2ATAT5-3',19.0,"20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 5 mM MgCl2",CaCl,Other Buffers,7.5,Not applicable,"The structured RNA libraries (Figure ​(Figure1A)1A) used for selection were 67-nt in length with a potential tetraloop (GUAA) flanked by two random regions: 10 nt upstream and 9 nt downstream of the tetraloop. 

The synthetic DNA template for the selection pool was 5′-TA2TACGACTCACTATAG3ATATC2TC2ATGATN10G-TA2N9ATCATGCATGA2GCGT2C2ATAT5 where N indicates any base. Nucleotides in the random region were synthesized from a mixture of phosphoramidites adjusted for the relative coupling efficiency of each monomer. The library template was amplified by PCR using primers LJM-4485 5′-TA2TACGACTCACTATAG3ATATC2 and LJM-4486 5′A5TATG2A2CGCT2CATGCAT.",None,None
2'-fluoro-RNA,AAUGCGAAGAAAGAGGUCUGAGACAUUCUGGGAGAACUGUGGGAGUGGAGGGUGGAUGGUUCUCUUCUGGAGUUGACGUUGCUU,84.0,0.5,Kd: 54.7 ± 5 nM,54.7,5'-AATGCGAAGAAAGAGGTCTGAGACATTCT-N60-CTTCTGGAGTTGACGTTGCTT-3',60.0,1 × PBS (137 mM NaCl; 2.7 mM KCl; 6.5 mM Na2HPO4; 1.5 mM KH2PO4) supplemented with 3 mM MgCl2,MgCl,PBS/phosphate buffers,7.4,"The shortened variant of f4. To test the susceptibility of raid3 for post-selective modification, we subjected a 2'-f-pymodified version of raid3 (raid3 2'-f-py).","Modified RAID3 with 2′-F-Py for stability against abundant serum nucleases like RNase A; In the first 3 cycles of selection, immobilized sIL-6R was used to ensure enrichment of unmodified RNA aptamers that bind to the native soluble cytokine receptor. Domain 3 of the IL-6R was used as the target for 8 additional selection cycles, aiming at aptamers specific for this site of the receptor.",None,None
ssRNA,AAUGCGAAGAAAGAGGUCUGAGACAUUCUCAACGAACUAUGAGGAAAGGGACCGUGCGAGGGUUGGGUUAGGGUUUGGAGCCACGGUCCUUCUGGAGUUGACGUUGCUU,109.0,0.5137614678899083,Kd: 97.7 ± 18.3 nM,97.7,5'-AATGCGAAGAAAGAGGTCTGAGACATTCT-N60-CTTCTGGAGTTGACGTTGCTT-3',60.0,1 × PBS (137 mM NaCl; 2.7 mM KCl; 6.5 mM Na2HPO4; 1.5 mM KH2PO4) supplemented with 3 mM MgCl2,MgCl,PBS/phosphate buffers,7.4,Not applicable,"In the first 3 cycles of selection, immobilized sIL-6R was used to ensure enrichment of unmodified RNA aptamers that bind to the native soluble cytokine receptor. Domain 3 of the IL-6R was used as the target for 8 additional selection cycles, aiming at aptamers specific for this site of the receptor.",None,None
ssRNA,AAUGCGAAGAAAGAGGUCUGAGACAUUCUGAAGAGAGAAAGCCAGUAGAGGGAAGAGGGAUGAGGGACGUGGGAAUCUUGGUAAUCAGUCUUCUGGAGUUGACGUUGCUU,110.0,0.4727272727272727,Kd: 179 ± 117 nM,179.0,5'-AATGCGAAGAAAGAGGTCTGAGACATTCT-N60-CTTCTGGAGTTGACGTTGCTT-3',60.0,1 × PBS (137 mM NaCl; 2.7 mM KCl; 6.5 mM Na2HPO4; 1.5 mM KH2PO4) supplemented with 3 mM MgCl2,MgCl,PBS/phosphate buffers,7.4,Not applicable,"In the first 3 cycles of selection, immobilized sIL-6R was used to ensure enrichment of unmodified RNA aptamers that bind to the native soluble cytokine receptor. Domain 3 of the IL-6R was used as the target for 8 additional selection cycles, aiming at aptamers specific for this site of the receptor.",None,None
ssRNA,AAUGCGAAGAAAGAGGUCUGAGACAUUCUUAAAAACGGCCCAUCGUUUGGCRCUGUGGGAGUGGAGGGUGGAUGGUGUUAAGCGAUUCUUCUGGAGUUGACGUUGCUU,107.0,0.48598130841121495,Kd: 34.8 ± 5.8 nM,34.8,5'-AATGCGAAGAAAGAGGTCTGAGACATTCT-N60-CTTCTGGAGTTGACGTTGCTT-3',60.0,"5 mM MgCl2, 4.5 g/L glucose in Dulbecco's Phosphate Buffered Saline (D-PBS, pH = 7.4), 0.1 mg/mL yeast tRNA, 1 mg/L bovine serum albumin (BSA)",MgCl,PBS/phosphate buffers,7.4,Not applicable,"In the first 3 cycles of selection, immobilized sIL-6R was used to ensure enrichment of unmodified RNA aptamers that bind to the native soluble cytokine receptor. Domain 3 of the IL-6R was used as the target for 8 additional selection cycles, aiming at aptamers specific for this site of the receptor.",None,None
ssDNA,AGCAGCACAGAGGTCAGATGACTTGTAGGGTTCGGCTGGTCAGGGTGTCCAAGTCTGTGGCCTATGCGTGCTACCGTGAA3′,80.0,0.5625,Kd: 20.5 ± 7.33 nM,20.5,5′-AGCAGCACAGAGGTCAGATG-40N-CCTATGCGTGCTACCGTGAA-3′,40.0,"Phosphate buffer saline (PBS) solution (137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.47 mM KH2PO4) with an adjusted pH 7.6",MgCl/CaCl,Other Buffers,7.4,Not applicable,None,None,None
ssDNA,AGCAGCACAGAGGTCAGATGTTTGGGGTGGTTGGGGGTTGTTGTTTTGGGGGTGGAGGGTCCTATGCGTGCTACCGTGAA3′,80.0,0.5625,Kd: 37.6 ± 5.92 nM,37.6,5′-AGCAGCACAGAGGTCAGATG-40N-CCTATGCGTGCTACCGTGAA-3′,40.0,"20 mM HEPES, 120 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, pH 7.35",MgCl/CaCl,Other Buffers,7.4,Not applicable,None,None,MAMSPGPLFLVFLLGLVVIPPTLSQDDSRYTKFLTQHYDAKPKGRDDRYCESMM...ISP
ssDNA,AGCAGCACAGAGGTCAGATGACTTGTAGGGTTCGGCTGGTCAGGGTGTCCAAGTCTGTGGTTTTTTTTTTTTTTTTTTTTTTTTTTTTGGGGTGGTTGGGGGTTGTTGTTTTGGGGGTGGAGGGTCCTATGCGTGCTACCGTGAA3′,145.0,0.4689655172413793,Kd: 0.062 nM,0.062,5′-AGCAGCACAGAGGTCAGATG-40N-CCTATGCGTGCTACCGTGAA-3′,40.0,"Binding buffer (4.5g/L glucose, 5 mM MgCl2, 1 mg/mL BSA, 0.1 mg/mL yeast tRNA in 0.01 M PBS, pH 7.4)",MgCl/CaCl,Other Buffers,7.4,"Linked aba1 with aba65 through a flexible, poly-t linker",None,None,MAMSPGPLFLVFLLGLVVIPPTLSQDDSRYTKFLTQHYDAKPKGRDDRYCESMM...ISP
FANA XNA,AAAAGGTAGTGCTGAATTCGGGGCCATTAAGATATTCGTCGAAGTTCGGTTGTTTCCCTTCGCTATCCAGTTGGCCT,77.0,0.4675324675324675,Kd: 0.004 ± 0.003 nM,0.004,5′-AGGCCAACTGGATAGCGAA-N40-CGAATTCAGCACTACCTTTTGGCAAACGCTAATAAGGG-3′,40.0,"50 mM Tris–HCl (pH 8), 80 mM KCl, 2 mM MgCl2 and 1 mM DTT",MgCl,Tris Buffers,8.0,Not applicable,"Note that FANA is structurally distinct from the 2′-fluororibonucleotides described above as the sugar ring in FANA typically adopts a C2'/O4'-endo conformation as opposed to a C3'-endo conformation for 2′-fluoro-ribonucleotides, and the fluorine group in FANA is in the β as opposed to α conformation",None,None
FANA XNA,AAAAGGTAGTGCTGAATTCGGCCGACAATGATATTCGACGAAGCTCGGTTGTTTCCCTTTTCGCTATCCAGTTGGCCT,78.0,0.47435897435897434,Kd: 0.016 ± 0.006        ,0.016,5′-AGGCCAACTGGATAGCGAA-N40-CGAATTCAGCACTACCTTTTGGCAAACGCTAATAAGGG-3′,40.0,"50 mM Tris–HCl (pH 8), 80 mM KCl, 2 mM MgCl2 and 1 mM DTT",MgCl,Tris Buffers,8.0,Not applicable,"Note that FANA is structurally distinct from the 2′-fluororibonucleotides described above as the sugar ring in FANA typically adopts a C2'/O4'-endo conformation as opposed to a C3'-endo conformation for 2′-fluoro-ribonucleotides, and the fluorine group in FANA is in the β as opposed to α conformation",None,PISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPEN...AAN
FANA XNA,AAAAGGTAGTGCTGAATTCGCAGGCCGGTAAGTATCCAAGGGATCCGGTTATTTCCTCCCTTCGCTATCCAGTTGGCCT,79.0,0.5063291139240507,Kd: 0.270 ± 0.020 nM,0.27,5′-AGGCCAACTGGATAGCGAA-N40-CGAATTCAGCACTACCTTTTGGCAAACGCTAATAAGGG-3′,40.0,"50 mM Tris–HCl (pH 8), 80 mM KCl, 2 mM MgCl2 and 1 mM DTT",MgCl,Tris Buffers,8.0,Not applicable,"Note that FANA is structurally distinct from the 2′-fluororibonucleotides described above as the sugar ring in FANA typically adopts a C2'/O4'-endo conformation as opposed to a C3'-endo conformation for 2′-fluoro-ribonucleotides, and the fluorine group in FANA is in the β as opposed to α conformation",None,PISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPEN...AAN
ssDNA,AGCAGCACAGAGGTCAGATGCACAGTGCGTCACATTTAGGGCATTCCTATGCGTGCTACCGTGAA ,65.0,0.5230769230769231,Kd: 500 nM,500.0,5′AGCAGCACAGAGGTCAGATG-N25-CCTATGCGTGCTACCGTGAA-3′,25.0,"10 mM Tris, 2 mM NaCl, 1 mM EDTA at pH 7.6, 2× concentration",None,Tris Buffers,7.6,Not applicable,None,None,None
2'-fluoro-RNA,GGGAGGACGAUGCGGGCCUUCGUUUGUUUCGUCCACAGACGACUCGCCCGA ,51.0,0.6274509803921569,Kd: ~110 nM,110.0,5′-GGGAGGACGATGCGG-N20-CAGACGACTCGCCCGA-3′,20.0,"DPBS (pH 7.0 ~7.4) and Ca2+ and Mg2+, 1 mM CaCl2, 2.7 mM KCl, 1.47 mM KH2PO4, 1 mM MgCl2, 136.9 mM NaCl, 2.13 mM Na2HPO4 and yeast tRNA",MgCl/CaCl,PBS/phosphate buffers,7.0,Not appilcable," In the transcription reaction mixture, CTP and UTP were replaced with 2′-F-CTP and 2′-F-UTP to produce ribonuclease-resistant RNA.",None,None
ssDNA,CTCGTCTCGTTCTCTCAGTCTTCTTCTGGCTTGGTGGTTGGTGTGTCTGCTGATTTGGTAGACACGAAGAAGAAGGAGGA,80.0,0.5,Kd: 50.45 ± 11.06 nM,50.45,5'-CTCGTCTCGTTCTCTCAGTC-N40-GACACGAAGAAGAAGGAGGA-3',40.0,"1X binding buffer (1X BB; 5 mM MgCl2 in Dulbecco's phosphate buffered saline, pH 7.4 ± 0.2)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,CTCGTCTCGTTCTCTCAGTCTGGTTAGCACGGGACCCAGGCTATTGGCAACTTCTAGTCCGACACGAAGAAGAAGGAGGA,80.0,0.5375,Kd: 48.29 ± 9.45 nm,48.29,5'-CTCGTCTCGTTCTCTCAGTC-N40-GACACGAAGAAGAAGGAGGA-3',40.0,"1X binding buffer (1X BB; 5 mM MgCl2 in Dulbecco's phosphate buffered saline, pH 7.4 ± 0.2)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,MSSKNGVGHTDTSSVDKEELISQFPHLDRLDPSPWAQKILSRPPLGREKISVVL...VAR
ssDNA,CTCGTCTCGTTCTCTCAGTCGGACGAAGAGAGGGGGAGAGGGGGACGGAGCTGCTAAGGTGACACGAAGAAGAAGGAGGA,80.0,0.5875,Kd: 85.02 ± 25.74 nM,85.02,5'-CTCGTCTCGTTCTCTCAGTC-N40-GACACGAAGAAGAAGGAGGA-3',40.0,"PBS containing 0.05% Tween 20, 20 mM Tris, 500 mM imidazole pH 7.5",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,MSSKNGVGHTDTSSVDKEELISQFPHLDRLDPSPWAQKILSRPPLGREKISVVL...VAR
ssDNA,5′ATCCAGAGTGACGCAGCATTGGGTGTTAGGCTGGTCTTAATCGGGTCGGGTTGCTGTGGACACGGTGGCTTAGT3′,74.0,0.5540540540540541,Kd: 167.3 ± 30.2,167.3,5′-ATCCAGAGTGACGCAGCA-N40-TGGACACGGTGGCTTAGT-3′,40.0,"30 mM Tris-HCl at pH 8.4, 3.0 mM KCl, 600 mM NaCl, 0.6 mM MgCl2",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
2'-fluoro-RNA,5′GGGGAAUUCGGAGAGGGAGAAUAGUCAACAAAUCGUUUGGGGCGACUUCUCCUUCCUUUCUCCCUUCUCCC3′,71.0,0.5211267605633803,Kd: 50 nM,50.0,5′-GGGGAATTCGGAGAGGGAGAATAG-N25-CTTCCTTTCTCCCTTCTCCC-3′,25.0,"150 mmol/l NaCl, 2 mmol/l CaCl2, 20 mmol/l HEPES (pH 7.4), 0,01% BSA binding buffer",CaCl,Other Buffers,7.4,Not applicable,"DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.
",None,None
2'-fluoro-RNA,5′GGGAGACCCACCCAUAAAAGGGAGAGAGGAAGAGGGAUGGGGAUUAGACCAUAGGCUCCCAACCCCCAUAACCCAGAGGUCGAUAGUACUGGAUCCCCCCGGGAGAGAGGAAGAGGGAUGGGGAUUAGAAUAGGCUCCCAACCCCCCAUAACCCAGAGGUCGAUAGUACUGGAUCCCGGGAAAUAUGGGUGGGUCUCCCGGGAGAAUAGUCAACAAAUCGUUUGGGGCGACUUCUCCUUCCUUUCUCCUGU,251.0,0.549800796812749,Kd: 50 nM,50.0,5′-GGGGAATTCGGAGAGGGAGAATAG-N25-CTTCCTTTCTCCCTTCTCCC-3′,25.0,"150 mmol/l NaCl, 2 mmol/l CaCl2, 20 mmol/l HEPES (pH 7.4), 0,01% BSA binding buffer",CaCl,Other Buffers,7.4,Not applicable,"DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection.
The sequence was extracted from the figure 3. The very top of figure 3 has not been shown (the hirpin loop), it was assumed there is no nucleotide
MRP1-CD28 bi-specific aptamer: CD28 aptamer, linker, MRP1 aptamer",None,None
2'-fluoro-RNA,AUACCAGCUUAUUCAAUUGCACGAAUUUGCUGUGUUUUUGGGGGGGUCGGGGAGUAUAAGAUAGUAAGUGCAAUCU,76.0,0.42105263157894735,Kd: 225 nM,225.0,5'-AUACCAGCUUAUUCAAUU-N40-AGAUAGUAAGUGCAAUCU-3',40.0,"Phosphate-buffered saline (PBS, pH 7.4), 4.5 g/L glucose, 5 mM MgCl2, 0.1 mg/mL yeast tRNA, 1 mg/mL bovine serum albumin",MgCl,Tris Buffers,7.4,Not applicable,2′F modified RNA aptamers,None,None
ssDNA,GCCTGTTGTGAGCCTCCTAACGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATACATGCTTATTCTTGTCTCC,78.0,0.5,Kd: 8.25 ± 1.43 pM,0.00825,5′-GCCTGTTGTGAGCCTCCTAAC-N38-CATGCTTATTCTTGTCTCC-3′,38.0,"Phosphate-buffered saline (PBS, pH 7.4), 4.5 g/L glucose, 5 mM MgCl2, 0.1 mg/mL yeast tRNA, 1 mg/mL bovine serum albumin",None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,GCCTGTTGTGAGCCTCCTAACTCCTCGAGGGGGGGGGGATGAAAAGGAAAACGCAACAACATGCTTATTCTTGTCTCC,78.0,0.5256410256410257,Kd: 7.47 ± 1.72 pM,0.00747,5′-GCCTGTTGTGAGCCTCCTAAC-N38-CATGCTTATTCTTGTCTCC-3′,38.0,"Phosphate-buffered saline (PBS, pH 7.4), 4.5 g/L glucose, 5 mM MgCl2, 0.1 mg/mL yeast tRNA, 1 mg/mL bovine serum albumin",None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′ATACCAGTCTATTCAATTCCCGGCATGGTTGCGGAGCAGGAGTATAACACTACCATTGAGATAGTATGTGCAATCA,76.0,0.4342105263157895,Kd: 1.15 ± 1.01 × 10^-8 M−1,11.5,5′-ATACCAGTCTATTCAATT–N40-AGATAGTATGTGCAATCA- 3′,40.0,"Phosphate-buffered saline (PBS, pH 7.4), 4.5 g/L glucose, 5 mM MgCl2, 0.1 mg/mL yeast tRNA, 1 mg/mL bovine serum albumin",MgCl/CaCl,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,ATACCAGCTTATTCAATTCGACGATCGGACCGCAGTACCCACCCACCAGCCCCAACATCATGCCCATCCGTGTGTGAGATAGTAAGTGCAATCT,94.0,0.5106382978723404,Kd: 82 ± 30 nM,82.0,5'-ATACCAGCTTATTCAATT-N60-AGATAGTAAGTGCAATCT-3',60.0,"50 mM Tris, pH 7.5, 150 mM NaCl, 2 mM MgCl2",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,ATACCAGCTTATTCAATTCGACGATCGGACCGCAGTACCCACCCACCAGCCCCAACATCATGCCCATCCGTGTGTGAGATAGTAAGTGCAATCT,94.0,0.5106382978723404,Kd: 80 ± 26 nM,80.0,5'-ATACCAGCTTATTCAATT-N60-AGATAGTAAGTGCAATCT-3',60.0,"50 mM Tris, pH 7.5, 150 mM NaCl, 2 mM MgCl2",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
2'-O-Me-RNA,5′GGGAGAGCGGAAGCGUGCUGGGCCCCACGACAGCAUGCCAAUAGAUGCGCAUGGAGACGACAGCAUCAUAACCCAGAGGUCGAUGGAUCCCC,92.0,0.6086956521739131,Kd: 12.78 ± 1.907 nM,12.78,5′-GGGAGAGCGGAAGCGUGCUGGGCC-N40-CAUAACCCAGAGGUCGAUGGAUCCCC-3′,40.0,"30 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1.5 mM MgCl2, 2 mM dithiothreitol, 1% BSA",MgCl,Tris Buffers,7.5,Truncated,"2′-O-methyl pyrimidine nucleotides, 2'-hydroxyl purine nucleotides. Generated rnase-resistant 2′-o-methyl modified rna aptamer using mutant t7 rna polymerase that can incorporate 2′-o-methyl pyrimidine (c/u) nucleotides into in vitro transcribed rna [8]. The selected 2′-modified rna aptamer specifically bound to jev mtase with high affinity and efficiently inhibited its mtase activity.",None,None
2'-O-Me-RNA,5′GGGAGAGCGGAAGCGUGCUGGGCCCCACGACAGCAUGCCAAUAGAUGCGCAUGGAGACGACAGCAUCAUAACCCAGAGGUCGAUGGAUCCCC3′,92.0,0.6086956521739131,Kd: 11.04 ± 1.763 nM,11.04,5′-GGGAGAGCGGAAGCGUGCUGGGCC-N40-CAUAACCCAGAGGUCGAUGGAUCCCC-3′,40.0,"31 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1.5 mM MgCl2, 2 mM dithiothreitol, 1% BSA",MgCl,Tris Buffers,7.5,Truncated,"2′-O-methyl pyrimidine nucleotides, 2'-hydroxyl purine nucleotides. Generated rnase-resistant 2′-o-methyl modified rna aptamer using mutant t7 rna polymerase that can incorporate 2′-o-methyl pyrimidine (c/u) nucleotides into in vitro transcribed rna [8]. The selected 2′-modified rna aptamer specifically bound to jev mtase with high affinity and efficiently inhibited its mtase activity.",None,None
ssDNA,CAGTCCAGGACAGATTCGCGAGCCCACTCCAAACACGACCAACTCACGCTCTATCAACATCGCTATCCACGTGGATTTCATTCAGCGATT,90.0,0.5111111111111111,Kd: 58.5 nM,58.5,5′-CAGTCCAGGACAGATTCGCGAG-N45-CACGTGGATTTCATTCAGCGATT-3',45.0,"100 mM NaCl, 20 mM Tris-HCl, 5 mM MgCl2, pH 7.4",MgCl,Tris Buffers,7.5,5′-amino modification and a six carbon spacer. Then amino-modified aptamer was immobilized on the electrode surface for label-free detection of S. typhimurium.,None,None,None
ssDNA,CAGTCCAGGACAGATTCGCGAGGCACAATCCACCTCTCACCGCACGCCACGCACTGCCTCTGTCCCGCACGTGGATTTCATTCAGCGATT,90.0,0.5888888888888889,Kd: 19.63 nM,19.63,5′-CAGTCCAGGACAGATTCGCGAG-N45-CACGTGGATTTCATTCAGCGATT-3',45.0,"100 mM NaCl, 20 mM Tris-HCl, 5 mM MgCl2, pH 7.4",MgCl,Tris Buffers,7.5,5′-amino modification and a six carbon spacer. Then amino-modified aptamer was immobilized on the electrode surface for label-free detection of S. typhimurium.,None,None,MSSPSSAPTLIAPSPAARAADGRIRTYEVRTFGCQMNVHDSERLSGSLESAGYV...VEA
ssDNA,AATCGCTGAATGAAATCCACGTGGGAAGTGTGTGGGTGACCAGAGGTGTGGTGATGGGATTGTCGTACCTCGCGAATCTGTCCTGGACTG,90.0,0.5333333333333333,Kd: 51.02 nM,51.02,5'-AATCGCTGAATGAAATCCACGTG-N45-CCTCGCGAATCTGTCCTGGACTG-3',45.0,"4.5 g, glucose, 100 mg, yeast tRNA (Sigma-Aldrich), 1 g, bovine serum albumin, 5 mL, 1 M MgCl2 dissolved in 1 L, Dulbecco's PBS (DPBS) (Sigma-Aldrich)",MgCl,Tris Buffers,7.5,5′-amino modification and a six carbon spacer. Then amino-modified aptamer was immobilized on the electrode surface for label-free detection of S. typhimurium.,None,None,MSSPSSAPTLIAPSPAARAADGRIRTYEVRTFGCQMNVHDSERLSGSLESAGYV...VEA
ssDNA,AGAGACGGACACAGGATGAGCGGTGCAGGGGGGGCGGAGAAGAGGTTGAGGGGAGCGGGTCCTTCCCCAAGACAGCATCCA,81.0,0.6419753086419753,Kd: 51.46 ±14.90 nM,51.46,5'-AGAGACGGACACAGGATGAGC-N40-CCTTCCCCAAGACAGCATCCA-3',40.0,"BSA 1mg/ml in Dulbecco's PBS without calcium, magnesium (pH 7.3), Mg2Cl 5mM glucose 4.5g/L, Salmon Sperm DNA 0.1 mg/ml, yeast tRNA 0.1 mg/ml",MgCl/CaCl,Other Buffers,7.4,Not applicable,None,None,None
ssDNA,AGAGACGGACACAGGATGAGCGCAGGGGGGGCGGAGAAGAGGTTGAGGGGAGCGGGTCCTTCCCCAAGACAGCATCCA,78.0,0.6410256410256411,Kd: 403.70 ± 71.47 nM ,403.7,5'-AGAGACGGACACAGGATGAGC-N40-CCTTCCCCAAGACAGCATCCA-3',40.0,"BSA 1mg/ml in Dulbecco's PBS without calcium, magnesium (pH 7.3), Mg2Cl 5mM glucose 4.5g/L, Salmon Sperm DNA 0.1 mg/ml, yeast tRNA 0.1 mg/ml",MgCl/CaCl,Other Buffers,7.4,Not applicable,None,None,MSSKYPRSVRRCLPLCALTLEAALILLFYFFTHYDASLEDQKGLVASYQVGQDL...VGF
ssDNA,AGAGACGGACACAGGATGAGCGGCGCAGGGGGGGCGGAGAAGAGGTTGAGGGGAGCGGGTCCTTCCCCAAGACAGCATCCA,81.0,0.654320987654321,Kd: 543.30 ± 92.59 nM,543.3,5'-AGAGACGGACACAGGATGAGC-N40-CCTTCCCCAAGACAGCATCCA-3',40.0,"BSA 1mg/ml in Dulbecco's PBS without calcium, magnesium (pH 7.3), Mg2Cl 5mM glucose 4.5g/L, Salmon Sperm DNA 0.1 mg/ml, yeast tRNA 0.1 mg/ml",MgCl/CaCl,Other Buffers,7.4,Not applicable,None,None,MSSKYPRSVRRCLPLCALTLEAALILLFYFFTHYDASLEDQKGLVASYQVGQDL...VGF
ssDNA,AAGGAGCAGCGTGGAGGATATCCGTTCGTACTCGCAAGCTGATCCGCGGCGCGACTTGTGACAATTAGGGTGTGTCGTCGTGGT,84.0,0.5714285714285714,Kd: 22.62 ± 8.25 nM,22.62,5′‐AAGGAGCAGCGTGGAGGATA‐N45‐TTAGGGTGTGTCGTCGTGGT‐3′,45.0,"BSA 1mg/ml in Dulbecco's PBS without calcium, magnesium (pH 7.3), Mg2Cl 5mM glucose 4.5g/L, Salmon Sperm DNA 0.1 mg/ml, yeast tRNA 0.1 mg/ml",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,AAGGAGCAGCGTGGAGGATAACCACTAGTCTAAAAGACAGCCGTAGAGCCGGGACCGGTGCCACTTAGGGTGTGTCGTCGTGGT,84.0,0.5714285714285714,Kd: 22.18 ± 9.6 nM,22.18,5′‐AAGGAGCAGCGTGGAGGATA‐N45‐TTAGGGTGTGTCGTCGTGGT‐3′,45.0,"BSA 1mg/ml in Dulbecco's PBS without calcium, magnesium (pH 7.3), Mg2Cl 5mM glucose 4.5g/L, Salmon Sperm DNA 0.1 mg/ml, yeast tRNA 0.1 mg/ml",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,AAGGAGCAGCGTGGAGGATAACCATTAGTTTAAAAGACAGCCGTAGAGCCGGGACCGGTGCCACTTAGGGTGTGTCGTCGTGGT,84.0,0.5476190476190477,Kd: 65.79 ± 23.83,65.79,5′‐AAGGAGCAGCGTGGAGGATA‐N45‐TTAGGGTGTGTCGTCGTGGT‐3′,45.0,"10 mM Tris-HCl, 1 mM EDTA, 2 M NaCl, pH7.5",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,AAGGAGCAGCGTGGAGGATAGCGCTCCCAACGGCCACATACCAGTACACGCGGGACCGCGGCCTGTTAGGGTGTGTCGTCGTGGT,85.0,0.6352941176470588,Kd: 54.28 ± 36.47,54.28,5′‐AAGGAGCAGCGTGGAGGATA‐N45‐TTAGGGTGTGTCGTCGTGGT‐3′,45.0,"10 mM Tris-HCl, 1 mM EDTA, 2 M NaCl, pH7.5",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,AAGGAGCAGCGTGGAGGATATCCATTAGTCTAAAACACAGCCTTAGAGCCGGGACCGGAGCCGCTTAGGGTGTGTCTGCTTGGT,84.0,0.5476190476190477,Kd: 49.69 ± 24.98,49.69,5′‐AAGGAGCAGCGTGGAGGATA‐N45‐TTAGGGTGTGTCGTCGTGGT‐3′,45.0,"20 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1 mM MgCl2",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,AAGGAGCAGCGTGGAGGATACCGATGCCAGACACAATTGTTATCCCGCGCATGCCACCATCCGTCTTAGGGTGTGTCGTCGTGGT,85.0,0.5647058823529412,Kd: 45.18 ± 13.39,45.18,5′‐AAGGAGCAGCGTGGAGGATA‐N45‐TTAGGGTGTGTCGTCGTGGT‐3′,45.0,"20 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1 mM MgCl2",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,AAGGAGCAGCGTGGAGGATAGGGGATAGCGGGTGTATATTTAAGCTTTACGGCTGTGTGGTCTGTTAGGGTGTGTCGTCGTGGT,84.0,0.5238095238095238,Kd: 62.8 ± 31.84,62.8,5′‐AAGGAGCAGCGTGGAGGATA‐N45‐TTAGGGTGTGTCGTCGTGGT‐3′,45.0,"4.5 g/L glucose and 5 mM MgCl2, in Phosphate‐buffered saline (PBS) with yeast tRNA (0.1 mg/mL) and bovine serum albumin (BSA; 1 mg/mL)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,CGTGTPPACCATGGPGTGAGTGPGTAGGTGTZZTGAGGAGGT,36.0,0.5555555555555556,Kd: 35 nM,35.0,5′-AGAGAGCGTCGTGTGGA-N25-TGAGGAGGTGCGCAAGT-3′,25.0,"1 mM MgCl2, 0.5 mM CaCl2 in PBS (pH 7.4)",None,PBS/phosphate buffers,7.4,"Replacing aegis p with standard nucleotides, individually replacing the p's by a in the optimally truncated aptamer. Replacing two adjacent g:c pairs in stem ii by two stronger p:z pairs (aptamer pa1t4ppzz).",None,None,None
ssRNA,5′GGAGACAAGAAUAAACGCUCAAUGAUUUUGCAGCACUUCUUGUUAUCUUAACGAACUGUUGAUGAUUCGACAGGAGGCUCACAACAGGC3′,89.0,0.42696629213483145,Kd: 6 nM,6.0,5′GGAGACAAGAAUAAACGCUCAA-N43-UUCGACAGGAGGCUCACAACAGGC-3′,43.0,"50 mmol/l Tris-HCl pH 8.0 buffer containing 150 mmol/l NaCl, 1% Nonidet P-40, 2 µg/ml aprotinin, 1 µg/ml pepstatin, 2 µg/ml leupeptin, 1 mmol/l Na3VO4",None,Tris Buffers,8.0,Gl56 aptamer contains 2′-f-py modifications that are expected to increase endonuclease resistance.,None,None,None
ssDNA,AGCAGCACAGAGGTCAGATGCAATAAGCGATGCGCCCTCGCCTGGGGGCCTAGTCCTCTCCTATGCGTGCTACCGTGAA,79.0,0.5949367088607594,Kd: 32.24 ± 8.19 nM,32.0,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"100 mM of NaCl, 20 mM of Tris–HCl, 2 mM of MgCl2, 5 mM of KCl, 1 mM of CaCl2, and 0.02 % aqueous solution of Tween 20, pH 7.6",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,None,None
ssDNA,5′AGCAGCACAGAGGTCAGATGGCAGGGCACGCGGGTCGTCCACTGGAGATTACTGCTGCGCCCTATGCGTGCTACCGTGAA3′,80.0,0.6125,Kd: 101.62 ± 11.1 nM,101.62,5′-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"101 mM of NaCl, 20 mM of Tris–HCl, 2 mM of MgCl2, 5 mM of KCl, 1 mM of CaCl2, and 0.02 % aqueous solution of Tween 20, pH 7.6",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,None,MPRSTTPGGGTLAQQVVSLTNAERAKNGCGALTVDSQLQAAAQGHSDDMVARNF...GTR
ssDNA,GCAATGGTACGGTACTTCCGACAGCCGGGGCATCAGAGCAGCCGATTGTCTGTTGTGCCCAAAAGTGCACGCTACTTTGCTAA,83.0,0.5421686746987951,Kd: 0.20 nM,0.2,5′-GCAATGGTACGGTACTTCC-N40-CAAAAGTGCACGCTACTTTGCTAA-3′,40.0,"100 mM NaCl, 20 mM Tris-HCl, 2 mM MgCl2, 5 mM KCl, and 1 mM CaCl2 at pH 7.6",MgCl/CaCl,Tris Buffers,7.6,Not applicable,ssDNAs that were bound to OH-BDE47-immobilized magnetic beads,None,None
ssDNA,GCAATGGTACGGTACTTCCATTGCACGTCTCCGCCGCTTGGGTGGAGAGGCTATTCGGCCAAAAGTGCACGCTACTTTGCTAA,83.0,0.5421686746987951,Kd: 1.52 nM,1.52,5′-GCAATGGTACGGTACTTCC-N40-CAAAAGTGCACGCTACTTTGCTAA-3′,40.0,"100 mM NaCl, 20 mM Tris-HCl, 2 mM MgCl2, 5 mM KCl, and 1 mM CaCl2 at pH 7.6",MgCl/CaCl,Tris Buffers,7.6,Not applicable,ssDNAs that were bound to OH-BDE47-immobilized magnetic beads,None,None
ssDNA,CATCCATGGGAATTCGTCGACGAGATCTTTTTGAATATTCCTCAATGACCCAAAATTCCTGCCTAGGTTCGAGCTCG,77.0,0.45454545454545453,Kd: 0.03378 ± 0.00377 nM,0.03378,5'-CATCCATGGGATTCGTCGAC-N40-CTGCCT AGGCTCGAG-3',40.0,4.5 g of glucose and 5 ml of 1 M MgCl2 in 1 L of Dulbecco's Phosphate-Buffered Saline (DPBS) with yeast tRNA and BSA,MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,CATCCATGGGATTCGTCGACCCTGCAGGCATGCAAGCTTTCCCTATAGTGAGTCGTATTACTGCCT AGGCTCGAG,75.0,0.5333333333333333,Kd: 0.05749 ± 0.002214 nM,0.05749,5'-CATCCATGGGATTCGTCGAC-N40-CTGCCT AGGCTCGAG-3',40.0,4.5 g of glucose and 5 ml of 1 M MgCl2 in 1 L of Dulbecco's Phosphate-Buffered Saline (DPBS) with yeast tRNA and BSA,MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,GCGGAATTCTAATACGACTCACTATAGGGAACAGTCCGAGCCCCCCATGAACTAGGCTCCACAATGAGTTTGGGGGTCAATGCGTCATA,89.0,0.5056179775280899,Kd: 8.59 ± 1.23 nM,8.59,5'-GCGGAATTCTAATACGACTCACTATAGGGAACAGTCCGAGCC-N31-GGGTCAATGCGTCATA-3',31.0,"5 mmol/L MgCl2, 4.5 g/L glucose in Dulbecco's phosphate-buffered saline, 0.1 mg/mL yeast tRNA, 1 mg/L bovine serum albumin (BSA)",CaCl,Tris Buffers,7.2,Not applicable,None,None,None
ssDNA,AGCAGCACAGAGGTCATGGGGGGTGTGACTTTGGTGTGCCTATGCGTGCTACGGAA,56.0,0.5714285714285714,Kd: 11 nM,11.0,5′-AGCAGCACAGAGGTCATG-20N-CCTATGCGTGCTACGGAA-3',20.0,"5 mmol/L MgCl2, 4.5 g/L glucose in Dulbecco's phosphate-buffered saline, 0.1 mg/mL yeast tRNA, 1 mg/L bovine serum albumin (BSA)",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,None,None
ssDNA,CATACGATTTAGGTGACACTATAGGACGGTGGCAGGGAAAGGGGTCGGGCATATGGCGGAGGGGATTTCTCCTACTGGGATAGGTGGA,88.0,0.5454545454545454,Kd: 56.33 ± 15.87 nM,56.33,5'-CATACGATTTAGGTGACACTATAG-N40-ATTTCTCCTACTGGGATAGGTGGA-3',40.0,"1 × BB, 50 mM Tris-HCl pH 7.4, 5 mM KCl, 100 mM NaCl, 1 mM MgCl2",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,CATACGATTTAGGTGACACTATAGTCATCGGGATACCTGGTAAGGATAATTTCTCCTACTGGGATAGGTGGA,72.0,0.4305555555555556,Kd: 87.03 ± 17.32 nM,87.03,5'-CATACGATTTAGGTGACACTATAG-N40-ATTTCTCCTACTGGGATAGGTGGA-3',40.0,"1 × BB, 50 mM Tris-HCl pH 7.4, 5 mM KCl, 100 mM NaCl, 1 mM MgCl2",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,MGKYIRPLSDAVFTIASDDLWIESLAIQQLHTTANLPNMQRVVGMPDLHPGRGY...KKG
ssDNA,CATACGATTTAGGTGACACTATAGCCGCCCAGCGGGGGTAGGGCCGGACGTAGGAGGAGCTGCGATTTCTCCTACTGGGATAGGTGGA,88.0,0.5795454545454546,Kd:11.97 ± 2.94 nM,11.97,5'-CATACGATTTAGGTGACACTATAG-N40-ATTTCTCCTACTGGGATAGGTGGA-3',40.0,"NETN buffer media (20 mM Tris pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5% NP-40)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,MGKYIRPLSDAVFTIASDDLWIESLAIQQLHTTANLPNMQRVVGMPDLHPGRGY...KKG
ssDNA,CATACGATTTAGGTGACACTATAGCCGGAGGTGGGTGAGGTCTGCGGCAGGCTGTGTGGGTGGACCGGAGGGGGGTGAGGTCTGCGGCAGGCTGTGTGGGTGGAATTTCTCCTACTGGGATAGGTGGA,128.0,0.6015625,Kd: 161.0 ± 34.74 nM,161.0,5'-CATACGATTTAGGTGACACTATAG-N40-ATTTCTCCTACTGGGATAGGTGGA-3',40.0,"NETN buffer media (20 mM Tris pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5% NP-40)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,MGKYIRPLSDAVFTIASDDLWIESLAIQQLHTTANLPNMQRVVGMPDLHPGRGY...KKG
ssDNA,5′GATAGAATTCGAGCTCGGGCACTAGGTTGCAGGGGACTGCTCGGGATTGCGGATCAACCTAGTTGCTTCTCTCGTATGATGCGGGTCGACAAGCTTTAAT,100.0,0.52,Kd: 24 pM,24.0,5′-GATAGAATTCGAGCTCGGGC-N60-GCGGGTCGACAAGCTTTAAT-3',60.0,"20 mM Tris at pH 7.5 with 150 mM NaCl, 1 mM MgCl2, 2.7 mM KCl and 0.005% NP-40",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,5′GATAGAATTCGAGCTCGGGCGGCTGTTGTTGTTACCTATTGCGTGGCGATCGGACTTTCGATTCCGATTAACGCCGGAGGGCGGGTCGACAAGCTTTAAT,100.0,0.53,Kd: 134 nM,134.0,5′-GATAGAATTCGAGCTCGGGC-N60-GCGGGTCGACAAGCTTTAAT-3',60.0,"20 mM Tris at pH 7.5 with 150 mM NaCl, 1 mM MgCl2, 2.7 mM KCl and 0.005% NP-40",MgCl,Tris Buffers,7.5,Not applicable,None,None,MPAVASVPKELYLSSSLKDLNKKTEVKPEKISTKSYVHSALKIFKTAEECRLDR...VAT
ssDNA,TCCCTACGGCGCTAACGATGGTGAAAATGGGCCTAGGGTGGACGGTGCCACCGTGCTACAAC,62.0,0.5967741935483871,Kd: 11.84 nM,11.84,5'-TCCCTACGGCGCTAAC-N30-GCCACCGTGCTACAAC3',30.0,"20 mM Tris-HCl, pH 7.5, 100 mM NaCl, and 5 mM MgCl2",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,AGCAGCACAGAGGTCAGATGTGCGTGAGCGGTAGCCCCGTACGACCCACTGTGGTTGGGCCCTATGCGTGCTACCGTGAA,80.0,0.6125,Kd: 10.69 ± 0.89 nM,10.69,5'-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3',40.0,"Phosphate-buffere saline (PBS, pH 7.2)",None,PBS/phosphate buffers,7.2,Not applicable,utilized whole-bacterium-based SELEX,None,None
ssDNA,AGCAGCACAGAGGTCAGATGGTCTCTACTAAAAGTTTTGATCATACCGTTCACTAATTGACCTATGCGTGCTACCGTGAA,80.0,0.4375,Kd: 54.22 ± 8.02 nM,54.22,5'-AGCAGCACAGAGGTCAGATG-N40-CCTATGCGTGCTACCGTGAA-3',40.0,"50 mM Tris-HCl, 5 mM KCl, 100 mM NaCl, 1 mM MgCl2, pH 7.4",MgCl,Tris Buffers,7.4,Not applicable,None,None,None
ssDNA,CGTGATGATGTTGAGTTGGGGTGATGGGTGCATGTGATGAAAGGGGTTCGTGCTATGCTGTTTTGTCTAATAATACTAGTCCTTGCCAAGGTTTATTCCAGTAATGCCAACCAATCT,117.0,0.4358974358974359,Kd: 107.6 ± 67.8 pM,107.6,5'-CGTGATGATGTTGAGTTG-N80-CAGTAATGCCAACCAATCT-3',80.0,"100 mM NaCl, 1 mM MgCl2, 50 mM Tris-HCl, 5 mM KCl",MgCl,Tris Buffers,7.4,Not applicable,None,None,None
ssDNA,ATCCAGAGTGACGCAGCAGATAAGTAGGTATCCGTTTGAAAAACTTTTCTGACCGTCCGACTATGGACACGGTGGCTTAGT,81.0,0.4691358024691358,Kd: 52.7 ± 5.1 nM,52.7,5′-ATCCAGAGTGACGCAGCA-N45-TGGACACGGTGGCTTAGT-3′,45.0,"5 mM MgCl2 and 4.5 g/L glucose in Dulbecco's Phosphate Buffered Saline (D-PBS, pH = 7.4) and 0.1 mg/mL yeast tRNA and 1 mg/L bovine serum albumin (BSA)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,GGGGGTGGTACCAGAGATGCTGTGTGCGGCACTCCAGTCTGTTACGCCGCCAGAGAGGAGGTACCGTGGG,70.0,0.6428571428571429,Kd: <2.5 nM,2.5,5'-GGGGGTGGTACCAGAGATGC-N30-CAGAGAGGAGGTACCGTGGG-3',30.0,"Phosphate buffer saline (PBS) solution (137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4 and 1.47 mM KH2PO4) with an adjusted pH 7.6",None,PBS/phosphate buffers,7.6,Not applicable,None,None,None
ssDNA,5′AGCAATGGTACGGTACTTCCTCACTTCACACCGCATCTCTACGTCCGGTTGCGCTTTCCTTTGTGCCACGCTACTTTGCTAA3′,82.0,0.5121951219512195,Kd: 172.1 ± 26.55 nM,172.0,5′-AGCAATGGTACGGTACTTCC-42N-GTGCCACGCTACTTTGCTAA-3′,42.0,"HEPES-buffered saline, pH 7.5 with 2 mmol/L CaCl2) containing BSA (0.1 mg/mL), tRNA (0.1 mg/mL)",MgCl/CaCl,Other Buffers,7.3,Not applicable,None,None,None
ssDNA,CCTGAACCTGATGCCAACCTGCCAGCGGGCAGTGCGCGAGTGGGAAACCGAGGGGGACTGAGTAGCGAGCGTGTAGTGTG,80.0,0.6375,Kd: 138.2±100.1 nM,138.0,5′-CCTGAACCTGATGCCAACCT-N40-AGTAGCGAGCGTGTAGTGTG-3′,40.0,"HEPES-buffered saline, pH 7.5 with 2 mmol/L CaCl2) containing BSA (0.1 mg/mL), tRNA (0.1 mg/mL)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,AAGGGCTGGCTGGGATGGACCCTCCCGAAACGAGCTGTCTCTTAACGGAAGCTAATCTGCCTCACTCCACGGACCCCACT,80.0,0.5875,Kd: 971 nM,971.0,5′-AAGGGCTGGCTGGGATGGA-N42-TCACTCCACGGACCCCACT-3′,42.0,"HEPES-buffered saline, pH 7.5 with 2 mmol/L CaCl2) containing BSA (0.1 mg/mL), tRNA (0.1 mg/mL)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,AAGGGCTGGCTGGGATGGATGTAAGAAGGGAGGAAAGGACCTAAGACCTGCTATATTGCGATCACTCCACGGACCCCACT,80.0,0.5375,Kd: 309 nM,309.0,5′-AAGGGCTGGCTGGGATGGA-N42-TCACTCCACGGACCCCACT-3′,42.0,"HEPES-buffered saline, pH 7.5 with 2 mmol/L CaCl2) containing BSA (0.1 mg/mL), tRNA (0.1 mg/mL)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,MNTEIDATRPALGAAGLLGRLRALLRTGPAGGRIGTLSRLAIDGLPDTWTQLEA...EDA
ssDNA,ATACCAGCTTATTCAATTCCATGGTCCCTCGTGTTTATTATGTTGTCTGAACTGGCTGAGATTGCACTTACTATCT,76.0,0.39473684210526316,Kd: 39.32 ± 5.02 nM,39.32,5′-ATACCAGCTTATTCAATT-N40-AGATAGTAAGTGCAATCT-3′,40.0,"HEPES-buffered saline, pH 7.5 with 2 mmol/L CaCl2) containing BSA (0.1 mg/mL), tRNA (0.1 mg/mL)",None,Tris Buffers,8.0,Not applicable,Cy5 for detection probe at the 5' end; 5′-biotin-modified,None,None
ssDNA,ATACCAGCTTATTCAATTCCACACATACCAAAAACACAGCACACTTCATCAATTTCACGAGATTGCACTTACTATCT,77.0,0.36363636363636365,Kd: 15.89 ± 1.77 nM,15.89,5′-ATACCAGCTTATTCAATT-N40-AGATAGTAAGTGCAATCT-3′,40.0,"TBS buffer (10 mM Tris-HCl, 0.85% NaCl, pH 8.0)",None,Tris Buffers,8.0,5' amine for capture probe,5′-biotin-modified,None,MSRFIPIELHHASRLLNHGPTVLITSFDEQSQRRNIMAAAWSMPVEFEPPRVAI...LIE
ssDNA,5′GGACAAGAATCACCGCTCGCGTGCTCCAGTGGCTCTTCGGTACCAACCCAAAGTGACTCGTACAGGAGGCATACAG3′,76.0,0.5657894736842105,Kd: 2.6 ± 0.4 nM,2.6,5′-GGACAAGAATCACCGCTC-N40-CGTACAGGAGGCATACAG-3′,40.0,"SHMCK buffer (20 mM Hepes, 120 mM NaCl, 5 mM KCl, 1 mM MgCl2 and 1 mM CaCl2, pH 7.4) and elution buffer (7 M urea, 0.5 M NH4Ac, 1 mM EDTA, 0.2% SDS)",MgCl/CaCl,Other Buffers,7.4,Not applicable,None,None,None
ssDNA,CATGCTTCCCCAGGGAGATGGAGGTCTTTTTGGTTGTTGGTGGGGGAATCTTTTGGTATTGAGGAACATGCGTCGCAAAC,80.0,0.5,Kd: 5.026 ± 0.69 uM,5.026,5'-CATGCTTCCCCAGGGAGATG-N40-GAGGAACATGCGTCGCAAAC-3',40.0,"AS buffer (137 mM NaCl, 12.3 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4,5 mM MgCl2, 0.01% (v/v) Tween 20; pH 7.5)",MgCl,PBS/phosphate buffers,7.5,Not applicable,None,None,None
ssDNA,GGGATGGATCCAAGCTTACTGGCTCATTGGGTGGTGGCCTCTGGACGGGTTGTATGCGATGAGCGCAGGGAAGCTTCGATAGGAATTCGG,90.0,0.5666666666666667,Kd: 118 nM,118.0,5'-GGGATGGATCCAAGCTTACTGG-45N-GGGAAGCTTCGATAGGAATTCGG-3',45.0,"50 mM Tris, pH 7.5, 150 mM NaCl, 2 mM MgCl2",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,TAGCTCACTCATTAGGCACGGGTGGGCTCCAATATGAATCGCTTGCCCTGACGCTATCTGCATAGTTAAGCCAGCC,76.0,0.5263157894736842,Kd: 56 ± 87 nmol/mL,56.0,5`-TAGCTCACTCATTAGGCAC-N40-GCATAGTTAAGCCAGCC-3`,40.0,Binding buffer (BB) containing bovine serum albumin (BSA),None,Other Buffers,8.0,Not applicable,None,None,None
ssDNA,TAGCTCACTCATTAGGCACCGTAGTCTAGTGTCGATTAGTTTCCTTGAGACCTTGTGCTGCATAGTTAAGCCAGCC,76.0,0.47368421052631576,Kd: 37 ± 112 nmol/mL,37.0,5`-TAGCTCACTCATTAGGCAC-N40-GCATAGTTAAGCCAGCC-3`,40.0,Binding buffer (BB) containing bovine serum albumin (BSA),None,Other Buffers,8.0,Not applicable,None,None,MAISGVPVLGFFIIAVLMSAQESWAIKEEHVIIQAEFYLNPDQSGEFMFDFDGD...GPL
ssDNA,TAGCTCACTCATTAGGCACCGTAGTCTAGTGTCGATTAGTTTCCTTGCTATTGCAGACCTTGTGCTGCATAGTTAAGCCAGCC,83.0,0.46987951807228917,Kd: 58 ± 14 nmol/mL,58.0,5`-TAGCTCACTCATTAGGCAC-N40-GCATAGTTAAGCCAGCC-3`,40.0,PBS containing 5 mM MgCl2,None,Other Buffers,8.0,Not applicable,None,None,MAISGVPVLGFFIIAVLMSAQESWAIKEEHVIIQAEFYLNPDQSGEFMFDFDGD...GPL
ssDNA,TAGCTCACTCATTAGGCACTCGAGAGGGATCTCGGGGCGTGCGATGATTTTGCCTTCATGCATAGTTAAGCCAGCC,76.0,0.5263157894736842,Kd: 46 ± 24 nmol/mL,46.0,5`-TAGCTCACTCATTAGGCAC-N40-GCATAGTTAAGCCAGCC-3`,40.0,Binding buffer (BB) containing bovine serum albumin (BSA),None,Other Buffers,8.0,Not applicable,None,None,MAISGVPVLGFFIIAVLMSAQESWAIKEEHVIIQAEFYLNPDQSGEFMFDFDGD...GPL
ssDNA,TAGCTCACTCATTAGGCACGCGTTACGTTAGTGGCCGCCTATGAGGACAGGCGGTTGTAGCATAGTTAAGCCAGCC,76.0,0.5394736842105263,Kd: 128 ± 45 nmol/mL,128.0,5`-TAGCTCACTCATTAGGCAC-N40-GCATAGTTAAGCCAGCC-3`,40.0,"Selection buffer (SB, 40 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH7.5, 125 mM NaCl, 5 mM KCl, 1 mM MgCl2, 0.01% Tween 20)",None,Other Buffers,8.0,Not applicable,None,None,MAISGVPVLGFFIIAVLMSAQESWAIKEEHVIIQAEFYLNPDQSGEFMFDFDGD...GPL
ssDNA,TAGCTCACTCATTAGGCACTGGACGTCGTGGCGGAGGTTTTATAAAACGGCGCCACTGTGCATAGTTAAGCCAGCC,76.0,0.5263157894736842,Kd: 49 ± 39 nmol/mL,49.0,5`-TAGCTCACTCATTAGGCAC-N40-GCATAGTTAAGCCAGCC-3`,40.0,"Selection buffer (SB, 40 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH7.5, 125 mM NaCl, 5 mM KCl, 1 mM MgCl2, 0.01% Tween 20)",None,Other Buffers,8.0,Not applicable,None,None,MAISGVPVLGFFIIAVLMSAQESWAIKEEHVIIQAEFYLNPDQSGEFMFDFDGD...GPL
ssDNA,TAGCTCACTCATTAGGCACGGGGGGTTGTGCCATTTAAGATGACCGGTTGCCGCGATTTGCATAGTTAAGCCAGCC,76.0,0.5263157894736842,Kd: 34 ± 5 nmol/mL,34.0,5`-TAGCTCACTCATTAGGCAC-N40-GCATAGTTAAGCCAGCC-3`,40.0,"50 mM, Tris‐HCl pH 7.5, 150 mM, NaCl, 5 mM, MgCl2, 0.1%, BSA, 0.1%, Triton X‐100",None,Other Buffers,8.0,Not applicable,None,None,MAISGVPVLGFFIIAVLMSAQESWAIKEEHVIIQAEFYLNPDQSGEFMFDFDGD...GPL
ssDNA,CATGCTTACCTATAGTGAACCCCAACACACGTGTAGATCCTGCGGCTTTGAGAACTGACTCATAC,65.0,0.47692307692307695,Kd: 80 ± 14 nM,80.0,5′-CATGCTTACCTATAGTGAAC-N24-CTTTGAGAACTGACTCTAC-3′,24.0,"200 μg/ml mock-liposomes lacking protein, 2 mg/ml bovine serum albumin, 150 mM NaCl, 20 mM Tris-HCl (pH 7.4)",MgCl,Tris Buffers,7.4,Not applicable,None,None,None
ssDNA,CATGCTTACCTATAGTGAACCCAACGTCGAACTGAATCCCGTGTCCTTTGAGAACTGACTCATAC,65.0,0.46153846153846156,Kd: 13 ± 3 nM,13.0,5′-CATGCTTACCTATAGTGAAC-N24-CTTTGAGAACTGACTCTAC-3′,24.0,"150 mM Tris, 150 mM NaCl, 5 mM KCl, 5 mM MgCl2, pH 7.4",MgCl,Tris Buffers,7.4,Not applicable,None,None,MKLSVCLLLVTLALCCYQANAEFCPALVSELLDFFFISEPLFKLSLAKFDAPPE...CSV
ssDNA,CATGCTTACCTATAGTGAACGCGGCATGTTGGCATCTTGGTCCTGCTTTGAGAACTGACTCATAC,65.0,0.47692307692307695,Kd: 105 ± 20 nM,105.0,5′-CATGCTTACCTATAGTGAAC-N24-CTTTGAGAACTGACTCTAC-3′,24.0,"Binding buffer (50 mM Tris-HCl, 100 mM NaCl, 5 mM KCl, 1 mM MgCl2, pH 7.4)",MgCl,Tris Buffers,7.4,Not applicable,None,None,MKLSVCLLLVTLALCCYQANAEFCPALVSELLDFFFISEPLFKLSLAKFDAPPE...CSV
ssDNA,CATGCTTACCTATAGTGAACCACGACACGCGCGATCGTCTCACTGCTTTGAGAACTGACTCATAC,65.0,0.49230769230769234,Kd: 78 ± 15 nM,78.0,5′-CATGCTTACCTATAGTGAAC-N24-CTTTGAGAACTGACTCTAC-3′,24.0,"Binding buffer (20 mM Tris−HCl, 100 mM NaCl, 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2, 0.02% Tween 20, pH 7.6)",MgCl,Tris Buffers,7.4,Not applicable,None,None,MKLSVCLLLVTLALCCYQANAEFCPALVSELLDFFFISEPLFKLSLAKFDAPPE...CSV
ssDNA,CATGCTTACCTATAGTGAACCCACCACACAGCGGATACACCATGGCTTTGAGAACTGACTCATAC,65.0,0.47692307692307695,Kd: 19 ± 5 nM,19.0,5′-CATGCTTACCTATAGTGAAC-N24-CTTTGAGAACTGACTCTAC-3′,24.0,"Binding buffer (20 mM Tris−HCl, 100 mM NaCl, 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2, 0.02% Tween 20, pH 7.6)",MgCl,Tris Buffers,7.4,Not applicable,None,None,MKLSVCLLLVTLALCCYQANAEFCPALVSELLDFFFISEPLFKLSLAKFDAPPE...CSV
ssDNA,CATGCTTACCTATAGTGAACCCGAAGAGGATGTGCGGTCCCATTGCTTTGAGAACTGACTCATAC,65.0,0.47692307692307695,Kd: 72 ± 9 nM,72.0,5′-CATGCTTACCTATAGTGAAC-N24-CTTTGAGAACTGACTCTAC-3′,24.0,"PH 7.4 PBS containing 4.5 mM MgCl2, 0.005% Tween 20, 100 μg/mL tRNA (Sigma, R8759)",MgCl,Tris Buffers,7.4,Not applicable,None,None,MKLSVCLLLVTLALCCYQANAEFCPALVSELLDFFFISEPLFKLSLAKFDAPPE...CSV
ssDNA,CATGCTTACCTATAGTGAACCCGGGACAGAACGTGCGCTTTGAGCTTTGAGAACTGACTCATAC,64.0,0.484375,Kd: 3 ± 1 nM,2.0,5′-CATGCTTACCTATAGTGAAC-N24-CTTTGAGAACTGACTCTAC-3′,24.0,"Tris⋅Cl (20 mm, pH 7.5), NaCl (100 mm), KCl (5 mm), MgCl2 (1 mm), CaCl2 (1 mm, selection buffer, SB)",MgCl,Tris Buffers,7.4,Not applicable,None,None,None
ssDNA,CATGCTTACCTATAGTGAACGGTTGGCATCTTGGTCCTGCTTTGCTTTGAGAACTGACTCATAC,64.0,0.453125,Kd: 54 ± 13 nM,54.0,5′-CATGCTTACCTATAGTGAAC-N24-CTTTGAGAACTGACTCTAC-3′,24.0,"PH 7.4 PBS containing 2.0 mM MgCl2, 0.02% Tween 20, 100 µg/mL Salmon Sperm DNA (ThermoFisher, 15632011)",MgCl,Tris Buffers,7.4,Not applicable,None,None,MKLSVCLLLVTLALCCYQANAEFCPALVSELLDFFFISEPLFKLSLAKFDAPPE...CSV
ssDNA,CATGCTTACCTATAGTGAACTGTTGGCATCTTGGTCCTGCTTTGCTTTGAGAACTGACTCATAC,64.0,0.4375,Kd: 49 ± 20 nM,49.0,5′-CATGCTTACCTATAGTGAAC-N24-CTTTGAGAACTGACTCTAC-3′,24.0,"PH 7.4 PBS containing 2.0 mM MgCl2, 0.02% Tween 20, 100 µg/mL Salmon Sperm DNA (ThermoFisher, 15632011)",MgCl,Tris Buffers,7.4,Not applicable,None,None,MKLSVCLLLVTLALCCYQANAEFCPALVSELLDFFFISEPLFKLSLAKFDAPPE...CSV
ssDNA,CATGCTTACCTATAGTGAACGTTGGCATCTTGGTCCTGCTTTGACTTTGAGAACTGACTCATAC,64.0,0.4375,Kd: 8 ± 3 nM,8.0,5′-CATGCTTACCTATAGTGAAC-N24-CTTTGAGAACTGACTCTAC-3′,24.0,"PH 7.4 PBS containing 2.0 mM MgCl2, 0.02% Tween 20, 100 µg/mL Salmon Sperm DNA (ThermoFisher, 15632011)",MgCl,Tris Buffers,7.4,Not applicable,None,None,MKLSVCLLLVTLALCCYQANAEFCPALVSELLDFFFISEPLFKLSLAKFDAPPE...CSV
ssDNA,5′GCTGTGTGACTCCTGCAAATATAGCGGGCAGGGGTGGGGGGGTGTTTGCGGCTCTGGGATCGCAGCTGTATCTTGTCTCC3′,80.0,0.6,Kd: 13.4 nM,13.4,5′-GCTGTGTGACTCCTGCAA-N43-GCAGCTGTATCTTGTCTCC-3′,43.0,"D-PBS supplemented with 4.5 g/L, glucose, 5 mM, MgCl2, 0.1 mg/mL, yeast tRNA, 1 mg/mL, BSA",None,PBS/phosphate buffers,7.5,Not applicable,None,None,None
ssDNA,5′GCTGTGTGACTCCTGCAAGCGGGAAGAGGGCAGGGGTGGGAGGGTAACGCGGAAAGGGCAAGCAGCTGTATCTTGTCTCC,80.0,0.6125,Kd: 138.6 nM,138.6,5′-GCTGTGTGACTCCTGCAA-N43-GCAGCTGTATCTTGTCTCC-3′,43.0,"50 mM sodium phosphate, 100 mM NaCl, pH 7.4",None,PBS/phosphate buffers,7.5,Not applicable,None,None,MDSYLLMWGLLTFIMVPGCQAELCDDDPPEIPHATFKAMAYKEGTMLNCECKRG...RTI
ssRNA,GGGUCGUCGCGGGUUGGCUCGUAGAUCGGGCCGGUACAGACGACCCAGACGACUCGCUGAGGAUCCGAGA,70.0,0.6571428571428571,Kd: 0.9 ± 0.1 nM,0.9,5′-GGGGGAATTCTAATACGACTCACTATA-N40-CAGACGACTCGCTGAGGATCCGAGA-3′,40.0,"PBS [pH 7.4], 1 mM MgCl2, 1 mM CaCl2",MgCl/CaCl,PBS/phosphate buffers,7.4,Truncated version of mf11 aptamer,None,None,MERDPHADTVAWAPGTMTPLKVLFLVTLLLGAFLQETRAARGTNVGQECCMEYF...VRP
ssRNA,GAGCAGCAUUUGUGGUUUCCCGAUCGCUUCCC,32.0,0.5625,Kd: 7.5 ± 1.5 nM,7.5,5′-GGGGGAATTCTAATACGACTCACTATA-N40-CAGACGACTCGCTGAGGATCCGAGA-3′,40.0,"PBS [pH 7.4], 1 mM MgCl2, 1 mM CaCl2",MgCl/CaCl,PBS/phosphate buffers,7.4,Truncated version of mf35 aptamer,None,None,MERDPHADTVAWAPGTMTPLKVLFLVTLLLGAFLQETRAARGTNVGQECCMEYF...VRP
ssDNA,AGAGTGCTGTTACTATCGGGGCGCGTAGATGACGAGCAGTCCTAACATCGTTTAGGACAACTGAACAAGGTGGTAT,76.0,0.4868421052631579,Kd: 35.5 nM,35.5,5'-AGAGTGCTGTTACTATCG-N40-AACTGAACAAGGTGGTAT-3',40.0,"PBS containing 0.05% Tween 20 and 20 mM Tris, 500 mM imidazole pH 7.5",None,PBS/phosphate buffers,7.5,Not applicable,None,None,None
ssDNA,5′GCGCGGATCCCGCGCCGAGGGAGACGCGAACCTTCTCGCCTTGGGCGCGCGAAGCTTGCG3′,60.0,0.7333333333333333,Kd: 11.0 ± 2.7 nM via gel shift assay & 530 ± 11 nM via nonlinear fitting of the saturation binding curve from ELISA. IC50: 15 ± 1.5 μM,11.0,5′-GCGCGGATCCCGCGC-N30-CGCGCGAAGCTTGCG-3′,30.0,"30 mM Tris-HCl at pH 8.4, 3.0 mM KCl, 600 mM NaCl, and 0.6 mM MgCl2",MgCl,Tris Buffers,8.4,Not applicable,None,None,None
ssDNA,CCATTCGTACGCAACAGGGATGCATCGACTGTAAACACGTGGATGGCTCTGAATGC,56.0,0.5178571428571429,Kd: 47.71 nM,47.0,5'CCATTCGTACGCAACAGG-N20-GTGGATGGCTCTGAATGC3',20.0,10 mM PBS,None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,CCATTCGTACGCAACAGGCGACCTAAACAACGCATCAGGTGGATGGCTCTGAATGC,56.0,0.5357142857142857,Kd: 51.36 nM,51.36,5'CCATTCGTACGCAACAGG-N20-GTGGATGGCTCTGAATGC3',20.0,"DPBS, 4.5 g, glucose, 100 mg tRNA, 1 g BSA, 5 ml, 1 M MgCl2, pH 7",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MKMKIIILLGFLGATLSAPLLLNLNNGQLLPLQLQGPFNSWIPPFSGILQQQQQ...REP
ssDNA,AGCAGAGTTCACGACCCGATAAGGGGAAAACACATTTCGGATCTCCGTTGTCGCCCTGATACCGAGTTACATACCAATCGTCGCAG,86.0,0.5116279069767442,Kd:1.64 ± 0.52 nM,1.64,5′-AGCAGAGTTCACGACCCGATAAG-N40-GAGTTACATACCAATCGTCGCAG-3′,40.0,"2 mM MgCl2, 50 mM Tris (pH 7.5), 150 mM NaCl in distilled water",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,AGCAGAGTTCACGACCCGATAAGGGCGATGCCGATCCCTGTGGCCGTAGGGACAGTCCCGCTAGAGTTACATACCAATCGTCGCAG,86.0,0.5813953488372093,Kd: 1.69 ± 0.38 nM,1.69,5′-AGCAGAGTTCACGACCCGATAAG-N40-GAGTTACATACCAATCGTCGCAG-3′,40.0,"2 mM MgCl2, 50 mM Tris (pH 7.5), 150 mM NaCl in distilled water",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,AGCAGAGTTCACGACCCGATAAGGGGAAAACACATTTCGGATCTCCGTTGTCGCCCTGGTACCGAGTTACATACCAATCGTCGCAG,86.0,0.5232558139534884,Kd: 3.92 ± 1.22 nM,3.92,5′-AGCAGAGTTCACGACCCGATAAG-N40-GAGTTACATACCAATCGTCGCAG-3′,40.0,"Four kinds, incubation solutions (separately adding 1 mM MgCl2, 2.7 mM KCl, 40 mM NaCl) were used: a) 25 mM trizma base, 192 mM glycine, 5 mM K2HPO4 (TGK, pH 8.3), b) 25 mM Tris–HCl (pH 7.4), c) 50 mM H3BO3/Na2B4O7 solution (BBS, pH 8.7), d) 8.1 mM Na2HPO4, 1.1 mM KH2PO4 (PBS, pH 7.4)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,AGCAGAGTTCACGACCCGATAAGGGGAAAATACATTTCGGATCTCCGTTGTCGCCCTGATACCGAGTTACATACCAATCGTCGCAG,86.0,0.5,Kd: 2.01± 0.58 nM,2.01,5′-AGCAGAGTTCACGACCCGATAAG-N40-GAGTTACATACCAATCGTCGCAG-3′,40.0,"Phosphate-buffered saline (PBS, pH 7.4), 4.5 g/L glucose, 5 mM MgCl2, 0.1 mg/mL yeast tRNA, and 1 mg/mL bovine serum albumin",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,AGCAGAGTTCACGACCCGATAAGGGGAAAATACATTTCGGATCTCCGTTGTCGCCCTGGTACCGAGTTACATACCAATCGTCGCAG,86.0,0.5116279069767442,Kd: 3.47 ± 0.90 nM,3.47,5′-AGCAGAGTTCACGACCCGATAAG-N40-GAGTTACATACCAATCGTCGCAG-3′,40.0,"Phosphate-buffered saline (PBS, pH 7.4), 4.5 g/L glucose, 5 mM MgCl2, 0.1 mg/mL yeast tRNA, and 1 mg/mL bovine serum albumin",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,AGCAGAGTTCACGACCCGATAAGGGCGATGCCGATCCCTGTGGCCGTAGGGGCAGTCCCGCTAGAGTTACATACCAATCGTCGCAG,86.0,0.5930232558139535,Kd: 0.61 ± 0.14 nM,0.61,5′-AGCAGAGTTCACGACCCGATAAG-N40-GAGTTACATACCAATCGTCGCAG-3′,40.0,"Yeast tRNA (0.1 mg mL−1, Sigma), BSA (1 mg mL−1, Sigma) into 4.5 g L−1 glucose, 5 mM MgCl2 in Dulbecco's PBS without calcium, magnesium",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,TCACGCCCGATAAGGGCGATGCCGATCCCTGTGGCCGTAGGGCAGTCCCCTAG,53.0,0.660377358490566,Kd: 49.32 ± 14.53 nM,49.32,5′-AGCAGAGTTCACGACCCGATAAG-N40-GAGTTACATACCAATCGTCGCAG-3′,40.0,"Phosphate-buffered saline (PBS, pH 7.4), 4.5 g/L glucose, 5 mM MgCl2, 0.1 mg/mL yeast tRNA, and 1 mg/mL bovine serum albumin",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′GCTGTGTGACTCCTGCAAGCGGGAAGAGGGCAGGGGAGGGAGGGTGACGCGGAAGAGGCAAGCAGCTGTATCTTGTCTCC,80.0,0.625,Kd: 66 nM,66.0,5′-GCTGTGTGACTCCTGCAA-N43-GCAGCTGTATCTTGTCTCC-3′,43.0,"Phosphate-buffered saline (PBS) 1X pH 7.4, with 1 mM, CaCl2·2H2O [Panreac], 0.5 mM, MgCl2·6H2O [VWR]",None,PBS/phosphate buffers,7.5,Not applicable,None,None,None
ssDNA,ACCGTCTGAGCGATTCGTACTTTATTCGGGAAGGGTATCAGCGGGG,46.0,0.5434782608695652,Kd: 3.7 nM,3.7,5′-TGTACCGTCTGAGCGATTCGTAC-N34-AGCCAGTCAGTGTTAAGGAGTGC-3′,34.0,"10 mM sodium phosphate, 0.15 M NaCl, pH7.5 (PBS), MgCl2 1 mM BSA 0.2%",MgCl,Tris Buffers,7.4,Truncated version of r12.45,None,CCNC1=NC(=NC(=N1)Cl)NC(C)C,None
ssDNA,5′ATACCAGCTTATTCAATTGGAATAAGGGGGTATTACTGTCTGGTAAACAAACGCTATGCGAGGGGATTCAAGATAGTAAGTGCAATCT3′,88.0,0.3977272727272727,Kd: 96.91 ± 4.5 nM,96.91,5′-ATACCAGCTTATTCAATT-N52-AGATAGTAAGTGCAATCT-3′,52.0,"4.5 g of glucose, 100 mg of yeast tRNA (Sigma-Aldrich), 1 g of bovine serum albumin, and 5 mL of 1 M MgCl2 dissolved in 1 L of Dulbecco's PBS (DPBS) (Sigma-Aldrich)",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssRNA,AUCGUUACCUUAGAAGCUUGUGAGUUUUUCGCGGCGAAGACAAGGCUCGGGAUCCGACACGACCCUAUAGUGAGUCGUAUUA,82.0,0.4878048780487805,Kd: 38 nM,38.0,5'-ATCGTTACCTTAGAAGCTT-N30-GGATCCGACACGACCCTATAGTGAGTCGTATTA-3',30.0,"BSA 1mg/ml in Dulbecco's PBS without calcium and magnesium (pH 7.3), Mg2Cl 5mM, glucose 4.5g/L, Salmon Sperm DNA 0.1 mg/ml and yeast tRNA 0.1 mg/ml",None,PBS/phosphate buffers,7.3,Not applicable,None,None,None
ssRNA,AUCGUUACCUUAGAAGCUUAGGCACGACGCAUAGCCUUGGGAGCGAGGAGGAUCCGACACGACCCUAUAGUGAGUCGUAUUA,82.0,0.5121951219512195,Kd: 16.5 nM,16.5,5'-ATCGTTACCTTAGAAGCTT-N30-GGATCCGACACGACCCTATAGTGAGTCGTATTA-3',30.0,"BSA 1mg/ml in Dulbecco's PBS without calcium and magnesium (pH 7.3), Mg2Cl 5mM, glucose 4.5g/L, Salmon Sperm DNA 0.1 mg/ml and yeast tRNA 0.1 mg/ml",None,PBS/phosphate buffers,7.3,Not applicable,None,None,None
ssRNA,AUCGUUACCUUAGAAGCUUUGCGAAGGGGGGCAGAGGUUUGACGCGAGAGGAUCCGACACGACCCUAUAGUGAGUCGUAUUA,82.0,0.5121951219512195,Kd: 52.7 nM,52.7,5'-ATCGTTACCTTAGAAGCTT-N30-GGATCCGACACGACCCTATAGTGAGTCGTATTA-3',30.0,"BSA 1mg/ml in Dulbecco's PBS without calcium and magnesium (pH 7.3), Mg2Cl 5mM, glucose 4.5g/L, Salmon Sperm DNA 0.1 mg/ml and yeast tRNA 0.1 mg/ml",None,PBS/phosphate buffers,7.3,Not applicable,None,None,None
ssRNA,AUCGUUACCUUAGAAGCUUAACGGCAUGACCUAACCUGGAGGCGCAUCAGGAUCCGACACGACCCUAUAGUGAGUCGUAUUA,82.0,0.4878048780487805,Kd: 156.0 nM,156.0,5'-ATCGTTACCTTAGAAGCTT-N30-GGATCCGACACGACCCTATAGTGAGTCGTATTA-3',30.0,"BSA 1mg/ml in Dulbecco's PBS without calcium and magnesium (pH 7.3), Mg2Cl 5mM, glucose 4.5g/L, Salmon Sperm DNA 0.1 mg/ml and yeast tRNA 0.1 mg/ml",None,PBS/phosphate buffers,7.3,Not applicable,None,None,None
ssRNA,AUCGUUACCUUAGAAGCUUCCCAAAAAGGAUUGGGGCGUCUGCAUGACCGGAUCCGACACGACCCUAUAGUGAGUCGUAUUA,82.0,0.4878048780487805,Kd: 71.2 nM,71.2,5'-ATCGTTACCTTAGAAGCTT-N30-GGATCCGACACGACCCTATAGTGAGTCGTATTA-3',30.0,"DPBS, 5 mM MgCl2, 22.5 mM d-glucose, 1 mg/mL BSA, 100 μg/mL tRNA (Baker's Yeast)",None,PBS/phosphate buffers,7.3,Not applicable,None,None,None
ssRNA,AUCGUUACCUUAGAAGCUUAGCUCGAAAGUGGGCUGGCGAUGUGUCCCGGGAUCCGACACGACCCUAUAGUGAGUCGUAUUA,82.0,0.5121951219512195,Kd: 30.7 nM,30.7,5'-ATCGTTACCTTAGAAGCTT-N30-GGATCCGACACGACCCTATAGTGAGTCGTATTA-3',30.0,"20 mM HEPES pH 7.4, 150 mM NaCl, 2 mM CaCl2",None,PBS/phosphate buffers,7.3,Not applicable,None,None,None
ssDNA,ATCGAGTGGACGAGTGCCTCCGGTACGAGCTGTCTGATGGGTTTGCGCGCAGGATCCA,58.0,0.603448275862069,Kd: 3.07 nM,3.04,5′-GATGTGGTAGGTGATCGAGTG-N40-GCAGGATCCATCCACCTCTA-3′,40.0,"1 L, DPBS with 4.5 g, glucose, 100 mg yeast tRNA, 1g BSA, 5 ml, MgCl2 1M",None,Tris Buffers,7.5,The majority of the primer binding regions were removed from the aptamer sequences: 8 bases from the initial primer binding region and 10 bases from the ending primer binding region were synthesized along with the middle 40 random region to yield a 58-base aptamer.,None,None,None
ssDNA,5′GTCTTGACTAGTTACGCCGGGAACAATATGTTCAAGGGCTCTTTAAAGTTTTAGTTCGTTTGTCATTCAGTTGGCGCCTC3′,80.0,0.4375,Kd: 371 ±  0.02 nM,371.0,5′-GTCTTGACTAGTTACGCC-N44-TCATTCAGTTGGCGCCTC-3′,44.0,"10 mM Tris pH 7.5, 10 mM MgCl2, 50 mM KCl, 25 mM NaCl",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,5′GTCTTGACTAGTTACGCCGGGAACAATATGTTCAAGGGCTTTTTTTTTTTTTAGTTCGTTTGTCATTCAGTTGGCGCCTC3′,80.0,0.4125,Kd: 90 ± 2E-5 nM,90.0,5′-GTCTTGACTAGTTACGCC-N44-TCATTCAGTTGGCGCCTC-3′,44.0,"10 mM Tris pH 7.5, 10 mM MgCl2, 50 mM KCl, 25 mM NaCl",MgCl,Tris Buffers,7.5,Truncated (28-mer) and mutated derived from aptamer h63,None,None,MATTLPVQRHPRSLFPEFSELFAAFPSFAGLRPTFDTRLMRLEDEMKEGRYEVR...STN
ssDNA,TGCGGAAGCCACCAGGAGTTAGGGCCCGACGTGACGGCACGTCGGATATCTCATGCGTGTACGAGCCAAAGAGCCGCCAA,80.0,0.6125,Kd: 4.98±1.26 nM,4.98,5′-TGCGGAAGCCACCAGGAGTT-40N-ACGAGCCAAAGAGCCGCCAA-3′,40.0,PBS containing 10% FCS and 0.02% NaN3,None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
2'-fluoro-RNA,GGUUACCAGCCUUCACUGCGGACGGACAGAGAGUGCAACCUGCCGUGCCGCACCACGGUCGGUCACAC,68.0,0.6470588235294118,Kd: 72 ±11 nM for integrin α5β1,72.0,5′-GTGTGACCGACCGTGGTGC-N30-GCAGTGAAGGCTGGTAACC-3′,30.0,1 mM MgCl2 and 0.5 mM CaCl2 in PBS (pH 7.4),MgCl/CaCl,PBS/phosphate buffers,7.4,Not applicable,"2′-fluoropyrimidine modification, End-labeled with a single cyanine 5 fluorescent dye
This SELEX combines three rounds of protein-SELEX surrounded by 15 rounds of cell-SELEX on two different cell lines genetically modified to overexpress integrin α5, the human GBM U87MG cell line, and the Chinese hamster ovaries CHO-B2 cell line.",None,None
ssDNA,AGCAGCACAGAGGTCAGATGTAGGTCGTACTCTGGCGGCCTGTTTGGCCCTATCGCTGCTACCGTGAA,68.0,0.5735294117647058,Kd: 0.082 nM,0.082,5′-AGCAGCACAGAGGTCAGATG-N30-CCTATGCGTGCTACCGTGAA-3′,30.0,"PBS buffer (pH 7.4), 100 mM NaCl, 5 mM KCl, 2 mM MgCl2, 1 mM CaCl2",MgCl/CaCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,AGCAGCACAGAGGTCAGATGTGTGCGTGCTTGGGGTATAGTCGGGTCGGCCTATCGCTGCTACCGTGAA,69.0,0.5797101449275363,Kd: 1.6 nM,1.6,5′-AGCAGCACAGAGGTCAGATG-N30-CCTATGCGTGCTACCGTGAA-3′,30.0,"40 mM HEPES pH 7.4 (or 40 mM Bicine pH 8.0), 125 mM KCl, 5 mM MgCl2, 5% DMSO",MgCl/CaCl,PBS/phosphate buffers,7.4,Not applicable,None,None,MKANLLVLLCALAAADADTICIGYHANNSTDTVDTVLEKNVTVTHSVNLLEDSH...ICI
ssDNA,AGCAGCACAGAGGTCAGATGAGGTGATGAGATTTGTACCTCTCGCGGCACCCTATCGCTGCTACCGTGAA,70.0,0.5428571428571428,Kd: 57 nM,57.0,5′-AGCAGCACAGAGGTCAGATG-N30-CCTATGCGTGCTACCGTGAA-3′,30.0,"40 mM HEPES pH 7.4 (or 40 mM Bicine pH 8.0), 125 mM KCl, 5 mM MgCl2, 5% DMSO",MgCl/CaCl,PBS/phosphate buffers,7.4,Not applicable,None,None,MKANLLVLLCALAAADADTICIGYHANNSTDTVDTVLEKNVTVTHSVNLLEDSH...ICI
ssDNA,AGCAGCACAGAGGTCAGATGATTGGATCGTGACGGTTGTTGGGGCTCCGCCTATCGCTGCTACCGTGAA,69.0,0.5652173913043478,Kd: 35000 nM,35000.0,5′-AGCAGCACAGAGGTCAGATG-N30-CCTATGCGTGCTACCGTGAA-3′,30.0,"40 mM HEPES pH 7.4 (or 40 mM Bicine pH 8.0), 125 mM KCl, 5 mM MgCl2, 5% DMSO",MgCl/CaCl,PBS/phosphate buffers,7.4,Not applicable,None,None,MKANLLVLLCALAAADADTICIGYHANNSTDTVDTVLEKNVTVTHSVNLLEDSH...ICI
ssDNA,AGCAGCACAGAGGTCAGATGTCTGCAGCGTGCAGGGCTGTGTGCTTACCCCCTATCGCTGCTACCGTGAA,70.0,0.5857142857142857,Kd: 0.088 nM,0.088,5′-AGCAGCACAGAGGTCAGATG-N30-CCTATGCGTGCTACCGTGAA-3′,30.0,"40 mM HEPES pH 7.4, 100 mM KCl, 1 mM MgCl2, 0.1% DMSO.",MgCl/CaCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,AGCAGCACAGAGGTCAGATGCTAGCCGTGAGCGTGGTGAGCTCGGTTGACCCTATCGCTGCTACCGTGAA,70.0,0.5857142857142857,Kd: 0.14 nM,0.14,5′-AGCAGCACAGAGGTCAGATG-N30-CCTATGCGTGCTACCGTGAA-3′,30.0,"40 mM HEPES pH 7.4, 100 mM KCl, 1 mM MgCl2, 0.1% DMSO.",MgCl/CaCl,PBS/phosphate buffers,7.4,Not applicable,None,None,MDSNTVSSFQDILMRMSKMQLGSSSEDLNGMITQFESLKLYRDSLGEAVMRMGD...QLI
ssDNA,AGCAGCACAGAGGTCAGATGGCGCGGGCGGTGCGTCGGTGTCCCGCTGGCCTATCGCTGCTACCGTGAA,69.0,0.6666666666666666,Kd: 0.60 nM,0.6,5′-AGCAGCACAGAGGTCAGATG-N30-CCTATGCGTGCTACCGTGAA-3′,30.0,"40 mM HEPES pH 7.4, 100 mM KCl, 1 mM MgCl2, 0.1% DMSO.",MgCl/CaCl,PBS/phosphate buffers,7.4,Not applicable,None,None,MDSNTVSSFQDILMRMSKMQLGSSSEDLNGMITQFESLKLYRDSLGEAVMRMGD...QLI
ssDNA,AGCAGCACAGAGGTCAGATGGTGGTTGTTTTGGGCGAAGTGGCCATGGTCCCTATCGCTGCTACCGTGAA,70.0,0.5571428571428572,Kd: 1.7 nM,1.7,5′-AGCAGCACAGAGGTCAGATG-N30-CCTATGCGTGCTACCGTGAA-3′,30.0,"40 mM HEPES pH 7.4, 100 mM KCl, 1 mM MgCl2, 0.1% DMSO.",MgCl/CaCl,PBS/phosphate buffers,7.4,Not applicable,None,None,MDSNTVSSFQDILMRMSKMQLGSSSEDLNGMITQFESLKLYRDSLGEAVMRMGD...QLI
ssDNA,5′ATCCATTGCCACTGACTACCTACCACCACACCACATCTCCAGCCTCAACGTCGCTTTGTCGAAGTCAGTCGGTCGTTAGT3′,80.0,0.525,Kd: 57.66 ± 5.93 nM,56.66,5′-ATCCATTGCCACTGACTACC-N40-GAAGTCAGTCGGTCGTTAGT-3′,40.0,"40 mM HEPES pH 7.4, 100 mM KCl, 1 mM MgCl2, 0.1% DMSO.",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′ACTGACTACCTACCACCACACCACATCTCCAGCCTCAACGTCGCTTTGTCGAAGTCAGTC3′,60.0,0.5333333333333333,Kd: 39.20 ± 8.20 nM,39.2,5′-ATCCATTGCCACTGACTACC-N40-GAAGTCAGTCGGTCGTTAGT-3′,40.0,"20 mM HEPES, pH 7.4, 150 mM NaCl, 2 mM CaCl2, 0.01% BSA",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′CGATCAAACGTTCAAGCGGGGCCCGGAGGCGTGACTTGGACAGGCAGGCGTTACGATGCATCCCGCAAATGACGCATGA3′,79.0,0.5949367088607594,Kd: 148.13 ± 6.53 nM,148.13,5′-CGATCAAACGTTCAAGCGGG-N40-ATCCCGCAAATGACGCATGA-3′,40.0,"20 mM HEPES, pH 7.4, 150 mM NaCl, 2 mM CaCl2, 0.01% BSA",MgCl,Tris Buffers,7.4,Not applicable,None,None,None
ssDNA,5′CGATCAAACGTTCAAGCGGGGCCCAAGCGGCGTGGTCTGAAGTCCTGGCTGACTGCGGCGATCCCGCAAATGACGCATGA3′,80.0,0.6125,Kd: 183.30 ± 56.27 nM,183.3,5′-CGATCAAACGTTCAAGCGGG-N40-ATCCCGCAAATGACGCATGA-3′,40.0,"320 mM NaCl, 50 mM Tris-HCl,  pH 7.5, 5 mM MgCl, ",MgCl,Tris Buffers,7.4,Not applicable,None,None,None
ssDNA,TAGGGAAGAGAAGGACATATGATTAGGCCGTAAACGGGGCTAGGCGGGGATCATTGACTAGTACATGACCACTTGA,76.0,0.4868421052631579,Kd: 24.86 nM,24.86,5′-TAGGGAAGAGAAGGACATATGAT-N30-TTGACTAGTACATGACCACTTGA-3',30.0,"HBSMClT [HBSMC [HEPES buffered saline (pH 7.4), 1 mm MgCl2, 1 mm CaCl2], 0.01% I-block (Tropix Inc., Bedford, MA), 0.05% Tween 20]",MgCl,PBS/phosphate buffers,7.4,Not applicable,"Other sequences exist, this is best",None,None
ssDNA,GGACGGTTGCGCTATATTTAACCAAAAGTCTGGATTAACA,40.0,0.4,Kd: 177 ± 65 nM,177.0,5'-AGGGTTGATAGGTTAAGAGC-N40-CGATGTCAACTAGCTGTTGGG-3',40.0,"1X DPBS, 5 mM MgCl2",None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,AGGCAGGACACCGTAACCGGTGCATCTATGGCTACTAGCTTTTCCTGCCT,50.0,0.54,Kd: 2.2 ± 0.022 nM,2.2,5'-GACAGGCAGGACACCGTAAC-N40-CTGCTACCTCCCTCCTCTTC-3',40.0,"1X DPBS, 5 mM MgCl2",None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,GCAGGACACCGTAACGGGCGCACGCTCTGAATTTTGCATATGAAACAATTCTGTCCTGC,59.0,0.5084745762711864,Kd: 4.0 ± 0.49 nM,4.0,5'-GACAGGCAGGACACCGTAAC-N40-CTGCTACCTCCCTCCTCTTC-3',40.0,"20 mM HEPES (pH 7.0), 150 mM NaCl, 1 mM MgCl2, 2 mM dithiothreitol, 40 U RNase inhibitor",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MKILILGIFLFLCSTPAWAKEKHYYIGIIETTWDYASDHGEKKLISVDTEHSNI...KSG
ssDNA,AGGCAGGACACCGTAACGGTGCGGTCATATCCGGCTTTGCTTTTCCTGCCT,51.0,0.5686274509803921,Kd: 4.7 ± 0.54 nM,4.7,5'-GACAGGCAGGACACCGTAAC-N40-CTGCTACCTCCCTCCTCTTC-3',40.0,"4.5 g/liter glucose, 5 mM MgCl2 in Dulbecco's PBS with calcium chloride, magnesium chloride (Sigma), adding yeast tRNA (0.1 mg/ml, Sigma), BSA (1 mg/ml, Fisher)",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MKILILGIFLFLCSTPAWAKEKHYYIGIIETTWDYASDHGEKKLISVDTEHSNI...KSG
ssDNA,GCAGGACACCGTAACGGGCGCACGCTCTGAATTTTTCATATGAAACAATTCTGTCCTGC,59.0,0.4915254237288136,Kd: 1.9 ± 0.23 nM,1.9,5'-GACAGGCAGGACACCGTAAC-N40-CTGCTACCTCCCTCCTCTTC-3',40.0," 1 ×PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4·12H2O, 2 mM KH2PO4)",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MKILILGIFLFLCSTPAWAKEKHYYIGIIETTWDYASDHGEKKLISVDTEHSNI...KSG
ssDNA,GCAGGACACCGTAACACGGGCTTTTGCTTTATCGTACCCTTTATGCTAGATTGTCCTGC,59.0,0.4915254237288136,Kd: 1.0 ± 0.12 nM,1.0,5'-GACAGGCAGGACACCGTAAC-N40-CTGCTACCTCCCTCCTCTTC-3',40.0,"1X DPBS, 5 mM MgCl2",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MKILILGIFLFLCSTPAWAKEKHYYIGIIETTWDYASDHGEKKLISVDTEHSNI...KSG
ssDNA,CAGGCAGGACACCGTAACCTTTCAGGGTGGTGCCGTTTCGGGCTTTGTCTCTTCCTGCCTG,61.0,0.5901639344262295,Kd: 2.6 ± 0.34 nM,2.6,5'-GACAGGCAGGACACCGTAAC-N40-CTGCTACCTCCCTCCTCTTC-3',40.0,"40 mM HEPES (pH 7.5), 102 mM NaCl, 5 mM KCl, 5 mM MgCl2, 0.05% Tween-20",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MKILILGIFLFLCSTPAWAKEKHYYIGIIETTWDYASDHGEKKLISVDTEHSNI...KSG
ssRNA,GGGAGGACGAUGCGGUCCUGUCGUCUGUUCGUCCCCAGACGACUCGCCCGA,51.0,0.6666666666666666,Kd: 122.0 ± 5.23 nM,122.0,5'-GGGAGGACGAUGCGG-N20-CAGACGACUCGCCCGA-3',20.0,"HEPES-buffered saline, pH 7.5 with 2 mmol/L CaCl2) containing BSA (0.1 mg/mL) and tRNA (0.1 mg/mL)",CaCl,Other Buffers,7.5,Not applicable,None,None,None
ssRNA,GGGAGGACGAUGCGGCGUUUCCUCUGGUUCGUCCCCAGACGACUCGCCCGA,51.0,0.6666666666666666,Kd: 96.9 ± 5.77 nM,96.9,5'-GGGAGGACGAUGCGG-N20-CAGACGACUCGCCCGA-3',20.0,"HEPES-buffered saline, pH 7.5 with 2 mmol/L CaCl2) containing BSA (0.1 mg/mL) and tRNA (0.1 mg/mL)",CaCl,Other Buffers,7.5,Not applicable,None,None,MDSYLLMWGLLTFIMVPGCQAELCDDDPPEIPHATFKAMAYKEGTMLNCECKRG...RTI
ssRNA,GGGAGGACGAUGCGGUGAGUCGUUCCCUUCGUCCCCAGACGACUCGCCCGA,51.0,0.6666666666666666,Kd: 68.2 ± 2.73 nM,68.2,5'-GGGAGGACGAUGCGG-N20-CAGACGACUCGCCCGA-3',20.0,"RNA binding buffer 20 mM Na3PO4, pH 7.4/120 mM NaCl/2.5 mM KCl/0.12 mM MgSO4/40mM HEPES, pH 7.4)",CaCl,Other Buffers,7.5,Not applicable,None,None,MDSYLLMWGLLTFIMVPGCQAELCDDDPPEIPHATFKAMAYKEGTMLNCECKRG...RTI
ssRNA,GGGAGGACGAUGCGGGCCGUUGUUGUGUGCCGCCCCAGACGACUCGCCCGA,51.0,0.7058823529411765,Kd: 35.7 ± 1.56 nM,35.7,5'-GGGAGGACGAUGCGG-N20-CAGACGACUCGCCCGA-3',20.0,"RNA binding buffer 20 mM Na3PO4, pH 7.4/120 mM NaCl/2.5 mM KCl/0.12 mM MgSO4/40mM HEPES, pH 7.4)",CaCl,Other Buffers,7.5,Not applicable,None,None,MDSYLLMWGLLTFIMVPGCQAELCDDDPPEIPHATFKAMAYKEGTMLNCECKRG...RTI
ssRNA,GGGAGGACGAUGCGGAUUCUGGUUACUGGCCGCCCCAGACGACUCGCCCGA,51.0,0.6666666666666666,Kd: 46.1 ± 1.76 nM,46.1,5'-GGGAGGACGAUGCGG-N20-CAGACGACUCGCCCGA-3',20.0,"HEPES-buffered saline, pH 7.5 with 2 mmol/L CaCl2) containing BSA (0.1 mg/mL) and tRNA (0.1 mg/mL)",CaCl,Other Buffers,7.5,Not applicable,None,None,MDSYLLMWGLLTFIMVPGCQAELCDDDPPEIPHATFKAMAYKEGTMLNCECKRG...RTI
ssDNA,GTCTTGACTAGTTACGCCGGTGTGTTGACTGAGGGGGTGGGGTGGGTGGTGGTGGATATAGCTCATTCAGTTGGCGCCTC,80.0,0.575,Kd: 12 nM,12.0,5'-GTCTTGACTAGTTACGCC-N44-TCATTCAGTTGGCGCCTC-3',44.0,"10 mM Tris [pH 7.5], 10 mM MgCl2, 50 mM KCl, 25 mM NaCl)",MgCl,Tris Buffers,7.5,Not appilcable,"Pool was obtained from a cited paper: Dhiman, A., Haldar, S., Mishra, S. K., Sharma, N., Bansal, A., Ahmad, Y., Kumar, A., Sharma, T. K., & Tyagi, J. S. (2018). Generation and application of DNA aptamers against HspX for accurate diagnosis of tuberculous meningitis. Tuberculosis (Edinburgh, Scotland), 112, 27–36. https://doi.org/10.1016/j.tube.2018.07.004",None,None
ssDNA,5′CTCCTCTGACTGTAACCACGACACGCACAAATGTCAGTGTACCGCACTCGCACATTCTTAGCATAGGTAGTCCAGAAGCC3′,80.0,0.5125,Kd: 25 nM,25.0,5′-CTCCTCTGACTGTAACCACG-N40-GCATAGGTAGTCCAGAAGCC-3′,40.0,"Dulbecco's phosphate buffered saline (DPBS, Sigma-Aldrich, St. Louis, MO, USA)",None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′CTCCTCTGACTGTAACCACGGTGCGCGTACCACCATGTGTACACACTGCATGTTTGGTTAGCATAGGTAGTCCAGAAGCC3′,80.0,0.525,Kd: 15 nM,15.0,5′-CTCCTCTGACTGTAACCACG-N40-GCATAGGTAGTCCAGAAGCC-3′,40.0,"Dulbecco's phosphate buffered saline (DPBS, Sigma-Aldrich, St. Louis, MO, USA)",None,PBS/phosphate buffers,7.4,Not applicable,None,None,MALPQVLSFGLLLAVATAAVAAAQGECNCENYKLTTNCSLNSNGQCQCTSVGTQ...HSG
ssDNA,5′ATACCAGCTTATTCAATTCAGGAAGACAACTCCGACTAGAATTGATAATCAAGAATTCGTCTGGGGGGAATGTGCGAGATAGTAAGTGCAATCT3′,94.0,0.40425531914893614,Kd: 55 nM,55.0,5′-ATACCAGCTTATTCAATT-N60-AGATAGTAAGTGCAATCT-3′,60.0,"50 mM Tris, pH 7.5, 150 mM NaCl and 2 mM MgCl2",MgCl,Tris Buffers,7.5,Not applicable,None,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)NC(=O)N4CCNC4=O)C(=O)O)C,None
ssDNA,5′ATTGGCACTCCACGCATAGGACGCATAGGGTGCGACCACATACGCCCCATGTATGTCCCTTGGTTGTGCCCTATGCGTCCTATGCGTGCTACCGTGAA3′,98.0,0.5612244897959183,Kd: 2.26 ± 0.06 nM,2.26,5′-ATTGGCACTCCACGCATAGG-N40-CCTATGCGTGCTACCGTGAA-3′,40.0,"DPBS buffer (0.1 g CaCl2, 0.2 g KCl, 0.2 g KH2PO4, 0.1 g MgCl2.6H2O, 8 g NaCl, and 1.15 g Na2HPO4; 1 L, pH 7.5)",MgCl/CaCl,PBS/phosphate buffers,7.5,Not applicable,None,None,None
ssDNA,5′GCTGTGTGACTCCTGCAATCCGATCGGTATATCCGTCGGATTTTTTTTTTGGTCACTGCATGTGACCGCAGCTGTATCTTGTCTCC3′,86.0,0.4883720930232558,Kd: 67nM,67.0,5′‐GCTGTGTGACTCCTGCAA‐N42‐GCAGCTGTATCTTGTCTCC‐3′,42.0,"Binding buffer (50 mM Tris–HCl, 5 mM KCl, 100 mM NaCl, 1 mM MgCl2, pH 7.4)",MgCl,Tris Buffers,7.4,The t1 and t4 were linked with 10 oligos (dt) and created dimer aptamer,None,None,None
2'-fluoro-RNA,5′ACGUAUCCCUUUUCGCGUA3′,19.0,0.47368421052631576,Kd: 39.89 ± 3.37 nM,39.89,5’-GGGACACAATGGACG-N40-TAACGGCCGACATGAGAG-3’,40.0,PBS containing 5 mM MgCl2,MgCl,PBS/phosphate buffers,7.4,"For all of the aptamers, an amino-modifier-c6-tfa phosphoramidite group (6-[trifluoroacetylamino]hexyl-[(2-cyanoethyl)-(n,n-diisopropyl)]- phosphoramidite) and an inverted deoxythymidine group were added to the 5′- and 3′-end of the aptamers, respectively, for enhanced nuclease resistance. ","#- This research article doesn't utilize a pool by experimenting with the in silico protocol. EP23 aptamer sequence includes the substitution (from 5' to 3') of 2′-fluoro for 2′-hydroxyl group in NTPs #2, 4, 6, 7, 8, 9, 10, 11, 12, 13, 14, 16, 18.
Pool was found in:  Xiang D., et al., Superior performance of aptamer in tumor penetration over antibody: Implication of aptamer-based theranostics in solid tumors. Theranostics 5, 1083–1097 (2015). 
Aptamer sequence found in: Shigdar S., et al., RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule. Cancer Sci. 102, 991–998 (2011).",None,None
2'-fluoro-RNA,5′ACGUUUCCCUUUUCGCGUA3′,19.0,0.47368421052631576,Kd: 10.78 ± 1.37 nM,10.78,Initial Sequence: ACGUAUCCCUUUUCGCGUA,0.0,PBS containing 5 mM MgCl3,MgCl,PBS/phosphate buffers,7.4,"For all of the aptamers, an amino-modifier-c6-tfa phosphoramidite group (6-[trifluoroacetylamino]hexyl-[(2-cyanoethyl)-(n,n-diisopropyl)]- phosphoramidite) and an inverted deoxythymidine group were added to the 5′- and 3′-end of the aptamers, respectively, for enhanced nuclease resistance. ","#- This research article doesn't utilize a pool by experimenting with the in silico protocol. A5U aptamer sequence includes the substitution (from 5' to 3') of 2′-fluoro for 2′-hydroxyl group in NTPs #2, 4, 6, 7, 8, 9, 10, 11, 12, 13, 14, 16, 18. An amino-modifier-C6-TFA phosphoramidite group (6-[trifluoroacetylamino]hexyl-[(2-cyanoethyl)-(N,N-diisopropyl)]- phosphoramidite) and an inverted deoxythymidine group were added to the 5′- and 3′-ends of the aptamer, respectively.",None,MAGPQALAFGLLLAVVTATLAAAQRDCVCDNYKLATSCSLNEYGECQCTSYGTQ...LNA
2'-fluoro-RNA,5′ACGUAUCCCUUUUCUCGUA3′,19.0,0.42105263157894735,Kd: 11.91 ± 0.95 nM,11.91,Initial Sequence: ACGUAUCCCUUUUCGCGUA,0.0,PBS containing 5 mM MgCl4,MgCl,PBS/phosphate buffers,7.4,"For all of the aptamers, an amino-modifier-c6-tfa phosphoramidite group (6-[trifluoroacetylamino]hexyl-[(2-cyanoethyl)-(n,n-diisopropyl)]- phosphoramidite) and an inverted deoxythymidine group were added to the 5′- and 3′-end of the aptamers, respectively, for enhanced nuclease resistance. ","#- This research article doesn't utilize a pool by experimenting with the in silico protocol. G15U aptamer sequence includes the substitution (from 5' to 3') of 2′-fluoro for 2′-hydroxyl group in NTPs #2, 4, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 18. An amino-modifier-C6-TFA phosphoramidite group (6-[trifluoroacetylamino]hexyl-[(2-cyanoethyl)-(N,N-diisopropyl)]- phosphoramidite) and an inverted deoxythymidine group were added to the 5′- and 3′-ends of the aptamer, respectively.",None,MAGPQALAFGLLLAVVTATLAAAQRDCVCDNYKLATSCSLNEYGECQCTSYGTQ...LNA
5-uracil-modified-DNA,GATATGTCCAGCCTGTCGAATGCCtAGttCtGCCttAAtAtGGtCGGttAAGCCTAAACTGATGTGCGGCGTAACC,76.0,0.4868421052631579,Kd: 6.2 pM,0.0062,5'-GATATGTCCAGCCTGTCGAATGC-N30-CTAAACTGATGTGCGGCGTAACC-3',30.0,"Selection buffer (SB; 40 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH7.5, 125 mM NaCl, 5 mM KCl, 1 mM MgCl2, 0.01% Tween 20)",MgCl,Other Buffers,7.5,Not applicable,"Used a modified DNA library containing the following base-appended base modifications: analog adenine derivative at the fifth position of uracil (Uad), analog guanine derivative at the fifth position of uracil (Ugu), and analog adenine derivative at the seventh position of adenine (Aad). *t indicates Ugu",None,None
5-uracil-modified-DNA,GTATAGTAGCCAGCCAGCCTTAGGCTGCTGGCTCGTGaGaCGGaTaTCaGGTCTCATAAACGGCGAGGTGTCAATTCC,78.0,0.5384615384615384,Kd: 235 pM,0.235,5'-GTATAGTAGCCAGCCAGCCTTAGG-N30-CATAAACGGCGAGGTGTCAATTCC3',30.0,"Selection buffer (SB; 40 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH7.5, 125 mM NaCl, 5 mM KCl, 1 mM MgCl2, 0.01% Tween 20)",MgCl,Other Buffers,7.5,Not applicable,"Used a modified DNA library containing the following base-appended base modifications: analog adenine derivative at the fifth position of uracil (Uad), analog guanine derivative at the fifth position of uracil (Ugu), and analog adenine derivative at the seventh position of adenine (Aad).*a indicates Aad",None,None
ssRNA,5′AUCCAGAGUGACGCAGCUAACUUAAUCAACCGCAGGUUGAUUAGCCCAUUAGCUGGACACGGUGGCUUAGU3′,71.0,0.49295774647887325,Kd: 20 nM,20.0,5′-ATCCAGAGTGACGCA-N45-TGGACACGGTGGCTTAGT-3′,45.0,"50 mM of Tris‐HCl pH 7.5, 150 mM of NaCl, 5 mM of MgCl2, 0.1% of BSA, and 0.1% of Triton X‐100",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,TCCAGCACTCCACGCATAACGAATTGTGCTCAATGCGCCCCTGCAGTGAATGTGGAATTTGTTATGCGTGCGACGGTGAA,80.0,0.5125,Kd: 412.3 ± 124.6 nM,412.3,5'-TCCAGCACTCCACGCATAAC-N40-GTTATGCGTGCGACGGTGAA-3',40.0,"1mM CaCl2, 2.5 mM KCl, 1.5 mM KH2PO4, 0.5 mM MgCl2·6H2O, 137 mM NaCl, 8mM Na2HPO4, pH 7.2",MgCl/CaCl,PBS/phosphate buffers,7.2,Not applicable,None,None,None
ssDNA,5′TAGGGAAGAGAAGGACATATGATGCAATGGAACCGCTGAACGACCCTAGCATTATCAGTGTGGTTGACTAGTACATGACCACTTGA3′,86.0,0.45348837209302323,Kd: 114.9 nM at 27 °C and 63.4 nM at 37 °C,114.9,5′-TAGGGAAGAGAAGGACATATGAT-N40-TTGACTAGT ACATGACCACTTGA-3′,40.0,"Binding buffer (50 mM Tris-HCl, 100 mM NaCl, 5 mM KCl and 1 mM MgCl2, pH 7.4)",MgCl,Tris Buffers,7.4,Not applicable,None,None,None
ssDNA,GCTGTGTGACTCCTGCAAACTACTGGTGTTCCTTGCCCTGTTTCAATAAATCGTGTGTGCCGCAGCTGTATCTTGTCTCC,80.0,0.5,Kd: 56.45 nM,56.45,5´-GCTGTGTGACTCCTGCAA-N43-GCAGCTGTATCTTGTCTCC-3´,43.0,"Binding buffer (20 mM Tris−HCl, 100 mM NaCl, 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2 and 0.02% Tween 20, pH 7.6)",MgCl/CaCl,Tris Buffers,7.6,Not applicable,Fluorescence is observed when Apt122 is labled with ATTO 647 N; allows for TAC detection,None,None
ssDNA,GCTGTGTGACTCCTGCAAACTACTGGTGTTCCTTGCCCTGTTTCAATAAATCGTGTGTGCCGCAGCTGTATCTTGTCTCC,80.0,0.5,Kd: 180 nM,180.0,5´-GCTGTGTGACTCCTGCAA-N43-GCAGCTGTATCTTGTCTCC-3´,43.0,"Binding buffer (20 mM Tris−HCl, 100 mM NaCl, 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2 and 0.02% Tween 20, pH 7.6)",MgCl/CaCl,Tris Buffers,7.6,Not applicable,None,None,None
ssDNA,GGACAGGACCACACCCAGCGCGGTCGGCGGGTGGGCGGGGGGAGAACGAGGTAGGGGTCAGGCTCCTGTGTGTCGCTTTGT,81.0,0.691358024691358,Kd: 19.6 nM,19.6,5′-GGACAGGACCACACCCAGCG-N40-GGCTCCTGTGTGTCGCTTTGT-3′,40.0,"PH 7.4 PBS containing 4.5 mM MgCl2, 0.005% Tween 20, and 100 μg/mL tRNA (Sigma, R8759)",MgCl,PBS/phosphate buffers,7.4,Addition of an antimir-21 dnazyme component that will recognize and inhibit the expression of endogenous mir-21 target in the cytoplasm,"Forward primer, 5′-TTTTTTTTTTTTTTTTTTTT/iSp9/ACAAAGCGACACACAGGAGCC-3′; reverse primer, 5′-GGACAGGACCACACCCAGCG-3′.",None,None
ssDNA,ATACCAGCTTATTCAATTATTCAATTCGAGGCGGGTGGGTGGGTTGAATGATAGTAAGTGCAATCT,66.0,0.4090909090909091,Kd: 1 mM,1000000.0,5'-ATACCAGCTTATTCAATT-N40-GATAGTAAGTGCAATCT-3',40.0,"Tris⋅Cl (20 mm, pH 7.5), NaCl (100 mm), KCl (5 mm), MgCl2 (1 mm) and CaCl2 (1 mm; selection buffer, SB)",MgCl/CaCl,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,5’TAACACGACAGACGTTCGGAGGTCGAACCCTGACAGCGTGGG,42.0,0.5952380952380952,Kd: 38.71 ± 6.22 nM via ELISA assay,38.71,5′-TAGGGAAGAGAAGGACATATGAT-N43-TTGACTAGTACATGACCACTTGA-3′,43.0,"PH 7.4 PBS containing 2.0 mM MgCl2, 0.02% Tween 20, and 100 µg/mL Salmon Sperm DNA (ThermoFisher, 15632011)",MgCl,PBS/phosphate buffers,7.4,Not applicable,utilized Competitive SELEX,None,None
ssDNA,5’TAACACGACAGACGTTCGGAGGTCGAACCCTGACAGCGTGGG,42.0,0.5952380952380952,Kd: 96.92 nM and 113.20 nM for MDA-MB-231 and HEK293T/CD63 cells respectively via flow cytometry,96.92,5′-TAGGGAAGAGAAGGACATATGAT-N43-TTGACTAGTACATGACCACTTGA-3′,43.0,"PH 7.4 PBS containing 2.0 mM MgCl2, 0.02% Tween 20, and 100 µg/mL Salmon Sperm DNA (ThermoFisher, 15632011)",MgCl,PBS/phosphate buffers,7.4,Not applicable,utilized Competitive SELEX,None,None
ssDNA,5′TAGGGAAGAGAAGGACATATGATTAACCACCCCACCTCGCTCCCGTGACACTAATGCTAATTCCAATTGACTAGTACATGACCACTTGA3′,89.0,0.449438202247191,Kd: 78.43 ± 12.53 nM via ELISA assay,78.43,5′-TAGGGAAGAGAAGGACATATGAT-N43-TTGACTAGTACATGACCACTTGA-3′,43.0,"PH 7.4 PBS containing 2.0 mM MgCl2, 0.02% Tween 20, and 100 µg/mL Salmon Sperm DNA (ThermoFisher, 15632011)",MgCl,PBS/phosphate buffers,7.4,Not applicable,utilized Competitive SELEX,None,None
ssDNA,ACCGACCGTGCTGGACTCATCTCGCTTTTTTCACGGTCCACACTACTATGAGCGAGCCTGGCG,63.0,0.5714285714285714,Kd: 15 ± 1.74 nM,15.0,5′-ACCGACCGTGCTGGACTCA-N25-ACTATGAGCGAGCCTGGCG-3′,25.0,"D-PBS supplemented with 4.5 g/L of glucose, 5 mM of MgCl2, 0.1 mg/mL of yeast tRNA, and 1 mg/mL of BSA",MgCl,PBS/phosphate buffers,7.4,Not applicable,"Binding buffer obtained from a different paper - Wu, X., Zhao, Z., Bai, H., Fu, T., Yang, C., Hu, X., Liu, Q., Champanhac, C., Teng, I. T., Ye, M., & Tan, W. (2015). DNA Aptamer Selected against Pancreatic Ductal Adenocarcinoma for in vivo Imaging and Clinical Tissue Recognition. Theranostics, 5(9), 985–994. https://doi.org/10.7150/thno.11938",None,None
ssRNA,GGGACGAAGACCAACUGAACUUUGUGGUGGCGGCUACUCGUGUUCUUUUGACUUUGUCCGUGCUGCCACCUUACUUC,77.0,0.5194805194805194,Kd: 20 ± 6.0 nM,20.0,5'-GGACGAAGACCAACUGAACUGAACUUU-N55-UUGUCCGUGCUGCCACCUUACUUC-3',55.0,"50 mM sodium phosphate, and 100 mM NaCl, pH 7.4",None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,ATGCGGATCCCGCGCGCAGTGCAGGGAGCCGCTCCACGTACGTTGCGCGAAGCTTGCGC,59.0,0.6949152542372882,Kd: 1.748 ± 0.227 nM,1.748,5′-ATGCGGATCCCGCGC-N30-GCGCGAAGCTTGCGC-3′,30.0,"PBS, pH 7.4",None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5’GGCCATTGTGGACTTCTTTGGGTAATTCAGGGGCTCGATT3’,40.0,0.5,Kd: 8.8nM,8.8,5´-ATACCAGCTTATTCAATT-N40-AGATAGTAAGTGCAATCT-3´,40.0,"20 mM Tris pH 7.6, 100 mM NaCl, 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2, 0.02% v/v Tween 20",MgCl/CaCl,Tris Buffers,7.6,Not applicable,"the antibody, rituximab, was extensively heat treated and that heat treated formation was what the aptamer bound to",None,None
ssDNA,5´ATACCAGCTTATTCAATTTAGTATTCACGGCAGAGTCTGGCAGACTTGTCTTCTTGTGAGATAGTAAGTGCAATCT3´,76.0,0.39473684210526316,Kd: 65.8 nM,65.8,5´-ATACCAGCTTATTCAATT-N40-AGATAGTAAGTGCAATCT-3´,40.0,"20 mM Tris pH 7.6, 100 mM NaCl, 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2, 0.02% v/v Tween 20",MgCl/CaCl,Tris Buffers,7.6,Not applicable,"the antibody, rituximab, was extensively heat treated and that heat treated formation was what the aptamer bound to",None,None
ssDNA,5´ATACCAGCTTATTCAATTGGACTTGTTTGCTCGAACGATGGTTTGTGCTTTTGTGTTAGATAGTAAGTGCAATCT3´,75.0,0.37333333333333335,Kd: 86.7 nM,86.7,5´-ATACCAGCTTATTCAATT-N40-AGATAGTAAGTGCAATCT-3´,40.0,"20 mM Tris pH 7.6, 100 mM NaCl, 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2, 0.02% v/v Tween 20",MgCl/CaCl,Tris Buffers,7.6,Not applicable,"the antibody, rituximab, was extensively heat treated and that heat treated formation was what the aptamer bound to",None,None
ssDNA,5´ATACCAGCTTATTCAATTCGCTCCGTTTACTCGGTCTGCTATTGGCTTGCCTTTGTTTAGATAGTAAGTGCAATCT3´,76.0,0.40789473684210525,Kd: 56.5 nM,56.5,5´-ATACCAGCTTATTCAATT-N40-AGATAGTAAGTGCAATCT-3´,40.0,"20 mM Tris pH 7.6, 100 mM NaCl, 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2, 0.02% v/v Tween 20",MgCl/CaCl,Tris Buffers,7.6,Not applicable,"the antibody, rituximab, was extensively heat treated and that heat treated formation was what the aptamer bound to",None,None
ssDNA,5’ACTTCGGCTAGTTAGGGGGTAGTTTAGATCGTCTCTACAT3’,40.0,0.45,Kd: 17.6 nM,17.6,5´-ATACCAGCTTATTCAATT-N40-AGATAGTAAGTGCAATCT-3´,40.0,"20 mM Tris pH 7.6, 100 mM NaCl, 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2, 0.02% v/v Tween 20",MgCl/CaCl,Tris Buffers,7.6,Not applicable,"the antibody, rituximab, was extensively heat treated and that heat treated formation was what the aptamer bound to",None,None
ssDNA,5´ATACCAGCTTATTCAATTGGCGTATGCAGTTTTGTAGGGTTATCAAGGCTTGACGATTAGATAGTAAGTGCAATCT3´,76.0,0.3815789473684211,Kd: 82.4 nM,82.4,5´-ATACCAGCTTATTCAATT-N40-AGATAGTAAGTGCAATCT-3´,40.0,"20 mM Tris pH 7.6, 100 mM NaCl, 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2, 0.02% v/v Tween 20",MgCl/CaCl,Tris Buffers,7.6,Not applicable,"the antibody, rituximab, was extensively heat treated and that heat treated formation was what the aptamer bound to",None,None
ssDNA,5′ATACCAGCTTATTCAATTAAGCGGGGTTGAGATATATTAACTAGACAACTTGTTAAAACTCGCGACTACAGATAGTAAGTGCAATCT3′,87.0,0.3563218390804598,Kd: 148.41 ± 1.5 nM via flow cytometry analysis,148.41,5′-ATACCAGCTTATTCAATT-N52-AGATAGTAAGTGCAATCT-3′,52.0,"DPBS, and 4.5 g of glucose, 100 mg tRNA, 1 g BSA and 5 ml of 1 M MgCl2; pH 7",MgCl,Tris Buffers,7.0,Not applicable,utilized human embryonic kidney 293T (HEK293T) to overexpress HBsAg | utilized modified cell-SELEX,None,None
ssDNA,5′GACAGGCAGGACACCGTAACGGCAGGACACCGTAACGGGTATGCAGCTATCCCGGGCGCTGTCTGAAGATCGTGTGCTGCTCTGCTACCTCCCTCCTCTTC3′,101.0,0.6039603960396039,Kd: 0.81 ± 0.13 nM via SPR & 12.9 ± 1.03 nM via microarray chip ,0.81,5′-GACAGGCAGGACACCGTAAC-N40-CTGCTACCTCCCTCCTCTTC-3′ also 5′-GACAGGCAGGACACCGTAAC-3N-GTCC-5N-GGAC-2N-GCC-4N-GGC-3N-GTTACGGTGCTGCTACCTCCCTCCTCTTC-3′,40.0,"1 × PBSMCT: 137 mM NaCl, 2.7 mM KCl, 5 mM MgCl2 and 1 mM CaCl2, 0.05% Tween-20, pH 7.4",MgCl/CaCl,PBS/phosphate buffers,7.4,Not applicable,"utilized two pools, however XK-10 sequence was most present in both end round libraries | utilized Precision-SELEX. . Primers for PCR amplification consisted of TAMRA-modified forward primer (TAMRA-FP) and biotinylated-modified reverse primer (Biotin-RP). TAMRA-FP: 5′-TAMRA-GACAGGCAGGACACCGTAAC-3′, Biotin-RP: 5′-Biotin-GAAGAGGAGGGAGGTAGCAG-3′.",None,None
ssDNA,5′ATACCAGCTTATTCAATTGGCGATGAGAACGGGAGCCTGATGATACACACGAGCGATCGCTCATAAAAGCCGTGCCCGAGATAGTAAGTGCAATCT3′,96.0,0.4791666666666667,Kd: 55.5 nM via fluorescence-based assay,55.5,5′-ATACCAGCTTATTCAATT-N60-AGATAGTAAGTGCAATCT-3′,60.0,"2 mM MgCl2, 50 mM Tris (pH 7.5) and 150 mM NaCl in distilled water",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,5’ATGACGGGGGTCTAGGCAAGTAATAACGGGGGCAAGCTTTTCTATCTCGTTCTAGGGTA3’,59.0,0.4915254237288136,Kd: 69.34 nM via fluorescence-based assay,69.34,5′-ATACCAGCTTATTCAATT-N60-AGATAGTAAGTGCAATCT-3′,60.0,"2 mM MgCl2, 50 mM Tris (pH 7.5) and 150 mM NaCl in distilled water",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,5′CCTAACCGATATCACACTCACCGCGTGAGCGGGGAGGCGATGCCCAGGCTAACTTGACTCAGTTGGTCGTCATTGGAGTATC,82.0,0.5609756097560976,Kd: 3.18 μM via sequence homology using Clustal X software & 4.51 nM via TFI assay,3.18,5′-CCTAACCGATATCACACTCAC-N40-GTTGGTCGTCATTGGAGTATC-3′,40.0,"Four kinds of incubation solutions (separately adding 1 mM MgCl2, 2.7 mM KCl, and 40 mM NaCl) were used: a) 25 mM trizma base, 192 mM glycine, 5 mM K2HPO4 (TGK, pH 8.3); b) 25 mM Tris–HCl (pH 7.4); c) 50 mM H3BO3/Na2B4O7 solution (BBS, pH 8.7); d) 8.1 mM Na2HPO4, 1.1 mM KH2PO4 (PBS, pH 7.4)",MgCl,Tris Buffers,8.3,Not applicable,utilized CE-SELEX,None,None
ssDNA,TTACGTCAAGGTGTCACTCCGCCAGGTGTGCGACGGTCGT,40.0,0.6,Kd: 1.8 ± 0.5 nM & inhibition constant (IC50) of 7.1 ± 0.6 nM,1.8,5'-TTACGTCAAGGTGTCACTCC-N40-GAAGCATCTCTTTGGCGTG-3',40.0,"HEPES buffer: 50 mM HEPES, 150 mM NaCl, 6 mM KCl, 2.5 mM MgCl2, 2.5 mM CaCl2, 0.01% v/v Tween-20, pH 7.4",MgCl/CaCl,Other Buffers,7.4,Truncated begining at the 3' end to 40 nucleotides total,None,None,None
ssDNA,5′ACCGGGTGAGGGGGGTCCAGTGTTAGTAGCGATGGAGGGGTGAC3′,44.0,0.6363636363636364,Kd: 1.97 ± 0.48 μM via ELASA,1970.0,5′-GGTGACTGCTACTGTGTTGG-N44-CCACACATCCAAGCAGAACC-3′,44.0,"50 mM Tris, 137 mM NaCl, 5 mM MgCl2, pH 7.4",MgCl,Tris Buffers,7.4,Truncated on both sides to remove the primer binding sites,None,None,None
ssDNA,5′ATACCAGCTTATTCAATTGTAGAGTATAAAAAGAGTGATGATCTTTTGTAGGTTTTTTAGATAGTAAGTGCAATCT3′,76.0,0.2894736842105263,Kd: 95.73 ± 14.27 nM via flow cytometry analysis & 16.3 nM via SPR,95.73,5′-ATACCAGCTTATTCAATT-N40-AGATAGTAAGTGCAATCT-3′,40.0,"Yeast tRNA (0.1 mg mL−1, Sigma) and BSA (1 mg mL−1, Sigma) into 4.5 g L−1 glucose and 5 mM MgCl2 in Dulbecco's PBS without calcium and magnesium",MgCl,PBS/phosphate buffers,7.4,Not applicable,utilized Cell-SELEX,None,None
ssDNA,CGTTAGACG,9.0,0.5555555555555556,Kd: 24.6 nM via fluorescence intensity,24.6,5′-GACAGGCAGGACACCGTAAC-N40-CTGCTACCTCCCTCCTCTTC-3′,40.0,"20 mM Tris-HCl, 100 mM NaCl, 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2, pH 7.4",MgCl/CaCl,Tris Buffers,7.4,Truncated into a 9-mer,utilized GO-SELEX,None,None
ssDNA,GACGCTTACTCAGGTGTGACTCGGGGTGTAGCTCGTTATGATTCGGACAAGACTTACCTTGCGCCTCTGGGATCGAAGGACGCAGATGAAGTCTC,95.0,0.5368421052631579,Kd: 220.86 nM via flow cytometry,220.86,5'-GACGCTTACTCAGGTGTGACTCG-50N-CGAAGGACGCAGATGAAGTCTC-3',50.0,"10% FBS (Life Technologies), 1.0 g/L bovine serum albumin (Solarbio, Beijing, China), 5 g/L glucose, 0.1 mg/ml yeast tRNA (Invitrogen, Carlsbad, CA, USA) and 5 mM MgCl2) and phosphatebuffered saline (PBS; 10 mM Na2HPO4.12 H2O, 2 mM KH2PO4,137 mM NaCl)",MgCl,PBS/phosphate buffers,7.4,Not applicable,Forward primer was labelled with 6-carboxyfluorescein (FAM) (5'-FAMGACGCTTACTCAGGTGTGACTCG-3'). Reverse primer was labelled with biotin (5'-Biotin-GAGACTTCATCTGCGTCCTTCG-3').,None,None
ssDNA,GACGCTTACTCAGGTGTGACTCGTGAACCCACCTCAGGGCATCTTACATTTCTTCTAAGTTGTTACCATGTTTCGAAGGACGCAGATGAAGTCTC,95.0,0.47368421052631576,Kd: 176.63 nM via flow cytometry,176.63,5'-GACGCTTACTCAGGTGTGACTCG-50N-CGAAGGACGCAGATGAAGTCTC-3',50.0,"10% FBS (Life Technologies), 1.0 g/L bovine serum albumin (Solarbio, Beijing, China), 5 g/L glucose, 0.1 mg/ml yeast tRNA (Invitrogen, Carlsbad, CA, USA) and 5 mM MgCl2) and phosphatebuffered saline (PBS; 10 mM Na2HPO4.12 H2O, 2 mM KH2PO4,137 mM NaCl)",MgCl,PBS/phosphate buffers,7.4,Not applicable,Forward primer was labelled with 6-carboxyfluorescein (FAM) (5'-FAMGACGCTTACTCAGGTGTGACTCG-3'). Reverse primer was labelled with biotin (5'-Biotin-GAGACTTCATCTGCGTCCTTCG-3').,None,None
ssDNA,GACGCTTACTCAGGTGTGACTCGTCCGTCGGTTCGCCTTGCGAGTGCACGCCGCCAGCCGTTACATAAAGTCTGCCCACTCGAAGGACGCAGATGAAGTCTC,102.0,0.5882352941176471,Kd: 278.66 nM via flow cytometry,278.66,5'-GACGCTTACTCAGGTGTGACTCG-50N-CGAAGGACGCAGATGAAGTCTC-3',50.0,"10% FBS (Life Technologies), 1.0 g/L bovine serum albumin (Solarbio, Beijing, China), 5 g/L glucose, 0.1 mg/ml yeast tRNA (Invitrogen, Carlsbad, CA, USA) and 5 mM MgCl2) and phosphatebuffered saline (PBS; 10 mM Na2HPO4.12 H2O, 2 mM KH2PO4,137 mM NaCl)",MgCl,PBS/phosphate buffers,7.4,Not applicable,Forward primer was labelled with 6-carboxyfluorescein (FAM) (5'-FAMGACGCTTACTCAGGTGTGACTCG-3'). Reverse primer was labelled with biotin (5'-Biotin-GAGACTTCATCTGCGTCCTTCG-3').,None,None
ssDNA,5′ATACCAGCTTATTCAATTCCATATGTGAGTTTCTTTTTTTGTTTCTCTTGGGCGGGCGAGATAGTAAGTGCAATCT3′,76.0,0.3815789473684211,Kd: 16.2 ± 3.22 nM via flow analysis,16.2,5′‐ATACCAGCTTATTCAATT-N40-AGATAGTAAGTGCAATCT‐3′,40.0,"4.5 g/L glucoses, 5 mM MgCl2, 0.1 mg/ml yeast tRNA (Invitrogen), and 1 mg/ml bovine serum albumin (BSA) (Amresco) into PBS",MgCl,PBS/phosphate buffers,7.4,Not applicable,utilized Cell-SELEX,None,None
ssDNA,AGATACTGCCATTCATTGCATCCACATCGGAGAACAGGCGCACTGTCGGAGGAACCGCAACGTCGAGTACTAAGCTATGTGTCGA,85.0,0.5176470588235295,Kd: 314 ± 101.2 nM via direct ELONA,314.0,5'-AGATACTGCCATTCATTGCAT-N40-TCGAGTACTAAGCTATGTGTCGA-3',40.0,"50 mM Tris–HCl, 100 mM NaCl, 5 mM KCl, 1 mM MgCl2, and 0.01% Tween 20; pH 7.4",MgCl,Tris Buffers,7.4,Not applicable,"*pool not reported, determined from sequence reporting",None,None
ssDNA,GATGTGAGTGACGTGGATCGAGCGGATGTGAAGGCTGAAAGTGGCTTTGGGCGGTCGTAAGTGTCACAGAGCATGCAACAAGACC,85.0,0.5411764705882353,Kd: 23 ± 14.2 nM via direct ELONA,23.0,5'-GATGTGAGTGACGTGGATCGAG-N40-GTCACAGAGCATGCAACAAGACC-3',40.0,"50 mM Tris–HCl, 100 mM NaCl, 5 mM KCl, 1 mM MgCl2, and 0.01% Tween 20; pH 7.4",MgCl,Tris Buffers,7.4,Not applicable,"*pool not reported, determined from sequence reporting",None,None
ssDNA,ATCCAGAGTGACGCAGCAAACCCAAGCAAACTACCTCTATACCCTTCGACCTTCATCATGGACACGGTGGCTTAGT,76.0,0.5,Kd: 0.57 ± 0.13 nM via direct ELONA,0.57,5'-ATCCAGAGTGACGCAGCA-N40-TGGACACGGTGGCTTAGT-3',40.0,"50 mM Tris–HCl, 100 mM NaCl, 5 mM KCl, 1 mM MgCl2, and 0.01% Tween 20; pH 7.4",MgCl,Tris Buffers,7.4,Not applicable,"*pool not reported, determined from sequence reporting",None,None
ssDNA,ATCCAGAGTGACGCAGCACGTTTGGGCGGTATGAGTTCGGGGGTATACCGCAGTGGACACGGTGGCTTAGT,71.0,0.5774647887323944,Kd: 80.12 ± 7.01 based on fluorescence intensity,80.12,5′-ATCCAGAGTGACGCAGCA-N35-TGGACACGGTGGCTTAGT-3′,35.0,"PBS, pH 7.0 containing 1.4 mM MgCl2, 1 μg μL−1 BSA, and 1 μg μL−1 salmon sperm DNA",MgCl,PBS/phosphate buffers,7.0,Not applicable,utilized Spore-SELEX based on Cell-SELEX,None,None
ssDNA,ATCCAGAGTGACGCAGCACGTTTGGGCGGTATGAGTTCGGGGGTATACCGCAGTGGACACGGTGGCTTAGT,71.0,0.5774647887323944,Kd: 35.17 ± 12.11 based on fluorescence intensity,35.17,5′-ATCCAGAGTGACGCAGCA-N35-TGGACACGGTGGCTTAGT-3′,35.0,"PBS, pH 7.0 containing 1.4 mM MgCl2, 1 μg μL−1 BSA, and 1 μg μL−1 salmon sperm DNA",MgCl,PBS/phosphate buffers,7.0,Not applicable,utilized Spore-SELEX based on Cell-SELEX,None,None
ssDNA,ATCCAGAGTGACGCAGCACGTTTGGGCGGTATGAGTTCGGGGGTATACCGCAGTGGACACGGTGGCTTAGT,71.0,0.5774647887323944,Kd:101.19 ± 25.41 based on fluorescence intensity,101.19,5′-ATCCAGAGTGACGCAGCA-N35-TGGACACGGTGGCTTAGT-3′,35.0,"PBS, pH 7.0 containing 1.4 mM MgCl2, 1 μg μL−1 BSA, and 1 μg μL−1 salmon sperm DNA",MgCl,PBS/phosphate buffers,7.0,Not applicable,utilized Spore-SELEX based on Cell-SELEX,None,None
ssDNA,5′GCCTGTTGTGAGCCTCCTAACGCATCCACCGTGAATATTGTAACGCTATATGTGAGTGGCTAAGTGCACCCATGCTTATTCTTGTCTCCC3′,90.0,0.4888888888888889,Kd: 44.3 ± 13.3 nM,44.3,5′-GCCTGTTGTGAGCCTCCTAAC-N49-CATGCTTATTCTTGTCTCCC-3′,49.0,"Phosphate-buffered saline (PBS) 1X pH 7.4, with 1 mM of CaCl2·2H2O [Panreac] and 0.5 mM of MgCl2·6H2O [VWR]",MgCl/CaCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′GCCTGTTGTGAGCCTCCTAACATGTTGTTGCCGGGACGCCTCCTTCACCAAAGTTGGTGTCCCCACCTACCATGCTTATTCTTGTCTCCC3′,90.0,0.5444444444444444,Kd: 17.7 ± 2.7 nM,17.7,5′-GCCTGTTGTGAGCCTCCTAAC-N49-CATGCTTATTCTTGTCTCCC-3′,49.0,"Phosphate-buffered saline (PBS) 1X pH 7.4, with 1 mM of CaCl2·2H2O [Panreac] and 0.5 mM of MgCl2·6H2O [VWR]",MgCl/CaCl,PBS/phosphate buffers,7.4,Not applicable,None,None,MAPSAWAICWLLGGLLLHGGSSGPSPGPSVPRLRLSYRDLLSANRSAIFLGPQG...EAT
ssDNA,5′ACGCTCGGATGCCACTACAGGGAGGGGGGGGGAAAGTAAGCGGGGGGTCGGCGGCCTCATGGACGTGCTGGTGA3′,74.0,0.6756756756756757,Kd: 45.82 ± 5.01 nM,45.82,5′-ACGCTCGGATGCCACTACAG-N35-CTCATGGACGTGCTGGTGA-3′,35.0,"10 mM sodium phosphate, 0.15 M NaCl, pH7.5 (PBS), MgCl2 1 mM, BSA 0.2%",MgCl,PBS/phosphate buffers,7.5,Not applicable,None,None,MAPSAWAICWLLGGLLLHGGSSGPSPGPSVPRLRLSYRDLLSANRSAIFLGPQG...EAT
ssDNA,ACGCTCGGATGCCACTACAGGGACGGCGGATGGGGGCGGTGGGTGGGTTTCTTGCCTCATGGACGTGCTGGTGA3′,74.0,0.6486486486486487,Kd: 60.06 ± 7.05 nM,60.06,5′-ACGCTCGGATGCCACTACAG-N35-CTCATGGACGTGCTGGTGA-3′,35.0,"10 mM sodium phosphate, 0.15 M NaCl, pH7.5 (PBS), MgCl2 1 mM, BSA 0.2%",MgCl,PBS/phosphate buffers,7.5,Not applicable,None,None,None
ssDNA,ACGCTCGGATGCCACTACAGGTTGCGAGGTGGGGGGTGGGTAGGGTGGGAAGTGCCCTCATGGACGTGCTGGTGA,75.0,0.64,Kd: 128.8 ± 55.56 nM,128.8,5′-ACGCTCGGATGCCACTACAG-N35-CTCATGGACGTGCTGGTGA-3′,35.0,"10 mM sodium phosphate, 0.15 M NaCl, pH7.5 (PBS), MgCl2 1 mM, BSA 0.2%",MgCl,PBS/phosphate buffers,7.5,Not applicable,None,None,MPRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAKKEWKVGLPIGQGGFGCIYLA...VQK
ssDNA,5′AAGGAGCAGCGTGGAGGTTACCAGGAGGACCCTATTCTCGTGTATCGACGAGATCCAGTGACCACGACGACACACCCTAA3′,80.0,0.55,Kd: 19.3 ± 3.2 nM,19.3,5′-AAGGAGCAGCGTGGAGGTTA-N40-ACCACGACGACACACCCTAA-3′,40.0,"100 mM NaCl, 5 mM KCl, 50 mM Tris–HCl, and 1 mM MgCl2, pH 7.5",MgCl,Tris Buffers,7.5,Not applicable,None,None,None
ssDNA,GCCTGTTGTGAGCCTCCTAACCCGTAGGGTTAGGGGCGGATCGTCAGGGTGGATAAGGCAGGGAGACAAGAATAAGCA,78.0,0.5641025641025641,Kd: 6.62 × 10^-10 M - (didn't provide in nM),0.662,5'-GCCTGTTGTGAGCCTCCTAAC-N40-GGGAGACAAGAATAAGCA-3',40.0,PBS,None,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,5′ATAGGAGTCACGACGACCAGAATTTCGGGATGATGGTTTTATGGCCGCTTCGTATGTGCGTCTACCTCTTGACTAAT,77.0,0.4675324675324675,Kd: 21.3 ± 3.9 nM,21.3,5′-ATAGGAGTCACGACGACCAGAA-N30-TATGTGCGTCTACCTCTTGACTAAT-3',30.0,"50 mM Tris-HCl, 5 mM KCl, 100 mM NaCl, 1 mM MgCl2, pH 7.4",MgCl,Tris Buffers,7.4,Not applicable,None,None,None
ssDNA,ATAGGAGTCACGACGACCAGAAAGAGTGCTACAGCATGATGGTTTGGGCACCGTACCGAACGTATGTGCGTCTACCTCTTGACTAAT,87.0,0.4942528735632184,Kd: 12.0 ± 4.4 nM,12.0,5'-ATAGGAGTCACGACGACCAGAA-N40-TATGTGCGTCTACCTCTTGACTAAT-3',40.0,"50 mM Tris-HCl, 5 mM KCl, 100 mM NaCl, 1 mM MgCl2, pH 7.4",MgCl,Tris Buffers,7.4,Not applicable,None,None,MMDLQHGSLFLQTPKIVADKDYSVTANSKIVVVTAGVRQQEGESRLNLVQRNVN...KDL
ssDNA,ATAGGAGTCACGACGACCAGAAAGACTTCCGATAGGTTAGGGTTATAGAAAATGCAGGGGAGTAAAAAGAGCTATGTGCGTCTACCTCTTGACTAAT,97.0,0.4329896907216495,Kd: 10.2 ± 4.7 nM,10.2,5'-ATAGGAGTCACGACGACCAGAA-N50-TATGTGCGTCTACCTCTTGACTAAT-3',50.0,"50 mM Tris-HCl, 5 mM KCl, 100 mM NaCl, 1 mM MgCl2, pH 7.4",MgCl,Tris Buffers,7.4,Not applicable,None,None,MMDLQHGSLFLQTPKIVADKDYSVTANSKIVVVTAGVRQQEGESRLNLVQRNVN...KDL
ssDNA,ATAGGAGTCACGACGACCAGAAGCATGTGAGGAGAGAACAAATGAAGTGGCCTATGTGCGTCTACCTCTTGACTAAT,77.0,0.4675324675324675,Kd: 19.3 ± 6.2 nM,19.3,5'-ATAGGAGTCACGACGACCAGAA-N30-TATGTGCGTCTACCTCTTGACTAAT-3',30.0,"50 mM Tris-HCl, 5 mM KCl, 100 mM NaCl, 1 mM MgCl2, pH 7.4",MgCl,Tris Buffers,7.4,Not applicable,None,None,MMDLQHGSLFLQTPKIVADKDYSVTANSKIVVVTAGVRQQEGESRLNLVQRNVN...KDL
2'-fluoro-RNA,GGACUUGGAUAACCUCACCGCAAUGGCGGCUUGUCAGACGACUCGCUGAGGAUCCGAG,58.0,0.5862068965517241,Kd: 11.4 ± 3.0 nM (FV); Kd: 4.73 ± 0.69 nM (FVa),11.4,5'-GGGAGGACGAUGCGG-N40-CAGACGACUCGCUGAGGAUCCGAGA-3',40.0,"20 mM Hepes pH 7.4, 150 mM NaCl, 2 mM CaCl2",CaCl,Other Buffers,7.4,Not applicable,all C and U were 2'F modified,None,None
ssDNA,ATCCAGAGTGACGCAGCATCGCAACGATTAGTATGCACCCACCGTATAGGTTGGTCTCTGGACACGGTGGCTTAGT,76.0,0.5263157894736842,Kd: 1.22 ± 0.31 nM,1.22,5'ATCCAGAGTGACGCAGCA-N40-TGGACACGGTGGCTTAGT3',40.0,"1 L of DPBS with 4.5 g of glucose, 100 mg yeast tRNA, 1g BSA, and 5 ml of MgCl2 1M",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,ATCCAGAGTGACGCAGCATCGCAACGATTAGTATGCACCCACCGTATAGGTTGGTCTCTGGACACGGTGGCTTAGT,76.0,0.5263157894736842,Kd: 2.09 ± 0.29 nM,2.09,5'-ATCCAGAGTGACGCAGCA-N40-TGGACACGGTGGCTTAGT-3',40.0,"1 L of DPBS with 4.5 g of glucose, 100 mg yeast tRNA, 1g BSA, and 5 ml of MgCl2 1M",MgCl,PBS/phosphate buffers,7.4,Not applicable,None,None,None
ssDNA,CACGACGACAGAGACCACAGCACGTGGCCCACGTTAATCCGTTATAAGTCAAGCTCGATCCAGCAGCCAGAGACGAACA,79.0,0.5443037974683544,Kd: 89.41 ± 18 nM,89.41,5'-CACGACGACAGAGACCACAG-N40-CCAGCAGCCAGAGACGAACA-3',40.0,"50 mM Tris-HCl pH 7.0, 110 mM NaCl, 1 mM MgCl2",MgCl,Tris Buffers,7.0,Not applicable,None,None,None
ssDNA,CACGACGACAGAGACCACAGGGGGGCGTCAAGCGGGGTCACATCGGAGTAGGGAATCTTGCCAGCAGCCAGAGACGAACA,80.0,0.6125,Kd: 231.9 ± 15 nM,231.9,5'-CACGACGACAGAGACCACAG-N40-CCAGCAGCCAGAGACGAACA-3',40.0,"50 mM Tris-HCl pH 7.0, 110 mM NaCl, 1 mM MgCl2",MgCl,Tris Buffers,7.0,Not applicable,None,None,MFVFLVLLPLVSSQCVMPLFNLITTTQSYTNSFTRGVYYPDKVFRSSVLHLTQD...FEK
ssRNA,GACGCAACUGAAUGAAAUGGUGAAGGACGGGUCCAGGUGUGGCUGCUUCGGCAGUGCAGCUUGUUGAGUAGAGUGUGAGCUCCGUAACUAGUCGCGUC,98.0,0.5510204081632653,KD: 537 nM,537.0,5ʼ-ATACGCTCTAGAATTCAATT-N70-AGATAGCTCGAGCAATGC-3ʼ,70.0,"40 mM HEPES pH 7.4 (or 40 mM Bicine pH 8.0), 125 mM KCl, 5 mM MgCl2, and 5% DMSO",MgCl,Other Buffers,7.4,Truncation and mutagenesis of 24-2 (Spinach),Purified single stranded DNA library was then used in a PCR reaction to gently amplify the library and to create double stranded DNA templates for RNA in vitro synthesis.,None,None
ssRNA,GAGACGGUCGGGUCCAGAUAUUCGUAUCUGUCGAGUAGAGUGUGGGCUC,49.0,0.5510204081632653,KD: 360 nM,360.0,5'GAGACGCAACTGAATGAA-N26-CTGCTTCGGCAG-N26-TCCGTAACTAGTCGCGTCAC-3',26.0,"40 mM HEPES pH 7.4, 100 mM KCl, 1 mM MgCl2, and 0.1% DMSO.",MgCl,Other Buffers,7.4,"Truncation T2 region, mutation (Analysis revealed that most of the improved variants acquired mutations stabilizing this terminal stem-loop either by enhanced base-pairing or by introduction of the stable tetraloop GAAA.28 This suggests that specific terminal stem-loop sequences improve aptamer folding in vivo.
We decided to combine the mutations that shorten the aptamer while preserving its fluorescence. This generated 29-1-3-1. This aptamer exhibited similar overall colony fluorescence as 29-1","Modification of the Terminal Stem-Loop of Broccoli. Purified single stranded DNA library was then used in a PCR reaction to gently amplify the library and to create double stranded DNA templates for RNA in vitro synthesis.
The middle fixed region in pool indicates a fixed region which is predicted to form a stable tetraloop and which was previously shown to facilitate  the formation of structured aptamers during SELEX.
we created a library of 29-1-T2 mutants using a “doping” strategy similar to the mutagenesis approach originally described by Bartel et al.27 Briefly, a DNA library is synthesized so that each encoded aptamer resembles the parent aptamer, however every nucleotide has a certain and controlled probability of being converted into one of the other three nucleotides. Parent sequence (used as library) was 5'GAGACGGUCGGGUCCAGCACAAAAAUGUUGCUGUUGAGUAGAGUGUGGGCUC3'",None,None
2'-fluoro-RNA,-AUGGGGACUAUACCGCGUAAUGCUGCCUCCCCAU-,34.0,0.5588235294117647,Kd: 0.58 ± 0.1 nM,0.58,5′-GGGAGAGAGGAAGAGGGAUGGG-N40-CAUAACCCAGAGGUCGAU-3′,40.0,"20 mM HEPES, pH 7.4, 150 mM NaCl, 2 mM CaCl2, and 0.01% BSA",CaCl,Other Buffers,7.4,Truncation of 9.3,Starting library contained 2'-fluoropyrimidines (2′F cytidine triphosphate and uridine triphosphate),None,MQRVNMIMAESPGLITICLLGYLLSAECTVFLDHENANKILNRPKRYNSGKLEE...KLT
ssRNA,CGGAUGGAAGGCGUGGUUAGAAUCCAAUAGCCCAUCCG,38.0,0.5526315789473685,Kd: 135 ± 25 µM,135000.0,Not reported. The paper stated in vitro T7-transcription of a DNA template containing 50 randomized nucleotides flanked by two fixed 20-mer sequences,50.0,"320 mM NaCl, 50 mM Tris-HCI,  pH 7.5, and 5 mM MgCI, ",MgCl,Tris Buffers,7.5,"Truncation: A short 38-mer aptamer containing the two sequences was chemi_x0002_cally synthesized based upon the secondary structure model. This truncated version of the aptamer, termed D-Rl6c, contains the structural clements necessary for specific binding to arginine ","An RNA library with 10"" variants was generated by in vitro T7-transcription of a DNA template containing 50 randomized nucleotides flanked by two fixed 20-mer sequences for PCR amplification. The transcribed RNAs were selected on a o-arginine affinity column.",C(CC(C(=O)O)N)CN=C(N)N,None
ssRNA,CGGAUGGAAGGCGUGGUUAGAAUCCAAUAGCCCAUCCG,38.0,0.5526315789473685,Kd:  129 ± 18 µM,129000.0,Not reported. The paper stated in vitro T7-transcription of a DNA template containing 50 randomized nucleotides flanked by two fixed 20-mer sequences,50.0,"320 mM NaCl, 50 mM Tris-HCI,  pH 7.5, and 5 mM MgCI, ",MgCl,Tris Buffers,7.5,"Truncation: A short 38-mer aptamer containing the two sequences was chemi_x0002_cally synthesized based upon the secondary structure model. This truncated version of the aptamer, termed D-Rl6c, contains the structural clements necessary for specific binding to arginine ","An RNA library with 10"" variants was generated by in vitro T7-transcription of a DNA template containing 50 randomized nucleotides flanked by two fixed 20-mer sequences for PCR amplification. The transcribed RNAs were selected on a o-arginine affinity column.",C(CC(C(=O)O)N)CN=C(N)N,None
2'-fluoro-RNA,GGGAGGACGAUGCGGUGCCCACUAUGCGUGCCGAAAAACAUUUCCCCCUCUACCCCAGACGACUCGCGCGA,71.0,0.6197183098591549,Kd: 4 nM,4.0,5′-TCGCGCGAGTCGTCTG-40N-CCGCATCGTCCTCCC-3′,40.0,"Dulbecco's phosphate-buffered saline with MgCl2 and CaCl2 (Life Technologies, Inc.) and 0.05% bovine serum albumin",MgCl/CaCl,PBS/phosphate buffers,7.4,"Truncation: Family II aptamers E9P2-1 and E9P2-2 together represented 56% of the E9P2 pool. Thus, family II aptamers dominated the advanced pools and displayed high affinity for TN-C withKds of 1–10 × 10−9m.",DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection..,None,None
2'-fluoro-RNA,GGGCGGCUUUGCCAAGUGCUUGGGAGGACGAUGCGGAUCAGCCAUGUUUACGUCACUCCUAAGCAUUGGCAAAGCCGCCCUU,82.0,0.573170731707317,Kd: 2.9 nM,2.9,5′-TCGCGCGAGTCGTCTG-40N-CCGCATCGTCCTCCC-3′,40.0,"Dulbecco's phosphate-buffered saline with MgCl2 and CaCl2 (Life Technologies, Inc.) and 0.05% bovine serum albumin",MgCl/CaCl,PBS/phosphate buffers,7.4,"Truncation: To facilitate chemical synthesis, we reduced the aptamer portion of the A10-Plk1chimera from 71 (corresponding to original A10 aptamer)26 to 39 nucleotides (nt) (A10-3.2 aptamer)).","pool modified with 2′F-CTP, 2′F-UTP, ATP, GTP. DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection..

Many of the information was extracted from parent paper which may include pool type and binding buffer (https://pubmed.ncbi.nlm.nih.gov/11590140/)

The Kd is Relative affinity of A10 PSMA aptamer and truncated A10 aptamers to cells expressing PSMA.",None,None
2'-fluoro-RNA,GGGACCGAAAAAGACCUGACUUCUAUACUAAGUCUACGUUCCC,43.0,0.46511627906976744,Kd: 130,130.0,5′-GGGAGGACGAUGCGG-40N-CAGACGACUCGCCCGA-3',40.0,"HBSMCIT [HBSMC [HEPES buffered saline (pH 7.4), 1 mm MgCl2, and 1 mm CaCl2], 0.01% I-block (Tropix Inc., Bedford, MA), and 0.05% Tween 20]",MgCl/CaCl,Other Buffers,7.4,"RNA Turncation: To generate the A9 truncations, the sequence of full-length A9 as previously reported (Lupold et al., 2002) (5′-GGGAGGACGAUGCGGACCGAAAAAGACCUGACUUCUAUACUAAGUCUACGUUCCCAGACGACUCGCCCGA-3′) was loaded into the program RNAStructure 4.6 (MATHEWS, 2006; Mathews et al., 2007). Using a computer-guided “rational truncation” approach, bases were removed from the 5′ and 3′ ends such that the predicted secondary structure of the remaining oligonucleotide was as similar as possible to that of full-length A9. Where necessary, base changes were made at the 5′ and 3′ ends to maintain a 5′-GGG transcription start codon and a complementary 3′-CCC. To create the illustrations, the secondary structures were rendered with the program VARNA 3.7 (Darty et al., 2009).","A9 and A9g RNA aptamers inhibit PSMA NAALADase enzymatic activity with approximate IC50 values of 10 nM. PSMA, prostate-specific membrane antigen.
pool modified with 2′F-CTP, 2′F-UTP, ATP, GTP. DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection..
Many of the information was extracted from parent paper which may include pool type and binding buffer. (https://pubmed.ncbi.nlm.nih.gov/11590140/)",None,None
2'-fluoro-RNA,GGGACCGAAAAAGACCUGACUUCUAUACUAAGUCUACGUUCCC,43.0,0.46511627906976744,Kd: 5,5.0,5′-GGGAGGACGAUGCGG-40N-CAGACGACUCGCCCGA-3',40.0,"HBSMCIT [HBSMC [HEPES buffered saline (pH 7.4), 1 mm MgCl2, and 1 mm CaCl2], 0.01% I-block (Tropix Inc., Bedford, MA), and 0.05% Tween 20]",MgCl/CaCl,Other Buffers,7.4,"RNA Turncation: To generate the A9 truncations, the sequence of full-length A9 as previously reported (Lupold et al., 2002) (5′-GGGAGGACGAUGCGGACCGAAAAAGACCUGACUUCUAUACUAAGUCUACGUUCCCAGACGACUCGCCCGA-3′) was loaded into the program RNAStructure 4.6 (MATHEWS, 2006; Mathews et al., 2007). Using a computer-guided “rational truncation” approach, bases were removed from the 5′ and 3′ ends such that the predicted secondary structure of the remaining oligonucleotide was as similar as possible to that of full-length A9. Where necessary, base changes were made at the 5′ and 3′ ends to maintain a 5′-GGG transcription start codon and a complementary 3′-CCC. To create the illustrations, the secondary structures were rendered with the program VARNA 3.7 (Darty et al., 2009).","A9 and A9g RNA aptamers inhibit PSMA NAALADase enzymatic activity with approximate IC50 values of 10 nM. PSMA, prostate-specific membrane antigen.
pool modified with 2′F-CTP, 2′F-UTP, ATP, GTP. DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection..
Many of the information was extracted from parent paper which may include pool type and binding buffer. (https://pubmed.ncbi.nlm.nih.gov/11590140/)",None,None
2'-fluoro-RNA,GGGCCGAAAAAGACCUGACUUCUAUACUAAGUCUACGUCCC,41.0,0.4878048780487805,Kd ~ 130,130.0,5′-GGGAGGACGAUGCGG-40N-CAGACGACUCGCCCGA-3',40.0,"HBSMCIT [HBSMC [HEPES buffered saline (pH 7.4), 1 mm MgCl2, and 1 mm CaCl2], 0.01% I-block (Tropix Inc., Bedford, MA), and 0.05% Tween 20]",MgCl/CaCl,Other Buffers,7.4,"RNA Turncation: To generate the A9 truncations, the sequence of full-length A9 as previously reported (Lupold et al., 2002) (5′-GGGAGGACGAUGCGGACCGAAAAAGACCUGACUUCUAUACUAAGUCUACGUUCCCAGACGACUCGCCCGA-3′) was loaded into the program RNAStructure 4.6 (MATHEWS, 2006; Mathews et al., 2007). Using a computer-guided “rational truncation” approach, bases were removed from the 5′ and 3′ ends such that the predicted secondary structure of the remaining oligonucleotide was as similar as possible to that of full-length A9. Where necessary, base changes were made at the 5′ and 3′ ends to maintain a 5′-GGG transcription start codon and a complementary 3′-CCC. To create the illustrations, the secondary structures were rendered with the program VARNA 3.7 (Darty et al., 2009).

Based on the data just provided, we hypothesized that a further truncation of A9g which retains suridine at position 39 should result in an RNA aptamer with comparable PSMA inhibitory activity to A9g. To test this hypothesis, we removed the most distal G-C base-pair of A9g (A9L; 41 mer). We also introduced a base change at the first position to maintain the 5′-GGG T7 RNA polymerase transcription start (Fig. 5C; left panel). As predicted, A9L was equally as effective as A9g at inhibiting PSMA enzymatic activity (Fig. 5C; right panel). Elimination of additional bases from the 5′ or 3′ termini (eg, A9h; 37 mer) abrogated inhibition of PSMA enzymatic activity (Fig. 5C; right panel). These findings were consistent with altered folding of these shorter RNAs as predicted by using the RNA secondary structure prediction algorithm (RNAStructure 4.6) and loss of sequence elements (eg, U at position 39) required for function.","pool modified with 2′F-CTP, 2′F-UTP, ATP, GTP. DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection..
Many of the information was extracted from parent paper which may include pool type and binding buffer. (https://pubmed.ncbi.nlm.nih.gov/11590140/)",None,None
2'-fluoro-RNA,GGGCCGAAAAAGACCUGACUUCUAUACUAAGUCUACGUCCC,41.0,0.4878048780487805,Kd ~ 5,5.0,5′-GGGAGGACGAUGCGG-40N-CAGACGACUCGCCCGA-3',40.0,"HBSMCIT [HBSMC [HEPES buffered saline (pH 7.4), 1 mm MgCl2, and 1 mm CaCl2], 0.01% I-block (Tropix Inc., Bedford, MA), and 0.05% Tween 20]",MgCl/CaCl,Other Buffers,7.4,"RNA Turncation: To generate the A9 truncations, the sequence of full-length A9 as previously reported (Lupold et al., 2002) (5′-GGGAGGACGAUGCGGACCGAAAAAGACCUGACUUCUAUACUAAGUCUACGUUCCCAGACGACUCGCCCGA-3′) was loaded into the program RNAStructure 4.6 (MATHEWS, 2006; Mathews et al., 2007). Using a computer-guided “rational truncation” approach, bases were removed from the 5′ and 3′ ends such that the predicted secondary structure of the remaining oligonucleotide was as similar as possible to that of full-length A9. Where necessary, base changes were made at the 5′ and 3′ ends to maintain a 5′-GGG transcription start codon and a complementary 3′-CCC. To create the illustrations, the secondary structures were rendered with the program VARNA 3.7 (Darty et al., 2009).

Based on the data just provided, we hypothesized that a further truncation of A9g which retains suridine at position 39 should result in an RNA aptamer with comparable PSMA inhibitory activity to A9g. To test this hypothesis, we removed the most distal G-C base-pair of A9g (A9L; 41 mer). We also introduced a base change at the first position to maintain the 5′-GGG T7 RNA polymerase transcription start (Fig. 5C; left panel). As predicted, A9L was equally as effective as A9g at inhibiting PSMA enzymatic activity (Fig. 5C; right panel). Elimination of additional bases from the 5′ or 3′ termini (eg, A9h; 37 mer) abrogated inhibition of PSMA enzymatic activity (Fig. 5C; right panel). These findings were consistent with altered folding of these shorter RNAs as predicted by using the RNA secondary structure prediction algorithm (RNAStructure 4.6) and loss of sequence elements (eg, U at position 39) required for function.","pool modified with 2′F-CTP, 2′F-UTP, ATP, GTP. DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection..
Many of the information was extracted from parent paper which may include pool type and binding buffer.",None,None
2'-fluoro-RNA,GGGAGGACGAUGCGGAUCAGCCAUGUUUACGUCACUCCU,39.0,0.5641025641025641,Kd: 2.9 nM,2.9,5′-TCGCGCGAGTCGTCTG-40N-CCGCATCGTCCTCCC-3′,40.0,"Dulbecco's phosphate-buffered saline with MgCl2 and CaCl2 (Life Technologies, Inc.) and 0.05% bovine serum albumin",MgCl/CaCl,PBS/phosphate buffers,7.4,"Truncation: To facilitate chemical synthesis, we reduced the aptamer portion of the A10-Plk1chimera from 71 (corresponding to original A10 aptamer)26 to 39 nucleotides (nt) (A10-3.2 aptamer)).","pool modified with 2′F-CTP, 2′F-UTP, ATP, GTP. DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection..

Many of the information was extracted from parent paper which may include pool type and binding buffer (https://pubmed.ncbi.nlm.nih.gov/11590140/)

The Kd is Relative affinity of A10 PSMA aptamer and truncated A10 aptamers to cells expressing PSMA.",None,None
2'-fluoro-RNA,5′AGCCGCGAGGGGAGGGAUAGGGUAGGGCGCGGCU3′,34.0,0.7352941176470589,Kd: 3.49 ± 1.3,3.49,5'-CGGAATTCGTAATACGACTCACTATAGGGACGCGTGGTACC-N50-AAGCTTCCGCGGGGATCCAA3',50.0,"20 mM HEPES (pH 7.0), 150 mM NaCl, 1 mM MgCl2, 2 mM dithiothreitol, and 40 U RNase inhibitor",MgCl,Other Buffers,7.0,"Truncation: ""SE15-8 truncated mini RNA aptamer (Mini).""","The 2′-fluorine-modified RNA (2′ FY-RNA) library consisted of T7 in vitro transcription with the random DNA libraries (1.0 × 1014 molecules) and modified NTPs (Epicentre, Madison, WI)
DNA library/pool was used as a template to generate the RNA pool used in the selection. A T7 promoter sequence might be necessary to use this DNA library/pool as a template to generate the RNA pool in the selection..
",None,None
ssDNA,ATCTAACTGCTGCGCCGCCGGGAAAATACTGTACGGTTAGA,41.0,0.5121951219512195,Kd:0.8 nM,0.8,5'-ATACCAGCTTATTCAATT-52N-AGATAGTAAGTGCAATCT-3',52.0,4.5 g/liter glucose and 5 mM MgCl2 in Dulbecco's PBS with calcium chloride and magnesium chloride (Sigma) and adding yeast tRNA (0.1 mg/ml; Sigma) and BSA (1 mg/ml; Fisher),MgCl,PBS/phosphate buffers,7.4,"Truncation: ""An optimized and truncated DNA sequence of sgc8, sgc8c, which had identical binding properties as sgc815 and which had previously been labeled with a biotin tag at the 5′-end, was incubated with the solubilized membrane proteins. The binding complex of sgc8 and its target was then extracted using streptavidin-coated magnetic beads.""","Pool information and binding buffer obtained from 2006 paper (https://doi.org/10.1073/pnas.0602615103)

more information on this aptamer in this paper (https://pubmed.ncbi.nlm.nih.gov/21168488/)",None,None
5-uracil-modified-DNA,"5’GCCTGUAUCCGCAGUAUCGGCAUUCAGCGAC3’


",31.0,0.5806451612903226,Kd: 2.85 nM via filter binding assay,2.85,5′-TATGAGTGACCGTCCGCCTG-N40-CAGCCACACCACCAGCCAAA-3,40.0,"40 mM HEPES (pH 7.5), 102 mM NaCl, 5 mM KCl, 5 mM MgCl2, and 0.05% Tween-20",MgCl,Other Buffers,7.5,This is the truncated form of the full length IR-A43F (100-00-1355) aptamer sequence.,Modified nucleobase 5-[N-(1-naphthylmethyl)carboxamide]-2′-deoxyuridine (Nap-dU) was used in this sequence,None,None
